Sentence,class,file
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 345 VSP and 3D printing in prosthetic orbital reconstruction  9.,Non-OADS,/arxiv_data1/oa_pdf/ec/44/imcrj-9-341.PMC5098757.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fc/d2/imcrj-9-337.PMC5098758.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fc/d2/imcrj-9-337.PMC5098758.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 337–340International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 337 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S119347Retropupilar positioning of foldable iris-claw  intraocular lens for correction of aphakia with no  capsular support Mun Yueh Faria1–3  Nuno Pinto Ferreira1–3  Ivo Gama1–3  Joana Medeiros Pinto1–4  Mario Canastro1–3  Manuel Monteiro Grillo1–3 1Hospital Santa Maria, Ophthalmology  Department, 2Vision Study Center,   University of Lisbon, 3Faculty of  Medicine, University of Lisbon, Lisbon,    4Hospital Divino Espirito Santo, Ponta  Delgada, PortugalSummary:  Iris-claw intraocular lens (ICIOL) for aphakia needs a large 5.4 mm corneal incision  for its implantation.",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/imcrj-9-337.PMC5098758.pdf
"2Correspondence: Mun Yueh Faria Ophthalmology Department, Hospital de Santa Maria, Avenida Professor Egas Moniz 1649-035 Lisboa, PortugalEmail munfaria1@gmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Faria et alRunning head recto: Foldable iris claw for aphakiaDOI: http://dx.doi.org/10.2147/IMCRJ.S119347 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/imcrj-9-337.PMC5098758.pdf
Or use: http://youtu.be/rs1XmVr57dE,Non-OADS,/arxiv_data1/oa_pdf/fc/d2/imcrj-9-337.PMC5098758.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/imcrj-9-337.PMC5098758.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 340 Faria et al aphakic eye without capsular support, avoiding large corneal  incisions and further postoperative complications.",Non-OADS,/arxiv_data1/oa_pdf/fc/d2/imcrj-9-337.PMC5098758.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/09/9a/imcrj-9-347.PMC5098759.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/09/9a/imcrj-9-347.PMC5098759.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 347–351International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 347 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S114710Proximal femoral fracture surgery in a patient  with osteopetrosis tarda: complications and  treatment strategy Fırat Seyfettinoglu Ümit T uhanio ğlu Hasan Ulas OgurHakan Cicek Department of Trauma and  Orthopedics, Adana Numune Training  and Educational  Hospital,  Adana, T urkeyAbstract:  Osteopetrosis is a rare, inherited disease characterized by defects in osteoclastic  function that results in defective bone resorption.",Non-OADS,/arxiv_data1/oa_pdf/09/9a/imcrj-9-347.PMC5098759.pdf
"From Correspondence: Fırat Seyfettinoglu Department of Trauma and Orthopedics Adana, Numune Training and Educational Hospital, Serinevler mah, Ege Bagtur Bulvarı, Yüreğir/Adana, TurkeyTel +90 532 716 9721Fax +90 322 355 0155Email firatseyf@yahoo.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Seyfettinoglu et alRunning head recto: Proximal femoral fracture surgery in a patient with osteopetrosisDOI: http://dx.doi.org/10.2147/IMCRJ.S114710",Non-OADS,/arxiv_data1/oa_pdf/09/9a/imcrj-9-347.PMC5098759.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/09/9a/imcrj-9-347.PMC5098759.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 351 Proximal femoral fracture surgery in a patient with osteopetrosis the antimicrobial treatment was terminated, the infection was  seen to flare up again.",Non-OADS,/arxiv_data1/oa_pdf/09/9a/imcrj-9-347.PMC5098759.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cb/cd/oarrr-8-045.PMC5098760.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Open Access Rheumatology: Research and Reviews 2016:8 45–49Open Access Rheumatology: Research and Reviews Dove press submit your manuscript | www.dovepress.co m Dove press  45ORiginAl ReseARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S10191 1Polymyalgia rheumatica: observations of disease  evolution without corticosteroid treatment Arthur e Brawer Division of Rheumatology,   Department of Medicine, Monmouth  Medical center, long Branch, nJ, UsA correspondence: Arthur e Brawer   Division of Rheumatology, Department  of Medicine, Monmouth Medical center,  300 second Avenue, long Branch,  nJ 07740, UsA   T el +1 732 870 3133   Fax +1 732 222 0824   email arthurbrawer@optimum.ne tObjectives:  The diagnostic diversity of polymyalgia rheumatica (PMR) can easily be obscured  by the widespread use of corticosteroids (CSs) early in the disease course.",Non-OADS,/arxiv_data1/oa_pdf/cb/cd/oarrr-8-045.PMC5098760.pdf
"Open Access Rheumatology Research and Reviews Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-rheumatology-research-and-reviews-journa lOpen Access Rheumatology Research and Reviews is an international,  peer-reviewed, open access journal, publishing all aspects of clinical  and experimental rheumatology in the clinic and laboratory including  the following topics: Pathology, pathophysiology of rheumatological  diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacological approaches for the  treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/cb/cd/oarrr-8-045.PMC5098760.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/cd/oarrr-8-045.PMC5098760.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c4/1d/oarrr-8-051.PMC5098761.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/c4/1d/oarrr-8-051.PMC5098761.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Open Access Rheumatology: Research and Reviews 2016:8 51–59Open Access Rheumatology: Research and Reviews Dove press submit your manuscript | www.dovepress.co m Dove press  51Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S8731 2Rheumatoid arthritis in patients with Hiv:  management challenges Matthew B Carroll Joshua H Fields Philip G Clerc Department of Rheumatology, Keesler  Medical Center, Keesler Air Force  Base, Biloxi, MS, USA Correspondence: Matthew B Carroll   Keesler Medical Center, 301 Fisher  Avenue, Keesler Air Force Base, Biloxi,  MS 39534, USA   T el +1 228 376 3629   Fax +1 228 376 0184   email matthew.carroll.1@us.af.mi lAbstract:  Over the past few decades, HIV has been transformed from a once-uniformly fatal  disease to now a manageable but complex multisystem illness.",Non-OADS,/arxiv_data1/oa_pdf/c4/1d/oarrr-8-051.PMC5098761.pdf
"Available from: https://actgnetwork.org/study/ a5314-mtx-hiv-positive s. Accessed August 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c4/1d/oarrr-8-051.PMC5098761.pdf
"Open Access Rheumatology Research and Reviews Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-rheumatology-research-and-reviews-journa lOpen Access Rheumatology Research and Reviews is an international,  peer-reviewed, open access journal, publishing all aspects of clinical  and experimental rheumatology in the clinic and laboratory including  the following topics: Pathology, pathophysiology of rheumatological  diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacological approaches for the  treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c4/1d/oarrr-8-051.PMC5098761.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/1d/oarrr-8-051.PMC5098761.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/80/e0/oaem-8-087.PMC5098762.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/80/e0/oaem-8-087.PMC5098762.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Emergency Medicine 2016:8 87–95Open Access Emergency Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 87 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S103912 Pulmonary embolism: new treatments for an old  problem John Ryan Emergency Department, St Vincent’s  University Hospital, Dublin, IrelandAbstract:  Nonvitamin K antagonist oral anticoagulants, previously referred to as novel oral  anticoagulants, have emerged in recent years as attractive treatment options for acute pulmonary  embolism (PE).",Non-OADS,/arxiv_data1/oa_pdf/80/e0/oaem-8-087.PMC5098762.pdf
"9,10 The NOACs are  characterized by convenient oral administration, fixed dosing regimens, a fast onset of action, minimal drug–drug interactions, no dietary restrictions, and no  requirement Correspondence: John Ryan   Emergency Department, St Vincent’s  University Hospital, Elm Park, Merrion Road, Dublin 4, Ireland   Tel +353 1 221 3815   Fax +353 1 221 4908   Email J.Ryan@svuh.ieJournal name: Open Access Emergency Medicine Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: RyanRunning head recto: New treatments for pulmonary embolismDOI: http://dx.doi.org/10.2147/OAEM.S103912",Non-OADS,/arxiv_data1/oa_pdf/80/e0/oaem-8-087.PMC5098762.pdf
Available from: http://www.nice.org.uk/guidance/TA287.,Non-OADS,/arxiv_data1/oa_pdf/80/e0/oaem-8-087.PMC5098762.pdf
Available from: http://www.nice.org.uk/guidance/ta341.,Non-OADS,/arxiv_data1/oa_pdf/80/e0/oaem-8-087.PMC5098762.pdf
Available from: http://www.nice.org.uk/guidance/ta327.,Non-OADS,/arxiv_data1/oa_pdf/80/e0/oaem-8-087.PMC5098762.pdf
Available from: http://www.nice.org.uk/guidance/ta354.,Non-OADS,/arxiv_data1/oa_pdf/80/e0/oaem-8-087.PMC5098762.pdf
"Open Access Emergency Medicine 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-emergency-medicine-journalThe Open Access Emergency Medicine is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/80/e0/oaem-8-087.PMC5098762.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 95 New treatments for pulmonary embolism  25.,Non-OADS,/arxiv_data1/oa_pdf/80/e0/oaem-8-087.PMC5098762.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/89/98/oaem-8-097.PMC5098763.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/89/98/oaem-8-097.PMC5098763.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Emergency Medicine 2016:8 97–101Open Access Emergency Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 97 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S117687 Isolated oculomotor nerve palsy resulting from  acute traumatic tentorial subdural hematoma Victoria Cui1 Timur Kouliev2 1Washington University School  of Medicine, St Louis, MO, USA;   2Emergency Department, Beijing  United Family Hospital, Beijing, ChinaAbstract:  Acute subdural hematoma (SDH) resulting from head trauma is a potentially life- threatening condition that requires expedient diagnosis and intervention to ensure optimal  patient outcomes.",Non-OADS,/arxiv_data1/oa_pdf/89/98/oaem-8-097.PMC5098763.pdf
"In tentorial SDH, the hematoma origi-nates on the surface of the tentorium cerebelli, an extension of dura mater separating Correspondence: Victoria Cui 6401 Deer Hollow Lane, Austin, TX 78750, USATel +1 512 289 3718Email cui.victoria@wustl.eduJournal name: Open Access Emergency Medicine Article Designation: CASE REPORTY ear: 2016V olume: 8Running head verso: Cui and KoulievRunning head recto: Isolated oculomotor nerve palsy and acute subdural hematomaDOI: http://dx.doi.org/10.2147/OAEM.S117687",Non-OADS,/arxiv_data1/oa_pdf/89/98/oaem-8-097.PMC5098763.pdf
"Open Access Emergency Medicine 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-emergency-medicine-journalThe Open Access Emergency Medicine is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/89/98/oaem-8-097.PMC5098763.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 101 Isolated oculomotor nerve palsy and acute subdural hematoma  9.,Non-OADS,/arxiv_data1/oa_pdf/89/98/oaem-8-097.PMC5098763.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/eb/a8/oajsm-7-143.PMC5098764.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/eb/a8/oajsm-7-143.PMC5098764.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2016:7 143–151Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 143 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S108126Radial extracorporeal shockwave therapy for the  treatment of finger tenosynovitis (trigger digit) Nikos Malliaropoulos1–5 Rosanna Jury1,2,5 Debasish Pyne3–5 Nat Padhiar3,5 Jennifer T urner6 Vasileios Korakakis3,7 Maria Meke1  Heinz Lohrer3,8 1Sports and Exercise Medicine,   Thessaloniki Musculoskeletal Clinic,   2Thessaloniki National Track and  Field Centre, Sports Medicine Clinic  of S.E.G.A.S., Thessaloniki, Greece;   3European Sports Care, 4Department  of Rheumatology, Sports Clinic,  Barts Health NHS Trust,  5Centre  for Sports & Exercise Medicine,  Queen Mary University of London,  London, UK;  6Healthcare Group  Guernsey, Guernsey; 7Aspetar,   Orthopaedic and Sports Medicine Hospital, Doha, Qatar;  8European  SportsCare Network (ESN), Zentrum für Sportorthopädie, Wiesbaden-Nordenstadt, GermanyIntroduction: Stenosing tenosynovitis that is characterized by the inability to flex the digit  smoothly, usually leads to prolonged rehabilitation or surgery.",Non-OADS,/arxiv_data1/oa_pdf/eb/a8/oajsm-7-143.PMC5098764.pdf
"5 It is the most common flexor tendinopathy,2 with  highest incidence in women (75%) and in those aged between 52 and 62 years,6 with  the fourth digit (ring finger) and thumb most often affected.3 Trigger digits are usually idiopathic; however, some authors argue that there is  a possible correlation with excessive use of the hand.7,8 Other potential risk factors Correspondence: Rosanna Jury Centre for Sports & Exercise Medicine, Queen Mary University of London, Bancroft Road, London E1 4DG, UKTel +44 79 6907 0470Email rj6g10@soton.ac.ukJournal name: Open Access Journal of Sports Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Malliaropoulos et alRunning head recto: Effect of rESWT on stenosing tenosynovitis treatmentDOI: http://dx.doi.org/10.2147/OAJSM.S108126",Non-OADS,/arxiv_data1/oa_pdf/eb/a8/oajsm-7-143.PMC5098764.pdf
Available from: http://www.guideline.gov/content.aspx?id=34435.,Non-OADS,/arxiv_data1/oa_pdf/eb/a8/oajsm-7-143.PMC5098764.pdf
"Open Access Journal of Sports Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/eb/a8/oajsm-7-143.PMC5098764.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/a8/oajsm-7-143.PMC5098764.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5a/73/oarrr-8-017.PMC5098765.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/5a/73/oarrr-8-017.PMC5098765.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Open Access Rheumatology: Research and Reviews 2016:8 17–22Open Access Rheumatology: Research and Reviews Dove press submit your manuscript | www.dovepress.co m Dove press  17Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S8394 8Adult-onset Still’s disease: current challenges and  future prospects Mariam Siddiqui1 Michael S Putman2 Anisha B Dua1 1Department of Rheumatology,   2Department of internal Medicine, The  University of Chicago Medical Center,   Chicago, iL, USA Correspondence: Anisha B Dua   Department of Rheumatology,   The University of Chicago Medical  Center, 5841 S Maryland Avenue,  MC0930, Chicago, iL 60637, USA   T el +1 773 702 6119   Fax +1 773 834 7065   email adua@uchicago.ed uAbstract:  Adult-onset Still’ s disease (AOSD) – a multi-systemic inflammatory condition  characterized by high fevers, polyarthritis, an evanescent rash, and pharyngitis – has been a  challenging condition to diagnose expediently and treat effectively.",Non-OADS,/arxiv_data1/oa_pdf/5a/73/oarrr-8-017.PMC5098765.pdf
"Open Access Rheumatology Research and Reviews Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-rheumatology-research-and-reviews-journa lOpen Access Rheumatology Research and Reviews is an international,  peer-reviewed, open access journal, publishing all aspects of clinical  and experimental rheumatology in the clinic and laboratory including  the following topics: Pathology, pathophysiology of rheumatological  diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacological approaches for the  treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5a/73/oarrr-8-017.PMC5098765.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/73/oarrr-8-017.PMC5098765.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02204293  NLM Identifier NCT 0220429 3.,Non-OADS,/arxiv_data1/oa_pdf/5a/73/oarrr-8-017.PMC5098765.pdf
Available  from: https://clinicaltrials.gov/ct2/show/NCT02398435 NLM Identifier  NCT NCT0239843 5.,Non-OADS,/arxiv_data1/oa_pdf/5a/73/oarrr-8-017.PMC5098765.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/fb/oarrr-8-001.PMC5098766.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Rheumatology: Research and Reviews 2016:8 1–16Open Access Rheumatology: Research and Reviews Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S8167 3A systematic review to evaluate exercise  for anterior cruciate ligament injuries: does  this approach reduce the incidence of knee  osteoarthritis?,Non-OADS,/arxiv_data1/oa_pdf/b5/fb/oarrr-8-001.PMC5098766.pdf
"Open Access Rheumatology Research and Reviews Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-rheumatology-research-and-reviews-journa lOpen Access Rheumatology Research and Reviews is an international,  peer-reviewed, open access journal, publishing all aspects of clinical  and experimental rheumatology in the clinic and laboratory including  the following topics: Pathology, pathophysiology of rheumatological  diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacological approaches for the  treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b5/fb/oarrr-8-001.PMC5098766.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/fb/oarrr-8-001.PMC5098766.pdf
Available from:  http://www.pedro.org.au/english/downloads /.,Non-OADS,/arxiv_data1/oa_pdf/b5/fb/oarrr-8-001.PMC5098766.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2a/0c/oarrr-8-037.PMC5098767.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Open Access Rheumatology: Research and Reviews 2016:8 37–44submit your manuscript | www.dovepress.co m Dove press  37 http: //dx.doi.org/10.2147/OARRR.S5683 7An evidence-based review of certolizumab pegol  in the treatment of active psoriatic arthritis: place  in therapy María Laura Acosta-Felquer Javier Rosa enrique R Soriano Rheumatology Unit, internal Medical  Services, and University institute,   Hospital italiano de Buenos Aires,   Buenos Aires, Argentina Correspondence: enrique R Soriano   Rheumatology Unit, internal Medical  Services, and University institute, Hospital  italiano de Buenos Aires, Juan D. Perón  4190 (C1181ACH),   Buenos Aires,  Argentina   T el + 54 11 4959 0200 ext 5443   Fax +54 11 4959 0378   email enrique.soriano@hospitalitaliano.",Non-OADS,/arxiv_data1/oa_pdf/2a/0c/oarrr-8-037.PMC5098767.pdf
"Open Access Rheumatology Research and Reviews Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-rheumatology-research-and-reviews-journa lOpen Access Rheumatology Research and Reviews is an international,  peer-reviewed, open access journal, publishing all aspects of clinical  and experimental rheumatology in the clinic and laboratory including  the following topics: Pathology, pathophysiology of rheumatological  diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacological approaches for the  treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/2a/0c/oarrr-8-037.PMC5098767.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/0c/oarrr-8-037.PMC5098767.pdf
"Available from:  http://www.remicade.com/shared/product/remicade/prescribing- information.pd f. Accessed March 10, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2a/0c/oarrr-8-037.PMC5098767.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Open Access Rheumatology: Research and Reviews 2016:8 23–36submit your manuscript | www.dovepress.co m Dove press  23 http: //dx.doi.org/10.2147/OARRR.S8534 0Management of rheumatoid arthritis during  pregnancy: challenges and solutions Megan L Krause Ashima Makol Division of Rheumatology,   Department of internal Medicine,   Mayo Clinic, MN, USA Correspondence: Ashima Makol   Division of Rheumatology, Department of  internal Medicine, Mayo Clinic,   200 First Street Southwest, Rochester,  MN 55905, USA   T el +1 507 284 1625   Fax +1 507 284 0564   email makol.ashima@mayo.ed uAbstract:  Rheumatoid arthritis, a chronic inflammatory autoimmune disease with significant  physical disability, affects women three times more frequently than men, often in their childbear - ing years.",Non-OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
"Available  from: https://www.federalregister.gov/articles/2014/12/04/2014-28241/ content-and-format-of-labeling-for-human-prescription-drug-and- biological-products-requirements-fo r. Accessed October 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
Available from: http://www.pfizer.,Non-OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
Available from: http://www.simponi.,Non-OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
Available from: http://www.remicade.,Non-OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
"2014. http://www.gene.com/download/pdf/ rituxan_prescribing.pd f. Accessed August 2, 2015.",OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
Available from: http://www.xeljanz.,Non-OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
"A vailable from: http://toxnet.nlm.nih.gov/newtoxnet/   lactmed.ht m. Accessed June 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
"Open Access Rheumatology Research and Reviews Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-rheumatology-research-and-reviews-journa lOpen Access Rheumatology Research and Reviews is an international,  peer-reviewed, open access journal, publishing all aspects of clinical  and experimental rheumatology in the clinic and laboratory including  the following topics: Pathology, pathophysiology of rheumatological  diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacological approaches for the  treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/ cfCFR/CFRSearch.cfm?fr =201.5 7.,OADS,/arxiv_data1/oa_pdf/01/02/oarrr-8-023.PMC5098768.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/ndt-12-2839.PMC5098769.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2839–2841Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2839Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11924 7 Vertebral artery dissection with compelling  evidence on duplex ultrasound presenting  only with neck pain Timo siepmann Monique Borchert Kristian Barlinn Department of Neurology, Carl  Gustav Carus University Hospital,   T echnische Universität Dresden,   Dresden, GermanyAbstract:  Vertebral artery dissection (VAD) is among the most common identifiable etiologies  of stroke in young adults and poses a diagnostic challenge due to nonspecific symptoms and  substantial variability of imaging results.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/ndt-12-2839.PMC5098769.pdf
"Neither physical  examination nor medical and family history revealed any indications of connective Correspondence: Timo siepmann Department of Neurology, Carl Gustav  Carus University Hospital, Technische  Universität Dresden, Fetscherstrasse 74,  01307 Dresden, Germany Tel +49 351458 3565 Fax +49 351458 4365 email timo.siepmann@uniklinikum- dresden.d e Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Siepmann et al Running head recto: Vertebral artery dissection DOI: http://dx.doi.org/10.2147/NDT.S119247",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/ndt-12-2839.PMC5098769.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a6/dc/ndt-12-2839.PMC5098769.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/dc/ndt-12-2839.PMC5098769.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9a/9d/ndt-12-2827.PMC5098770.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2827–2837Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2827OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11511 6 effect of Yi-nao-jie-yu decoction on  γ-aminobutyric acid type a receptor in the  hippocampus and serum inflammatory factors  in a rat model of poststroke anxiety Wen Zhang1 ruizhen Zhao1 Xiaoli li1 Xia cui1 Zijun Zhao1 Yingqiu Mao2 Fengzhi Wu3 Qisheng Tang1 1Department of encephalopathy, The  Third affiliated hospital, 2center  of scientific research, 3center of  Journals, Beijing University of chinese  Medicine, chaoyang District, Beijing,   People’s republic of chinaBackground:  The Yi-nao-jie-yu decoction (YNJYD) is a herbal preparation widely used in  the clinics of traditional Chinese medicine and has been recently used as an important new  therapeutic agent in poststroke anxiety (PSA).",Non-OADS,/arxiv_data1/oa_pdf/9a/9d/ndt-12-2827.PMC5098770.pdf
"correspondence: Qisheng Tang Department of encephalopathy, The  Third Affiliated Hospital, Beijing  University of chinese Medicine,  No 51 anwai Xiaoguan, chaoyang  District, Beijing 100029, People’s  republic of china Tel +86 10 5207 5206 email tangqishengbucm@126.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Zhang et al Running head recto: Anti-poststroke anxiety effects of YNJYD DOI: http://dx.doi.org/10.2147/NDT.S115116",Non-OADS,/arxiv_data1/oa_pdf/9a/9d/ndt-12-2827.PMC5098770.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/9a/9d/ndt-12-2827.PMC5098770.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/9d/ndt-12-2827.PMC5098770.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d2/b5/ndt-12-2869.PMC5098771.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2869–2874Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2869OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11354 9 The reduction of csF tumor necrosis factor  alpha levels in schizophrenia: no correlations  with psychopathology and coincident metabolic  characteristics haibing Zhu1 Danfeng Wang2 Xiuqin liu3 1Department of Psychiatry, Panyu  central hospital, 2Department of  Psychiatry, guangzhou Psychiatric  hospital, 3Department of Nuclear  Medicine, The First affiliated hospital,   sun Yat-sen University, guangzhou,   guangdong, People’s republic  of chinaAim:  The aim of this study was to assess whether tumor necrosis factor alpha (TNF- α) levels  are correlated with the behavioral syndrome of schizophrenia and/or metabolic abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/d2/b5/ndt-12-2869.PMC5098771.pdf
"Indeed, cytok - ines display immunological, neurochemical, and neuroendocrine activities that impact correspondence: haibing Zhu Department of Psychiatry, Panyu central  hospital, 8 east Fuyu road, south Bridge  street, Panyu district, guangzhou 511400,  guangdong, People’s republic of china Tel +86 20 3485 9898 Fax +86 20 3485 9898 email zhb-ck@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Zhu et al Running head recto: CSF TNF- α levels in schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S113549",Non-OADS,/arxiv_data1/oa_pdf/d2/b5/ndt-12-2869.PMC5098771.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d2/b5/ndt-12-2869.PMC5098771.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/b5/ndt-12-2869.PMC5098771.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/2c/ndt-12-2843.PMC5098772.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2843–2849Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2843OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11625 7 effects of multiple training modalities in patients  with alzheimer’s disease: a pilot study shu-Yu Tai1–4 chia-ling hsu5 shu-Wan huang5 Tzu-chiao Ma6,7 Wen-chien hsieh8,9 Yuan-han Yang5,7,10,11 1Department of Family Medicine,  Kaohsiung Municipal Ta-T ung hospital,  Kaohsiung Medical University,  2Department of Family Medicine,  Kaohsiung Medical University  hospital, Kaohsiung Medical  University, 3Department of Family  Medicine, school of Medicine, college  of Medicine, Kaohsiung Medical  University, 4research center for  environmental Medicine, Kaohsiung  Medical University, 5Department  of Neurology, Kaohsiung Municipal  Ta-T ung hospital, Kaohsiung Medical  University, 6graduate institute of  Oral health sciences, Kaohsiung  Medical University, 7Mentality  Protection center, Fo guang shan  compassion Foundation, 8Department  of social Work, Kaohsiung Municipal  Ta-T ung hospital, Kaohsiung Medical  University, 9Department of sociology  and social Work, Kaohsiung Medical  University, 10Department of Neurology,  Kaohsiung Medical University hospital,  Kaohsiung Medical University,  11Department of and Master’s Program  in Neurology, Faculty of Medicine,  Kaohsiung Medical University,  Kaohsiung city, TaiwanObjective:  This pilot study investigated the effects of multiple training modalities on cognition,  neuropsychiatric symptoms, caregivers’ burden, and quality of life in patients with Alzheimer’s  disease (AD).",Non-OADS,/arxiv_data1/oa_pdf/f3/2c/ndt-12-2843.PMC5098772.pdf
"Keywords:  multiple training modalities, Alzheimer’s disease, quality of life, cognitive func - tion, caregivers’ burden Introduction The rapid increase in the elderly population ( $65 years) has become a challenging medical  problem in developed countries.1,2 The proportion of elderly people in the total popula - tion of Taiwan has risen continually over the past 3 decades from 4.1% in 1980 to 11.5%  in 2013; this is the highest rate of aging worldwide.3 Dementia is a major public health  problem related to the aging population in developed countries, and Alzheimer’s disease  (AD), a chronic neurodegenerative disease that usually starts slowly and worsens over  time, accounts for 60%–70% of dementia cases.4,5 As the disease progresses, symptoms  can include problems with language, disorientation (eg,  getting lost easily), mood swings,  loss of motivation, lack of self-care, and challenging behavior.4,5 These symptoms  progressively interfere with vital activities of daily living and independence.6 Effective  nonpharmacological interventions that entail fewer side effects compared with pharma - cological interventions must be developed to lessen the functional impact of AD.7,8correspondence: Yuan-han Yang Department of Neurology, Kaohsiung  Ta-Tung Municipal hospital, 68 Jhonghua  3rd road, cianjin District, Kaohsiung  80145, Taiwan, republic of china Tel +886 7 3121101 5408 Fax +886 7 3162158 email endless@kmu.edu.t w Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Tai et al Running head recto: Multiple training modalities on AD DOI: http://dx.doi.org/10.2147/NDT.S116257",Non-OADS,/arxiv_data1/oa_pdf/f3/2c/ndt-12-2843.PMC5098772.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f3/2c/ndt-12-2843.PMC5098772.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/2c/ndt-12-2843.PMC5098772.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/19/b8/ndt-12-2859.PMC5098773.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2859–2867Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2859OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11714 6 Efficacy of ketamine in the rapid treatment of major  depressive disorder: a meta-analysis of randomized,  double-blind, placebo-controlled studies Yu han1–3 Jianjun Chen2–4 Dezhi Zou1–3 Peng Zheng1–3 Qi li1–3 haiyang Wang1–3 Pengfei li1–3 Xinyu Zhou1–3 Yuqing Zhang1–3 Yiyun liu1–3 Peng Xie1–3 1Department of Neurology, The First  affiliated hospital of chongqing  Medical University, 2institute of  Neuroscience and the collaborative  innovation center for Brain science,   3chongqing Key laboratory of  Neurobiology, 4institute of life  sciences, chongqing Medical  University, chongqing, People’s  republic of chinaBackground:  An increasing number of studies are reporting that ketamine could be treated  as a novel antidepressant for major depressive disorder (MDD).",Non-OADS,/arxiv_data1/oa_pdf/19/b8/ndt-12-2859.PMC5098773.pdf
"Nowadays, worldwide, about 33% MDD patients  do not respond to the existing antidepressants.13 Therefore, many novel treatments  have been developed to treat MDD, such as electroconvulsive therapy and transcranial  magnetic stimulation.14–17correspondence: Peng Xie Department of Neurology, The First  Affiliated Hospital of Chongqing Medical  University, 1 Yixueyuan road, Yuzhong  District, chongqing 400016, People’s  republic of china Tel +86 23 6848 5490 Fax +86 23 6848 5111 email xiepeng@cqmu.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Han et al Running head recto: Efficacy of ketamine in the treatment of major depressive disorder DOI: http://dx.doi.org/10.2147/NDT.S117146",Non-OADS,/arxiv_data1/oa_pdf/19/b8/ndt-12-2859.PMC5098773.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/19/b8/ndt-12-2859.PMC5098773.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/b8/ndt-12-2859.PMC5098773.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/20/56/ndt-12-2851.PMC5098775.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2851–2858Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2851MeTho Dologyopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S11853 1 A modification of intraluminal middle cerebral  artery occlusion/reperfusion model for ischemic  stroke with laser Doppler flowmetry guidance  in mice Qiang Cai1,* Gang Xu2,* Junhui liu1 Long Wang1 Gang Deng1 Jun liu3 Zhibiao Chen1 1Department of Neurosurgery,   Renmin Hospital of Wuhan  University, Wuhan, 2Department of  Neurosurgery, Xiantao First People’s  Hospital, Xiantao, 3Department of  Emergency, The Central Hospital  of Wuhan, Wuhan, Hubei, People’s  Republic of China *These authors contributed equally  to this workAbstract:  Stroke is one of the common causes of death and disability in the world.",Non-OADS,/arxiv_data1/oa_pdf/20/56/ndt-12-2851.PMC5098775.pdf
"To overcome these  shortcomings, we optimized the operative procedure and shortened the surgical time  to improve the survival rate of the mice.Correspondence: Zhibiao Chen Department of Neurosurgery, Renmin  Hospital of Wuhan University, No 238,  Jiefang Road, Wuchang District, Wuhan,  Hubei 430060, People’s Republic of China Tel +86 139 0717 4679 email zhibiaochen@sina.co m  Jun liu Department of Emergency, The Central  Hospital of Wuhan, No 26, Shenli Street,  Jianghan, Wuhan, Hubei 430014, People’s  Republic of China Tel +86 159 2717 2939 email ljjc8152@sina.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Methodology Y ear: 2016 Volume: 12 Running head verso: Cai et al Running head recto: A modified method for MCAO/R model in mice DOI: http://dx.doi.org/10.2147/NDT.S118531",Non-OADS,/arxiv_data1/oa_pdf/20/56/ndt-12-2851.PMC5098775.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/20/56/ndt-12-2851.PMC5098775.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/56/ndt-12-2851.PMC5098775.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f3/93/mder-9-383.PMC5098776.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f3/93/mder-9-383.PMC5098776.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 383–388Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 383 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S112185 A new laryngeal mask supraglottic airway device  with integrated balloon line: a descriptive and  comparative bench study YingHai Zhou1 Korinne Jew2 1Research & Development, Patient  Monitoring & Recovery, Medtronic  T echnology Center, Shanghai, People’s Republic of China;  2Medical Affairs,   Minimally Invasive Therapies Group,  Medtronic, Boulder, CO, USAAbstract:  Laryngeal masks are invasive devices for airway management placed in the supra- glottic position.",Non-OADS,/arxiv_data1/oa_pdf/f3/93/mder-9-383.PMC5098776.pdf
"Laryngeal masks are Correspondence: YingHai Zhou China Technology Center, 6F, Building 3, 2388 Chenhang Road, Shanghai, 201114, People’s Republic of ChinaTel +86 21 3323 0127Fax +86 21 3323 0222Email renny.zhou@medtronic.comJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Zhou and JewRunning head recto: Shiley™ laryngeal maskDOI: http://dx.doi.org/10.2147/MDER.S112185",Non-OADS,/arxiv_data1/oa_pdf/f3/93/mder-9-383.PMC5098776.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/f3/93/mder-9-383.PMC5098776.pdf
Available from: http://emedicine.medscape.com/article/82527   -overview - a1.,Non-OADS,/arxiv_data1/oa_pdf/f3/93/mder-9-383.PMC5098776.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c8/18/jpr-9-933.PMC5098777.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c8/18/jpr-9-933.PMC5098777.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 933–940Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  933 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S115901A novel nonpharmacological intervention –  breathing-controlled electrical stimulation for  neuropathic pain management after spinal cord  injury – a preliminary study Shengai Li1,2  Matthew Davis1  Joel E Frontera1  Sheng Li1,2 1Department of Physical Medicine and  Rehabilitation, University of T exas  Health Science Center at Houston,   2TIRR Memorial Hermann Research  Center, TIRR Memorial Hermann Hospital, Houston, TX, USAObjective: The objective of this study was to examine the effectiveness of a novel nonpharma- cological intervention – breathing-controlled electrical stimulation (BreEStim) – for neuropathic  pain management in spinal cord injury (SCI) patients.",Non-OADS,/arxiv_data1/oa_pdf/c8/18/jpr-9-933.PMC5098777.pdf
"Pharmacological interventions Correspondence: Sheng Li TIRR Memorial Hermann Research Center, TIRR Memorial Hermann Hospital, 1333 Moursund, Houston, TX 77030, USATel +1 713 797 7125Email sheng.li@uth.tmc.eduJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Li et alRunning head recto: BreEStim for neuropathic pain after SCIDOI: http://dx.doi.org/10.2147/JPR.S115901",Non-OADS,/arxiv_data1/oa_pdf/c8/18/jpr-9-933.PMC5098777.pdf
17–19 Technical details of  BreEStim are available online in a methodology video article: http://www.jove.com/video/50077/.,Non-OADS,/arxiv_data1/oa_pdf/c8/18/jpr-9-933.PMC5098777.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/c8/18/jpr-9-933.PMC5098777.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 940 Li et al 33.,Non-OADS,/arxiv_data1/oa_pdf/c8/18/jpr-9-933.PMC5098777.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 587–614Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 587 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S93680The role of the multidisciplinary health care  team in the management of patients with Marfan  syndrome Yskert von Kodolitsch,1 Meike  Rybczynski,1 Marina Vogler,2 Thomas S  Mir,3 Helke Schüler,1 Kerstin Kutsche,4  Georg Rosenberger,4 Christian  Detter,5 Alexander M Bernhardt,5 Axel  Larena-Avellaneda,6 Tilo Kölbel,6  E Sebastian Debus,6 Malte Schroeder,7,8  Stephan J Linke,9,10 Bettina Fuisting,9  Barbara Napp,1 Anna Lena Kammal,11  Klaus Püschel,11 Peter Bannas,12 Boris  A Hoffmann,13 Nele Gessler,13 Eva  Vahle-Hinz,14 Bärbel Kahl-Nieke,14  Götz Thomalla,15 Christina Weiler- Normann,16 Gunda Ohm,17 Stefan  Neumann,18 Dieter Benninghoven,19  Stefan Blankenberg,1 Reed E Pyeritz,20 1Clinic of Cardiology, University Heart  Centre, 2Marfan Hilfe Deutschland e.V.,   Zentrumsehstärke, 3Clinic for Pediatric  Cardiology, University Heart Centre,   4Institute of Human Genetics, 5Clinic of  Cardiovascular Surgery, University Heart  Centre, 6Clinic of Vascular Medicine,   University Heart Centre, 7Department of  Trauma, Hand, and Reconstructive Surgery,   8Department of Orthopedics, 9Clinic  of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg,   Germany;  10Smilow Center for Translational  Research, Perelman School of Medicine,   University of Pennsylvania, Philadelphia,   PA, USA; 11Department of Legal Medicine,   12Diagnostic and Interventional Radiology  Department and Clinic, 13Clinic of  Electrophysiology, University Heart Centre,   14Department of Orthodontics, Center  for Dental and Oral Medicine, 15Clinic of  Neurology, 16Martin Zeitz Center for Rare  Diseases, 17Strategic Business Development,   18Business Unit Quality Management,   University Medical Center Hamburg- Eppendorf, 19Mühlenberg-Clinic for  Rehabilitation, Bad Malente-Gremsmühlen,   20Zentrumsehstärke, Hamburg, GermanyAbstract: Marfan syndrome (MFS) is a rare, severe, chronic, life-threatening disease  with multiorgan involvement that requires optimal multidisciplinary care to normalize  both prognosis and quality of life.",Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
"We show how with the support of health care managers self-determined team members organize themselves in an organizational struc-ture to create a common meaning, to maximize therapeutic success of patients with MFS.Journal name: Journal of Multidisciplinary Healthcare Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: von Kodolitsch et alRunning head recto: Multidisciplinary health care for management of patients with MFSDOI: http://dx.doi.org/10.2147/JMDH.S93680 Correspondence: Yskert von Kodolitsch   University Hospital Hamburg-Eppendorf,  Martinistrasse 52, 20246 Hamburg, Germany   Tel +49 40 7410 57328   Fax +49 40 7410 54840   Email kodolitsch@uke.de",Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
"6) Marfan-board meetings take place every 3 months; all other conferences take place by phone, or directly together with the patient, 9) We cooperate intensively with the Marfan organization, 10) with other B-centers, and 11) with GPs, although formal C-centers are not established, and 13) we provide a plethora of disease information material, but we do not have SOPs for these issues, 14)  Our center enlists in the Orphanet database ( http://www.orpha.net/ national/DE-DE/index/startseite/ ) with annual up-date of  information, 15) we do not have a structured educational program on MFS, but we provide training in our case conferences almost on a daily basis.",Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
"Identified variants should  be evaluated for their presence in mutation databases, such as Human Gene Mutation Database ( http://www.hgmd.",Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
"org/) or ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/) and single-nucleotide polymorphism databases, such as the dbSNP Database (http://www.ncbi.nlm.nih.gov/snp/) or the Exome Aggregation Consortium (http://exac.broadinstitute.org/).",OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
Available from: http://www.bmg.bund.de/themen/praevention/gesundheitsgefahren/seltene-erkrankungen.html.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
Available from https://www.cff.org/for-caregivers/cf-care-centers/.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
Available from https://www.mda.org/services/your-mda-care-center.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
Available from http://curehht.org/resources/hht-treatment-centers/.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
Available from https://www.marfan.org/.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
Available from http://www.gadacanada.ca/.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
Avail-able from: http://www.marfan.de/images/stories/pdf/Wissenschaft/Umfrage_MarfanCenter_2016.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
Available from: http://www.marfan.de/weiterfuehrende-infos/336-umfrage-marfan-sprechstunden-2016.html.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
Available from: http://www.uke.de/english/departments-institutes/centers/martin-zeitz-center-for-rare-diseases/index.html.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
Available from: https://www.g-ba.de/informationen/richtlinien/40/.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
Avail-able from: https://en.wikipedia.org/w/index.php?title= Game_of_ Thrones&oldid=719414408.,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 614 von Kodolitsch et al,Non-OADS,/arxiv_data1/oa_pdf/cb/05/jmdh-9-587.PMC5098778.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/78/5e/mder-9-389.PMC5098779.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/78/5e/mder-9-389.PMC5098779.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 389–393Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 389 ORIGINAL RESEARCH   open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S107426 Minimal adverse effects profile following  implantation of periauricular percutaneous  electrical nerve field stimulators: a retrospective  cohort study Arthur Roberts1–3 Alec Sithole4 Marcos Sedghi5 Charles A Walker6,7 Theresa M Quinn8 1Indiana Craniofacial Center,   2Department of Oral Pathology,   Medicine and Radiology, Indiana  University School of Dentistry,  Indianapolis, IN, USA;  3Department  of Anesthesia, Critical Care, and Pain Management, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK;   4Department of Computer Science,   Mathematics and Physics, Missouri Western State University, St Joseph,  MO,  5Conservative Care Specialists  Medical Group, Los Angeles, CA,   6Walker Pain Management Center,   Jackson, TN, 7Bethel University,   Paris, TN, 8Wisconsin Pain Solutions,   Menomonee Falls, WI, USAAbstract: The periauricular percutaneous implantation of the Neuro-Stim System™ fam- ily of devices EAD, MFS, and BRIDGE is a procedure involving the use of a non-opiate,  neuromodulation analgesic for relieving acute and chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/78/5e/mder-9-389.PMC5098779.pdf
"The results are disruption of ascending nociceptive stimuli and mitigation of descend-ing nociceptive signals into the gray matter of the dorsal horn of the spinal column.Correspondence: Arthur Roberts Department of Oral Pathology, Medicine and Radiology, Indiana University School of Dentistry, Suite 250, 3750 Guion Road, Indianapolis, IN, USAEmail asmr@me.comJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCH Y ear: 2016V olume: 9Running head verso: Roberts et alRunning head recto: Adverse effects following implantation of stimulatorsDOI: http://dx.doi.org/10.2147/MDER.S107426",Non-OADS,/arxiv_data1/oa_pdf/78/5e/mder-9-389.PMC5098779.pdf
Available from: http://www.fda.gov/AboutFDA/Transparency/Basics/ ucm194438.htm.,Non-OADS,/arxiv_data1/oa_pdf/78/5e/mder-9-389.PMC5098779.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/78/5e/mder-9-389.PMC5098779.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02673684.,Non-OADS,/arxiv_data1/oa_pdf/78/5e/mder-9-389.PMC5098779.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8c/39/jmdh-9-575.PMC5098780.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8c/39/jmdh-9-575.PMC5098780.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 575–585Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 575 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S115588The reablement team’s voice: a qualitative study  of how an integrated multidisciplinary team  experiences participation in reablement Kari Margrete Hjelle1,2 Olbjørg Skutle2,3 Oddvar Førland2,4 Herdis Alvsvåg4 1Department of Occupational  Therapy, Physiotherapy and  Radiography, Faculty of Health and Social Sciences, Bergen University College, Bergen, Norway;  2Centre  for Care Research Western Norway,  Bergen University College, Bergen,  Norway;  3Department of Health  and Social Educators, Faculty of Health and Social Sciences, Bergen University College, Bergen, Norway;   4VID Specialized University, Bergen,   NorwayBackground: Reablement is an early and time-limited home-based rehabilitation intervention  that emphasizes intensive, goal-oriented, and multidisciplinary assistance for people experi- encing functional decline.",Non-OADS,/arxiv_data1/oa_pdf/8c/39/jmdh-9-575.PMC5098780.pdf
"1,2 Approaching older people by considering their intrinsic capabilities Correspondence: Kari Margrete Hjelle Centre for Care Research Western Norway, Bergen University College, Postbox 7030, 5020 Bergen, NorwayEmail kari.hjelle@hib.noJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Hjelle et alRunning head recto: The reablement team’ s voiceDOI: http://dx.doi.org/10.2147/JMDH.S115588",Non-OADS,/arxiv_data1/oa_pdf/8c/39/jmdh-9-575.PMC5098780.pdf
"Creative Commons license available from: https://creativecommons.org/licenses/ by/4.0/legalcode.20 Abbreviation:  COPM, Canadian Occupational Performance Measurement.",Non-OADS,/arxiv_data1/oa_pdf/8c/39/jmdh-9-575.PMC5098780.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/8c/39/jmdh-9-575.PMC5098780.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 585 The reablement team’s voice  6.,Non-OADS,/arxiv_data1/oa_pdf/8c/39/jmdh-9-575.PMC5098780.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bd/89/jep-8-061.PMC5098781.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bd/89/jep-8-061.PMC5098781.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Experimental Pharmacology 2016:8 61–67Journal of Experimental Pharmacology Dovepress submit your manuscript | www.dovepress.com Dovepress  61 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JEP .S121133Diuretic activity of the aqueous crude extract and  solvent fractions of the leaves of Thymus serrulatus  in mice Amelework Eshetu Melka1 Eyasu Makonnen1 Asfaw Debella2 Netsanet Fekadu2 Bekesho Geleta2 1Department of Pharmacology,   School of Medicine, College of Health  Sciences, Addis Ababa University,  Addis Ababa, Ethiopia;  2Directorate  of Traditional and Modern Medicine Research, Ethiopian Public Health Institute, Addis Ababa, EthiopiaAbstract: The present study was undertaken to investigate the diuretic activity and acute toxicity  profile of the crude aqueous extract and solvent fraction of the leaves of Thymus serrulatus in  saline-loaded Swiss albino mice.",Non-OADS,/arxiv_data1/oa_pdf/bd/89/jep-8-061.PMC5098781.pdf
"Box 1242, Addis Ababa, EthiopiaTel +251 91 109 1969Email bekeshog@gmail.comJournal name: Journal of Experimental Pharmacology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Melka et alRunning head recto: Diuretic activity of extract and fractions of T. serrulatus leaves in miceDOI: http://dx.doi.org/10.2147/JEP .S121133",Non-OADS,/arxiv_data1/oa_pdf/bd/89/jep-8-061.PMC5098781.pdf
Available from: http://ntp.niehs.nih.gov/iccvam/SuppDocs/FedDocs/OECD/OECDtg425.pdf.,OADS,/arxiv_data1/oa_pdf/bd/89/jep-8-061.PMC5098781.pdf
Available from: http://etd.aau.edu.et/ bitstream/123456789/5658/1/11.%20Addisu%20bekele.pdf.,OADS,/arxiv_data1/oa_pdf/bd/89/jep-8-061.PMC5098781.pdf
"Journal of Experimental Pharmacology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-experimental-pharmacology-journalThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of laboratory and experimental pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/bd/89/jep-8-061.PMC5098781.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/89/jep-8-061.PMC5098781.pdf
Available from: https://pubchem.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/bd/89/jep-8-061.PMC5098781.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b2/22/jir-9-199.PMC5098782.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b2/22/jir-9-199.PMC5098782.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Inflammation Research 2016:9 199–208Journal of Inflammation Research Dovepress submit your manuscript | www.dovepress.com Dovepress 199 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S86958 Targeting neuroinflammation in Alzheimer’s  disease Maria Rosanna Bronzuoli1 Aniello Iacomino2 Luca Steardo1 Caterina Scuderi1 1Department of Physiology and  Pharmacology “Vittorio Erspamer”,   Sapienza University of Rome,  Rome, Italy;  2Faculty of Psychology,   University of Rome “G.",Non-OADS,/arxiv_data1/oa_pdf/b2/22/jir-9-199.PMC5098782.pdf
"The reasons for this failure are probably due to the scant knowledge of the cellular and molecular mechanisms implicated in AD pathogenesis and of the approved therapies that coarsely affect both Correspondence: Caterina Scuderi Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, P.le Aldo Moro, 5, Rome 00185, ItalyTel +39 06 4991 2713Fax +39 06 4991 2480Email caterina.scuderi@uniroma1.it Journal name: Journal of Inflammation Research Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Bronzuoli et alRunning head recto: Targeting neuroinflammation in Alzheimer’ s diseaseDOI: http://dx.doi.org/10.2147/JIR.S86958",Non-OADS,/arxiv_data1/oa_pdf/b2/22/jir-9-199.PMC5098782.pdf
"Journal of Inflammation Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Inflammation Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-inflammation-research-journalThe Journal of Inflammation Research is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation including original research, reviews, symposium reports, hypothesis for - mation and commentaries on: acute/chronic inflammation; mediators of inflammation; cellular processes; molecular mechanisms; pharmacology and novel anti-inflammatory drugs; clinical conditions involving inflam-mation.",Non-OADS,/arxiv_data1/oa_pdf/b2/22/jir-9-199.PMC5098782.pdf
Visit http://www.dove   press.com/testimonials.php to read real quotes from published authors.Dovepress 208 Bronzuoli et al 122.,Non-OADS,/arxiv_data1/oa_pdf/b2/22/jir-9-199.PMC5098782.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/76/6d/jbm-7-255.PMC5098784.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/76/6d/jbm-7-255.PMC5098784.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2016:7 255–261Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  255 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S114585Pain frequency, severity and QT dispersion in  adult patients with sickle cell anemia: correlation  with inflammatory markers Taysir S Garadah1,2  Ahmed A Jaradat2  Mohammed E AlAlawi1  Adla B Hassan1  Reginald P Sequeira2 1Salmanyia Medical Complex, Ministry  of Health, 2College of Medicine  and Medical Sciences, Arabian Gulf  University, Manama, Kingdom of BahrainBackground: Inflammatory markers are increased during vaso-occlusive crisis (VOC) in adult  patients with sickle cell anemia (SCA), but this is not clear in clinical steady state.",Non-OADS,/arxiv_data1/oa_pdf/76/6d/jbm-7-255.PMC5098784.pdf
"3 Bone pain in patients with SCA varies from acute clinical painful VOC or osteo- myelitis to more chronic and debilitating disease, such as osteoporosis, osteopenia Correspondence: Taysir S Garadah College of Medicine and Medical Sciences, Arabian Gulf University, PO Box 18725, Manama, Kingdom of Bahrain   Tel +973 1723 9712 Fax +973 1723 0730 Email garadaht@hotmail.comJournal name: Journal of Blood Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Garadah et alRunning head recto: Pain frequency and severity  in adult patients with SCADOI: http://dx.doi.org/10.2147/JBM.S114585",Non-OADS,/arxiv_data1/oa_pdf/76/6d/jbm-7-255.PMC5098784.pdf
"Journal of Blood Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/76/6d/jbm-7-255.PMC5098784.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 261 Pain frequency and severity  in adult patients with SCA,Non-OADS,/arxiv_data1/oa_pdf/76/6d/jbm-7-255.PMC5098784.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Trends in Hearing 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/ad/f8/10.1177_2331216516673639.PMC5098797.pdf
Retrieved from http://scholarcommons.usf.edu/etd/1550/.8 Trends in Hearing,Non-OADS,/arxiv_data1/oa_pdf/ad/f8/10.1177_2331216516673639.PMC5098797.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Trends in Hearing 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/dc/33/10.1177_2331216516670387.PMC5098798.pdf
"Retrieved from Oticon A/S http://www.oticon.global/professionals/evidence Levitt, H. (1971).",OADS,/arxiv_data1/oa_pdf/dc/33/10.1177_2331216516670387.PMC5098798.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5f/0b/ijn-11-5697.PMC5098928.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5697–5708International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5697OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11127 4 Formulation, characterization and tissue  distribution of a novel ph-sensitive long-circulating  liposome-based theranostic suitable for molecular  imaging and drug delivery Yin Duan1,2 lihui Wei1–3 Julia Petryk2,3 T errence D ruddy2,3 1Nordion Inc., 2cardiac Positron  emission Tomography (P eT)  radiochemistry research core  laboratory, canadian Molecular  Imaging center of excellence,   University of Ottawa heart Institute,   3Division of cardiology, University of  Ottawa heart Institute, Ottawa, ON,   canadaPurpose:  When designing liposome formulas for treatment and diagnostic purposes, two of the  most common challenges are 1) the lack of a specific release mechanism for the encapsulated  contents and 2) a short circulation time due to poor resistance to biological fluids.",Non-OADS,/arxiv_data1/oa_pdf/5f/0b/ijn-11-5697.PMC5098928.pdf
"Theranosis, a  new interdisciplinary field in the realm of biomedical sciences, has the ultimate  goal of forming optimized and personalized diagnostic and therapeutic strategies.1–3 correspondence: Yin Duan cardiac Positron emission Tomography  (PeT) radiochemistry research core  laboratory, University of Ottawa heart  Institute, 40 ruskin street, Ontario K1Y  4W7, canada email dyduan81@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Duan et al Running head recto: Novel theranostic suitable for molecular imaging and drug delivery DOI: http://dx.doi.org/10.2147/IJN.S111274",Non-OADS,/arxiv_data1/oa_pdf/5f/0b/ijn-11-5697.PMC5098928.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5f/0b/ijn-11-5697.PMC5098928.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/0b/ijn-11-5697.PMC5098928.pdf
"INTRODUCTION The primary cilium is a microtubule (MT)-based, nonmotile projection located on the  surface of most vertebrate cells that senses extracellular information to transduce signals  required for cell proliferation, embryogenesis, and tissue homeostasis ( Ishikawa and  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/93/c3/nihms824070.PMC5099117.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and four figures and can be found with this article online  at http://dx.doi.org/10.1016/j.celrep.2015.01.003 HHS Public Access Author manuscript Cell Rep .,Non-OADS,/arxiv_data1/oa_pdf/93/c3/nihms824070.PMC5099117.pdf
[J Adv Prosthodont 2016;8:333-8] KEYWORDS: Denture cleansers; Sodium perborate; Sodium hypochlorite; Complete denture; Mechanical properties; Physical propertieshttps://doi.org/10.4047/jap.2016.8.5.333 http://jap.or.kr J Adv Prosthodont 2016;8:333-8 INTRODUCTION Home care instructions provided to patients after insertion  of complete dentures are important in maintaining oral mucosal health and the longevity of  the prostheses.,Non-OADS,/arxiv_data1/oa_pdf/53/17/jap-8-333.PMC5099124.pdf
"+9031221513 36: e-mail, zlemacr@gmail.comReceived January 14, 2016 / Last Revision June 29, 2016 / Accepted  August 8, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/17/jap-8-333.PMC5099124.pdf
ORCID Ozlem Acar  http://orcid.org/0000-0002-2866-1308 REfERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/53/17/jap-8-333.PMC5099124.pdf
"[J Adv Prosthodont 2016;8:339-44] KEYWORDS: Shear bond strength; Pre-surface treatment; Metal alloy; Zirconia; Lithium disilicatehttps://doi.org/10.4047/jap.2016.8.5.339 http://jap.or.kr J Adv Prosthodont 2016;8:339-44 INTRODUCTION For more than 40 years, metal ceramic restorations (MCRs)  have been widely used in the fabrication of  fixed partial den-tures (FPDs) and still represent the gold standard nowadays.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/jap-8-339.PMC5099125.pdf
"+603-92898006/7839: e-mail, drtasyatarib@yahoo.comReceived January 28, 2016 / Last Revision June 21, 2016 / Accepted  August 8, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/15/jap-8-339.PMC5099125.pdf
ORCID Natasya Ahmad Tarib  http://orcid.org/0000-0001-7653-0495 REfERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/e9/15/jap-8-339.PMC5099125.pdf
[J Adv Prosthodont 2016;8:345-53] KEYWORDS: Perception of implant esthetics; Patient satisfaction; Single-tooth implants; Pink esthetic score/white esthetic scorehttps://doi.org/10.4047/jap.2016.8.5.345 http://jap.or.kr J Adv Prosthodont 2016;8:345-53 INTRODUCTION The outcome of dental implant treatment is frequently  described using success criteria from clinical and radiologic aspects generally based on the defined thresholds of  objec - tive clinical parameters of peri-implant lesions.,Non-OADS,/arxiv_data1/oa_pdf/67/0c/jap-8-345.PMC5099126.pdf
"+16048273361: e-mail, ahmed.ballo@dentistry.ubc.caReceived February 3, 2016 / Last Revision June 24, 2016 / Accepted  August 8, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/0c/jap-8-345.PMC5099126.pdf
ORCID Ahmed M. Ballo  http://orcid.org/0000-0002-2978-705X REfERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/67/0c/jap-8-345.PMC5099126.pdf
"[J Adv Prosthodont 2016;8:354-62] KEYWORDS: Intraoral scanner; Digital impression; Reproducibility of intraoral scanner; Trueness; Precisionhttps://doi.org/10.4047/jap.2016.8.5.354 http://jap.or.kr J Adv Prosthodont 2016;8:354-62 INTRODUCTION With the recent acceleration of the application of digital  technology in the dental medicine, various intraoral scan-ners (IOSs) that can acquire intraoral images without using the impression material have been introduced in addition to the existing CAD/CAM system.",Non-OADS,/arxiv_data1/oa_pdf/4b/dd/jap-8-354.PMC5099127.pdf
"+82 2 6747 6535: e-mail, jimarn@snu.ac.krReceived February 5, 2016 / Last Revision June 24, 2016 / Accepted  August 8, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/dd/jap-8-354.PMC5099127.pdf
ORCID Ji-Man Park  http://orcid.org/0000-0003-0018-1166REfERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/4b/dd/jap-8-354.PMC5099127.pdf
"[J Adv Prosthodont 2016;8:363-71] KEYWORDS: Postoperative radiotherapy; Head and neck cancer; Local irradiation; Implant; Empty lacunahttps://doi.org/10.4047/jap.2016.8.5.363 http://jap.or.kr J Adv Prosthodont 2016;8:363-71 INTRODUCTION Radiotherapy is widely used to treat head and neck cancer, as  a primary therapy, adjuvant to surgery, or as a palliative treat - ment for unresectable head and neck malignancies.",Non-OADS,/arxiv_data1/oa_pdf/b3/d6/jap-8-363.PMC5099128.pdf
ORCID Re-Mee Doh  http://orcid.org/0000-0001-8512-9134  REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/b3/d6/jap-8-363.PMC5099128.pdf
[J Adv Prosthodont 2016;8:372-9] KEYWORDS: Alginate impression material; Alginate mixer; Mechanical properties of alginate; Preparing methods  of alginatehttps://doi.org/10.4047/jap.2016.8.5.372 http://jap.or.kr J Adv Prosthodont 2016;8:372-9 INTRODUCTION Irreversible hydrocolloid materials are commonly used for  both diagnostic and definitive impression procedures.1  Impression yields a detailed recording of  the mouth plaster model.,Non-OADS,/arxiv_data1/oa_pdf/2d/1c/jap-8-372.PMC5099129.pdf
"+905422787499: e-mail, karanikurtulus@sdu.edu.trReceived March 9, 2016 / Last Revision August 23, 2016 / Accepted  September 13, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/1c/jap-8-372.PMC5099129.pdf
The Journal of Advanced Prosthodontics     379NOMENCLATURE ORCID Karani Kurtulus  http://orcid.org/0000-0002-2608-3065 Kenan Tüfekci  http://orcid.org/0000-0002-3036-6375 REfERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/2d/1c/jap-8-372.PMC5099129.pdf
"[J Adv Prosthodont 2016;8:380-7] KEYWORDS: Impression materials; CBCThttps://doi.org/10.4047/jap.2016.8.5.380 http://jap.or.kr J Adv Prosthodont 2016;8:380-7 INTRODUCTION Synthetic elastomers, including polysulfide polymers, con - densation and addition silicone, polyethers, and hydrocol- loids, are used in dentistry to make impressions for repro-ducing oral conditions.",Non-OADS,/arxiv_data1/oa_pdf/7c/fc/jap-8-380.PMC5099130.pdf
"+902220000-3834: e-mail, muratalkurt@hotmail.comReceived March 9, 2016 / Last Revision July 27, 2016 / Accepted August  8, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/fc/jap-8-380.PMC5099130.pdf
ORCID Murat Alkurt  http://orcid.org/0000-0001-9324-0158Zeynep Yesil Duymus  http://orcid.org/0000-0001-7162-8792Numan Dedeoglu  http://orcid.org/0000-0003-0892-3654 REfERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/7c/fc/jap-8-380.PMC5099130.pdf
[J Adv Prosthodont 2016;8:388-95] KEYWORDS: Dental Implant-Abutment Connection; Titanium grade; Yield strength; Static loading; Implant failurehttps://doi.org/10.4047/jap.2016.8.5.388 http://jap.or.kr J Adv Prosthodont 2016;8:388-95 INTRODUCTION Osseointegrated dental implants have become increasingly  important in the field of oral rehabilitation1 with many  studies reporting up to 99% the long-term success of  den-tal implants.,Non-OADS,/arxiv_data1/oa_pdf/fe/0c/jap-8-388.PMC5099131.pdf
394ORCID Su-Jung Park  http://orcid.org/0000-0002-4111-2231 Suk-Won Lee  http://orcid.org/0000-0003-2726-3567Richard Leesungbok  http://orcid.org/0000-0002-8381-723XSu-Jin Ahn  http://orcid.org/0000-0003-2128-1561 REfERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/fe/0c/jap-8-388.PMC5099131.pdf
"[J Adv Prosthodont 2016;8:396-403] KEYWORDS: Hydrophilicity; Dental implant; Survival ratehttps://doi.org/10.4047/jap.2016.8.5.396 http://jap.or.kr J Adv Prosthodont 2016;8:396-403 INTRODUCTION At implant placement, having good primary stability and  being without micromotion at the secondary bone healing are a very important factors for the successful implant placement.",Non-OADS,/arxiv_data1/oa_pdf/c7/d3/jap-8-396.PMC5099132.pdf
"Various techniques such as blasting and acid etching, resorbable Corresponding author:  Young-Kyun Kim Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul  National University Bundang Hospital, 300 Gumi-dong, Bundang-gu, Seongnam 13620, Republic of KoreaTel: +82317872780: e-mail, kyk0505@snubh.org Received March 16, 2016 / Last Revision June 3, 2016 / Accepted August  8, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/d3/jap-8-396.PMC5099132.pdf
ORCID Seong-Beom Kim  http://orcid.org/0000-0002-9181-467X Pil-Young Yun  http://orcid.org/0000-0001-6097-1229Sang-Yun Kim  http://orcid.org/0000-0002-2952-5404Yang-Jin Yi  http://orcid.org/0000-0001-8341-4759 Ji-Yun Kim  http://orcid.org/0000-0001-6976-0743 Young-Kyun Kim  http://orcid.org/0000-0002-7268-3870 REfERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/c7/d3/jap-8-396.PMC5099132.pdf
[J Adv Prosthodont  2016;8:404-10] KEYWORDS: Gluma desensitizer; Retention; Crowns; Self-adhesive cementhttps://doi.org/10.4047/jap.2016.8.5.404 http://jap.or.kr J Adv Prosthodont 2016;8:404-10 INTRODUCTION Retention is an important factor in determining the success  and clinical service of FPDs.1 The retention of crown is  based on the presence of  two almost parallel vertical sur - faces from tooth preparation; Al-Omari et al.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/jap-8-404.PMC5099133.pdf
"+989123131755: e-mail, drarashazizi@yahoo.comReceived April 26, 2016 / Last Revision July 20, 2016 / Accepted August  8, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/ec/jap-8-404.PMC5099133.pdf
ORCID Arash Azizi  http://orcid.org/0000-0001-9219-1219 REfERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/f3/ec/jap-8-404.PMC5099133.pdf
"[J Adv  Prosthodont 2016;8:411-6] KEYWORDS: Palatal obturators; Denture precision attachment; Melanomahttps://doi.org/10.4047/jap.2016.8.5.411 http://jap.or.kr J Adv Prosthodont 2016;8:411-6 INTRODUCTION Patients who underwent maxillectomy due to benign or  malignant tumor, will have defect in palatal area.",Non-OADS,/arxiv_data1/oa_pdf/74/2a/jap-8-411.PMC5099134.pdf
"82312195869: e-mail, dragon_001@hanmail.net Received January 29, 2016 / Last Revision July 20, 2016 / Accepted  August 8, 2016 © 2016  The Korean Academy of Prosthodontics This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/2a/jap-8-411.PMC5099134.pdf
ORCID Dong-Jae Seong  http://orcid.org/0000-0003-0423-4755Seoung-Jin Hong  http://orcid.org/0000-0002-7460-8487Seung-Ryong Ha  http://orcid.org/0000-0003-4176-6865Young-Gi Hong  http://orcid.org/0000-0002-1356-8274 Hyo-Won Kim  http://orcid.org/0000-0001-5318-821X REfERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/74/2a/jap-8-411.PMC5099134.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/jmedgenet-2016-103902).,Non-OADS,/arxiv_data1/oa_pdf/ab/91/jmedgenet-2016-103902.PMC5099175.pdf
Market prices taken from theNHS test directory hosted on the UKGTN website (http://ukgtn.nhs.uk) were used for the actual genetic testing of BRCA1/ BRCA2 .,OADS,/arxiv_data1/oa_pdf/ab/91/jmedgenet-2016-103902.PMC5099175.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Tischkowitz M, Douglas F, Hodgson S, Walker L, Porteous ME, Morrison PJ, Side LE, Kennedy MJ,Houghton C, Donaldson A, Rogers MT, Dorkins H, Miedzybrodzka Z, Gregory H,Eason J, Barwell J, McCann E, Murray A, Antoniou AC, Easton DF.",Non-OADS,/arxiv_data1/oa_pdf/ab/91/jmedgenet-2016-103902.PMC5099175.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ jmedgenet-2016-103814).,OADS,/arxiv_data1/oa_pdf/0f/9a/jmedgenet-2016-103814.PMC5099177.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ropers HH.,Non-OADS,/arxiv_data1/oa_pdf/0f/9a/jmedgenet-2016-103814.PMC5099177.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Levi AJ, Raynault MF , Bergh PA, et al.",Non-OADS,/arxiv_data1/oa_pdf/a8/c0/acupmed-2015-011014.PMC5099178.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ thoraxjnl-2015-207736).,Non-OADS,/arxiv_data1/oa_pdf/4e/20/thoraxjnl-2015-207736.PMC5099182.pdf
"This de ﬁn- ition of EP is the current minimal standard for follow-up inCanada, varies from that of WHO (<28 weeks GA; http://www.who.int/mediacentre/factsheets/fs363/en/) but is consistent withthe GA recommendation of the National Institute of ChildHealth and Human Development (NICHD).",Non-OADS,/arxiv_data1/oa_pdf/4e/20/thoraxjnl-2015-207736.PMC5099182.pdf
"Height,weight and body mass index (BMI) were converted to z-scoresusing available normative data (http://www.cdc.gov/growthcharts/cdc_charts.htm).",OADS,/arxiv_data1/oa_pdf/4e/20/thoraxjnl-2015-207736.PMC5099182.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1O ’Reilly M, Sozo F, Harding R. Impact of preterm birth and bronchopulmonary dysplasia on the developing lung: long-term consequences for respiratory health.Clin Exp Pharmacol Physiol 2013;40:765 –73.",Non-OADS,/arxiv_data1/oa_pdf/4e/20/thoraxjnl-2015-207736.PMC5099182.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/ acupmed-2015-011036).,Non-OADS,/arxiv_data1/oa_pdf/24/88/acupmed-2015-011036.PMC5099186.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Airaksinen O, Hildebrandt J, Mannion A, et al.",Non-OADS,/arxiv_data1/oa_pdf/24/88/acupmed-2015-011036.PMC5099186.pdf
2004. http://www.backpaineurope.org/web/files/WG2_Guidelines.pdf(accessed 5 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/24/88/acupmed-2015-011036.PMC5099186.pdf
Dosage Recommendations 2010. http://waltza.co.za/documentation-links/ recommendations/dosage-recommendations/ (accessed 4 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/24/88/acupmed-2015-011036.PMC5099186.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 20 Atkins D, Best D, Briss P , et al, GRADE W orking Group.",OADS,/arxiv_data1/oa_pdf/24/88/acupmed-2015-011036.PMC5099186.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2015-208562).,Non-OADS,/arxiv_data1/oa_pdf/50/80/annrheumdis-2015-208562.PMC5099191.pdf
"Correspondence to Professor Munther Khamashta,Graham Hughes Lupus Research Laboratory, Division of Women ’s Health, King ’s College London, The RayneInstitute, Lambeth Wing 4th Floor, St Thomas ’Hospital, London SE1 7EH, UK;munther.khamashta@kcl.ac.uk Received 10 September 2015 Revised 15 February 2016 Accepted 21 February 2016Published Online First23 March 2016 ▸http://dx.doi.org/10.1136/ annrheumdis-2016-209345 To cite: Khamashta M, Merrill JT, Werth VP, et al.",Non-OADS,/arxiv_data1/oa_pdf/50/80/annrheumdis-2015-208562.PMC5099191.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus.",Non-OADS,/arxiv_data1/oa_pdf/50/80/annrheumdis-2015-208562.PMC5099191.pdf
"Hum Genomics Proteomics 2009;2009:Article ID 374312. http://dx.doi.org/10.4061/2009/374312 21 Merrill JT, Wallace DJ, Petri M, et al.",OADS,/arxiv_data1/oa_pdf/50/80/annrheumdis-2015-208562.PMC5099191.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ injuryprev-2015-041933).,Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
"1Center for Health Policy/ PCOR, Stanford UniversitySchool of Medicine, Stanford,California, USA 2Department of Statistics, University of California,Berkeley, California, USA 3Melbourne School of Population and Global Health, University of Melbourne,Parkville, Australia; Email:celia.m.kemp@gmail.com Correspondence to Professor David Studdert,Center for Health Policy /PCOR, Stanford University School of Medicine, 117 Encina Commons, Stanford,CA 94305, USA;studdert@stanford.edu Received 10 December 2015 Revised 31 March 2016 Accepted 20 April 2016Published Online First19 July 2016 ▸http://dx.doi.org/10.1136/ injuryprev-2016-042076 To cite: Studdert DM, Walter SJ, Kemp C, et al.Inj Prev 2016; 22:314–320.ABSTRACT Background Recent government inquiries in several countries have identi ﬁed the length of time it takes coroners to investigate deaths due to injury and otherunnatural causes as a major problem.",Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
"However, NCIS regularly makes the dataset available to authorised users.Information on how to request the data can be found at http://www.ncis.org.au/ how-to-access-data-on-the-ncis/.Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, whichpermits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Law Reform Committee, Parliament of Victoria.",Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
September 2006. http://www.parliament.vic.gov.au/lawreform/inquiries/article/1192 (accessed 10 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
http://www.justice.govt.nz/publications/global-publications/c/coroners-act-review-proposals-for-reform-cabinet-paper-one (accessed 10 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
http://www.justice.govt.nz/publications/global-publications/c/ coroners-act-review-proposals-for-reform-paper-2 (accessed 10 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
Command Paper Cm 5854. https://www.gov.,Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
https://consult.justice.gov.uk/digital-communications/ coroner-reforms (accessed 10 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
"Dublin: Stationery Of ﬁce, 2000. http://www.justice.ie/en/JELR/ReviewCoronerService.",Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
"Boston Globe , 17 June 2014. http://www.bostonglobe.com/business/2014/06/16/grieving-families-face-insurance- ﬁnancial-problems-from-delays-state-death-certi ﬁcates/ CdqKPttNPvoDncewrajliN/story.html (accessed 10 Dec 2015).",Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
http://www.courts.sa.gov.au/OurCourts/CoronersCourt/Lists/ Coroners20Annual20Reports/Attachments/2/AR_2006-2007.pdf (accessed 10 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
March 2013. http://www.communitylaw.org.au/cb_pages/federation_reports.php (accessed 10 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
"16 May 2013. https://www.gov.uk/government/uploads/system/ Studdert DM, et al.Inj Prev 2016; 22:314–320.",Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
http://www.ncis.org.au/wp-content/uploads/2013/10/NCIS-Annual-Report-FINAL-2012-13.pdf (accessed 10 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
http://www.courts.sa.gov.au/OurCourts/CoronersCourt/Lists/ Coroners20Annual20Reports/Attachments/3/AR_2007-2008.pdf (accessed 10 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/8d/9a/injuryprev-2015-041933.PMC5099192.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ gutjnl-2016-311393).,OADS,/arxiv_data1/oa_pdf/e2/5a/gutjnl-2016-311393.PMC5099195.pdf
"Correspondence to Professor Julia Mayerle, Department of Medicine A, University Medicine, Ernst-Moritz-Arndt-University,Greifswald, Ferdinand- Sauerbruchstrasse, Greifswald 17475, Germany; mayerle@uni-greifswald.de Received 3 January 2016 Revised 1 April 2016 Accepted 18 April 2016 Published Online First12 May 2016 ▸http://dx.doi.org/10.1136/ gutjnl-2016-312092 To cite: Mahajan UM, Teller S, Sendler M, et al .",Non-OADS,/arxiv_data1/oa_pdf/e2/5a/gutjnl-2016-311393.PMC5099195.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Maitra A, Leach SD.",Non-OADS,/arxiv_data1/oa_pdf/e2/5a/gutjnl-2016-311393.PMC5099195.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2015-208406).,Non-OADS,/arxiv_data1/oa_pdf/f1/c9/annrheumdis-2015-208406.PMC5099198.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Loeser RF, Goldring SR, Scanzello CR, et al.",Non-OADS,/arxiv_data1/oa_pdf/f1/c9/annrheumdis-2015-208406.PMC5099198.pdf
The function of δwas plotted using the Desmos Graph Calculator (https://www.desmos.com/calculator).,OADS,/arxiv_data1/oa_pdf/9c/15/gutjnl-2015-310142.PMC5099199.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Yuan Y, Ford AC, Khan KJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/9c/15/gutjnl-2015-310142.PMC5099199.pdf
"http://www.iarc.fr/en/publications/pdfsonline/wrk/wrk8/index.php 15 Malfertheiner P, Bazzoli F, Delchier JC, et al.Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracyclinegiven with omeprazole versus clarithromycin-based triple therapy: a randomised,open-label, non-inferiority, phase 3 trial.",Non-OADS,/arxiv_data1/oa_pdf/9c/15/gutjnl-2015-310142.PMC5099199.pdf
http://www.nhi.gov.tw/webdata/webdata.aspx?,Non-OADS,/arxiv_data1/oa_pdf/9c/15/gutjnl-2015-310142.PMC5099199.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2015-208426).,Non-OADS,/arxiv_data1/oa_pdf/98/ec/annrheumdis-2015-208426.PMC5099201.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Smolen JS, Landewé R, Breedveld FC, et al.",Non-OADS,/arxiv_data1/oa_pdf/98/ec/annrheumdis-2015-208426.PMC5099201.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Chaloupka FJ, Yurkeli AA, Fong GT.",Non-OADS,/arxiv_data1/oa_pdf/76/84/tobaccocontrol-2016-053079.PMC5099202.pdf
2014. http://www.cdc.gov/tobacco/stateandcommunity/best_practices/index.htm (accessed 7 Mar 2016).,OADS,/arxiv_data1/oa_pdf/76/84/tobaccocontrol-2016-053079.PMC5099202.pdf
National Cancer Institute-sponsored Tobacco Use Supplement to the Current Population Survey (May 2010–2011): http://thedataweb.rm.census.gov/ftp/cps_ftp.html#cpssupps.,Non-OADS,/arxiv_data1/oa_pdf/76/84/tobaccocontrol-2016-053079.PMC5099202.pdf
2005. http://www.ncsl.org/issues-research/tribal/state-tribal-relations- publications.aspx#PS (accessed 10 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/76/84/tobaccocontrol-2016-053079.PMC5099202.pdf
New York Times 2011. http://www.nytimes.com/2011/05/10/nyregion/ ruling-clears-new-york-to-tax-tribes-cigarette-sales.html (accessed 29 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/76/84/tobaccocontrol-2016-053079.PMC5099202.pdf
http://www.sciencedirect.com/science/article/pii/S0167629604001225 (accessed 23 Apr 2015).17 Bureau of Indian Affairs.,Non-OADS,/arxiv_data1/oa_pdf/76/84/tobaccocontrol-2016-053079.PMC5099202.pdf
Fedl Reg 2015;80. http://www.bia.,Non-OADS,/arxiv_data1/oa_pdf/76/84/tobaccocontrol-2016-053079.PMC5099202.pdf
http://www.nps.gov/nagpra/DOCUMENTS/ResMAP.HTM (accessed 23 Mar2016).,OADS,/arxiv_data1/oa_pdf/76/84/tobaccocontrol-2016-053079.PMC5099202.pdf
2015. http://www.bia.,Non-OADS,/arxiv_data1/oa_pdf/76/84/tobaccocontrol-2016-053079.PMC5099202.pdf
20778. http://www.nber.org/papers/w20778.pdf (accessed Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/76/84/tobaccocontrol-2016-053079.PMC5099202.pdf
9 May 2011. http://www.reuters.com/article/newyork-tobacco-idUSN0924451920110509 (accessed 20 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/76/84/tobaccocontrol-2016-053079.PMC5099202.pdf
New York Times 22 Feb 2012. http://www.nytimes.com/2012/02/23/nyregion/indian-tribes-make-own-cigarettes-to-avoid-ny-tax.html?_r=0 (accessed 22 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/76/84/tobaccocontrol-2016-053079.PMC5099202.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2015-208659).,OADS,/arxiv_data1/oa_pdf/a3/a8/annrheumdis-2015-208659.PMC5099203.pdf
"Genotyping, epigenotyping and RNA-sequencing were performed at the SNP&SEQ Technology Platform at theNational Genomics Infrastructure (NGI) hosted by Science for Life Laboratory inUppsala, Sweden (http://www.genotyping.se; http://www.sequencing.se).",OADS,/arxiv_data1/oa_pdf/a3/a8/annrheumdis-2015-208659.PMC5099203.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Jonsson R, Bolstad AI, Brokstad KA, et al.",Non-OADS,/arxiv_data1/oa_pdf/a3/a8/annrheumdis-2015-208659.PMC5099203.pdf
A fulldescription of the SCTC Research Initiative is avail-able at http://sctcresearch.org/PublicHome.,Non-OADS,/arxiv_data1/oa_pdf/5d/cf/tobaccocontrol-2016-053153.PMC5099204.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1O f ﬁce on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion.",Non-OADS,/arxiv_data1/oa_pdf/5d/cf/tobaccocontrol-2016-053153.PMC5099204.pdf
"http://www.cdc.gov/tobacco/data_statistics/ tables/trends/cig_smoking/index.htm 2 Holford TR, Meza R, Warner KE, et al .",OADS,/arxiv_data1/oa_pdf/5d/cf/tobaccocontrol-2016-053153.PMC5099204.pdf
"Atlanta: U.S. Department of Health andHuman Services, Centers for Disease Control and Prevention and National Cancer Institute, 2015. http://www.cdc.gov/uscs 8 Frieden TR.",Non-OADS,/arxiv_data1/oa_pdf/5d/cf/tobaccocontrol-2016-053153.PMC5099204.pdf
2005. http://cancercontrol.cancer.gov/brp/ tcrb/monographs/16/index.html 13 National Cancer Institute (NCI).,Non-OADS,/arxiv_data1/oa_pdf/5d/cf/tobaccocontrol-2016-053153.PMC5099204.pdf
2006. http://cancercontrol.cancer.gov/brp/ tcrb/monographs/17/index.html 14 National Cancer Institute (NCI).,Non-OADS,/arxiv_data1/oa_pdf/5d/cf/tobaccocontrol-2016-053153.PMC5099204.pdf
2012. http://cancercontrol.cancer.gov/brp/tcrb/scrfa.html (accessed 26 April 2015).,Non-OADS,/arxiv_data1/oa_pdf/5d/cf/tobaccocontrol-2016-053153.PMC5099204.pdf
http://norml.org/states18 National Conference of State Legislatures.,Non-OADS,/arxiv_data1/oa_pdf/5d/cf/tobaccocontrol-2016-053153.PMC5099204.pdf
"2016. http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx 19 Delnevo CD, Bover-Manderski MT, Hrywna M. Cigar, marijuana, and blunt use among US adolescents: are we accurately estimating the prevalence of cigarsmoking among youth?",Non-OADS,/arxiv_data1/oa_pdf/5d/cf/tobaccocontrol-2016-053153.PMC5099204.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1O ’Gara PT, Kushner FG, Ascheim DD, et al.",Non-OADS,/arxiv_data1/oa_pdf/44/e9/heartjnl-2015-309039.PMC5099205.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Delnevo CD, Giovenco DP, Steinberg MB, et al.",Non-OADS,/arxiv_data1/oa_pdf/38/de/tobaccocontrol-2016-053096.PMC5099206.pdf
2016. http://www.pharmatimes.com/Article/16-01-04/MHRA_licenses_e-cigarette_as_a_ medicine.aspx (accessed 31 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/38/de/tobaccocontrol-2016-053096.PMC5099206.pdf
"Nicovations Limited, 2015. http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con616843.",Non-OADS,/arxiv_data1/oa_pdf/38/de/tobaccocontrol-2016-053096.PMC5099206.pdf
2012. http://www.knowledgenetworks.com/knpanel/docs/GfK-KnowledgePanel (R)-Demographic-Pro ﬁle.pdf (accessed 1 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/38/de/tobaccocontrol-2016-053096.PMC5099206.pdf
2015. https://www.gov.uk/government/uploads/system/uploads/attachment_data/ ﬁle/457102/Ecigarettes_an_evidence_update_A_report_ commissioned_by_Public_Health_England_FINAL.pdf (accessed 31 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/38/de/tobaccocontrol-2016-053096.PMC5099206.pdf
http://www.smokinginengland.info/latest-statistics/ (accessed 18Jul 2016).,OADS,/arxiv_data1/oa_pdf/38/de/tobaccocontrol-2016-053096.PMC5099206.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ heartjnl-2015-308883).,Non-OADS,/arxiv_data1/oa_pdf/cd/98/heartjnl-2015-308883.PMC5099208.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Hunt SA, Abraham WT, Chin MH, et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/98/heartjnl-2015-308883.PMC5099208.pdf
http://www.nice.org.uk/ nicemedia/pdf/Arrhythmias_FAD.pdf 14 National Institute for Health and Clinical Excellence.,Non-OADS,/arxiv_data1/oa_pdf/cd/98/heartjnl-2015-308883.PMC5099208.pdf
"Cardiac resynchronisation therapy for the treatment of heart failure: Final Appraisal Determination.http://www.nice.org.uk/nicemedia/pdf/Heartfailure_FAD.pdf 15 Woods B, Hawkins N, Mealing S, et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/98/heartjnl-2015-308883.PMC5099208.pdf
https://www.nice.org.uk/guidance/ta314/ documents 17 National Institute for Health and Care Excellence.,Non-OADS,/arxiv_data1/oa_pdf/cd/98/heartjnl-2015-308883.PMC5099208.pdf
"https://www.nice.org.uk/article/pmg9/chapter/foreword 18 Briggs ACK, Sculpher M. Decision Modelling for Health Economic Evaluation .",Non-OADS,/arxiv_data1/oa_pdf/cd/98/heartjnl-2015-308883.PMC5099208.pdf
"https://www.york.ac.uk/ media/che/documents/papers/discussionpapers/CHE%20Discussion%20Paper%20172.pdf 21 Cowie MR, Fox KF, Wood DA, et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/98/heartjnl-2015-308883.PMC5099208.pdf
NHS Reference costs 2012. https://www.gov.uk/government/ collections/nhs-reference-costs 23 Curtis L. Unit costs of health and social care 2012 http://www.pssru.ac.uk/ 24 British National Formulary.,Non-OADS,/arxiv_data1/oa_pdf/cd/98/heartjnl-2015-308883.PMC5099208.pdf
http://www.bnf.org/ 25 National Institute for Health and Care Excellence.,Non-OADS,/arxiv_data1/oa_pdf/cd/98/heartjnl-2015-308883.PMC5099208.pdf
"Implantable cardioverter deﬁbrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120): http://www.nice.org.uk/guidance/ta314/documents/ arrythmias-icds-heart-failure-cardiac-resynchronisation-fad-document2 26 Goldenberg I, Gillespie J, Moss AJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/98/heartjnl-2015-308883.PMC5099208.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/gutjnl-2014-308883).,Non-OADS,/arxiv_data1/oa_pdf/23/79/gutjnl-2014-308883.PMC5099209.pdf
"Correspondence to Dr Pierre-Emmanuel Rautou,Paris—Centre de recherche Cardiovasculaire à l ’HEGP, INSERM —U970, 56, rue Leblanc, 75373 Paris,cedex 15, France;pierre-emmanuel.rautou@ inserm.fr Received 24 November 2014 Revised 9 August 2015Accepted 13 August 2015Published Online First 3 September 2015 ▸http://dx.doi.org/10.1136/ gutjnl-2015-310044 To cite: Loyer X, Paradis V, Hénique C, et al.Gut 2016; 65:1882 –1894.ABSTRACT Objective Previous studies suggested that microRNA- 21 may be upregulated in the liver in non-alcoholicsteatohepatitis (NASH), but its role in the developmentof this disease remains unknown.",Non-OADS,/arxiv_data1/oa_pdf/23/79/gutjnl-2014-308883.PMC5099209.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Chalasani N, Younossi Z, Lavine JE, et al.",Non-OADS,/arxiv_data1/oa_pdf/23/79/gutjnl-2014-308883.PMC5099209.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ tobaccocontrol-2016-053094).,Non-OADS,/arxiv_data1/oa_pdf/9e/43/tobaccocontrol-2016-053094.PMC5099210.pdf
"W e purchased LCC-related tweets from Gnip (http://www.gnip.com), the of ﬁcial T witter data provider.",Non-OADS,/arxiv_data1/oa_pdf/9e/43/tobaccocontrol-2016-053094.PMC5099210.pdf
"A tweet was included in the data set if it matched one or moreof the keyword rules (eg, brands: swisher OR swishers, swishaOR swishas, splitarillo OR splitarillos; product names, includingslang terms: rello OR rellos, rillo OR rillos, blunt- ‘james blunt ’-‘emily blunt ’-st_blunt- ‘too blunt ’-‘be blunt ’) (see online supplementary appendix 1 for a complete list of search rules).Keyword rules were chosen based on the trends (eg, throughuse of http://www.topsy.com that showed the volume of relevantT weets over the past 30 days as well as examples of actualT weets containing the searched keyword), prior literature andresearch team expert consensus based on knowledge ofLCC-related terminology and brands.",Non-OADS,/arxiv_data1/oa_pdf/9e/43/tobaccocontrol-2016-053094.PMC5099210.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Sterling K, Berg CJ, Thomas AN, et al.",Non-OADS,/arxiv_data1/oa_pdf/9e/43/tobaccocontrol-2016-053094.PMC5099210.pdf
"https://federalregister.gov/a/2016-10685 14 Substance Abuse and Mental Health Services Administration, Results from the 2011 National Survey on Drug Use and Health: Detailed Tables, 2012. http://www.samhsa.gov/data/sites/default/ ﬁles/Revised2k11NSDUHSummNatFindings/ Revised2k11NSDUHSummNatFindings/NSDUHresults2011.htm 15 Soldz S, Huyser DJ, Dorsey E. The cigar as a drug delivery device: youth use of blunts.",OADS,/arxiv_data1/oa_pdf/9e/43/tobaccocontrol-2016-053094.PMC5099210.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Mehta RH, Granger CB, Alexander KP, et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/da/heartjnl-2015-308905.PMC5099211.pdf
"Hyattsville, MD: National Center for Health Statistics (US), 2006. http://www.ncbi.nlm.nih.gov/books/NBK21002/ 3 Hochholzer W, Wiviott SD, Antman EM, et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/da/heartjnl-2015-308905.PMC5099211.pdf
"http://apps.who.int/gho/ data/view.main.60580 1654 Petroni T, et al.Heart 2016; 102:1648–1654.",OADS,/arxiv_data1/oa_pdf/e9/da/heartjnl-2015-308905.PMC5099211.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/ tobaccocontrol-2016-053076).,Non-OADS,/arxiv_data1/oa_pdf/d7/4b/tobaccocontrol-2016-053076.PMC5099212.pdf
"included webinars and teleconferences organised by CDC ’s Ofﬁce on Smoking and Health with state TCPs and national partners, pointers to the SCTC website from others (eg, http://www.CounterT obacco.Org and http://www.T obacconomics.org),email announcements to key non-governmental agencies (eg, Campaign for T obacco-Free Kids) as well as social media post- ings (T witter and Facebook).",Non-OADS,/arxiv_data1/oa_pdf/d7/4b/tobaccocontrol-2016-053076.PMC5099212.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Lee JG, Henriksen L, Rose SW, et al.",Non-OADS,/arxiv_data1/oa_pdf/d7/4b/tobaccocontrol-2016-053076.PMC5099212.pdf
"2016. https://www.ftc.gov/system/ ﬁles/documents/reports/federal-trade-commission- cigarette-report-2013/2013cigaretterpt.pdf 5 Agaku IT, King BA, Dube SR. Trends in exposure to pro-tobacco advertisements over the Internet, in newspapers/magazines, and at retail stores among U.S. middle and high school students, 2000 –2012.",Non-OADS,/arxiv_data1/oa_pdf/d7/4b/tobaccocontrol-2016-053076.PMC5099212.pdf
"2015. http://www.healthystoreshealthy community.com/ 22 Lange T, Hoefges M, Ribisl KM.",Non-OADS,/arxiv_data1/oa_pdf/d7/4b/tobaccocontrol-2016-053076.PMC5099212.pdf
"Final report for the California Tobacco Advertising Survey (2011) Submitted to the California Tobacco Control Program, CaliforniaDepartment of Public Health, 2013. https://www.cdph.ca.gov/programs/tobacco/Documents/Resources/Publications/CTAS11-FinalReport-FINAL%20APPROVED.pdf 30 Barker DC, Jackson K, Rimkus L. Bridging the Gap Community Obesity Measures Project, Tobacco Store Observation Form Reliability Table.",Non-OADS,/arxiv_data1/oa_pdf/d7/4b/tobaccocontrol-2016-053076.PMC5099212.pdf
"George Warren Brown School of Social Work at Washington University in St. Louisand the Tobacco Control Legal Consortium, 2015. http://cphss.wustl.edu/Products/ ProductsDocuments/ASPiRE_2015_STARS_Report.pdf 32 Feinstein AR, Cicchetti DV.",Non-OADS,/arxiv_data1/oa_pdf/d7/4b/tobaccocontrol-2016-053076.PMC5099212.pdf
"2016. http://cphss.wustl.edu/Products/Documents/ASPiRE_2014_ReportToTheNation.pdf 38 Schmitt CL, Lee YO, Curry LE, et al.",OADS,/arxiv_data1/oa_pdf/d7/4b/tobaccocontrol-2016-053076.PMC5099212.pdf
"Hermiston Herald, 2015. http://www.hermistonherald.com/hh/local-news/20150203/tobacco-placement- targets-teens-in-county 41 Flood J, Minkler M, Hennessey Lavery S, et al.",Non-OADS,/arxiv_data1/oa_pdf/d7/4b/tobaccocontrol-2016-053076.PMC5099212.pdf
"Annual Meeting for SRNT 2016. http://tobacconomics.org/research/evaluating- implementation-of-chicagos-city-ordinance-restricting-sales-of- ﬂavored-tobacco- products-near-schools/ 43 Leischow SJ, Henderson PN, Laux F, et al.Implementing STARS in Indian Country: observations and experiences society for research on nicotine and tobacco .",Non-OADS,/arxiv_data1/oa_pdf/d7/4b/tobaccocontrol-2016-053076.PMC5099212.pdf
"2016.https://www.phenxtoolkit.org/index.php?pageLink=browse.protocols&id=741000 45 Siripachot P, Wongsuriyanan S, Hamann S. Development and ﬁndings from an instrument for retail point of sale assessment in youth-frequented locations inThailand.",Non-OADS,/arxiv_data1/oa_pdf/d7/4b/tobaccocontrol-2016-053076.PMC5099212.pdf
"http://www.cdph.ca.gov/programs/tobacco/Documents/Resources/Publications/Tobacco%20Marketing%20in%20Californias%20Retail% 20Environment_Notations_Final%202.9.16.pdf i74 Henriksen L, et al.Tob Control 2016; 25:i67–i74.",Non-OADS,/arxiv_data1/oa_pdf/d7/4b/tobaccocontrol-2016-053076.PMC5099212.pdf
"METHODS Collaboration As part of the State and Community T obacco Control (SCTC) research initiative (http://www.sctcresearch.org), this project was developed in stra-tegic partnership with Denver Public Health andJefferson County Public Health departments inColorado.",OADS,/arxiv_data1/oa_pdf/52/cc/tobaccocontrol-2016-053091.PMC5099213.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Substance Abuse and Mental Health Services Administration.,Non-OADS,/arxiv_data1/oa_pdf/52/cc/tobaccocontrol-2016-053091.PMC5099213.pdf
https://www.colorado.gov/paci ﬁc/cdphe/ marijuanause 3 Substance Abuse and Mental Health Services Administration.,OADS,/arxiv_data1/oa_pdf/52/cc/tobaccocontrol-2016-053091.PMC5099213.pdf
"http://www.cdc.gov/nchs/products/ databriefs/db217.htm 5 Cohn A, Villanti A, Richardson A, et al.",OADS,/arxiv_data1/oa_pdf/52/cc/tobaccocontrol-2016-053091.PMC5099213.pdf
"The triangulum: tobacco, marijuana, and e-cigarettes, 2016. http://trdrp.yes4yes.com/events/webinar_form.php?",Non-OADS,/arxiv_data1/oa_pdf/52/cc/tobaccocontrol-2016-053091.PMC5099213.pdf
"The US vaporizer market is booming, 2015. http://www.businessinsider.",Non-OADS,/arxiv_data1/oa_pdf/52/cc/tobaccocontrol-2016-053091.PMC5099213.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/heartjnl-2016-309576).,Non-OADS,/arxiv_data1/oa_pdf/14/9a/heartjnl-2016-309576.PMC5099214.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Haider AW, Larson MG, Benjamin EJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/14/9a/heartjnl-2016-309576.PMC5099214.pdf
"Competing interests KMR is the Chair of the Board of Directors of Counter Tools (http://countertools.org), a non-pro ﬁt from which he receives compensation.",Non-OADS,/arxiv_data1/oa_pdf/b7/00/tobaccocontrol-2016-053230.PMC5099216.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Jamal AH, David M, O ’Connor E, et al.",Non-OADS,/arxiv_data1/oa_pdf/b7/00/tobaccocontrol-2016-053230.PMC5099216.pdf
2012. http://appliedresearch.cancer.gov/tus-cps/.,Non-OADS,/arxiv_data1/oa_pdf/b7/00/tobaccocontrol-2016-053230.PMC5099216.pdf
"http://thedataweb.rm.census.gov/ftp/cps_ftp.html#cpssupps 20 ScheuermannTS, Mburu WE, Mathur C, et al.",OADS,/arxiv_data1/oa_pdf/b7/00/tobaccocontrol-2016-053230.PMC5099216.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/thoraxjnl-2015-207781).,Non-OADS,/arxiv_data1/oa_pdf/e7/b1/thoraxjnl-2015-207781.PMC5099217.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Amulic B, Cazalet C, Hayes GL, et al.",Non-OADS,/arxiv_data1/oa_pdf/e7/b1/thoraxjnl-2015-207781.PMC5099217.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Arnett JJ.,Non-OADS,/arxiv_data1/oa_pdf/1f/db/tobaccocontrol-2016-053086.PMC5099219.pdf
http://www.cdc.gov/tobacco/data_statistics/surveys/nats (accessed 11 Mar 2016).,OADS,/arxiv_data1/oa_pdf/1f/db/tobaccocontrol-2016-053086.PMC5099219.pdf
http://navajobusiness.com/fastFacts/Overview.htm (accessed 2016).,Non-OADS,/arxiv_data1/oa_pdf/ec/63/tobaccocontrol-2016-053109.PMC5099220.pdf
2015. http://www.sctcresearch.org/research-areas/secondhand-smoke-policies/networks-among-tribal-organizations-clean-air-poli/ (accessed 15 Feb 2016).What this paper adds ▸Federally recognized American Indian tribes like the Navajo Nation are sovereign and exempt from state tobacco controllaws.,Non-OADS,/arxiv_data1/oa_pdf/ec/63/tobaccocontrol-2016-053109.PMC5099220.pdf
"The health consequences of involuntary exposure to tobacco smoke: A report of the surgeon general, 2006. http://www.surgeongeneral.gov/ library/reports/secondhandsmoke/fullreport.pdf 14 Guide to Community Preventive Services.",Non-OADS,/arxiv_data1/oa_pdf/ec/63/tobaccocontrol-2016-053109.PMC5099220.pdf
http://www.no-smoke.org/document.php?id=730 32 Patterson JM.,Non-OADS,/arxiv_data1/oa_pdf/ec/63/tobaccocontrol-2016-053109.PMC5099220.pdf
Navajo Times http://www.navajotimes.com/politics/2011/0811/081311smoking.php#top 34 Fonseca F. (20 Aug 2011).,Non-OADS,/arxiv_data1/oa_pdf/ec/63/tobaccocontrol-2016-053109.PMC5099220.pdf
The Arizona Republic http://www.azcentral.com.,Non-OADS,/arxiv_data1/oa_pdf/ec/63/tobaccocontrol-2016-053109.PMC5099220.pdf
The Arizona Republic http://www.azcentral.com.,Non-OADS,/arxiv_data1/oa_pdf/ec/63/tobaccocontrol-2016-053109.PMC5099220.pdf
(2011) President Ben Shelly Vetoes Navajo Nation Smoking Regulation Act of 2011 [Press Release].http://www.navajonsn.gov/News%20Releases/OPVP/Aug11/8511_ PresidentBenShellyVetoesNavajoNationSmokingRegulationActof2011.pdf 37 Exec.,Non-OADS,/arxiv_data1/oa_pdf/ec/63/tobaccocontrol-2016-053109.PMC5099220.pdf
"Acknowledgements This paper contains some material that was originally published in a June 2015 report available here: http://publichealthlawcenter.org/ sites/default/ ﬁles/resources/ASPiRE_2015_NYC_CaseStudy.pdf Figure 2 Signs for Sensible Tobacco Enforcement and Tobacco 21. i8 Moreland-Russell S, et al.Tob Control 2016; 25:i6–i9.",Non-OADS,/arxiv_data1/oa_pdf/51/36/tobaccocontrol-2016-053089.PMC5099222.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 U.S. Department of Health and Human Services.,Non-OADS,/arxiv_data1/oa_pdf/51/36/tobaccocontrol-2016-053089.PMC5099222.pdf
"St. Louis, MO: Center for Public Health Systems Science at the Brown School atWashington University, the National Cancer Institute, and State and Community Tobacco Control Research, 2015. https://cphss.wustl.edu/Products/ ProductsDocuments/ASPiRE_2015_NYC_CaseStudy.pdf (accessed 24 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/51/36/tobaccocontrol-2016-053089.PMC5099222.pdf
Secondary Increasing the Minimum Legal Sale Age forTobacco Products to 21 2014. http://www.tobaccofreekids.org/research/factsheets/pdf/0376.pdf 9 Institute of Medicine of the National Academies.,Non-OADS,/arxiv_data1/oa_pdf/51/36/tobaccocontrol-2016-053089.PMC5099222.pdf
"PublicHealth Implications of Raising the Minimum Age of Legal Access to TobaccoProducts, 2015. http://www.nationalacademies.org/hmd/~/media/Files/Report%20Files/2015/TobaccoMinAge/tobacco_minimum_age_report_brief.pdf (accessed 24 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/51/36/tobaccocontrol-2016-053089.PMC5099222.pdf
"Secondary A Regulation Limiting Tobacco and Nicotine Access by Youth ( “Youth Access Regulation ”), 2011. http://www.bphc.org/ boardofhealth/regulati ons/Documents/Tobacco_Control_Youth_Access_ Regulation.pdf 19 Grimshaw V. Interview, bureau of chronic disease prevention and tobacco control .",Non-OADS,/arxiv_data1/oa_pdf/51/36/tobaccocontrol-2016-053089.PMC5099222.pdf
http://www.nyc.gov/html/doh/downloads/pdf/smoke/tobacco-21-faq.pdf (accessed 16 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/51/36/tobaccocontrol-2016-053089.PMC5099222.pdf
Secondary Flat Phil 2015. http://nycsmokefree.org/ ﬂatphil 22 New York City Council Committee on Health.,Non-OADS,/arxiv_data1/oa_pdf/51/36/tobaccocontrol-2016-053089.PMC5099222.pdf
"1020, 1021, and 250A, May 2,2013 2013. http://council.nyc.gov/html/home/home.shtml 23 Tobacco companies challenge NYC coupon ban.",Non-OADS,/arxiv_data1/oa_pdf/51/36/tobaccocontrol-2016-053089.PMC5099222.pdf
"Press Association, Inc. 2014. from: https://www.highbeam.com/doc/1A1-1497f39c14e149499b7decef67d69f35.html (accessed 24 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/51/36/tobaccocontrol-2016-053089.PMC5099222.pdf
"Secondary New York City Point-of-Sale Legislation, 2013. http://countertobacco.org/new-york-city-point-sale- legislation 25 Lagreid P. Suffolk County, NY Raises Tobacco Purchase Age to 21 (Update).",Non-OADS,/arxiv_data1/oa_pdf/51/36/tobaccocontrol-2016-053089.PMC5099222.pdf
"Secondary Suffolk County, NY Raises Tobacco Purchase Age to 21 (Update) 2014. http://halfwheel.com/suffolk-county-n-y-raises-tobacco-purchase-age-21/ 51561 26 Glantz SA, Smith LR.",Non-OADS,/arxiv_data1/oa_pdf/51/36/tobaccocontrol-2016-053089.PMC5099222.pdf
"Competing interests KMR is the Chair of the Board of Directors of Counter Tools (http://countertools.org), a non-pro ﬁt from which he receives compensation.",Non-OADS,/arxiv_data1/oa_pdf/3f/95/tobaccocontrol-2016-053075.PMC5099223.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Federal Trade Commission.,Non-OADS,/arxiv_data1/oa_pdf/3f/95/tobaccocontrol-2016-053075.PMC5099223.pdf
"Secondary The War in the Store 2015. http://countertobacco.org/warinthestore 3 Henriksen L. Comprehensive tobacco marketing restrictions: promotion, packaging, price and place.",Non-OADS,/arxiv_data1/oa_pdf/3f/95/tobaccocontrol-2016-053075.PMC5099223.pdf
"Overview of the Family Smoking Prevention and Tobacco Control Act Secondary Overview of the Family Smoking Prevention andTobacco Control Act 2015. http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm246129.htm 18 Lange T, Hoefges M, Ribisl KM.",Non-OADS,/arxiv_data1/oa_pdf/3f/95/tobaccocontrol-2016-053075.PMC5099223.pdf
Secondary State Tax Increase Legislation 2016. http://www.natocentral.org/?page_id=2603 25 Centers for Disease Control and Prevention.,Non-OADS,/arxiv_data1/oa_pdf/3f/95/tobaccocontrol-2016-053075.PMC5099223.pdf
Secondary Grants Notice: CDC-RFA-DP15-1509 2014. http://www.grants.gov/web/ grants/search-grants.html?keywords=DP15-1509 26 Centers for Disease Control and Prevention (CDC).,Non-OADS,/arxiv_data1/oa_pdf/3f/95/tobaccocontrol-2016-053075.PMC5099223.pdf
"2016. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm499234.htm 31 Schleicher NC, Johnson T, Ahmad I, et al.",OADS,/arxiv_data1/oa_pdf/3f/95/tobaccocontrol-2016-053075.PMC5099223.pdf
Secondary Tobacco Marketing in Californias Retail Environment 2015.http://www.cdph.ca.gov/programs/tobacco/Documents/Resources/Publications/Tobacco%20Marketing%20in%20Californias%20Retail%20Environment_ Notations_Final%202.9.16.pdf 32 National Conference of State Legislatures.,Non-OADS,/arxiv_data1/oa_pdf/3f/95/tobaccocontrol-2016-053075.PMC5099223.pdf
"Secondary Alternative Nicotine Products, Electronic Cigarettes 2016.http://www.ncsl.org/research/health/alternative-nicotine-products-e-cigarettes.aspx 33 Luke D, Moreland-Russell S, Combs T, et al.",Non-OADS,/arxiv_data1/oa_pdf/3f/95/tobaccocontrol-2016-053075.PMC5099223.pdf
2015. http://cphss.wustl.edu/Products/ProductsDocuments/ ASPiRE_2015_ReportToTheNation.pdf#PointofSaleReporttotheNation: PolicyActivity2012-2014 34 McLaughlin I.,Non-OADS,/arxiv_data1/oa_pdf/3f/95/tobaccocontrol-2016-053075.PMC5099223.pdf
"Secondary Healthy Stores for a Healthy Community 2014. http://healthystoreshealthycommunity.com/ Luke DA, et al.Tob Control 2016; 25:i44–i51.",Non-OADS,/arxiv_data1/oa_pdf/3f/95/tobaccocontrol-2016-053075.PMC5099223.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ To cite Roeseler A, Meaney M, Riordan M, et al .Tob Control 2016; 25:i1–i3.",Non-OADS,/arxiv_data1/oa_pdf/3b/1c/tobaccocontrol-2016-053350.PMC5099224.pdf
"http://www.sctcresearch.org/ i2 Roeseler A, et al .Tob Control October 2016 Vol 25 No S1Editorial",Non-OADS,/arxiv_data1/oa_pdf/3b/1c/tobaccocontrol-2016-053350.PMC5099224.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 U.S. Department of Health and Human Services.,Non-OADS,/arxiv_data1/oa_pdf/01/b2/tobaccocontrol-2016-053012.PMC5099225.pdf
https://nces.ed.gov/ programs/handbook/data/pdf/appendix_d.pdf (accessed 5 Feb 2014).,OADS,/arxiv_data1/oa_pdf/01/b2/tobaccocontrol-2016-053012.PMC5099225.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Centers for Disease Control and Prevention (CDC).,Non-OADS,/arxiv_data1/oa_pdf/e8/fe/tobaccocontrol-2016-053045.PMC5099226.pdf
Tobacco Control State Highlights 2012. http://www.cdc.gov/tobacco/data_statistics/state_data/state_highlights/2012/pdfs/states/north_carolina.pdf (accessed 3 Mar 2016).,OADS,/arxiv_data1/oa_pdf/e8/fe/tobaccocontrol-2016-053045.PMC5099226.pdf
2010. https://www.dshs.state.tx.us/chs/brfss/query/brfss_form.shtm (accessed 7 Mar 2016).,OADS,/arxiv_data1/oa_pdf/e8/fe/tobaccocontrol-2016-053045.PMC5099226.pdf
2016. https://smartystreets.com/ (accessed 28 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/e8/fe/tobaccocontrol-2016-053045.PMC5099226.pdf
2007. http://www.cdc.gov/brfss/annual_data/pdf-ques/2008brfss.pdf (accessed 15 Jan 2016).,OADS,/arxiv_data1/oa_pdf/e8/fe/tobaccocontrol-2016-053045.PMC5099226.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Wilson S. Research is ceremony: indigenous research methods .,Non-OADS,/arxiv_data1/oa_pdf/9a/8b/tobaccocontrol-2016-053081.PMC5099227.pdf
2008. http://www.navajo-nsn.gov/News%20Releases/George%20Hardeen/Aug08/President %20Shirley%20vetoes%20Commercial%20Tobacco%20ban%20legislation%20for %20Aug%20%207.pdf (accessed 23 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/9a/8b/tobaccocontrol-2016-053081.PMC5099227.pdf
2009. http://www.navajo-nsn.gov/News%20Releases/Joshua%20Lavar%20Butler/Oct09/091021spkr_NNC_Fall_Session_Day_Three.pdf 26 Clark F. In becoming Sa ’ah Naaghai Bik ’eh Hozhoon: the historical challenges and triumphs of Dine College .,Non-OADS,/arxiv_data1/oa_pdf/9a/8b/tobaccocontrol-2016-053081.PMC5099227.pdf
"March 15, 2016. http://www.navajonationcouncil.org/pressReleases/2016/Mar/LOC_receives_report_from_Navajo_Division_of_Public_Safety_regarding_initiatives_of_public_safety.pdf (accessed 1 Jul 2016).",Non-OADS,/arxiv_data1/oa_pdf/9a/8b/tobaccocontrol-2016-053081.PMC5099227.pdf
"Kelowna,BC: Unviersity Of British Columbia Okanagan, 2010. http://www.cyhrnet.ca/pamphletsbrochures.php (accessed 1 July 2016).",Non-OADS,/arxiv_data1/oa_pdf/9a/8b/tobaccocontrol-2016-053081.PMC5099227.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/tobaccocontrol-2016-053093).,Non-OADS,/arxiv_data1/oa_pdf/c9/a4/tobaccocontrol-2016-053093.PMC5099228.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 International Agency for Research on Cancer.,Non-OADS,/arxiv_data1/oa_pdf/c9/a4/tobaccocontrol-2016-053093.PMC5099228.pdf
http://archive.boston.com/business/globe/articles/2003/10/18/at_some_vendors_cost_of_cigarettes_rises_as_state_enforces_pricing_law/ (accessed 18 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/c9/a4/tobaccocontrol-2016-053093.PMC5099228.pdf
2000. https://www.tax.ny.,Non-OADS,/arxiv_data1/oa_pdf/c9/a4/tobaccocontrol-2016-053093.PMC5099228.pdf
2011. http://publichealthlawcenter.org/sites/default/ ﬁ les/resources/tclc-guide- cigminimumpricelaws-2011.pdf (accessed 16 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/c9/a4/tobaccocontrol-2016-053093.PMC5099228.pdf
"Information Brief Minnesota House of Representatives Research Department, 2000. http://www.leg.state.mn.us/docs/pre2003/other/000646.pdf (accessed 24 Mar 2016).",Non-OADS,/arxiv_data1/oa_pdf/c9/a4/tobaccocontrol-2016-053093.PMC5099228.pdf
http://www.tobaccopolicycenter.org/documents/Price%20Promotion%20Local%20Regulation%20FINAL.pdf (accessed 18 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/c9/a4/tobaccocontrol-2016-053093.PMC5099228.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ gutjnl-2016-312444).,OADS,/arxiv_data1/oa_pdf/d1/63/gutjnl-2016-312444.PMC5099229.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 American Association for the Study of Liver Diseases and the Infectious Diseases Society of America.,Non-OADS,/arxiv_data1/oa_pdf/d1/63/gutjnl-2016-312444.PMC5099229.pdf
"Recommendations for testing, managing, and treating hepatitis C. http://www.Hcvguidelines.org/full-Report-View (accessed 21 Apr 2015).",Non-OADS,/arxiv_data1/oa_pdf/d1/63/gutjnl-2016-312444.PMC5099229.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ bjsports-2016-096134).,Non-OADS,/arxiv_data1/oa_pdf/5b/9b/bjsports-2016-096134.PMC5099231.pdf
DTI data were processed with the Functional MRI of the Brain (FMRIB) Software Library (FSL) software package (http://www.fmrib.ox.ac.uk/fsl).,OADS,/arxiv_data1/oa_pdf/5b/9b/bjsports-2016-096134.PMC5099231.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Daneshvar DH, Nowinski CJ, McKee AC, et al.",Non-OADS,/arxiv_data1/oa_pdf/5b/9b/bjsports-2016-096134.PMC5099231.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/c2/main.PMC5099258.pdf
The  osteochondral  cylinder  which  is regularly  obtained  after  preparation  for  creating  the  entrance  point of  the  nail  was  then  extracorporally  processed  by  removing  carti- http://dx.doi.org/10.1016/j.ijscr.2016.10.064 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/7a/c2/main.PMC5099258.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 961–969 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.10.002 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/a2/8f/main.PMC5099260.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/8f/main.PMC5099260.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/8f/main.PMC5099260.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/f7/main.PMC5099262.pdf
"The  patient  had  CT  in  our  hospital, http://dx.doi.org/10.1016/j.ijscr.2016.10.053 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/64/f7/main.PMC5099262.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Polycystic kidney and hepatic disease 1 (PKHD1 ) Autosomal recessive polycystic kidney disease(ARPKD)Next generation sequencing (NGS)PhylogeneticPathogenicity prediction 1.,Non-OADS,/arxiv_data1/oa_pdf/10/19/main.PMC5099264.pdf
http://dx.doi.org/10.1016/j.gdata.2016.10.0092213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/10/19/main.PMC5099264.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/19/main.PMC5099264.pdf
The Protein sequence alignments were performed using ClustalW ( http://www.clustal.org/clustal2 )a n d AB C Fig.,OADS,/arxiv_data1/oa_pdf/10/19/main.PMC5099264.pdf
The pairwise distance matrix between DNA sequences was constructed using the evolutionary model default parameter “JC69 ”in Bioconductor program ( https://www.bioconductor.org ).,OADS,/arxiv_data1/oa_pdf/10/19/main.PMC5099264.pdf
"The results obtained by using the two different methods [(CLCbio and PhyML ( http://atgc.lirmm.fr/phyml )] were al- most identical, in addition to their corresponding internal bootstrapsupport, demonstrating the reliability of the phylogenetic analysis.",OADS,/arxiv_data1/oa_pdf/10/19/main.PMC5099264.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/aa/main.PMC5099265.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.10.016 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/aa/main.PMC5099265.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 7 e9,Non-OADS,/arxiv_data1/oa_pdf/cb/aa/main.PMC5099265.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Colorectal cancerKiller cell immunoglobulin-like receptorMeta-analysis 1.,Non-OADS,/arxiv_data1/oa_pdf/aa/53/main.PMC5099266.pdf
http://dx.doi.org/10.1016/j.gdata.2016.10.010 2213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/aa/53/main.PMC5099266.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/53/main.PMC5099266.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/c9/main.PMC5099267.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2016.10.002 2211-3207/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/c9/main.PMC5099267.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 971–978 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.10.003 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/1f/e7/main.PMC5099268.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/e7/main.PMC5099268.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/1f/e7/main.PMC5099268.pdf
< http://www.paralympic.org/nordic-skiing/rules- and-regulations/classiﬁcation >.,Non-OADS,/arxiv_data1/oa_pdf/1f/e7/main.PMC5099268.pdf
"We reported cisplatin- induced increase in the nitration of proteins in the cochlear sensory http://dx.doi.org/10.1016/j.redox.2016.10.016 Received 28 September 2016; Received in revised form 3 October 2016; Accepted 12 October 2016⁎Corresponding author at: Institute of Environmental Health Sciences, Wayne State University, 6135 Woodward Avenue, Detroit, MI 48202, USA.",OADS,/arxiv_data1/oa_pdf/67/e9/main.PMC5099269.pdf
This is an open access article under the  CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).Available online 31 October 2016 crossmark,Non-OADS,/arxiv_data1/oa_pdf/67/e9/main.PMC5099269.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: StigmaWeight stigmaEatingDiet Obesity College students 1.,Non-OADS,/arxiv_data1/oa_pdf/39/e9/main.PMC5099270.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.10.005 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/39/e9/main.PMC5099270.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/e9/main.PMC5099270.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/39/e9/main.PMC5099270.pdf
https://annualreport.asu.edu/sites/ default/ ﬁles/asu_innovation_2015_yearinreview_web.pdf (Published 2015.,Non-OADS,/arxiv_data1/oa_pdf/39/e9/main.PMC5099270.pdf
https://nces.ed.gov/ programs/digest/d14/tables/dt14_303.40.asp (Published May 2015.,OADS,/arxiv_data1/oa_pdf/39/e9/main.PMC5099270.pdf
nov. MALDI-TOF MS spectrum accession number The MALDI-TOF MS spectrum of “Ezakiella massiliensis ”is available at http://www.mediterranee-infection.com/article.php?,Non-OADS,/arxiv_data1/oa_pdf/5e/34/main.PMC5099271.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.09.011,Non-OADS,/arxiv_data1/oa_pdf/5e/34/main.PMC5099271.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,15,1 6 –17 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5e/34/main.PMC5099271.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.09.016,Non-OADS,/arxiv_data1/oa_pdf/8e/c8/main.PMC5099272.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,15,1 4–15 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/8e/c8/main.PMC5099272.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/87/main.PMC5099273.pdf
The http://dx.doi.org/10.1016/j.ijscr.2016.10.048 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/87/main.PMC5099273.pdf
"Wu,  Multiple  primary malignancies involving  lung  cancer,  BMC  Cancer  15  (2015)  696,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6a/87/main.PMC5099273.pdf
"24  (2015)  e11–e33,  http://dx.doi.org/ 10.1016/j.hlc.2014.08.012 .",OADS,/arxiv_data1/oa_pdf/6a/87/main.PMC5099273.pdf
"31  (2007)  322–324,  http://dx.doi.org/10.1016/j.ejcts.",OADS,/arxiv_data1/oa_pdf/6a/87/main.PMC5099273.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.10.015 2213-0071/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f4/e6/main.PMC5099274.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 1 e3,Non-OADS,/arxiv_data1/oa_pdf/f4/e6/main.PMC5099274.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Fast food restaurantSit-down restaurantProcessed meatRed meat Reﬁned grains Sweets 1.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/main.PMC5099275.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.10.011 2211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/main.PMC5099275.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/9a/main.PMC5099275.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/59/9a/main.PMC5099275.pdf
Available from: http://www.ers.usda.gov/publications/eib-economic- information-bulletin/eib105/report-summary.aspx ).,Non-OADS,/arxiv_data1/oa_pdf/59/9a/main.PMC5099275.pdf
"In terms of aging, both MsrA and MsrB1 now appear to bedispensable for mouse longevity [7,8] , though there was historical http://dx.doi.org/10.1016/j.redox.2016.10.012 Received 30 September 2016; Received in revised form 20 October 2016; Accepted 22 October 2016⁎Correspondence to: UTHSCSA, 15355 Lambda Drive, San Antonio, TX 78245, USA.",Non-OADS,/arxiv_data1/oa_pdf/78/99/main.PMC5099276.pdf
This is an open access article under the  CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).Available online 25 October 2016 crossmark,Non-OADS,/arxiv_data1/oa_pdf/78/99/main.PMC5099276.pdf
This  is  an  open  access  article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/ba/main.PMC5099278.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.08.019 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/e5/ba/main.PMC5099278.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.10.050 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
"(2015),  http://dx.doi.org/10.1002/jso.24063 , n/a-n/a.",OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
"45  (2015)  986–997,  http://dx.doi.org/ 10.1111/eci.12495 .",Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
"24  (2003)  539–553,  http://dx.doi.org/10.1210/er.2002-0013 .",Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
"11  (2015)  101–111,  http://dx.doi.org/10.1038/nrendo.2014.188 .",Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
"400 (2015)  349–358,  http://dx.doi.org/10.1007/s00423-015-1277-z .",Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
"81  (2014)  642–651,  http://dx.doi.org/ 10.1111/cen.12542 .",Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
"Cancer  48  (2012) 1739–1749,  http://dx.doi.org/10.1016/j.ejca.2011.07.016 .",Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
"171  (2014) R111–R122, http://dx.doi.org/10.1530/EJE-14-0113 .",Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
"104  (2012)  700–708,  http://dx.doi.org/10.1093/jnci/djs188 .",Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
"Cancer  135  (2014)  2711–2720,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
"112 (2015) 492–495,  http://dx.doi.org/10.1002/jso.24031 .",Non-OADS,/arxiv_data1/oa_pdf/2f/6e/main.PMC5099279.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/36/main.PMC5099280.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.10.014 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/53/36/main.PMC5099280.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 4 e6,Non-OADS,/arxiv_data1/oa_pdf/53/36/main.PMC5099280.pdf
"To verify the functionality of MA, quanti ﬁcation of ferritin H as a substrate for the http://dx.doi.org/10.1016/j.redox.2016.10.015 Received 25 September 2016; Received in revised form 7 October 2016; Accepted 12 October 2016⁎Correspondence to: Department of Molecular Toxicology, German Institute of Human Nutrition, Potsdam-Rehbruecke (DIfE), Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany.",Non-OADS,/arxiv_data1/oa_pdf/0f/75/main.PMC5099282.pdf
This is an open access article under the  CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).Available online 26 October 2016 crossmark,Non-OADS,/arxiv_data1/oa_pdf/0f/75/main.PMC5099282.pdf
"389 https://doi.org/10.3345/kjp.2016.59.10.389Korean J Pediatr 2016;59(10):389-394 Respiratory support with heated humidified  high flow nasal cannula in preterm infants Ga Won Jeon, MD, PhD Department of Pediatrics, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea The incidence of bronchopulmonary dysplasia (BPD) has not decreased over the last decade.",Non-OADS,/arxiv_data1/oa_pdf/5f/d6/kjped-59-389.PMC5099285.pdf
"Frequently used NIVs in neonatal intensive care units (NICUs) are nasal continuous  positive airway pressure (nCPAP), which is the most commonly used ventilator, nasal  intermittent positive pressure ventilation (NIPPV), bi-level nCPAP (BiPAP), sigh CPAP Corresponding author: Ga Won Jeon, MD, PhD Department of Pediatrics, Busan Paik Hospital,  Inje University College of Medicine, 75 Bokji-ro,  Busanjin-gu, Busan 47392, Korea Tel: +82-51-890-6497 Fax: +82-51-895-7785 E-mail: iamgawon@hanmail.net Received: 26 September, 2015 Revised: 13 May, 2016 Accepted: 6 June, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2016;59(10):389-394 https://doi.org/10.3345/kjp.2016.59.10.389 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/5f/d6/kjped-59-389.PMC5099285.pdf
"https://doi.org/10.3345/kjp.2016.59.10.389Jeon GW  • High flow nasal cannula in preterm infants 390(SiPAP), and a heated, humidified high flow nasal cannula  (HHHFNC)8).",Non-OADS,/arxiv_data1/oa_pdf/5f/d6/kjped-59-389.PMC5099285.pdf
391 https://doi.org/10.3345/kjp.2016.59.10.389Korean J Pediatr 2016;59(10):389-394 Efficacy of HFNC compared to other NIV modes  1.,Non-OADS,/arxiv_data1/oa_pdf/5f/d6/kjped-59-389.PMC5099285.pdf
"https://doi.org/10.3345/kjp.2016.59.10.389Jeon GW  • High flow nasal cannula in preterm infants 3926 cmH2O; peak inspiratory pressure, 14–22 cmH2O; and rate, 12– 30 breaths/min), and HHHFNC set (flow rate started at 1 L/min  and increased by 0.5–1 L/min according to the infant’s weight  and respiratory status) were similar to those in other studies.",Non-OADS,/arxiv_data1/oa_pdf/5f/d6/kjped-59-389.PMC5099285.pdf
393 https://doi.org/10.3345/kjp.2016.59.10.389Korean J Pediatr 2016;59(10):389-394 body weight to allow air leakage between the prongs and nares.,Non-OADS,/arxiv_data1/oa_pdf/5f/d6/kjped-59-389.PMC5099285.pdf
https://doi.org/10.3345/kjp.2016.59.10.389Jeon GW  • High flow nasal cannula in preterm infants 394can Academy of Pediatrics.,Non-OADS,/arxiv_data1/oa_pdf/5f/d6/kjped-59-389.PMC5099285.pdf
"395 https://doi.org/10.3345/kjp.2016.59.10.395Korean J Pediatr 2016;59(10):395-401 Enterovirus 71 infection and neurological com­ plications Kyung Yeon Lee, MD, PhD Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea Since the outbreak of the enterovirus 71 (EV71) infection in Malaysia in 1997, large epidemics of EV71  have occurred in the Asia-Pacific region.",Non-OADS,/arxiv_data1/oa_pdf/69/b1/kjped-59-395.PMC5099286.pdf
"Corresponding author: Kyung Yeon Lee, MD, PhD Department of Pediatrics, Ulsan University Hospi - tal, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan  44033, Korea Tel: +82-52-250-8980,  Fax: +82-52-250-7068,  E-mail: pdsnoopy@naver.com Received: 15 August, 2015 Revised: 14 October, 2015 Accepted: 14 October, 2015 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2016;59(10):395­401 https://doi.org/10.3345/kjp.2016.59.10.395 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/69/b1/kjped-59-395.PMC5099286.pdf
"https://doi.org/10.3345/kjp.2016.59.10.395Lee KY  • Neurological diseases by enterovirus 71 396More than 7 million HFMD cases and 2,457 deaths were reported  in China during EV71 epidemics between 2008 and 20129,10).",Non-OADS,/arxiv_data1/oa_pdf/69/b1/kjped-59-395.PMC5099286.pdf
"397 https://doi.org/10.3345/kjp.2016.59.10.395Korean J Pediatr 2016;59(10):395-401 Therefore, early diagnosis of EV71 infection with neurological  involvement and prompt, appropriate management is crucial.",Non-OADS,/arxiv_data1/oa_pdf/69/b1/kjped-59-395.PMC5099286.pdf
"https://doi.org/10.3345/kjp.2016.59.10.395Lee KY  • Neurological diseases by enterovirus 71 398plays major roles in attachment, viral entry, and uncoating, and it  can enable effective EV71 infection35).",Non-OADS,/arxiv_data1/oa_pdf/69/b1/kjped-59-395.PMC5099286.pdf
"399 https://doi.org/10.3345/kjp.2016.59.10.395Korean J Pediatr 2016;59(10):395-401 although occasionally pleocytosis is not observed2,31).",Non-OADS,/arxiv_data1/oa_pdf/69/b1/kjped-59-395.PMC5099286.pdf
"https://doi.org/10.3345/kjp.2016.59.10.395Lee KY  • Neurological diseases by enterovirus 71 400of hand, foot and mouth disease during an epidemic in Taiwan,  1998.",Non-OADS,/arxiv_data1/oa_pdf/69/b1/kjped-59-395.PMC5099286.pdf
401 https://doi.org/10.3345/kjp.2016.59.10.395Korean J Pediatr 2016;59(10):395-401 infections: implications for early recognition and therapy.,Non-OADS,/arxiv_data1/oa_pdf/69/b1/kjped-59-395.PMC5099286.pdf
"https://doi.org/10.3345/kjp.2016.59.10.402Park K, et al.",OADS,/arxiv_data1/oa_pdf/1f/57/kjped-59-402.PMC5099287.pdf
"Corresponding author: Sooyoung Lee, MD, PhD Department of Pediatrics, Ajou University School  of Medicine, 164 World cup-ro, Yeongtong-gu,  Suwon 16499, Korea  Tel +82-31-219-5160,  Fax +82-31-219-4121,  E-mail: jsjs87@ajou.ac.kr Received: 24 May, 2016 Revised: 15 August, 2016 Accepted: 25 August, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2016;59(10):402-407 https://doi.org/10.3345/kjp.2016.59.10.402 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/1f/57/kjped-59-402.PMC5099287.pdf
"403 https://doi.org/10.3345/kjp.2016.59.10.402Korean J Pediatr 2016;59(10):402-407 The major allergens of BW are 8–10 kDa, 16 kDa, 19 kDa, and  24 kDa proteins; the 19 kDa protein is relatively specific for clini - cal reactions to BW9).",OADS,/arxiv_data1/oa_pdf/1f/57/kjped-59-402.PMC5099287.pdf
"https://doi.org/10.3345/kjp.2016.59.10.402Park K, et al.",OADS,/arxiv_data1/oa_pdf/1f/57/kjped-59-402.PMC5099287.pdf
405 https://doi.org/10.3345/kjp.2016.59.10.402Korean J Pediatr 2016;59(10):402-407 but few studies have been reported.,Non-OADS,/arxiv_data1/oa_pdf/1f/57/kjped-59-402.PMC5099287.pdf
"https://doi.org/10.3345/kjp.2016.59.10.402Park K, et al.",OADS,/arxiv_data1/oa_pdf/1f/57/kjped-59-402.PMC5099287.pdf
407 https://doi.org/10.3345/kjp.2016.59.10.402Korean J Pediatr 2016;59(10):402-407 Asthma Immunol 1995;75:56-61.,Non-OADS,/arxiv_data1/oa_pdf/1f/57/kjped-59-402.PMC5099287.pdf
"https://doi.org/10.3345/kjp.2016.59.10.408Seo E, et al.",OADS,/arxiv_data1/oa_pdf/ff/67/kjped-59-408.PMC5099288.pdf
"Despite the signi - ficant level of unresponsiveness to first-line treatment in patients with KD, the best second-Corresponding author: Jeong Jin Yu, MD Department of Pediatrics, Asan Medical Center,  University of Ulsan College of Medicine, 88 Olym - pic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-3924,  Fax: +82-2-473-3725,  E-mail: pediatrist@medimail.co.kr Received: 26 May, 2016 Revised: 26 August, 2016 Accepted: 29 August, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2016;59(10):408­413 https://doi.org/10.3345/kjp.2016.59.10.408 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/ff/67/kjped-59-408.PMC5099288.pdf
409 https://doi.org/10.3345/kjp.2016.59.10.408Korean J Pediatr 2016;59(10):408-413 line treatment remains unknown.,Non-OADS,/arxiv_data1/oa_pdf/ff/67/kjped-59-408.PMC5099288.pdf
"https://doi.org/10.3345/kjp.2016.59.10.408Seo E, et al.",OADS,/arxiv_data1/oa_pdf/ff/67/kjped-59-408.PMC5099288.pdf
"411 https://doi.org/10.3345/kjp.2016.59.10.408Korean J Pediatr 2016;59(10):408-413 data before the initial IVIG treatment which have been analyzed  for the prediction of unresponsiveness to initial IVIG treatment by  other authors18,20-22).",Non-OADS,/arxiv_data1/oa_pdf/ff/67/kjped-59-408.PMC5099288.pdf
"https://doi.org/10.3345/kjp.2016.59.10.408Seo E, et al.",OADS,/arxiv_data1/oa_pdf/ff/67/kjped-59-408.PMC5099288.pdf
413 https://doi.org/10.3345/kjp.2016.59.10.408Korean J Pediatr 2016;59(10):408-413 diology; Cardiac Surgery Committee for Development of Guide - lines for Medical Treatment of Acute Kawasaki Disease.,Non-OADS,/arxiv_data1/oa_pdf/ff/67/kjped-59-408.PMC5099288.pdf
"https://doi.org/10.3345/kjp.2016.59.10.414Yi KH, et al.",OADS,/arxiv_data1/oa_pdf/b7/10/kjped-59-414.PMC5099289.pdf
"Another study concluded that term SGA infants may have  relatively mild disorders that can easily be overlooked but later could have a major impact Corresponding author: Il Tae Hwang, MD Department of Pediatrics, Hallym University Kang - dong Sacred Heart Hospital, Hallym University Col - lege of Medicine, 150 Seongan-ro, Gangdong-gu,  Seoul 05355, Korea  Tel: +82-2-2224-2251,  Fax: +82-2-482-8334,  E-mail ithwang83@hallym.or.kr Received: 11 May, 2016 Revised: 2 September, 2016 Accepted: 7 September, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2016;59(10):414-420 https://doi.org/10.3345/kjp.2016.59.10.414 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/b7/10/kjped-59-414.PMC5099289.pdf
415 https://doi.org/10.3345/kjp.2016.59.10.414Korean J Pediatr 2016;59(10):414-420 on quality of life in adulthood9).,Non-OADS,/arxiv_data1/oa_pdf/b7/10/kjped-59-414.PMC5099289.pdf
"https://doi.org/10.3345/kjp.2016.59.10.414Yi KH, et al.",OADS,/arxiv_data1/oa_pdf/b7/10/kjped-59-414.PMC5099289.pdf
"417 https://doi.org/10.3345/kjp.2016.59.10.414Korean J Pediatr 2016;59(10):414-420 Discussion Our study demonstrated that term SGA children had higher  scores for delinquent behavior, aggressive behavior, and the ex - ternalizing scale on the K-CBCL.",Non-OADS,/arxiv_data1/oa_pdf/b7/10/kjped-59-414.PMC5099289.pdf
"https://doi.org/10.3345/kjp.2016.59.10.414Yi KH, et al.",OADS,/arxiv_data1/oa_pdf/b7/10/kjped-59-414.PMC5099289.pdf
419 https://doi.org/10.3345/kjp.2016.59.10.414Korean J Pediatr 2016;59(10):414-420 adolescents born at term with SGA had significantly lower verbal  IQs than those born AGA.,Non-OADS,/arxiv_data1/oa_pdf/b7/10/kjped-59-414.PMC5099289.pdf
"https://doi.org/10.3345/kjp.2016.59.10.414Yi KH, et al.",OADS,/arxiv_data1/oa_pdf/b7/10/kjped-59-414.PMC5099289.pdf
"421 https://doi.org/10.3345/kjp.2016.59.10.421Korean J Pediatr 2016;59(10):421-424 Recurrent macrophage activation syndrome  since toddler age in an adolescent boy with HLA  B27 positive juvenile ankylosing spondylitis Joon Hyeong Park, MD1, Yu Mi Seo, MD1, Seung Beom Han, MD1,2, Ki Hwan Kim, MD1, Jung Woo Rhim, MD1, Nack Gyun Chung,  MD1, Myung Shin Kim, MD3, Jin Han Kang, MD1,2, Dae Chul Jeong, MD1,2 1Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, 2Vaccine Bio Research Institute, College of Medicine, The Catholic University  of Korea, Seoul, 3Department of Laboratory Medicine, Catholic Genetic Laboratory Center, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of  Korea, Seoul, Korea Recurrent macrophage activation syndrome (MAS) is very rare.",Non-OADS,/arxiv_data1/oa_pdf/c7/ac/kjped-59-421.PMC5099290.pdf
"About 10% of secondary HLH, called as MAS, were associated with autoimmune disor ­Corresponding author: Dae Chul Jeong, MD Department of Pediatrics, Vaccine Bio Research  Institute, Seoul St. Mary’s Hospital, College of  Medicine, The Catholic University of Korea, 222  Banpodaero, Seocho-gu, Seoul 06591, Korea Tel: +82-2-2258-6180 Fax: +82-2-537-4544 E-mail: dcjeong@catholic.ac.kr Received: 3 May, 2016 Revised: 8 August, 2016 Accepted: 18 August, 2016 Copyright © 2016 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2016;59(10):421-424 https://doi.org/10.3345/kjp.2016.59.10.421 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/c7/ac/kjped-59-421.PMC5099290.pdf
"https://doi.org/10.3345/kjp.2016.59.10.421Park JH, et al.",OADS,/arxiv_data1/oa_pdf/c7/ac/kjped-59-421.PMC5099290.pdf
"423 https://doi.org/10.3345/kjp.2016.59.10.421Korean J Pediatr 2016;59(10):421-424 Discussion The clinical criteria for HLH include many nonspecific findings  that overlap with severe inflammatory conditions1,2).",Non-OADS,/arxiv_data1/oa_pdf/c7/ac/kjped-59-421.PMC5099290.pdf
"https://doi.org/10.3345/kjp.2016.59.10.421Park JH, et al.",OADS,/arxiv_data1/oa_pdf/c7/ac/kjped-59-421.PMC5099290.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Henkes H, Fischer S, Weber W, et al.",Non-OADS,/arxiv_data1/oa_pdf/fa/9d/neurintsurg-2015-012004.PMC5099317.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Przedborski S, Vila M, Jackson-Lewis V. Neurodegeneration: what is it and where are we?",Non-OADS,/arxiv_data1/oa_pdf/fc/0d/jnnp-2014-308350.PMC5099318.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Table 1 Pre-/post-implantation MAFA together with the ratio R for each tested device and all acquisitions Device Projection IR MAFApre MAFApost R Solitaire AB AP 2 6.20 6.00 0.97 AP 3 6.00 5.70 0.95Lateral 2 5.90 5.50 0.93Lateral 3 6.90 6.00 0.87 pCONus AP 2 6.10 6.00 0.98 AP 3 5.90 5.60 0.95Lateral 2 5.90 5.10 0.86Lateral 3 6.10 5.30 0.87 pCANvas AP 2 6.10 2.60 0.43 AP 3 6.00 2.70 0.45Lateral 2 5.90 2.20 0.37Lateral 3 5.60 2.30 0.41 AP, anteroposterior; IR, injection rate; MAFA, mean aneurysm flow amplitude.",Non-OADS,/arxiv_data1/oa_pdf/d8/ff/neurintsurg-2015-011927.PMC5099319.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Starr I.,Non-OADS,/arxiv_data1/oa_pdf/93/e5/jramc-2015-000563.PMC5099320.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ jramc-2015-000484).,OADS,/arxiv_data1/oa_pdf/e1/71/jramc-2015-000484.PMC5099321.pdf
All authors approved of the version of the article submitted forconsideration.. Funding The Australian Government Department of Defence (http://www.defence.,Non-OADS,/arxiv_data1/oa_pdf/e1/71/jramc-2015-000484.PMC5099321.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ahronson A, Cameron JE.",Non-OADS,/arxiv_data1/oa_pdf/e1/71/jramc-2015-000484.PMC5099321.pdf
"Removal of Gender Restrictions Secondary Removal of Gender Restrictions 27/9/2012, 2012. http://www.defencejobs.gov.au/ women/RemovalofGenderRestrictions/15/ 22 North FM, Syme SL, Feeney A, et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/71/jramc-2015-000484.PMC5099321.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/a1/main.PMC5099322.pdf
"However,  the  value http://dx.doi.org/10.1016/j.ejro.2016.10.004 2352-0477/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/31/a1/main.PMC5099322.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/31/a1/main.PMC5099322.pdf
Previous cases of vulvar SC vary in Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.10.008 2352-5789/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/5e/10/main.PMC5099323.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/10/main.PMC5099323.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/6e/main.PMC5099324.pdf
http://dx.doi.org/10.1016/j.idcr.2016.10.008 2214-2509/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/86/6e/main.PMC5099324.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  90–93 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/86/6e/main.PMC5099324.pdf
e00190 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
"B3LYP/6-31G* GAS E (hartree) μ(D) V (Å3) −2471.27 11,06 471,2 PCM E (hartree) μ(D) V (Å3) −2471.36 15,14 484,5 Solvation energy ΔGu#ΔGne ΔGc −236.07 18,31 −254,38 ΔV( Å3)=13.3 Article No~e00190 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
"B3LYP/6-31G*,aExperimental Parameter Gas PCM ExpbExpc Bond lengths (Å) C25-O3 1.388 1.401 C26-O4 1.387 1.402 C12-C13 1.534 1.530C12-C14 1.532 1.531 C12-C15 1.528 1.530 C13-C16 1.402 1.402 1.372 C16-C21 1.392 1.394 1.361 C21-C25 1.396 1.393 1.369C25-C23 1.394 1.392 1.361 C23-C18 1.395 1.395 1.371 C18-C13 1.401 1.402 1.375 C14-C17 1.400 1.403 1.372 C17-C22 1.394 1.394 1.361C22-C26 1.394 1.393 1.369 C26-C24 1.396 1.392 1.361 C24-C19 1.392 1.395 1.371 C19-C14 1.401 1.400 1.375 C15-N11 1.342 1.344 1.347N11-C28 1.337 1.343 1.324 C28-C29 1.394 1.392 1.381 C29-C27 1.393 1.394 1.369 C27-C20 1.393 1.392 1.365 C20-C15 1.401 1.401 1.361O5-Na43 2.151 2.263 2.518 O6-Na44 2.156 2.263 2.518 S1-O3 1.810 1.720 1.488 S1-O5 1.500 1.493 1.481 S1-O7 1.461 1.472 1.463 S1-O8 1.460 1.472 1.477 S2-O4 1.807 1.719 1.488S2-O6 1.500 1.493 1.481 S2-O9 1.461 1.472 1.463 S2-O10 1.459 1.472 1.477 (Continued ) Article No~e00190 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
The Wiberg bond index matrix in the NAO basis in gas phase shows bond order Article No~e00190 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
"Atoms MK NPA MEP Wiberg index Gas PCM Gas PCM Gas PCM Gas PCM 1S 1.137 1.141 2.537 2.564 −58.941 −58.949 4.210 4,217 2S 1.137 1.140 2.539 2.564 −58.948 −58.958 4.210 4,217 3O −0.759 −0.703 −0.847 −0.841 −22.284 −22.274 1.759 1,770 4O −0.752 −0.713 −0.846 −0.842 −22.291 −22.283 1.763 1,769 5O −0.661 −0.669 −1.055 −1.065 −22.332 −22.341 1.489 1,478 6O −0.662 −0.673 −1.055 −1.066 −22.339 −22.350 1.488 1,476 7O −0.484 −0.502 −0.925 −0.944 −22.345 −22.363 1.670 1,638 8O −0.479 −0.508 −0.918 −0.942 −22.345 −22.364 1.679 1,641 9O −0.489 −0.504 −0.926 −0.945 −22.352 −22.373 1.667 1,637 10 O −0.476 −0.500 −0.917 −0.941 −22.353 −22.373 1.681 1,641 11N −0.559 −0.579 −0.478 −0.459 −18.363 −18.367 3.074 3,073 12C −0.215 −0.521 −0.291 −0.294 −14.721 −14.720 3.958 3,958 13C −0.052 0.124 −0.026 −0.028 −14.733 −14.728 4.003 4,003 14C 0.179 0.296 −0.029 −0.024 −14.739 −14.737 4.004 4,005 15C 0.575 0.757 0.242 0.233 −14.696 −14.698 3.988 3,992 16C −0.043 −0.122 −0.217 −0.215 −14.742 −14.736 3.947 3,947 17C −0.233 −0.231 −0.220 −0.218 −14.746 −14.745 3.949 3,948 18C −0.071 −0.202 −0.226 −0.227 −14.746 −14.739 3.934 3,936 19C −0.105 −0.272 −0.205 −0.204 −14.751 −14.749 3.938 3,940 20C −0.418 −0.520 −0.262 −0.265 −14.730 −14.731 3.944 3,944 21C −0.380 −0.286 −0.255 −0.249 −14.744 −14.737 3.940 3,940 22C −0.288 −0.209 −0.257 −0.250 −14.752 −14.747 3.939 3,943 23C −0.336 −0.243 −0.253 −0.248 −14.742 −14.736 3.949 3,946 24C −0.290 −0.210 −0.255 −0.245 −14.749 −14.748 3.949 3,944 25C 0.575 0.478 0.284 0.280 −14.686 −14.678 3.905 3,900 26C 0.505 0.430 0.290 0.279 −14.691 −14.689 3.905 3,900 27C 0.105 0.136 −0.193 −0.195 −14.719 −14.720 3.943 3,944 28C 0.297 0.288 0.034 0.032 −14.703 −14.706 3.927 3,927 29C −0.367 −0.377 −0.279 −0.280 −14.729 −14.731 3.943 3,943 30H 0.064 0.127 0.252 0.256 −1.118 −1.114 0.939 0,937 31H 0.120 0.133 0.234 0.236 −1.111 −1.105 0.947 0,946 32H 0.146 0.136 0.231 0.232 −1.115 −1.113 0.948 0,948 33H 0.132 0.161 0.256 0.255 −1.118 −1.111 0.937 0,938 34H 0.126 0.201 0.252 0.249 −1.124 −1.123 0.938 0,940 (Continued ) Article No~e00190 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
"On the other hand, in gas phase are observed other eight closed-shell interactions ( ▿2ρ (r) > 0 ) of which four are ionic with low /C26(r)and high ▿2/C26(r)(Na43⋯O3, Article No~e00190 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.",OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Delocalization Gas PCM /C25N11-C15 →/C25*C20-C27 53.80 55.26 /C25N11-C15 →/C25*C28-C29 115.16 112.15 /C25C13-C18 →/C25*C16-C21 85.10 84.52 /C25C13-C18 →/C25*C23-C25 88.91 90.04 /C25C14-C17 →/C25*C19-C24 83.77 /C25C14-C17 →/C25*C22-C26 85.48 /C25C14-C19 →/C25*C17-C22 86.65 /C25C14-C19 →/C25*C24-C26 89.83 /C25C16-C21 →/C25*C13-C18 82.01 84.14 /C25C16-C21 →/C25*C23-C25 87.65 88.74 /C25C17-C22 →/C25*C14-C19 81.93 /C25C17-C22 →/C25*C24-C26 86.86 /C25C19-C24 →/C25*C14-C17 81.38 /C25C19-C24 →/C25*C22-C26 89.62 /C25C20-C27 →/C25*N11-C15 119.34 117.54 /C25C20-C27 →/C25*C28-C29 71.94 70.85 /C25C22-C26 →/C25*C14-C17 82.93 /C25C22-C26 →/C25*C19-C24 79.42 /C25C23-C25 →/C25*C13-C18 81.30 80.13 /C25C23-C25 →/C25*C13-C18 81.55 83.26 /C25C24-C26 →/C25*C14-C19 80.05 /C25C24-C26 →/C25*C17-C22 84.43 /C25C28-C29 →/C25*N11-C15 68.55 67.46 /C25C28-C29 →/C25*C20-C27 95.01 95.09 ΔETπ→π* 1532.92 1538.93 LP(2)O5 →σ*S1-O7 59.52 62.28 LP(2)O5 →σ*S1-O8 57.93 57.43 LP(3)O5 →σ*S1-O3 116.16 102.66 LP(2)O6 →σ*S2-O9 59.60 60.53 LP(2)O6 →σ*S2-O10 57.85 59.23 LP(3)O6 →σ*S2-O4 115.70 102.24 LP(2)O7 →σ*S1-O5 70.81 64.58 LP(2)O7 →σ*S1-O8 76.16 75.20 LP(3)O7 →σ*S1-O3 185.13 153.40 LP(2)O8 →σ*S1-O5 71.94 64.62 LP(2)O8 →σ*S1-O7 76.66 75.78 (Continued ) Article No~e00190 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
(Continued ) Delocalization Gas PCM LP(3)O8 →σ*S1-O3 188.60 155.83 LP(2)O9 →σ*S2-O6 70.51 64.41 LP(2)O9 →σ*S2-O10 76.03 75.32 LP(3)O9 →σ*S2-O4 183.96 153.65 LP(2)O10 →σ*S2-O6 72.06 64.66 LP(2)O10 →σ*S2-O9 76.87 75.57 LP(3)O10 →σ*S2-O4 188.64 154.87 LP(1)N11 →σ*C15-C20 42.26 ΔETLP→σ* 1804.13 1664.52 σS1-O3→/C25*C23-C25 61.15 σS2-O4→/C25*C22-C26 69.97 ΔETσ→π* 131.12 σS1-O5→σ*S1-O7 71.23 92.25 σS1-O5→σ*S1-O8 70.85 93.04 σS2-O6→σ*S2-O9 71.60 92.59 σS2-O6→σ*S2-O10 70.39 92.33 ΔETσ→σ* 284.07 370.21 /C25*N11-C15 →/C25*C20-C27 1075.84 1116.56 /C25*N11-C15 →/C25*C28-C29 884.44 748.55 /C25*C23-C25 →/C25*S1-O3 158.13 /C25*C23-C25 →/C25*C13-C18 1107.11 /C25*C24-C26 →/C25*S2-O4 184.21 /C25*C24-C26 →/C25*C14-C19 1078.31 ΔETπ*→π* 3067.39 3285.76 ΔETotal 6819.63 6859.42 Article No~e00190 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
)S1⋯O3 S1 −O5 S1 −O7 S1 −O8 Na43 ⋯O3 Na43 ⋯O5 N11 ⋯H33 S2 ⋯O4 S2 −O6 S2 −O9 S2 −O10 Na44 ⋯O4 Na44 ⋯O6 ρ(rc) 0.1800 0.2716 0.2833 0.2835 0.0201 0.0247 0.0088 0.1804 0.2715 0.2833 0.2835 0.0202 0.0247 ▿2ρ(rc) −0.2020 0.7773 0.9332 0.9353 0.1252 0.1551 0.0302 −0.2033 0.7852 0.9340 −0.9330 0.1262 0.1554 λ1 −0.2623 −0.4560 −0.4741 −0.4744 −0.0236 −0.0312 −0.0073 −0.2630 −0.4560 −0.4743 −0.4741 −0.0237 −0.0312 λ2 −0.2476 −0.4409 −0.4367 −0.4353 −0.0227 −0.0290 −0.0031 −0.2481 −0.4412 −0.4363 −0.4355 −0.0228 −0.0290 λ3 0.3081 1.6743 1.8440 1.8451 0.1715 0.2154 0.0410 0.3079 1.6757 1.8446 1.8427 0.1728 0.2157 jλ1j/λ3 0.8513 0.2724 0.2571 0.2571 0.1376 0.1448 0.1780 0.8542 0.2721 0.2571 0.2573 0.1372 0.1446 Distance (Å)1.720 1.493 1.472 1.472 2.316 2.263 2.617 1.719 1.493 1.472 1.472 2.313 2.263 Article No~e00190 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
"ExperimentalcB3LYP/6-31G* Methoda IR Gas phase Aqueous solution solid SQMbAssignments SQMbAssignments 3639w νOH H 2O 3458m νOH H 2O 3100 sh 3103 νC19-H34 3100 νC18-H33 3096 νC21-H36 3097 νC21-H36 3091 νC18-H33 3096 νC29-H42 3084 νC29-H42 3095 νC24-H39 3072 νC20-H35 3086 νC23-H38 3069 νC22-H37 3085 νC20-H35 3068w 3068 νC24-H39 3083 νC19-H34 3068 νC23-H38 3074 νC27-H40 3058 νC27-H40 3072 νC17-H32 3047w 3049 νC16-H31 3070 νC16-H31 3045 νC17-H32 3059 νC22-H37 2999w 3041 νC28-H41 3057 νC28-H41 2915w 2932 νC12-H30 2950 νC12-H30 1653m 1606 νC16-C21 1600 νC16-C21, νC23-C18 1616m 1593 νC27-C20 1592 νC28-C29, νC20-C15 1600 sh 1586 νC24-C19, νC14-C17 1583 νC18-C13, νC13-C16 1560 sh 1579 νC18-C13, νC13-C16 1580 νC14-C17, νC26-C24 1541 sh 1577 νC29-C27 1571 νC29-C27, νC15-N11 1529s 1560 νC19-C14, νC26-C24 1562 νC19-C14, νC22-C26 1495m 1502 βC16-H31 1498 βC16-H31, νC21-C25 1462m 1479 βC24-H39 1476 βC28-H41, βC20-H35 1454m 1476 βC28-H41, βC20-H35 1471 βC24-H39 1438w 1436 βC29-H42 1429 βC29-H42 1420 νC23-C18 1416 ρC12-H30 1405 ρ’C12-H30, βC17-H32, βC19-H34 1396 βC17-H32 1347 sh 1355 βC28-H41 1345 ρ’C12-H30 1324 ρC12-H30 1327 ρ’C12-H30, ρC12-H30 1301s 1306 βC22-H37 1302 βC19-H34 1271 sh 1295 νC25-C23, νC21-C25 1298 νC25-C23 1284 νC22-C26 1281 νN11-C28 1258 vs 1274 νaSO3(2) 1266 νN11-C28 1272 νaSO3(1) 1246 νC19-C14, ρC12-H30 (Continued ) Article No~e00190 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
"(Continued ) ExperimentalcB3LYP/6-31G* Methoda IR Gas phase Aqueous solution solid SQMbAssignments SQMbAssignments 1271 νN11-C28 1240 νC15-N11 1226s 1239 νC15-N11 1192 νC25-O3 1234 ρC12-H30, νC19-C14 1190 νaSO3(1) 1196sh 1211 νC25-O3 1190 νaSO3(2) 1183 sh 1204 νC26-O4 1185 νC26-O4 1186 νC20-C15 νC12-C151184 νC12-C15 1177 νaSO3(1) 1176 νC12-C13 1175 νaSO3(2) 1159 βC21-H36 1166 sh 1166 νC12-C13 1158 βC22-H37 1163 βC23-H38 1152 νC12-C14, νC24-C19 1130 sh 1161 νaSO3(2),νC26-O4 1143 νaSO3(2) 1121w 1157 νC12-C14 1143 βC27-H40 1151 βC27-H40 1142 νaSO3(1) 1105 βC21-H36, βC18-H33 1101 βC23-H38 1086s 1092 βC29-H42, νC17-C22 1089 νC17-C22 1073 sh 1090 νC17-C22 1088 νC27-C20 1033m 1044 νC28-C29 1043 νC29-C27 1009w 1020 βR1(1) 1016 βR1(1) 996 βR1(3) 1012 γC27-H40 995 γC27-H40 994 βR1(3) 993 βR1(2) 992 βR1(2) 979w 975 γC18-H33 980 γC28-H41 965w 966 γC28-H41 972 γC18-H33 952w 949 γC16-H31 963 γC19-H34 892s 948 νsSO3(2) 959 γC16-H31 892s 947 νsSO3(1) 951 νsSO3(1) 942 γC24-H39 950 νsSO3(2) 933 γC17-H32 947 γC17-H32 900 γC20-H35 911 γC20-H35 871m 889 γC22-H37 888 γC24-H39 868 γC23-H38 875 γC23-H38 842m 854 δC13C12C15 856 δC13C12C15 826 sh 837 γC19-H34 836 γC23-H38, γC24-H39 830 νC26-O4 831 γC23-H38 (Continued ) Article No~e00190 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
"(Continued ) ExperimentalcB3LYP/6-31G* Methoda IR Gas phase Aqueous solution solid SQMbAssignments SQMbAssignments 828 γC21-H36 829 γC21-H36 824 γC19-H34 822 γC24-H39 811 γC22-H37 816 γC22-H37 783m 809 δC13C12C14 806 δC13C12C14 762m 763 γC29-H42 769 γC29-H42 747w 747 tR 1(3) 752 tR 1(3) 731w 730 tR 1(2) 729 tR 1(2) 718w 710 tR 1(1) 711 tR 1(1) 676 sh 686 βR2(3),βR3(3) 681 βR2(3) 660m 646 βR2(1),βR3(1) 644 βR3(1) 650w 640 βR2(3) 642 βR2(1) 630 sh 629 βR2(2) 631 βR2(2) 625w 620 βR3(3) 626 νS1-O3 610w 610 βR3(2) 621 βR3(2) 598m 600 δsSO3(2) 615 νS2-O4 581w 596 δsSO3(1) 608 βR3(3) 575 sh 565 tR 1(1) 565 δsSO3(1) 560 sh 564 tR 1(2) 563 δsSO3(2) 528 sh 525 δaSO3(1) 523 δaSO3(1) 524 δaSO3(2) 522 δaSO3(2) 521w 519 δaSO3(1) 518 δaSO3(2),γC26-O4 514 sh 514 δaSO3(2),γC26-O4 514 δaSO3(1),γC25-O3, γC13-C12 500 sh 490 tR 2(3),γC15-C12 498 tR 2(3) 477 tR 2(2) 473 tR 2(2) 458 sh 468 tR 2(1) 468 tR 2(1) 429 sh 437 βC25-O3 441 βC25-O3 421w 422 βC26-O4 435 βC26-O4 412 tR 3(1) 415 tR 3(1) 405w 405 tR 3(3) 408 tR 3(2) 398w 399 tR 3(2) 407 tR 3(3) 380 νO6-Na44 373 νS1-O3 366 ρSO3(1) 355 νS2-O4,tR 1(2) 333 νS2-O4 342 ρSO3(1) 313 νS1-O3 322 ρSO3(2) 303 ρ’sO3(1) 310 ρ’sO3(1) (Continued ) Article No~e00190 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 25 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
"However, the f(νNa−O)constant values Article No~e00190 26 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 27 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 28 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 29 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 30 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
"Peralta, F. Ogliaro, M. Bearpark, J.J. Heyd, E. Article No~e00190 31 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 32 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 33 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
Article No~e00190 34 http://dx.doi.org/10.1016/j.heliyon.2016.e00190 2405-8440/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/32/main.PMC5099326.pdf
"8) Recently revised  recommendations allow some consideration of competitive sports after ensuring that effective treatment and appropriate precautionary measures such as automatic external defibrillators and personnel trained in basic life support are available, especially Review Article http://dx.doi.org/10.4070/kcj.2016.46.6.747 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Management of Patients with Long QT Syndrome Yongkeun Cho, MD Department of Internal Medicine, Kyungpook National Univeristy Hospital, Daegu, Korea Long QT syndrome (LQTS) is a rare cardiac channelopathy associated with syncope and sudden death due to torsades de pointes and  ventricular fibrillation.",Non-OADS,/arxiv_data1/oa_pdf/67/6b/kcj-46-747.PMC5099327.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/6b/kcj-46-747.PMC5099327.pdf
748  Medical and Surgical Treatment of Patients with Long QT Syndrome http://dx.doi.org/10.4070/kcj.2016.46.6.747 www.e-kcj.org among asymptomatic genotype-positive/phenotype-negative  patients.8)9) Many patients with ICDs including those with LQTS  can engage in vigorous competitive sports without significant morbidity and mortality.,Non-OADS,/arxiv_data1/oa_pdf/67/6b/kcj-46-747.PMC5099327.pdf
"749 Yongkeun Cho http://dx.doi.org/10.4070/kcj.2016.46.6.747 www.e-kcj.org aggravation of asthma.27) However, bronchial asthma is no longer  considered an absolute contraindication to ß-blockers.31) ß-blockers  are also associated with the development of clinically important  hypoglycemia in young children, especially those with LQT2.32)33) Long acting ß-blockers in maximally tolerated doses are  recommended and abrupt discontinuation should be avoided.",Non-OADS,/arxiv_data1/oa_pdf/67/6b/kcj-46-747.PMC5099327.pdf
"750  Medical and Surgical Treatment of Patients with Long QT Syndrome http://dx.doi.org/10.4070/kcj.2016.46.6.747 www.e-kcj.org survived a cardiac arrest, patients with syncope despite adequate  ß-blocker therapy (and LCSD), and some patients considered as high risk with a very long QTc interval (>550 ms), or signs of electrical instability such as T-wave alternans.",Non-OADS,/arxiv_data1/oa_pdf/67/6b/kcj-46-747.PMC5099327.pdf
751 Yongkeun Cho http://dx.doi.org/10.4070/kcj.2016.46.6.747 www.e-kcj.org 2.,Non-OADS,/arxiv_data1/oa_pdf/67/6b/kcj-46-747.PMC5099327.pdf
752  Medical and Surgical Treatment of Patients with Long QT Syndrome http://dx.doi.org/10.4070/kcj.2016.46.6.747 www.e-kcj.org 31.,Non-OADS,/arxiv_data1/oa_pdf/67/6b/kcj-46-747.PMC5099327.pdf
"12) It has been reported that CD137 is  expressed on a wide range of tumor cells,13) and both in tumor  vessel walls and tumor-liver tissue in patients with cancer.14)15) Review Article http://dx.doi.org/10.4070/kcj.2016.46.6.753 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The Roles of CD137 Signaling in Atherosclerosis In-Hyuk Jung, PhD1,2, and Goo Taeg Oh, DVM PhD1 1Department of Life Sciences, Ewha Womans University, Seoul, Korea, 2Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis,  MO, USA The tumor necrosis factor receptor superfamily (TNFRSF), which includes CD40, LIGHT, and OX40, plays important roles in the initiation  and progression of cardiovascular diseases, involving atherosclerosis.",OADS,/arxiv_data1/oa_pdf/53/df/kcj-46-753.PMC5099328.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/df/kcj-46-753.PMC5099328.pdf
"754  CD137 Signaling in Atherosclerosis http://dx.doi.org/10.4070/kcj.2016.46.6.753 www.e-kcj.org Therefore, many investigators have studied the anti-tumor effects  of CD137 as a therapeutic agent.",Non-OADS,/arxiv_data1/oa_pdf/53/df/kcj-46-753.PMC5099328.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.753 www.e-kcj.org attenuate the development of atherosclerosis.39) In many studies  of Treg cells functioning during this disease, Treg cells showed the  ability to inhibit both IFN- γ producing Th1 and IL-17 producing Th17  subsests of Teff cells.40) Treg cells can also inhibit pro-atherogenic  macrophage inflammation by promoting the differentiation of  M1 macrophages towards anti-inflammatory M2 macrophages.",Non-OADS,/arxiv_data1/oa_pdf/53/df/kcj-46-753.PMC5099328.pdf
"756  CD137 Signaling in Atherosclerosis http://dx.doi.org/10.4070/kcj.2016.46.6.753 www.e-kcj.org expression, leading to a positive correlation with the CRP level in  patients with ACS.",Non-OADS,/arxiv_data1/oa_pdf/53/df/kcj-46-753.PMC5099328.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.753 www.e-kcj.org plaques exacerbate matrix degradation, leading to lesion  instability.66) Previous studies in a mouse model of atherosclerosis  suggested that levels of MMP-2 and MMP-9 increase during atherosclerosis, and that MMP-2 and MMP-9 expression largely depends on bone marrow-derived macrophages.",Non-OADS,/arxiv_data1/oa_pdf/53/df/kcj-46-753.PMC5099328.pdf
"758  CD137 Signaling in Atherosclerosis http://dx.doi.org/10.4070/kcj.2016.46.6.753 www.e-kcj.org of Teff cells into plaque lesion sites, resulting in increased IFN- γ  expression.",Non-OADS,/arxiv_data1/oa_pdf/53/df/kcj-46-753.PMC5099328.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.753 www.e-kcj.org atherosclerosis.,Non-OADS,/arxiv_data1/oa_pdf/53/df/kcj-46-753.PMC5099328.pdf
760  CD137 Signaling in Atherosclerosis http://dx.doi.org/10.4070/kcj.2016.46.6.753 www.e-kcj.org 51.,Non-OADS,/arxiv_data1/oa_pdf/53/df/kcj-46-753.PMC5099328.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.753 www.e-kcj.org syndromes.,Non-OADS,/arxiv_data1/oa_pdf/53/df/kcj-46-753.PMC5099328.pdf
"Ninety Editorial http://dx.doi.org/10.4070/kcj.2016.46.6.762 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Staged versus One-Time Percutaneous Coronary Intervention Strategy for Multivessel Non-ST Segment Elevation Acute Coronary Syndrome Yun Gi Kim, MD, and Soon Jun Hong, MD Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Seoul, Korea Received:  September 12, 2016 Revision Received:  October 10, 2016 Accepted:  October 18, 2016 Correspondence:  Soon Jun Hong, MD, Department of Cardiology,  Cardiovascular Center, Korea University Anam Hospital, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, KoreaTel: 82-2-920-5445, Fax: 82-2-927-1478E-mail: psyche94@gmail.com • The author has no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/e4/fd/kcj-46-762.PMC5099329.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/fd/kcj-46-762.PMC5099329.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.762 www.e-kcj.org day landmark propensity matched analysis showed a favorable  result for the staged PCI strategy in terms of the primary outcome endpoint (1.2% vs. 3.3%, p=0.037) and cardiac death/MI (0.7% vs. 2.6%, p=0.031).",Non-OADS,/arxiv_data1/oa_pdf/e4/fd/kcj-46-762.PMC5099329.pdf
One-Time PCI for Non-ST Elevation ACS http://dx.doi.org/10.4070/kcj.2016.46.6.762 www.e-kcj.org ST-elevation myocardial infarction?,Non-OADS,/arxiv_data1/oa_pdf/e4/fd/kcj-46-762.PMC5099329.pdf
"The ESC recommended that when the benefit Editorial http://dx.doi.org/10.4070/kcj.2016.46.6.765 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Magnetic Resonance Imaging for Patients with Cardiac Implantable Electronic Devices: Reduced Concerns Regarding Safety, but Scrutiny Remains Critical Jung Im Jung, MD Department of Radiology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Received:  September 20, 2016 Accepted:  October 11, 2016 Corrspondence:  Jung Im Jung, MD, Department of Radiology, Seoul St.  Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Bandpo-daero, Seocho-gu, Seoul 06591, KoreaTel: 82-2-2258-1435, Fax: 82-2-599-6771E-mail: jijung@catholic.ac.kr • The author has no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/a5/a1/kcj-46-765.PMC5099330.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/a1/kcj-46-765.PMC5099330.pdf
"766  Safer MRI for Patients with CIED http://dx.doi.org/10.4070/kcj.2016.46.6.765 www.e-kcj.org of undergoing MRI outweighs the potential risks, 1.5 T MRI can  be performed in these patients with a low risk of complications, provided that appropriate precautions are taken.",Non-OADS,/arxiv_data1/oa_pdf/a5/a1/kcj-46-765.PMC5099330.pdf
"767 Jung Im Jung http://dx.doi.org/10.4070/kcj.2016.46.6.765 www.e-kcj.org While it is known that older CIEDs (typically those implanted  before 2002) are more susceptible to electromagnetic interference,13)  it is not possible to verify this fact based on the study by Hwang  et al.,15) because the type of CIED was not included in their data.",OADS,/arxiv_data1/oa_pdf/a5/a1/kcj-46-765.PMC5099330.pdf
"7)8) In addition, neutrophilia and relative  lymphocytopenia were shown to be independent predictors of Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.768 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Neutrophil Lymphocyte Ratio as a Predictor of Left Ventricular Apical Thrombus in Patients with Myocardial Infarction  Ahmet Goktug Ertem, MD1, Filiz Ozcelik, MD1, Haci Ahmet Kasapkara, MD2, Cemal Koseoglu, MD1, Serdal Bastug, MD1,  Huseyin Ayhan, MD2, Cenk Sari, MD1, Nihal Akar Bayram, MD2, Emine Bilen, MD1, Tahir Durmaz, MD2, Telat Keles, MD2,  and Engin Bozkurt, MD2 1Department of Cardiology, Ataturk Training and Research Hospital, Ankara, 2Department of Cardiology, Yildirim Beyazit University, Ankara, Turkey Background and Objectives: In this study, we examined the role of inflammatory parameters in an apical mural thrombus with a reduced  ejection fraction due to large anterior myocardial infarction (MI).Subjects and Methods: A total of 103 patients who had suffered from heart failure, 45 of whom had left ventricular apical thrombus (AT) after a large anterior MI, were enrolled in the study.",Non-OADS,/arxiv_data1/oa_pdf/35/23/kcj-46-768.PMC5099331.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/23/kcj-46-768.PMC5099331.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.768 www.e-kcj.org mortality in patients with heart failure9)10) as neutrophils play  an important role in tissue destruction.,Non-OADS,/arxiv_data1/oa_pdf/35/23/kcj-46-768.PMC5099331.pdf
770  Neutrophil Lymphocyte Ratio and Apical Thrombus http://dx.doi.org/10.4070/kcj.2016.46.6.768 www.e-kcj.org formation are important for apical thrombus formation.,Non-OADS,/arxiv_data1/oa_pdf/35/23/kcj-46-768.PMC5099331.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.768 www.e-kcj.org associated with saphenous venous graft disease.,Non-OADS,/arxiv_data1/oa_pdf/35/23/kcj-46-768.PMC5099331.pdf
772  Neutrophil Lymphocyte Ratio and Apical Thrombus http://dx.doi.org/10.4070/kcj.2016.46.6.768 www.e-kcj.org than control (-) group and these inflammatory marker were  independently associated with AT risk among our patients.,Non-OADS,/arxiv_data1/oa_pdf/35/23/kcj-46-768.PMC5099331.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.768 www.e-kcj.org Clin Appl Thromb Hemost 2015;21:446-52.,Non-OADS,/arxiv_data1/oa_pdf/35/23/kcj-46-768.PMC5099331.pdf
"4) The American  College of Cardiology/American Heart Association guidelines provide a class IIb recommendation that multivessel percutaneous coronary intervention ( PCI), in contrast  to culprit-only PCI, might  be reasonable in NSTE-ACS patients undergoing PCI (Level of Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.774 Print ISSN 1738-5520 • On-line ISSN 1738-5555 “One-Time” versus Staged Multivessel Intervention in Intermediate  to Very High-Risk Patients with Non-ST-Segment Elevation Acute Coronary Syndromes Xiaofan Yu, MD1,2,3, Yi Li, MD2, Qiancheng Wang, MD1, Ming Liang, MD2, Kai Xu, MD 2, and Yaling Han, MD2 1Department of Cardiology, The Second Hospital of Dalian Medical University, Dalian, Liao Ning, 2Department of Cardiology, General Hospital of Shenyang Military Region,  Shenyang, Liao Ning, 3Department of Cardiology, Anhui Provincial Hospital, Hefei, Anhui, China Background and Objectives:  To compare clinical outcomes of staged versus “one-time” percutaneous coronary intervention (PCI) in  intermediate to very high-risk patients with non–ST-segment elevation acute coronary syndromes (NSTE-ACS) and multivessel coronary  disease (MVD).",Non-OADS,/arxiv_data1/oa_pdf/4a/d5/kcj-46-774.PMC5099332.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/d5/kcj-46-774.PMC5099332.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.774 www.e-kcj.org Evidence: B).3) This recommendation is based on reports of studies  suggesting that multivessel PCI is superior to culprit vessel only  PCI in terms of repeat revascularization.5-8) However, there is still  uncertainty as to whether non-culprit lesions should be treated at the time of culprit-lesion PCI for NSTE-ACS.",Non-OADS,/arxiv_data1/oa_pdf/4a/d5/kcj-46-774.PMC5099332.pdf
"776  Multivessel PCI in NSTE-ACS http://dx.doi.org/10.4070/kcj.2016.46.6.774 www.e-kcj.org Outcomes and definitions The primary outcome was the incidence of major adverse cardiac  events (MACE), defined as the composite of cardiac death, MI and  target vessel revascularization (TVR) during 3-year follow-up.",OADS,/arxiv_data1/oa_pdf/4a/d5/kcj-46-774.PMC5099332.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.774 www.e-kcj.org Statistical analysis Continuous variables were expressed as mean±standard  deviation (SD), and categorical variables were expressed as number  and/or percentages.",OADS,/arxiv_data1/oa_pdf/4a/d5/kcj-46-774.PMC5099332.pdf
778  Multivessel PCI in NSTE-ACS http://dx.doi.org/10.4070/kcj.2016.46.6.774 www.e-kcj.org Meier method were compared with the log-rank test.,OADS,/arxiv_data1/oa_pdf/4a/d5/kcj-46-774.PMC5099332.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.774 www.e-kcj.org the “one-time” PCI group (p=0.129).,Non-OADS,/arxiv_data1/oa_pdf/4a/d5/kcj-46-774.PMC5099332.pdf
780  Multivessel PCI in NSTE-ACS http://dx.doi.org/10.4070/kcj.2016.46.6.774 www.e-kcj.org Fig.,OADS,/arxiv_data1/oa_pdf/4a/d5/kcj-46-774.PMC5099332.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.774 www.e-kcj.org The staged PCI group showed a lower 90-day incidence of MACE  (1.2% vs. 3.3%, p=0.037), mainly due to a lower composite rate of cardiac death or MI (0.7% vs. 2.6%, p=0.031).",Non-OADS,/arxiv_data1/oa_pdf/4a/d5/kcj-46-774.PMC5099332.pdf
782  Multivessel PCI in NSTE-ACS http://dx.doi.org/10.4070/kcj.2016.46.6.774 www.e-kcj.org terms of the composite of cardiac death or MI.,OADS,/arxiv_data1/oa_pdf/4a/d5/kcj-46-774.PMC5099332.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.774 www.e-kcj.org Postepy Kardiol Interwencyjnej 2013;9:136-45.,Non-OADS,/arxiv_data1/oa_pdf/4a/d5/kcj-46-774.PMC5099332.pdf
"CCC has been associated  with reduced infarct size,  morbidity,  and mortality  in the setting of myocardial infarction .1)  Various factors have been postulated  in the collateralization  mechanism including ischemia, the pressure  gradient between  donor and recipient arteries, endothelial mitogens such as  endothelial growth factor and endothelial shear stress  (ESS) .2)3)  As a determinant of shear stress, blood viscosity has been an  underappreciated entity in routine cardiovascular  evaluation despite  close relationships between multiple cardiovascular diseases .4) Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.784 Print ISSN 1738-5520  • On-line ISSN 1738-5555 The Association between Whole Blood Viscosity and Coronary Collateral  Circulation in Patients with Chronic Total Occlusion  Mehmet Serkan Cetin, MD, Elif Hande Ozcan Cetin, MD, Kevser Gülcihan Balcı, MD, Selahattin Aydin, MD,   Emek Ediboglu, MD, Muhammed Fatih Bayraktar, MD, Mustafa Mücahit Balcı, MD, Orhan Maden, MD,   Ahmet Temizhan MD, and  Sinan Aydogdu, MD Department of Cardiology, Türkiye Yüksek Ihtisas Training and Research Hospital, Ankara, Turkey Background and Objectives:  Coronary collateral circulation (CCC) has been attributed as inborn bypass mechanisms supporting ischemic  myocardium.",Non-OADS,/arxiv_data1/oa_pdf/9d/c1/kcj-46-784.PMC5099333.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.784 www.e-kcj.org Additionally, hyperviscosity has substantial pathophysiologic  similarities with traditional risk factors such as hypertension,  hypercholesterolemia, diabetes mellitus,  male gender, cigarette  smoking .5) Routine laboratory measurement of whole blood viscosity  (WBV) may be compelling because of non-standardized methods, the  necessity  of sophisticated devices and scarce  research data .6) WBV  can be calculated  with a validated equation from hematocrit (HCT)  and total plasma protein levels (TP) for low and high shear rate .7)  Obtaining an estimated value about WBV with this simple formula,  can provide clinicians a new tool for patient bedside  evaluations.",Non-OADS,/arxiv_data1/oa_pdf/9d/c1/kcj-46-784.PMC5099333.pdf
786  Coronary Collateral & Whole Blood Viscosity http://dx.doi.org/10.4070/kcj.2016.46.6.784 www.e-kcj.org Table 1.,Non-OADS,/arxiv_data1/oa_pdf/9d/c1/kcj-46-784.PMC5099333.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.784 www.e-kcj.org deviation (SD), and the categorical variables were expressed as  the number of patients and percentages.",OADS,/arxiv_data1/oa_pdf/9d/c1/kcj-46-784.PMC5099333.pdf
"788  Coronary Collateral & Whole Blood Viscosity http://dx.doi.org/10.4070/kcj.2016.46.6.784 www.e-kcj.org At multivariate analysis, we composed two different models to  evaluate the predictiveness of WBV parameters for each shear rate  (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/9d/c1/kcj-46-784.PMC5099333.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.784 www.e-kcj.org difficulties but also indicates the pattern of atheroma including  length, calcification and thrombosis of the lesion.26) In the present  study, WBV showed a positive correlation with The SYNTAX score.",Non-OADS,/arxiv_data1/oa_pdf/9d/c1/kcj-46-784.PMC5099333.pdf
790  Coronary Collateral & Whole Blood Viscosity http://dx.doi.org/10.4070/kcj.2016.46.6.784 www.e-kcj.org H.E.L.P.-apheresis.,Non-OADS,/arxiv_data1/oa_pdf/9d/c1/kcj-46-784.PMC5099333.pdf
"Ventricular repolarization abnormalities  play an important role in the occurrence of arrhythmia .6) QT  dispersion, a marker of repolarization homogeneity, is considered  a predictor of sudden cardiac death and mortality in patients with Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.791 Print ISSN 1738-5520  • On-line ISSN 1738-5555 The Relationship between Angiotensin-II Type 1 Receptor Gene   Polymorphism and Repolarization Parameters after a First Anterior  Acute Myocardial Infarction Onder Ozturk, MD1, Unal Ozturk, MD2, Sebnem Nergiz, PhD3, and M. Zulkif Karahan, MD1 1Department of Cardiology, Diyarbakır Gazi Yasargil Education and Research Hospital, 2Department of Public Health and Neurology,  Dicle University Medical Faculty,  3Department of Microbiology, Dicle University Medical Faculty, Diyarbakir, Turkey Background and Objectives:  Genetic influence on T-wave peak to End (Tpe) time in patients with a first anterior acute myocardial  infarction (AMI) is uncertain.",Non-OADS,/arxiv_data1/oa_pdf/df/65/kcj-46-791.PMC5099334.pdf
792  Repolarization Parameters and Gene Polymorphism http://dx.doi.org/10.4070/kcj.2016.46.6.791 www.e-kcj.org myocardial infarction.,Non-OADS,/arxiv_data1/oa_pdf/df/65/kcj-46-791.PMC5099334.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.791 www.e-kcj.org determined due to extremely low voltage (<0.1 mV), measurement  of QT interval was not established and consequently these leads  were excluded from analysis.",OADS,/arxiv_data1/oa_pdf/df/65/kcj-46-791.PMC5099334.pdf
794  Repolarization Parameters and Gene Polymorphism http://dx.doi.org/10.4070/kcj.2016.46.6.791 www.e-kcj.org artery disease or peak CK-MB concentrations (p>0.05).,Non-OADS,/arxiv_data1/oa_pdf/df/65/kcj-46-791.PMC5099334.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.791 www.e-kcj.org common genetic variants may have an important role in assisting  in primary prevention as well as improving utilization of life-saving  therapies.8)19) Our study shows that the AT1R AC/CC genotype conferred  an increased risk of repolarization abnormality in a patient with  AMI.,Non-OADS,/arxiv_data1/oa_pdf/df/65/kcj-46-791.PMC5099334.pdf
"796  Repolarization Parameters and Gene Polymorphism http://dx.doi.org/10.4070/kcj.2016.46.6.791 www.e-kcj.org on relation between the repolarization abnormalities (QTd, Tpe,  etc.)",OADS,/arxiv_data1/oa_pdf/df/65/kcj-46-791.PMC5099334.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.791 www.e-kcj.org QT dispersion in patients with acute myocardial infarction and heart  failure.,Non-OADS,/arxiv_data1/oa_pdf/df/65/kcj-46-791.PMC5099334.pdf
"798 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.798 Print ISSN 1738-5520 • On-line ISSN 1738-5555Introduction  Atrial fibrillation (AF) is the most common arrhythmia occurring after coronary artery bypass graft (CABG) surgery and is seen  in approximately 15-30% of the patients.1) Development of AF  after cardiac surgery is associated with increased morbidity, mortality, longer hospital stay and a two to three-fold increase in postoperative stroke.",Non-OADS,/arxiv_data1/oa_pdf/76/b0/kcj-46-798.PMC5099335.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/b0/kcj-46-798.PMC5099335.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.798 www.e-kcj.org atrial fibrillation (POAF) and severity and complexity of CAD.,OADS,/arxiv_data1/oa_pdf/76/b0/kcj-46-798.PMC5099335.pdf
800  SYNTAX Score and Atrial Fibrillation http://dx.doi.org/10.4070/kcj.2016.46.6.798 www.e-kcj.org Table 1.,Non-OADS,/arxiv_data1/oa_pdf/76/b0/kcj-46-798.PMC5099335.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.798 www.e-kcj.org 18.0 software package (SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/76/b0/kcj-46-798.PMC5099335.pdf
"802  SYNTAX Score and Atrial Fibrillation http://dx.doi.org/10.4070/kcj.2016.46.6.798 www.e-kcj.org CI=3.791-113.799, p<0.001) appeared as independent variables  predicting the development of POAF (Table 4).",OADS,/arxiv_data1/oa_pdf/76/b0/kcj-46-798.PMC5099335.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.798 www.e-kcj.org design.,Non-OADS,/arxiv_data1/oa_pdf/76/b0/kcj-46-798.PMC5099335.pdf
804 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.804 Print ISSN 1738-5520 • On-line ISSN 1738-5555Introduction Magnetic resonance imaging (MRI) is currently a common  and useful diagnostic tool in various clinical fields.,Non-OADS,/arxiv_data1/oa_pdf/9f/ba/kcj-46-804.PMC5099336.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/ba/kcj-46-804.PMC5099336.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.804 www.e-kcj.org after a CIED implantation by searching our electronic medical  record system and CIED implantation registry.,OADS,/arxiv_data1/oa_pdf/9f/ba/kcj-46-804.PMC5099336.pdf
"806  Magnetic Resonance Imaging of Cardiac Implantable Electronic Devices http://dx.doi.org/10.4070/kcj.2016.46.6.804 www.e-kcj.org The median device indwelling time was 936 days (range, 1-5550  days).",OADS,/arxiv_data1/oa_pdf/9f/ba/kcj-46-804.PMC5099336.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.804 www.e-kcj.org located leads, and one of the patients underwent a 3.0 Tesla MRI.",Non-OADS,/arxiv_data1/oa_pdf/9f/ba/kcj-46-804.PMC5099336.pdf
"808  Magnetic Resonance Imaging of Cardiac Implantable Electronic Devices http://dx.doi.org/10.4070/kcj.2016.46.6.804 www.e-kcj.org and MRI conditional devices, were safe under close medical  supervision during the examination; and (2) 57.5% of the patients we analyzed with a contraindication to an MRI had no adverse events during the procedure or after the 3-month follow-up.Several studies regarding the safety of an MRI in CIED patients  have been performed (Table 5), 8-12) though many concerns still  remain about performing an MRI in this particular group of patients, based on the reports of fatalities from late 1980s to the 2000s with Table 4.",Non-OADS,/arxiv_data1/oa_pdf/9f/ba/kcj-46-804.PMC5099336.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.804 www.e-kcj.org older devices.1)13)14) However, as in Table 5, MRIs were performed  safely without serious adverse effects in various conditions of CIED;  MRI-unsafe pacemakers,8-10)15) MRI-conditional pacemakers,16) ICD  devices,2)4)5)8)17)18) abandoned leads,19) and CRT devices.20)  Disturbances in the CIED circuitry or behavior attributable to  electromagnetic radiation emitted from an external source are known as EMI.",Non-OADS,/arxiv_data1/oa_pdf/9f/ba/kcj-46-804.PMC5099336.pdf
810  Magnetic Resonance Imaging of Cardiac Implantable Electronic Devices http://dx.doi.org/10.4070/kcj.2016.46.6.804 www.e-kcj.org References 1.,Non-OADS,/arxiv_data1/oa_pdf/9f/ba/kcj-46-804.PMC5099336.pdf
"1) Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.811 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Role of Soluble ST2 as a Marker for Rejection after Heart Transplant Ga Yeon Lee, MD, Jin-Oh Choi, MD, Eun-Seon Ju, BS, Yoo-Jung Lee, BS, and Eun-Seok Jeon, MD Division of Cardiology, Cardiac and Vascular Center, Department of Medicine, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea Background and Objectives: Endomyocardial biopsy is obligatory during the first year after heart transplant (HTx) for the surveillance of  acute rejection.",Non-OADS,/arxiv_data1/oa_pdf/5a/c1/kcj-46-811.PMC5099337.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/c1/kcj-46-811.PMC5099337.pdf
812  sST2 after Heart Transplantation http://dx.doi.org/10.4070/kcj.2016.46.6.811 www.e-kcj.org There has been an effort to predict acute allograft rejection  noninvasively using various biomarkers.,Non-OADS,/arxiv_data1/oa_pdf/5a/c1/kcj-46-811.PMC5099337.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.811 www.e-kcj.org Measurement of soluble ST2   Blood samples were obtained by venipuncture at the time  of endomyocardial biopsy and collected in a heparin tube.,OADS,/arxiv_data1/oa_pdf/5a/c1/kcj-46-811.PMC5099337.pdf
"814  sST2 after Heart Transplantation http://dx.doi.org/10.4070/kcj.2016.46.6.811 www.e-kcj.org (5.1%) samples were matched with pathologic results showing  any rejection and significant rejection, respectively; 328 (66.4%) samples of 0R, 141 (28.5%) samples of 1R, 19 (3.8%) samples of 2R, 3 (0.6%) samples of 3R and 3 (0.6%) samples of hemodynamically unstable humoral rejection.",Non-OADS,/arxiv_data1/oa_pdf/5a/c1/kcj-46-811.PMC5099337.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.811 www.e-kcj.org Fig.,OADS,/arxiv_data1/oa_pdf/5a/c1/kcj-46-811.PMC5099337.pdf
"816  sST2 after Heart Transplantation http://dx.doi.org/10.4070/kcj.2016.46.6.811 www.e-kcj.org in sST2 levels at the pre- and post- rejection periods in the early  postoperative period (109 [74-173], 74 [30-173], and 31 [17-213] ng/mL, p=0.31) or late postoperative period (19 [14-31], 29 [12-32], and 50 [17-107] ng/mL, p=0.16).",Non-OADS,/arxiv_data1/oa_pdf/5a/c1/kcj-46-811.PMC5099337.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.811 www.e-kcj.org Detailed information for 20 cases with significant rejection are  presented in Table 3.,Non-OADS,/arxiv_data1/oa_pdf/5a/c1/kcj-46-811.PMC5099337.pdf
818  sST2 after Heart Transplantation http://dx.doi.org/10.4070/kcj.2016.46.6.811 www.e-kcj.orgTable 3.,Non-OADS,/arxiv_data1/oa_pdf/5a/c1/kcj-46-811.PMC5099337.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.811 www.e-kcj.org (Level of recommendation III).2)  The role of sST2 as a biomarker to predict acute rejection  after HTx has been investigated previously.16)17) Pascual-Figal et  al.16)  reported that sST2 levels were increased as compared with  the pre-rejection period, and decreased again after treatment  of acute rejection.",Non-OADS,/arxiv_data1/oa_pdf/5a/c1/kcj-46-811.PMC5099337.pdf
Supplementary Materials The online-only Data Supplement is available with article at  http://dx.doi.org/10.4070/kcj.2016.46.6.811.,Non-OADS,/arxiv_data1/oa_pdf/5a/c1/kcj-46-811.PMC5099337.pdf
820  sST2 after Heart Transplantation http://dx.doi.org/10.4070/kcj.2016.46.6.811 www.e-kcj.org transplant recipients.,Non-OADS,/arxiv_data1/oa_pdf/5a/c1/kcj-46-811.PMC5099337.pdf
"Increased PLR values emerged as a valuable predictor adverse cardiovascular Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.821 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The Association between Platelet/Lymphocyte Ratio and Coronary  Artery Disease Severity in Asymptomatic Low Ejection Fraction Patients  Fatih Mehmet Uçar, MD1, Burak Açar, MD2, Murat Gul, MD2, Özcan Özeke, MD2, and Sinan Aydogdu, MD2 1Department of Cardiology, Trakya University Hospital, Edirne, 2Turkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey Background and Objectives: Coronary angiography (CAG) is generally needed in the setting of systolic heart failure (HF) with an  unidentified etiology as a part of diagnostic strategy.",Non-OADS,/arxiv_data1/oa_pdf/a6/bd/kcj-46-821.PMC5099338.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/bd/kcj-46-821.PMC5099338.pdf
"822  Platelet/Lymphocyte Ratio and Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2016.46.6.821 www.e-kcj.org events in certain types of acute coronary syndromes in the long  term7) and in predicting critical limb ischemia in peripheral artery  disease.8) Moreover , higher PLR values emerged as a significant  index that may independently predict the  severity of coronary arterosclerotic disease.",Non-OADS,/arxiv_data1/oa_pdf/a6/bd/kcj-46-821.PMC5099338.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.821 www.e-kcj.org with the Kolmogorov-Smirnov test.,Non-OADS,/arxiv_data1/oa_pdf/a6/bd/kcj-46-821.PMC5099338.pdf
"824  Platelet/Lymphocyte Ratio and Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2016.46.6.821 www.e-kcj.org group than controls (p<0.001); also, it was significantly higher  in the mild atherosclerosis group than control group (p=0.03).",Non-OADS,/arxiv_data1/oa_pdf/a6/bd/kcj-46-821.PMC5099338.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.821 www.e-kcj.org sensitivity of 76% and specificity of 60%.,Non-OADS,/arxiv_data1/oa_pdf/a6/bd/kcj-46-821.PMC5099338.pdf
826  Platelet/Lymphocyte Ratio and Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2016.46.6.821 www.e-kcj.org still at its infancy suggesting the need for future clinical studies  to validate absolute implications of this index in the setting of atherosclerotic heart disease.,Non-OADS,/arxiv_data1/oa_pdf/a6/bd/kcj-46-821.PMC5099338.pdf
"It was Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.827 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Endocan and Non-Dipping Circadian Pattern in Newly Diagnosed  Essential Hypertension Tolga Çimen, MD1, Murat Bilgin, MD1, Ahmet Akyel, MD1, Mehmet Ali Feleko ğlu, MD1, Ali Nallbani, MD1,   Şeyda Özdemir, MD2, Gönül Erden, MD2, Alpaslan Öztürk, MD2, Mehmet Do ğan, MD1, and Ekrem Yeter, MD1 1Department of Cardiology, Dı şkapı Yıldırım Beyazıt Training and Research Hospital, Ankara,  2Department of Clinical Biochemistry, Dı şkapı Yıldırım Beyazıt Training and  Research Hospital, Ankara, Turkey Background and Objectives: Non-dipper hypertension is frequently accompanied by endothelial dysfunction and activation.",Non-OADS,/arxiv_data1/oa_pdf/77/c7/kcj-46-827.PMC5099339.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/c7/kcj-46-827.PMC5099339.pdf
828  Endocan and Non-Dipper Hypertension http://dx.doi.org/10.4070/kcj.2016.46.6.827 www.e-kcj.org shown that endothelium-dependent vasodilation is much more  impaired in non-dippers.7) Endothelial cell-specific molecule-1 (endocan) is in structure of  dermatan sulfate pretoglycan and released actively by endothelial cells.,Non-OADS,/arxiv_data1/oa_pdf/77/c7/kcj-46-827.PMC5099339.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.827 www.e-kcj.org median (minimum-maximum) values.,OADS,/arxiv_data1/oa_pdf/77/c7/kcj-46-827.PMC5099339.pdf
830  Endocan and Non-Dipper Hypertension http://dx.doi.org/10.4070/kcj.2016.46.6.827 www.e-kcj.org non-dipper group than the other groups (Fig.,Non-OADS,/arxiv_data1/oa_pdf/77/c7/kcj-46-827.PMC5099339.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.827 www.e-kcj.org hypertensives and normotensives.,Non-OADS,/arxiv_data1/oa_pdf/77/c7/kcj-46-827.PMC5099339.pdf
"832  Endocan and Non-Dipper Hypertension http://dx.doi.org/10.4070/kcj.2016.46.6.827 www.e-kcj.org Conclusion In conclusion, circulatory levels of endocan were higher in  the non-dipper group in comparison with both dippers and  normotensives.",Non-OADS,/arxiv_data1/oa_pdf/77/c7/kcj-46-827.PMC5099339.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.827 www.e-kcj.org patients.,Non-OADS,/arxiv_data1/oa_pdf/77/c7/kcj-46-827.PMC5099339.pdf
"3)  Several epidemiological studies demonstrated that heart  rate is an independent predictor of development of sustained hypertension, 4) atherosclerosis,5) and cardiovascular mortality.6)7) A  population-based study conducted in 1780 Japanese participants suggested that even with systolic BP less than 135 mmHg, individuals with a heart rate equal to or more than 70 beats per min (bpm) had a higher risk of cardiovascular mortality; and an increase of 5 bpm in a resting heart rate was associated with a Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.834 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Resting Heart Rate and Aortic Stiffness in Normotensive Adults Jeongok G. Logan, PhD1, and Suk-Sun Kim, PhD2 1School of Nursing, University of Virginia, VA, USA, 2College of Nursing, Ewha Womans University, Seoul, Korea Background and Objective: Large-artery stiffness is an independent predictor of cardiovascular disease (CVD), and carotid-femoral pulse  wave velocity (cfPWV) is considered the gold standard measure of arterial stiffness.",Non-OADS,/arxiv_data1/oa_pdf/c7/d6/kcj-46-834.PMC5099340.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/d6/kcj-46-834.PMC5099340.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.834 www.e-kcj.org 17% increase in the 10-year risk of cardiovascular mortality after  controlling for BP.6) Another longitudinal study on 4695 patients  with isolated systolic hypertension demonstrated that individuals with heart rates more than 79 bpm had a 1.89 fold greater risk of mortality than those with a heart rate equal to or less than 79 bpm.,Non-OADS,/arxiv_data1/oa_pdf/c7/d6/kcj-46-834.PMC5099340.pdf
836  Heart Rate and Aortic Stiffness http://dx.doi.org/10.4070/kcj.2016.46.6.834 www.e-kcj.org (SBP) and diastolic blood pressure (DBP) were highly correlated.,OADS,/arxiv_data1/oa_pdf/c7/d6/kcj-46-834.PMC5099340.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.834 www.e-kcj.org associated with cfPWV among 102 normotensive Korean Americans  aged 21-60 years old.,Non-OADS,/arxiv_data1/oa_pdf/c7/d6/kcj-46-834.PMC5099340.pdf
"838  Heart Rate and Aortic Stiffness http://dx.doi.org/10.4070/kcj.2016.46.6.834 www.e-kcj.org heart rate; thus, further studies were suggested to calculate arterial  distensability using central aortic pulse pressure.13) A few other  studies similarly reported a significant association of heart rate and arterial stiffness as measured by brachial-ankle pulse wave velocity (ba-PWV).",Non-OADS,/arxiv_data1/oa_pdf/c7/d6/kcj-46-834.PMC5099340.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.834 www.e-kcj.org to bioavailability of NO;23) thus, ACE may contribute to arterial  stiffness by increasing angiotensin II and degrading bradykinin.",Non-OADS,/arxiv_data1/oa_pdf/c7/d6/kcj-46-834.PMC5099340.pdf
840  Heart Rate and Aortic Stiffness http://dx.doi.org/10.4070/kcj.2016.46.6.834 www.e-kcj.org between changes in the pulse wave velocity and changes in the  heart rate in middle-aged Japanese adults: a prospective study.,Non-OADS,/arxiv_data1/oa_pdf/c7/d6/kcj-46-834.PMC5099340.pdf
"4) Possible ethnic differences in the clinical  manifestations of patients with MFS have been suggested.5) Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.841 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Clinical Characteristics of Marfan Syndrome in Korea  A Young Lim, MD1, Ju Sun Song, MD2, Eun Kyoung Kim, MD1, Shin Yi Jang, RN1, Tae-Young Chung, MD3,   Seung-Hyuk Choi, MD1, Kiick Sung, MD4, June Huh, MD5, I-Seok Kang, MD5, Yeon Hyeon Choe, MD6, Chang-Seok Ki, MD2,  and Duk-Kyung Kim, MD1 1Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, 2Department of Laboratory Medicine and Genetics, Samsung  Medical Center, 3Department of Ophthalmology, Samsung Medical Center, 4Department of Thoracic and Cardiovascular Surgery, Heart Vascular Stroke Institute, Samsung  Medical Center, 5Department of Pediatrics, Heart Vascular Stroke Institute, Samsung Medical Center, 6Department of Radiology, HVSI Imaging Center, Heart Vascular  Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background and Objectives: Marfan syndrome (MFS) is a connective tissue disorder with autosomal dominant inheritance and a highly  variable clinical spectrum.",Non-OADS,/arxiv_data1/oa_pdf/e2/84/kcj-46-841.PMC5099341.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/84/kcj-46-841.PMC5099341.pdf
"842  Clinical  Characteristics of Marfan Syndrome  www.e-kcj.org http://dx.doi.org/10.4070/kcj.2016.46.6.841 However, there are limited data available on the clinical features of  Korean patients with MFS, and the available reports are based on only small numbers of patients.",Non-OADS,/arxiv_data1/oa_pdf/e2/84/kcj-46-841.PMC5099341.pdf
www.e-kcj.org http://dx.doi.org/10.4070/kcj.2016.46.6.841 height was 184.4±10.0 cm for male patients and 170.5±7.7 cm for  females.,OADS,/arxiv_data1/oa_pdf/e2/84/kcj-46-841.PMC5099341.pdf
"844  Clinical  Characteristics of Marfan Syndrome  www.e-kcj.org http://dx.doi.org/10.4070/kcj.2016.46.6.841 aortic aneurysm in 3 patients (15.8%), thoracoabdominal aortic  aneurysm in 6 patients (31.6%), and abdominal aortic aneurysm in 10 patients (52.6%).",Non-OADS,/arxiv_data1/oa_pdf/e2/84/kcj-46-841.PMC5099341.pdf
www.e-kcj.org http://dx.doi.org/10.4070/kcj.2016.46.6.841 median follow-up duration of 52.8 months.,Non-OADS,/arxiv_data1/oa_pdf/e2/84/kcj-46-841.PMC5099341.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.846Print ISSN 1738-5520 • On-line ISSN 1738-5555",Non-OADS,/arxiv_data1/oa_pdf/60/a6/kcj-46-846.PMC5099342.pdf
www.e-kcj.org http://dx.doi.org/10.4070/kcj.2016.46.6.846 mortality and morbidity in IE survivors who underwent early surgery  or experienced systemic embolic events remain controversial.4)6-9)  This study reports the long-term outcomes of the EASE trial.,Non-OADS,/arxiv_data1/oa_pdf/60/a6/kcj-46-846.PMC5099342.pdf
"848  Early Surgery in Infective Endocarditis www.e-kcj.org http://dx.doi.org/10.4070/kcj.2016.46.6.846 (SAS Institute Inc., Cary, NC, USA), was used for statistical analyses.",OADS,/arxiv_data1/oa_pdf/60/a6/kcj-46-846.PMC5099342.pdf
"www.e-kcj.org http://dx.doi.org/10.4070/kcj.2016.46.6.846 discussion In this randomized trial involving IE patients complicated  with severe valve disease and large vegetations, early surgery  significantly reduced the composite end point of death from any cause and embolic events during hospitalization, and the substantial benefit for early surgery was sustained throughout the follow-up period extending up to 7 years.",Non-OADS,/arxiv_data1/oa_pdf/60/a6/kcj-46-846.PMC5099342.pdf
850  Early Surgery in Infective Endocarditis www.e-kcj.org http://dx.doi.org/10.4070/kcj.2016.46.6.846 10.,Non-OADS,/arxiv_data1/oa_pdf/60/a6/kcj-46-846.PMC5099342.pdf
"851 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Original Article http://dx.doi.org/10.4070/kcj.2016.46.6.851 Print ISSN 1738-5520 • On-line ISSN 1738-5555Introduction Studies about the transcatheter atrial septal defect (ASD) closure  show that the procedure does not only have an excellent efficacy, but it also has the lowest complication rates.",Non-OADS,/arxiv_data1/oa_pdf/d9/da/kcj-46-851.PMC5099343.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/da/kcj-46-851.PMC5099343.pdf
"852  Differences of ASD Closure in Children, Adolescents and Adults http://dx.doi.org/10.4070/kcj.2016.46.6.851 www.e-kcj.org department of pediatric cardiology of Dr. Siyami Ersek Thoracic  and Cardiovascular Surgery Teaching and Research Hospital.",Non-OADS,/arxiv_data1/oa_pdf/d9/da/kcj-46-851.PMC5099343.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.851 www.e-kcj.org Complications  Complications requiring re-intervention, hospitalization, and  causing a permanent deficit in the 12-month follow-up period  were defined as major adverse events.",Non-OADS,/arxiv_data1/oa_pdf/d9/da/kcj-46-851.PMC5099343.pdf
"854  Differences of ASD Closure in Children, Adolescents and Adults http://dx.doi.org/10.4070/kcj.2016.46.6.851 www.e-kcj.org Table 1.",Non-OADS,/arxiv_data1/oa_pdf/d9/da/kcj-46-851.PMC5099343.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.851 www.e-kcj.org oversized devices for the closure of other defect(s) accompanying  multifenestrated defects (10 patients [2.7%], 1 patient [1.2%] and 3 patients (1.3%) in Group 1, 2 and 3, respectively; p=0.587).",Non-OADS,/arxiv_data1/oa_pdf/d9/da/kcj-46-851.PMC5099343.pdf
"856  Differences of ASD Closure in Children, Adolescents and Adults http://dx.doi.org/10.4070/kcj.2016.46.6.851 www.e-kcj.org during later follow-ups, no statistically significant differences were  also detected between three groups (Table 2).",OADS,/arxiv_data1/oa_pdf/d9/da/kcj-46-851.PMC5099343.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.851 www.e-kcj.org 6 total major complications developed during the use of Amplatzer  septal occluder (all 3 cases were adults) and the other 3 developed during the use of Cardi-O-Fix septal occluder (2 adult cases, 1 child case).",Non-OADS,/arxiv_data1/oa_pdf/d9/da/kcj-46-851.PMC5099343.pdf
"858  Differences of ASD Closure in Children, Adolescents and Adults http://dx.doi.org/10.4070/kcj.2016.46.6.851 www.e-kcj.org patients identified to have high left atrium pressure following  the defect closure.",Non-OADS,/arxiv_data1/oa_pdf/d9/da/kcj-46-851.PMC5099343.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.851 www.e-kcj.org no statistically significant differences between the three groups  regarding the residual shunt rates immediately after the implant, before discharge, and at later follow-ups with respect to not only all the patients but also all patients with complex defects.",Non-OADS,/arxiv_data1/oa_pdf/d9/da/kcj-46-851.PMC5099343.pdf
"860  Differences of ASD Closure in Children, Adolescents and Adults http://dx.doi.org/10.4070/kcj.2016.46.6.851 www.e-kcj.org who failed to regularly come for follow-up visits, probably 7 years  after the procedure although the date is not exactly certain.",Non-OADS,/arxiv_data1/oa_pdf/d9/da/kcj-46-851.PMC5099343.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.851 www.e-kcj.org requiring devices > or =20 mm in small children weighing <20 kg.,Non-OADS,/arxiv_data1/oa_pdf/d9/da/kcj-46-851.PMC5099343.pdf
"862 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Case Report http://dx.doi.org/10.4070/kcj.2016.46.6.862 Print ISSN 1738-5520 • On-line ISSN 1738-5555Introduction Although its incidence is decreasing, coronary stent dislodgement  continues to occur in this modern era of percutaneous coronary  interventions (PCI).",Non-OADS,/arxiv_data1/oa_pdf/cb/e2/kcj-46-862.PMC5099344.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/e2/kcj-46-862.PMC5099344.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.862 www.e-kcj.org was implanted in the proximal LAD and two DESs of 2.75×38 mm,  and 2.75×22 mm (Xience Xpedition, Abbott Vascular, Santa Clara, CA, USA) were implanted in the proximal and mid segments of the RCA, respectively (Fig.",Non-OADS,/arxiv_data1/oa_pdf/cb/e2/kcj-46-862.PMC5099344.pdf
864  Extraction of a Fully Deployed Coronary Stent http://dx.doi.org/10.4070/kcj.2016.46.6.862 www.e-kcj.org remnant part of the two stents.,Non-OADS,/arxiv_data1/oa_pdf/cb/e2/kcj-46-862.PMC5099344.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.862 www.e-kcj.org the stent just one day after the first procedure had been performed.,Non-OADS,/arxiv_data1/oa_pdf/cb/e2/kcj-46-862.PMC5099344.pdf
"866 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Case Report http://dx.doi.org/10.4070/kcj.2016.46.6.866 Print ISSN 1738-5520 • On-line ISSN 1738-5555Introduction Dengue is the most prevalent viral disease transmitted by  mosquitoes, producing clinical illness in 96 million cases annually.1)  Most of the dengue virus infections are symptomatic and can  present with a wide range of clinical manifestations, from mild febrile illness to life-threatening dengue shock syndrome.",Non-OADS,/arxiv_data1/oa_pdf/52/6d/kcj-46-866.PMC5099345.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/6d/kcj-46-866.PMC5099345.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.866 www.e-kcj.org transaminase 1280 IU/L (<40 IU/L), alkaline phosphatase to 750 IU/L  (<150 IU/L) and a decreased albumin level to 2.3 g/dL (>4 g/dL).",Non-OADS,/arxiv_data1/oa_pdf/52/6d/kcj-46-866.PMC5099345.pdf
868  Complete Heart Block in Association with Dengue Hemorrhagic Fever http://dx.doi.org/10.4070/kcj.2016.46.6.866 www.e-kcj.org hospital admission.,Non-OADS,/arxiv_data1/oa_pdf/52/6d/kcj-46-866.PMC5099345.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.866 www.e-kcj.org References 1.,Non-OADS,/arxiv_data1/oa_pdf/52/6d/kcj-46-866.PMC5099345.pdf
"Her initial electrocardiogram (EKG) presented sinus tachycardia at 104/min without significant ST deviations but cardiac biomarkers were elevated as follows: creatine Case Report http://dx.doi.org/10.4070/kcj.2016.46.6.870 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Life Threatening Complication of Self- made Remedy for Controlling  High Blood Pressure-Coronary Artery Vasospasm Associated with  Iatrogenic Thyrotoxicosis In Sook Kang, MD1,2, and Wook Bum Pyun, MD3 1Department of Internal Medicine, Green h ospital, Seoul, 2Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, 3Department of Internal  Medicine, School of Medicine, Ewha Womans University, Seoul, Korea We report the case of a middle aged woman who was previously diagnosed with hypertension.",OADS,/arxiv_data1/oa_pdf/dd/06/kcj-46-870.PMC5099346.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/06/kcj-46-870.PMC5099346.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.870 www.e-kcj.org kinase-MB fraction 16.5 ng/mL (normal, <5.0) and troponin T 0.202  ng/mL (normal, <0.01) with normal range creatine kinase 128 IU/L  (reference range, 55-245).",Non-OADS,/arxiv_data1/oa_pdf/dd/06/kcj-46-870.PMC5099346.pdf
"872  Kelp and Variant Angina http://dx.doi.org/10.4070/kcj.2016.46.6.870 www.e-kcj.org treatment with aspirin, nicorandil, nifedipine, and isosorbide  dinitrate.",Non-OADS,/arxiv_data1/oa_pdf/dd/06/kcj-46-870.PMC5099346.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.870 www.e-kcj.org previous reports.,OADS,/arxiv_data1/oa_pdf/dd/06/kcj-46-870.PMC5099346.pdf
874  Kelp and Variant Angina http://dx.doi.org/10.4070/kcj.2016.46.6.870 www.e-kcj.org 1988;148:1450-3.,OADS,/arxiv_data1/oa_pdf/dd/06/kcj-46-870.PMC5099346.pdf
"An electrocardiogram showed a nor mal sinus rhythm, and a brain computed tomography Case Report http://dx.doi.org/10.4070/kcj.2016.46.6.875 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Differential Diagnosis of a Left Atrial Mass after Surgical Excision of Myxoma: a Remnant or a Thrombus?",Non-OADS,/arxiv_data1/oa_pdf/ba/df/kcj-46-875.PMC5099347.pdf
876  Differential Diagnosis of Myxoma Remnant or Thrombus http://dx.doi.org/10.4070/kcj.2016.46.6.875 www.e-kcj.org scan appeared normal.,Non-OADS,/arxiv_data1/oa_pdf/ba/df/kcj-46-875.PMC5099347.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.875 www.e-kcj.org Lipomatous hypertrophy of the interatrial septum was also noted,  and no thrombus was seen in the left atrial appendage .",Non-OADS,/arxiv_data1/oa_pdf/ba/df/kcj-46-875.PMC5099347.pdf
"878  Differential Diagnosis of Myxoma Remnant or Thrombus http://dx.doi.org/10.4070/kcj.2016.46.6.875 www.e-kcj.org case showed a pedunculated thrombus along the right atrial wall,11)  whereas the other two cases showed a thrombus attached to the  right atrial side of the interatrial septum.10)12) Considering low blood  flow velocity in the right atrium, short-term anticoagulation has been suggested to prevent this complication after primary surgical or device closure of the atrial septal defect or a patent foramen ovale.",Non-OADS,/arxiv_data1/oa_pdf/ba/df/kcj-46-875.PMC5099347.pdf
"879 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Case Report http://dx.doi.org/10.4070/kcj.2016.46.6.879 Print ISSN 1738-5520 • On-line ISSN 1738-5555Introduction Percutaneous, echocardiography-guided pericardiocentesis  is a safe procedure, indicated for large or haemodynamically- significant, pericardial effusions.1)2) Tuberculosis is highly prevalent  in Southern Africa, with incidence rates of >1000 new cases per 100000 per year.",Non-OADS,/arxiv_data1/oa_pdf/d8/26/kcj-46-879.PMC5099348.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Fig.",Non-OADS,/arxiv_data1/oa_pdf/d8/26/kcj-46-879.PMC5099348.pdf
"880  Iatrogenic Pleuro-Pericardial Connection http://dx.doi.org/10.4070/kcj.2016.46.6.879 www.e-kcj.org 34%, end-diastolic, right atrial wall collapse and a distended, non- collapsing inferior vena cava.",Non-OADS,/arxiv_data1/oa_pdf/d8/26/kcj-46-879.PMC5099348.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.6.879 www.e-kcj.org the following mechanism: because the patient had pendulous  mammary tissue, her left breast was elevated manually prior to needle and guidewire placement, which resulted in the cephalic displacement of the subcutaneous tissue relative to the pericardial surface.",Non-OADS,/arxiv_data1/oa_pdf/d8/26/kcj-46-879.PMC5099348.pdf
"882 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Case Report   http://dx.doi.org/10.4070/kcj.2016.46.6.882 Print ISSN 1738-5520 • On-line ISSN 1738-5555Introduction Eosinophilic myocarditis, a disease characterized by eosinophilic  infiltration of the myocardium, is known to have several key imaging  features on cardiac magnetic resonance (CMR) imaging–high signal intensities on T2-weighted images (T2WI) and subendocardial enhancement on late Gadolinium enhancement (LGE) images.",Non-OADS,/arxiv_data1/oa_pdf/37/a2/kcj-46-882.PMC5099349.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/a2/kcj-46-882.PMC5099349.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.882 www.e-kcj.org during the mid-diastolic phase along the same short-axis planes as  the T2WI.,Non-OADS,/arxiv_data1/oa_pdf/37/a2/kcj-46-882.PMC5099349.pdf
884  Native T1 Mapping in Eosinophilic Myocarditis http://dx.doi.org/10.4070/kcj.2016.46.6.882 www.e-kcj.org sinus abnormality 4) extravascular eosinophil infiltration on biopsy2)  - and her eosinophilic myocarditis was thought to be a cardiac  manifestation of CSS.,Non-OADS,/arxiv_data1/oa_pdf/37/a2/kcj-46-882.PMC5099349.pdf
http://dx.doi.org/10.4070/kcj.2016.46.6.882 www.e-kcj.org cardiomyopathy.,Non-OADS,/arxiv_data1/oa_pdf/37/a2/kcj-46-882.PMC5099349.pdf
Sequence analyses and alignment The BLAST tool (http://www.ncbi.nlm.nih.gov/blast)  was used to detect sequence homology.,OADS,/arxiv_data1/oa_pdf/54/b3/CEJI-41-28572.PMC5099378.pdf
The translated amino acid sequences were analyzed with the Expert  Protein Analysis System (http://www.expasy.org/) and the protein domain features in the translated amino acids  were predicted by Simple Modular Architecture Research  Tool (SMART) (http://smart.embl-heidelberg.de/).,OADS,/arxiv_data1/oa_pdf/54/b3/CEJI-41-28572.PMC5099378.pdf
Nucleotide sequence deposition The BankIt tool was used to deposit the analyzed se - quence (rTLR-1) in the GenBank (http://www.ncbi.nlm.nih.gov/genbank/submit/).,OADS,/arxiv_data1/oa_pdf/54/b3/CEJI-41-28572.PMC5099378.pdf
The DNA sequence of Aca f 1 was submitted to the NCBI GenBank database of ( http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/14/5e/CEJI-41-28578.PMC5099384.pdf
The top line indicates the location  of secondary structures created by PSIPRED protein sequence analysis (http://bioinf.cs.ucl.ac.uk/psipred/).,OADS,/arxiv_data1/oa_pdf/14/5e/CEJI-41-28578.PMC5099384.pdf
This  allergenic member of the Ole e 1-like protein family of  a. farnesiana was named Aca f 1 in accordance with the  International Union of Immunological Societies (IUIS) Allergen Nomenclature Subcommittee (http://www.aller - gen.org/).,Non-OADS,/arxiv_data1/oa_pdf/14/5e/CEJI-41-28578.PMC5099384.pdf
30. http://www.ema.europa.eu/docs/pl_PL/document_li-brary/EPAR_-_Summary_for_the_public/human/002392/WC500135745.pdf-14.12.2015 31. http://www.ema.europa.eu/docs/pl_PL/document_library/EPAR_-_Product_Information/human/002532/WC500139484.pdf -14.12.2015 32.,Non-OADS,/arxiv_data1/oa_pdf/69/d2/CEJI-41-28583.PMC5099389.pdf
35. http://gis.gov.pl/images/ep/akt-1pso2016.pdf 36.,Non-OADS,/arxiv_data1/oa_pdf/b9/25/CEJI-41-28586.PMC5099392.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Aging pathways of proteinopathies in C. elegans D-K Kim et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/a2/79/emm2016109a.PMC5099420.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Genome engineering: re ﬁning molecular scissors A Eid and MM Mahfouz 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/41/e4/emm2016111a.PMC5099421.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Anti-IL4R αnanoparticles control lung in ﬂammation RH a l w a n i et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/eb/0b/emm201689a.PMC5099422.pdf
"The optical density of the bands was scanned and quanti ﬁed with ImageJ software version 1.40g (http://rsb.info.nih.gov/ij/, NIH), and Table 1 Primers used in this study Primer name Primer sequence Escherichia coli pU:BamHI-SodA 5'-CGC GGATCCG ATGAGCTATACCCTG-3' pD:XhoI-SodA 5'-CCG CTCGAG TTTTTTCGCCGCAA-3' pU:BamHI-SodB 5'-CGC GGATCCG ATGTCATTCGAATT-3' pD:XhoI-SodB 5'-CCG CTCGAG TGCAGCGAGATTTT-3' pU:BamHI-SodC 5'-CGC GGATCCG ATGAAACGTTTTAG-3' pD:XhoI-SodC 5'-CCG CTCGAG CTTAATTACACCAC-3' Table 2 The characteristics of prokaryotic expression vectors used in this study Feature VectorscDNA fragment of the heterologous proteinsSize of fusion proteins coding region (bp)Fusion proteins to be expressedSize of fusion proteins to be expressed (kD) pET28b-Tat-SodA BamHI-Tat-SodA- XhoI 743 Tat-SodA-6 × His 27.23 pET28b-SodA BamHI-SodA- XhoI 756 6 × His-SodA-6 × His 27.69 pET28b-Tat-SodB BamHI-Tat-SodB- XhoI 693 Tat-SodB-6 × His 25.42 pET28b-SodB BamHI-SodB- XhoI 705 6 × His-SodB-6 × His 25.87 pET28b-Tat-SodC BamHI-Tat-SodC- XhoI 597 Tat-SodC-6 × His 21.83 pET28b-SodC BamHI-SodC- XhoI 609 6 × His-SodC-6 × His 22.29High yields and soluble expression of superoxide dismutase YS u n et al 2 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/d6/fd/emm201691a.PMC5099423.pdf
The datawere analyzed using Microsoft Excel and Origin 9.5 software(http://www.originlab.com/).,OADS,/arxiv_data1/oa_pdf/d6/fd/emm201691a.PMC5099423.pdf
"The reaction mixtures, including 10 μl 2 × Master Mix, 0.08 μl forward primer, 0.08 μl reverse primer, 2 μl cDNA, 0.4 μl Taq DNA polymerase and 7.44 μl ddH 2O, were prepared and RT-qPCR performed according to the following program, using the primers shown in Table 1: one cycle of95 °C for 3 min and then 40 cycles of 95 °C for 12 s, 62 °C for 30 s and 72 °C for 30 s. The results were analyzed using SDS 1.4 software (Applied Biosystems, Waltham, MA, USA) based on the 2−ΔΔCt method, and histogram analysis was performed using Origin 9.5 software (http://www.originlab.com/).",OADS,/arxiv_data1/oa_pdf/d6/fd/emm201691a.PMC5099423.pdf
"Statistical analysis The data were statistically analyzed using SPSS software (version 21.0,SPSS, Chicago, IL, USA, http://spss.en.softonic.com/); groups were compared using Student ’st-test with signi ﬁcant differences de ﬁned as Po0.05, whereas Po0.01 represented a highly signi ﬁcant difference.",OADS,/arxiv_data1/oa_pdf/d6/fd/emm201691a.PMC5099423.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/High yields and soluble expression of superoxide dismutase YS u n et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/d6/fd/emm201691a.PMC5099423.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/4.0/ASCs pretreated with pioglitazone in emphysema YH o n g et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/78/38/emm201693a.PMC5099424.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/4.0/ rThe Author(s) 2016CD8 T-cell tolerance in liver transplantation YC Wong et al 12 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/d3/de/cti201653a.PMC5099425.pdf
"Introduction Mirror movements (MM) are characterized by involuntary move- ments of one side of the body that mirror intentional movements on the contralateral side.1They can be a manifestation of variouscongenital or acquired neurological disorders.2,3Autosomal dominant congenital mirror movements (CMM) are characterized by early onset MM that persist throughout life in the absence of other neurological symptoms.1Since CMM predominantly affects the hands, difficultyFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/59/31/tre-06-424-7522-1.PMC5099496.pdf
Mirror Movements Due to RAD51 Mutations Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/59/31/tre-06-424-7522-1.PMC5099496.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/59/31/tre-06-424-7522-1.PMC5099496.pdf
Mirror Movements Due to RAD51 Mutations Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/59/31/tre-06-424-7522-1.PMC5099496.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/59/31/tre-06-424-7522-1.PMC5099496.pdf
Mirror Movements Due to RAD51 Mutations Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/59/31/tre-06-424-7522-1.PMC5099496.pdf
"Developmental Cognitive Neuroscience  19  (2016)  248–257 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience jo  ur  nal  ho  me  pag  e:  http://www.elsevier.com/locate/dcn Age-related  differences in the  neural  correlates  of  trial-to-trial variations  of reaction time Nancy  E.  Adlemana,b,∗,  Gang  Chenc,  Richard  C.  Reynoldsc,  Anna  Frackmanb,1, Varun Razdanb,2,  Daniel  H.  Weissmand,  Daniel  S.  Pineb,  Ellen  Leibenluftb aDepartment  of  Psychology,  The  Catholic  University  of  America,  620  Michigan  Ave.,  NE,  Washington,  DC  20064,  USA bEmotion and Development  Branch,  National  Institute  of  Mental  Health,  National  Institutes  of  Health,  9000  Rockville  Pike,  Bethesda,  MD  20892,  USA cScientiﬁc  and  Statistical  Computing  Core,  National  Institute  of  Mental  Health,  National  Institutes  of  Health,  9000  Rockville  Pike,  Bethesda,  MD  20892,  USA dDepartment  of  Psychology,  University  of  Michigan,  530  Church  St,  Ann  Arbor,  MI  48109,  USA a  r  t  i  c  l  e  i  n  f  o Article history: Received  10  August  2015 Received  in  revised  form  6  May  2016 Accepted  8  May  2016 Available  online  12  May  2016 Keywords:Reaction time VariationfMRIDevelopmentRT-BOLDa  b  s  t  r  a  c  t Intra-subject  variation  in  reaction  time  (ISVRT)  is  a  developmentally-important  phenomenon  that decreases from  childhood  through  young  adulthood  in  parallel  with  the  development  of  executive  func- tions and  networks.",Non-OADS,/arxiv_data1/oa_pdf/03/82/main.PMC5099497.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/82/main.PMC5099497.pdf
"However,  most  developmental  studies examine  the  relationship  between  activation  and  neural  responses http://dx.doi.org/10.1016/j.dcn.2016.05.001 1878-9293/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/03/82/main.PMC5099497.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/03/82/main.PMC5099497.pdf
Imaging  analysis Functional magnetic  resonance  imaging  data  were  analyzed using  Analysis  of  Functional  NeuroImages  (AFNI;  http://afni.nimh.,OADS,/arxiv_data1/oa_pdf/03/82/main.PMC5099497.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.dcn.2016.05.001 .",OADS,/arxiv_data1/oa_pdf/03/82/main.PMC5099497.pdf
"Psychiatry,  http://dx.doi.org/10.1111/j.1469-7610.2012.02568.x .",Non-OADS,/arxiv_data1/oa_pdf/03/82/main.PMC5099497.pdf
; http://dx.doi.org/10.1101/030338; http://exac.broadinstitute.org; accessed Oct/Nov 2015).,OADS,/arxiv_data1/oa_pdf/a5/52/ACN3-3-844.PMC5099530.pdf
"Next, these variants were ﬁlteredusing stringent criteria for pathogenicity in CADASIL,namely missense mutations leading to the gain or the lossof a cysteine residue in one of the 34 EGFr domains oftheNOTCH3 protein (amino acid residues 40 –1373) (http://www.uniprot.org).",Non-OADS,/arxiv_data1/oa_pdf/a5/52/ACN3-3-844.PMC5099530.pdf
Four independently accessiblecohorts contributing to the ExAC database were also indi-vidually queried for pathogenic NOTCH3 mutations: 1000 Genomes (http://www.1000genomes.org); NHLBI-GO Exome Sequencing Project (http://evs.gs.washington.edu); Sequencing Initiative Suomi (http://www.sisu project.ﬁ/) and Type 2 DiabetesGenetics 17k exome sequence analysis (http://www.type2diabetesgenetics.org).,OADS,/arxiv_data1/oa_pdf/a5/52/ACN3-3-844.PMC5099530.pdf
; http://dx.doi.org/10.1101/030338).,Non-OADS,/arxiv_data1/oa_pdf/a5/52/ACN3-3-844.PMC5099530.pdf
"CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; LOVD, Leiden Open Variation Database (www.lovd.nl/NOTCH3); HGMD, The Human Gene Mutation Database (http://www.hgmd.cf.ac.uk).",Non-OADS,/arxiv_data1/oa_pdf/a5/52/ACN3-3-844.PMC5099530.pdf
Available at https://nctu.partners.org/ ProACT/(accessed December 2015).,Non-OADS,/arxiv_data1/oa_pdf/a9/56/ACN3-3-866.PMC5099532.pdf
http://statweb.stanford.edu/~tibs/ElemStatLearn/.,OADS,/arxiv_data1/oa_pdf/a9/56/ACN3-3-866.PMC5099532.pdf
Available at http://statweb.stanford.edu/~tibs/ ElemStatLearn/.,OADS,/arxiv_data1/oa_pdf/a9/56/ACN3-3-866.PMC5099532.pdf
"1Genome Reference Consortium Human Build 37 (GRCh37) http://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.13/ 2SIFT: http://sift.jcvi.org/, PP: PolyPhen-2 http://genetics.bwh.havard.edu/pph2/bgi.shtml, MT: MutationTaster http://www.mutationtaste r.org/ p.A319VAB Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/de/6f/ACN3-3-876.PMC5099533.pdf
Reported homozygous NALCN variants associated with the autosomal recessive IHPRFphenotype (MIM: 615419) are illustrated as black squares.We have referred to http://www.uniprot.org/uniprot/Q8IZF0 for the amino acid topology of human NALCN.,Non-OADS,/arxiv_data1/oa_pdf/de/6f/ACN3-3-876.PMC5099533.pdf
Available at http://eservice.hsa.gov.,Non-OADS,/arxiv_data1/oa_pdf/9f/3f/BCP-82-1636.PMC5099543.pdf
Available at https://www.moh.gov.sg/con- tent/moh_web/home/statistic s/Health_Facts_Singapore/ Admissions_and_Outpatient_Atten dances.html (last accessed 22 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/9f/3f/BCP-82-1636.PMC5099543.pdf
Supporting Information Additional Supporting Information may be found in the online version of this article at the publisher ’s web-site: http://onlinelibrary.wiley.com/doi/10.1111/bcp.,Non-OADS,/arxiv_data1/oa_pdf/9f/3f/BCP-82-1636.PMC5099543.pdf
"Tables of Links TARGETS Enzymes [2] OAT3 Carboxylesterase 1 P-glycoprotein CYP3A4 OATP1B1 Transporters [3] OCT2 OAT1LIGANDS Cyclosporine Quinidine Edoxaban Rifampin Erythromycin Vitamin C Ketoconazole These Tables lists key protein targets and ligands in this article that are hyperlinked to corresponding entries in http://www.guidetopharmacolog y.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACO LOGY [1], and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 [2, 3].",Non-OADS,/arxiv_data1/oa_pdf/13/12/BCP-82-1591.PMC5099547.pdf
Competing Interests All authors of this manuscript have completed the Uni ﬁed Competing Interest form at: http://www.icmje.org/coi_disclosure.pdf (available o n request from the correspond- ing author) and declare no support from any third partyorganization for the submitted work and no ﬁnancial rela- tionships with any organizations that might have an interestin the submitted work in the previous 3 years.,Non-OADS,/arxiv_data1/oa_pdf/13/12/BCP-82-1591.PMC5099547.pdf
Supporting Information Additional Supporting Information may be found in the online version of this article at the publisher ’s web-site: http://onlinelibrary.wiley.com/doi/10.1111/bcp.,Non-OADS,/arxiv_data1/oa_pdf/13/12/BCP-82-1591.PMC5099547.pdf
"Tables of Links TARGETS Enzymes [2] CYP1A2 CYP2C9 CYP2C19 CYP2D6 CYP3A4 Transporters [3] ABCB1 (P-glycoprotein)LIGANDS caffeine dextromethorphan fexofenadine losartan midazolam omeprazole These Tables list key protein targets and ligands in this article that are hyperlinked to corresponding entries in http://www.guidetopharmacology .org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY [1], and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 [2, 3].",Non-OADS,/arxiv_data1/oa_pdf/8f/6f/BCP-82-1580.PMC5099554.pdf
"Tables of Links TARGETS Other protein targets [2] CD20 TNF-alphaLIGANDS Rituximab These Tables lists key protein targets and ligands in this article that are hyperlinked to corresponding entries in http://www.guidetopharmacolog y.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY [1], and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 [2].",OADS,/arxiv_data1/oa_pdf/42/0e/BCP-82-1568.PMC5099556.pdf
"Competing Interests All authors have completed the Uni ﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (http://www.icmje.org/coi_disclosure .pdf) (available on request from the corresponding author) and declare the following ﬁnan- cial relationships with organizations that might have anTime (weeks)DAS28 034567 248 12 16 20 24 Time (weeks)DAS28 034567 24 8 12 16 20 24 Time (weeks)ACR20 Responder Rate 0.00.20.40.60.81.0 24 8 1 2 1 6 2 0 2 4 Time (weeks)ACR20 Responder Rate 0.00.20.40.60.81.0 24 8 1 2 16 20 24After BeforeDAS28 ACR20 Rituximab-US Rituximab-EU PF-05280586 Figure 5 Clinical response pro ﬁles for three treatment groups before (left panels) and after (right panels) matching, based on swollen joint counts and pa- tient ’s assessment of pain.",Non-OADS,/arxiv_data1/oa_pdf/42/0e/BCP-82-1568.PMC5099556.pdf
Sci Res 2013; Available at http://dx.doi.org/10.4236/ ojra.2013.32011 (last accessed 6 June 2016).,OADS,/arxiv_data1/oa_pdf/42/0e/BCP-82-1568.PMC5099556.pdf
Available at http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/42/0e/BCP-82-1568.PMC5099556.pdf
Available at http://www.fda.gov/downloads/drugs/guidancecomp lianceregulatoryinformation/ guidances/ucm291128.pdf (last accessed 6 June 2016).,Non-OADS,/arxiv_data1/oa_pdf/42/0e/BCP-82-1568.PMC5099556.pdf
Available at http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/42/0e/BCP-82-1568.PMC5099556.pdf
A vailable at http://www.gene.,Non-OADS,/arxiv_data1/oa_pdf/42/0e/BCP-82-1568.PMC5099556.pdf
Supporting Information Additional Supporting Information may be found in the online version of this article at the publisher ’s web-site: http://onlinelibrary.wiley.com/doi/10.1111/bcp.,Non-OADS,/arxiv_data1/oa_pdf/42/0e/BCP-82-1568.PMC5099556.pdf
"Tables of Links TARGETS Enzymes [2] Hydroxymethylglutaryl-CoA reductase Proprotein convertase subtilisin/kexin type 9 Other protein targets [3] NPC1 like 1LIGANDS Alirocumab Ezetimibe Atorvastatin Rosuvastatin Evolocumab Simvastatin These Tables list key protein targets and ligands in this article that are hyperlinked to corresponding entries in http://www.guidetopharmacology .org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY [1], and are permanently archived in the Concise Guide to PHARMA- COLOGY 2015/16 [2, 3].",OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
"Competing Interests All authors have completed the Uni ﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (availableon request from the corresponding author) and declare:IGB, OSD, UF, RD and WM received medical writing supportfrom EH and KA for the submitted work, funded by Amgen.R Da n dU Fh a v eb e e ne m p l o y e e so fA m g e na n do w ns t o c k sin Amgen in the previous 3 years.",Non-OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
Available at http://pi.amgen.,Non-OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
Available at http://www.accessdata.fda.gov/ drugsatfda_docs/label/2015/125559Orig1s000lbledt.pdf (lastaccessed 29 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
Availabl e at http://www.ema.europa.eu/ docs/en_GB/document_library/E PAR_-_Product_Information/ human/003882/WC500194521.pdf (last accessed 29 August2016).,Non-OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
Availabl e at http://www.ema.europa.eu/ docs/en_GB/document_library/E PAR_-_Product_Information/ human/003766/WC500191398.pdf (last accessed 29 August2016).,Non-OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
Available at http://www.athero.org/isa2015/A bstractBook.pdf (last accessed 29 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
Available at https://clinicaltrials.gov/ct2/show/ NCT01624142 (last accessed 29 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
Available at http://www.athero.org/is a2015/AbstractBook.pdf (last accessed 29 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
Available at http://www.athero.or g/isa2015/AbstractBook.pdf (last accessed 29 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
Available at http://www.athero.org/isa2015/Abstra ctBook.pdf (last accessed 29 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
Available at http://www.ncbi.nlm.nih.gov/ books/NBK83505/ ( last accessed 29 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
Supporting Information Additional Supporting Information may be found in the online version of this article at the publisher ’s web-site: http://onlinelibrary.wiley.com/doi/10.1111/bcp.,Non-OADS,/arxiv_data1/oa_pdf/24/38/BCP-82-1412.PMC5099564.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Daniel Fuster, MD, PhD,  Department of  Internal Medicine, Addiction Unit,  Hospital Universitari Germans  Trias i Pujol, Carretera de Canyet, S/N, 08916 Badalona,  Spain.",Non-OADS,/arxiv_data1/oa_pdf/c3/ca/WJH-8-1295.PMC5099582.pdf
"Core tip:  The present review is focused on alcohol  use disorder and hepatitis C virus (HCV) and human  immunodeficiency virus (HIV) infection, as well as HCV/Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i31.1295World J Hepatol   2016  November 8; 8(31): 1295-1308 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c3/ca/WJH-8-1295.PMC5099582.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/ca/WJH-8-1295.PMC5099582.pdf
Available from: URL: http://www.pnsd.msssi.,Non-OADS,/arxiv_data1/oa_pdf/c3/ca/WJH-8-1295.PMC5099582.pdf
"Available from: URL: http://www.hcvguidelines.org 95 North CS , Sims O, Hong BA, Jain MK, Brown G, Lisker ­Melman  M, Pollio DE.",Non-OADS,/arxiv_data1/oa_pdf/c3/ca/WJH-8-1295.PMC5099582.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c3/ca/WJH-8-1295.PMC5099582.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c3/ca/WJH-8-1295.PMC5099582.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Cheng-Maw Ho, MD, PhD, Clinical  Assistant Professor,  Department of Surgery, National Taiwan  University Hospital, 7 Chung-Shan S.",Non-OADS,/arxiv_data1/oa_pdf/38/88/WJH-8-1309.PMC5099583.pdf
Such Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i31.1309World J Hepatol   2016  November 8; 8(31): 1309-1317 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/38/88/WJH-8-1309.PMC5099583.pdf
World J Hepatol  2016; 8(31): 1309-1317  Available  from: URL:  http://www.wjgnet.co m/1948-5182 /full/v8/i31/1309.,Non-OADS,/arxiv_data1/oa_pdf/38/88/WJH-8-1309.PMC5099583.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i31.1309 INTRODUCTION Hepatocellular carcinoma (HCC) is the most common  primary liver cancer .,Non-OADS,/arxiv_data1/oa_pdf/38/88/WJH-8-1309.PMC5099583.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/38/88/WJH-8-1309.PMC5099583.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Shyam Kottilil, MD, PhD, Professor  of  Medicine, Institute of Human Virology, Division of Infectious  Diseases, University of Maryland School of Medicine, 725 West  Lombard Street, Baltimore, MD 21201,  United States.",Non-OADS,/arxiv_data1/oa_pdf/01/67/WJH-8-1318.PMC5099584.pdf
"skottilil@ihv.umaryland.ed u Telephone:  +1­410­7068614 Fax:  +1­410­7061952 Received:  May 29, 2016 Peer-review started:  May 29, 2016 First decision:  July 29, 2016 Revised:  August 19, 2016 Accepted:  September 8, 2016 Article in press:  September 9, 2016 Published online:  November 8, 2016 Abstract AIM To study impact of baseline mental health disease on  hepatitis C virus (HCV) treatment; and Beck’s Depres - sion Inventory (BDI) changes with sofosbuvir- and Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i31.1318World J Hepatol   2016  November 8; 8(31): 1318-1326 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/01/67/WJH-8-1318.PMC5099584.pdf
"World J Hepatol  2016; 8(31): 1318 ­1326   Available from: URL:  http://www.wjgnet.com/ 1948 ­5182 /full/ v8/i31/1318.htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i31.1318 INTRODUCTION An estimated 185 million people worldwide are currently  infected with chronic hepatitis C virus (HCV), and app­ roximately 3 to 4 million new infections occur each  year[1].",Non-OADS,/arxiv_data1/oa_pdf/01/67/WJH-8-1318.PMC5099584.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/01/67/WJH-8-1318.PMC5099584.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Linda L Wong, MD, Professor,  Cancer  Center, Department of Surgery, John A Burns School of Medicine,  University of Hawaii, 550 South Beretania Street, Suite 403,  Honolulu, HI 96813, United States.",Non-OADS,/arxiv_data1/oa_pdf/77/49/WJH-8-1327.PMC5099585.pdf
Age- adjusted mortality at 1 and 5-years were lower in the Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i31.1327World J Hepatol   2016  November 8; 8(31): 1327-1335 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/77/49/WJH-8-1327.PMC5099585.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/77/49/WJH-8-1327.PMC5099585.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/77/49/WJH-8-1327.PMC5099585.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Hatim Mohamed Yousif Mudawi, FRCP,  Professor,  Department of Internal Medicine, Faculty of Medicine,  University of Khartoum, PO Box 2245, Khartoum 11111,  Sudan.",Non-OADS,/arxiv_data1/oa_pdf/21/71/WJH-8-1336.PMC5099586.pdf
Thirty- two patients (34%) had liver cirrhosis (group A) and Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i31.1336World J Hepatol   2016  November 8; 8(31): 1336-1342 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/21/71/WJH-8-1336.PMC5099586.pdf
World J Hepatol  2016; 8(31): 1336 ­1342   Available from: URL:  http://www.wjgnet.com/ 1948 ­5182 /full/ v8/i31/1336.htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i31.1336 INTRODUCTION Variceal bleeding is a devastating complication of portal  hypertension.,Non-OADS,/arxiv_data1/oa_pdf/21/71/WJH-8-1336.PMC5099586.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/21/71/WJH-8-1336.PMC5099586.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Alberto Berardi, MD,  Neonatal Intensive  Care Unit, Department of Mother and Child, Policlinic University Hospital, Avenue del Pozzo, 71, 41124 Modena,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/2e/1b/WJCP-5-358.PMC5099587.pdf
"Rates  of sepsis workups, empirical antibiotics and outcome of  neonates at-risk (or not) for EOS were evaluated.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5409/wjcp.v5.i4.358World J Clin Pediatr  2016 November 8; 5(4): 358-364 ISSN 2219-2808 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Pediatrics WJCP",Non-OADS,/arxiv_data1/oa_pdf/2e/1b/WJCP-5-358.PMC5099587.pdf
World J Clin Pediatr  2016; 5(4): 358-364  Available  from: URL: http://www.wjgnet.com/2219-2808/full/v5/i4/358.htm   DOI: http://dx.doi.org/10.5409/wjcp.v5.i4.358 INTRODUCTION Infections are a leading cause of neonatal mortality.,Non-OADS,/arxiv_data1/oa_pdf/2e/1b/WJCP-5-358.PMC5099587.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/2e/1b/WJCP-5-358.PMC5099587.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Simon S Rabinowitz, MD, PhD, FAAP,  Professor,  Department of Pediatrics, Children’s Hospital at  Downstate, SUNY Downstate, 445 Lenox Road Box 49, Brooklyn,  NY 11203, United States.",Non-OADS,/arxiv_data1/oa_pdf/52/6c/WJCP-5-365.PMC5099588.pdf
Kaplan- Meier plots estimated the median volume of packed Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5409/wjcp.v5.i4.365World J Clin Pediatr  2016 November 8; 5(4): 365-369 ISSN 2219-2808 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Pediatrics WJCP,Non-OADS,/arxiv_data1/oa_pdf/52/6c/WJCP-5-365.PMC5099588.pdf
"World J Clin Pediatr  2016; 5(4): 365 ­369   Available from: URL: http://www.wjgnet.com/2219 ­2808/full/ v5/i4/365.htm  DOI: http://dx.doi.org/10.5409/wjcp.v5.i4.365 INTRODUCTION Preterm infants are among the most highly transfused  patient populations, in part because of the presumption  that packed red blood cells (PRBC) improve oxygen  delivery[1].",Non-OADS,/arxiv_data1/oa_pdf/52/6c/WJCP-5-365.PMC5099588.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/52/6c/WJCP-5-365.PMC5099588.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Parag K Shah, DNB, Consultant,  Depart­ ment of Pediatric Retina, Aravind Eye Hospital and Postgraduate  Institute of Ophthalmology, Avinashi Road, Coimbatore 641014,  Tamil Nadu, India.",Non-OADS,/arxiv_data1/oa_pdf/0a/f0/WJCP-5-370.PMC5099589.pdf
CONCLUSION Endogenous endophthalmitis is a challenge for ophtha -Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5409/wjcp.v5.i4.370World J Clin Pediatr  2016 November 8; 5(4): 370-373 ISSN 2219-2808 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Pediatrics WJCP,Non-OADS,/arxiv_data1/oa_pdf/0a/f0/WJCP-5-370.PMC5099589.pdf
"World J Clin Pediatr  2016; 5(4): 370 ­373   Available from: URL: http://www.wjgnet.com/2219 ­2808/full/ v5/i4/370.htm  DOI: http://dx.doi.org/10.5409/wjcp.v5.i4.370 INTRODUCTION Endogenous endophthalmitis is a rare, but highly de­ structive infection of the eye, in which the pathogenic  organisms reach through the systemic circulation.",Non-OADS,/arxiv_data1/oa_pdf/0a/f0/WJCP-5-370.PMC5099589.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/0a/f0/WJCP-5-370.PMC5099589.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Philippe Jouvet, MD, PhD,  Sainte-Justine  Hospital, University of Montreal, 3175 Chemin Côte Sainte  Catherine, Montreal, QC H3T 1C5,  Canada.",Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
"philippe.jouvet@umontreal.c a Telephone:  +1-514-3454927 Fax:  +1-514-3427731 Received:  June 27, 2016  Peer-review started:  July 6, 2016 First decision:  September 5, 2016 Revised:  September 25, 2016   Accepted:  October 22, 2016 Article in press:  October 24, 2016 Published online:  November 8, 2016 Abstract AIM To study the impact of vaccination critical illness due to  H1N1pdm09, we compared the incidence and severity  of H1N1pdm09 infection in Canada and France.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5409/wjcp.v5.i4.374World J Clin Pediatr  2016 November 8; 5(4): 374-382 ISSN 2219-2808 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Pediatrics WJCP",Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
"World J Clin Pediatr  2016; 5(4): 374-382  Available from:  URL: http://www.wjgnet.com/2219-2808/full/v5/i4/374.htm  DOI:  http://dx.doi.org/10.5409/wjcp.v5.i4.374 INTRODUCTION By March 2009, pandemic influenza A(H1N1)pdm09 had begun to spread from Mexico across the globe.",Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
"Available  from: URL: http://www.msss.gouv.qc.ca/extranet/pandemie/ etat_situation/ 8 Bone A , Guthmann JP, Nicolau J, Lévy-Bruhl D. Population  and risk group uptake of H1N1 influenza vaccine in mainland  France 2009-2010: results of a national vaccination campaign.",Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
"Available  from: URL: http://gfrup.sfpediatrie.com/sites/default/files/u12548/ cnerm2010_dauger.pdf 10 Weil-Olivier C , Lina B. Vaccination coverage with seasonal and  pandemic influenza vaccines in children in France, 2009-2010  season.",Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
Available from: URL:  http://www.sante.gouv.fr/IMG/pdf/Diaporama_d_information_sur_ la_grippe_A_H1N1_2009_donnees_epidemiologiques_et_clinique s_diagnostic_vaccination_traitement_.pd f 16 World Health Organization .,Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
Available from: URL: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
Available from: URL:  http://sante.gouv.fr/nouvelles-recommandations-sur-la-prise-en- charge-des-patients-grippes-10-decembre-2009.htm l 19 Ministère de la Santé et des Sports .,Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
Available from: URL:  http://www.sante.gouv.fr/dossier-de-presse-du-20-octobre-2009- lancement-de-la-campagne-de-vaccination-dans-les-etablissements -de-sante.htm l20 World Health Organization .,Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
"Available from:  URL: http://apps.who.int/iris/bitstream/10665/44518/1/97892415  48090_eng.pdf 21 Leteurtre S , Duhamel A, Grandbastien B, Lacroix J, Leclerc F.  Paediatric logistic organ dysfunction (PELOD) score.",OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
Available  from: URL: http://www12.statcan.ca/census-recensement/2006/as- sa/97-551/p2-eng.cfm 24 Insee .,OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
"Available  from: URL: http://www.insee.fr/fr/ppp/bases-de-donnees/irweb/ sd2005/dd/pdf/sd2005_pyra2006.pd f 25 Wichmann O , Stocker P, Poggensee G, Altmann D, Walter D,  Hellenbrand W, Krause G, Eckmanns T. Pandemic influenza  A(H1N1) 2009 breakthrough infections and estimates of vaccine  effectiveness in Germany 2009-2010.",Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
"Available from: URL:  http://www.grog.org/cgi-files/db.cgi?code=330&action=bulletin_grog 43 Brien S , Kwong JC, Buckeridge DL.",Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
"Available from:  URL: http://www.infactglobal.org/ P- Reviewer : Durandy YD, Pavlovic M, Sergi CM, Toyoda T     S- Editor : Ji FF    L- Editor : A    E- Editor : Li D  Flechelles O  et al.",Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/88/f4/WJCP-5-374.PMC5099590.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Rashmi Ranjan Das, MD,  Department  of Pediatrics, All India Institute of Medical Sciences, SIJUA,  Bhubaneswar 751019, India.",Non-OADS,/arxiv_data1/oa_pdf/58/f9/WJCP-5-383.PMC5099591.pdf
We need more good quality RCTs in  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5409/wjcp.v5.i4.383World J Clin Pediatr  2016 November 8; 5(4): 383-390 ISSN 2219-2808 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Pediatrics WJCP,Non-OADS,/arxiv_data1/oa_pdf/58/f9/WJCP-5-383.PMC5099591.pdf
World J Clin Pediatr  2016; 5(4): 383-390  Available  from: URL: http://www.wjgnet.com/2219-2808/full/v5/i4/383.,Non-OADS,/arxiv_data1/oa_pdf/58/f9/WJCP-5-383.PMC5099591.pdf
"htm  DOI: http://dx.doi.org/10.5409/wjcp.v5.i4.383 INTRODUCTION Nephrotic syndrome (NS) is a chronic childhood illness  characterized by heavy proteinuria, hypoalbuminemia  and oedema.",Non-OADS,/arxiv_data1/oa_pdf/58/f9/WJCP-5-383.PMC5099591.pdf
"To identify  unpublished trial results, we searched the United Stated  National Institutes of Health, Department of Health and  Human Services trials registry (http://www.clinicaltrials.",Non-OADS,/arxiv_data1/oa_pdf/58/f9/WJCP-5-383.PMC5099591.pdf
gov/) and the WHO International Clinical Trials Registry  Platform trial registry ( http://www.who.int/ictrp/en /).,Non-OADS,/arxiv_data1/oa_pdf/58/f9/WJCP-5-383.PMC5099591.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/58/f9/WJCP-5-383.PMC5099591.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Ziad A Memish, Professor,  College of  Medicine, Alfaisal University, P.O.",Non-OADS,/arxiv_data1/oa_pdf/80/66/WJCP-5-391.PMC5099592.pdf
CONCLUSION Utilizing serology for MERS-CoV infection in Jordan and  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5409/wjcp.v5.i4.391World J Clin Pediatr  2016 November 8; 5(4): 391-396 ISSN 2219-2808 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Pediatrics WJCP,Non-OADS,/arxiv_data1/oa_pdf/80/66/WJCP-5-391.PMC5099592.pdf
World J Clin Pediatr  2016; 5(4): 391-396   Available from: URL: http://www.wjgnet.com/2219-2808/full/ v5/i4/391.htm  DOI: http://dx.doi.org/10.5409/wjcp.v5.i4.391 INTRODUCTION Middle East respiratory syndrome-coronavirus (MERS- CoV) was first isolated in 2012 from a patient in the  Kingdom of Saudi Arabia (KSA)[1].,Non-OADS,/arxiv_data1/oa_pdf/80/66/WJCP-5-391.PMC5099592.pdf
Available from: URL: http://www.who.int/csr/disease/coro - navirus_infections/update_20130620/en/ 20 Saudi Ministry of Health C and CC .,Non-OADS,/arxiv_data1/oa_pdf/80/66/WJCP-5-391.PMC5099592.pdf
Available from: URL: http://www.moh.gov.sa/en/ccc/pressreleases/ pages/default.aspx 21 WHO .,Non-OADS,/arxiv_data1/oa_pdf/80/66/WJCP-5-391.PMC5099592.pdf
Available from: URL: http://www.who.int/emergencies/ COMMENTSAl-Tawfiq JA  et al.,OADS,/arxiv_data1/oa_pdf/80/66/WJCP-5-391.PMC5099592.pdf
Available  from: URL: http://www.who.int/csr/don/2014_04_26_mers/en/  37 WHO .,OADS,/arxiv_data1/oa_pdf/80/66/WJCP-5-391.PMC5099592.pdf
"Available from: URL: http://www.who.int/csr/don/2013_12_02/en/ P- Reviewer : Chen XL, Striker R    S- Editor : Ji FF    L- Editor : A     E- Editor : Li D  Al-Tawfiq JA  et al.",Non-OADS,/arxiv_data1/oa_pdf/80/66/WJCP-5-391.PMC5099592.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/80/66/WJCP-5-391.PMC5099592.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Roshanak Vameghi, MD, Professor   of Pediatrics, Pediatric Neurorehabilitation Research Center,  University of Social Welfare and Rehabilitation Sciences, V elenjak  Ave., Daneshjoo Blvd, Koodakyar St., Tehran 1985713834,  Iran.",Non-OADS,/arxiv_data1/oa_pdf/19/b1/WJCP-5-397.PMC5099593.pdf
"Since each theoretical  basis, has its own positive effects on language, and  since the two are not in opposition to one another, it can Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5409/wjcp.v5.i4.397World J Clin Pediatr  2016 November 8; 5(4): 397-403 ISSN 2219-2808 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Pediatrics WJCP",Non-OADS,/arxiv_data1/oa_pdf/19/b1/WJCP-5-397.PMC5099593.pdf
World J Clin Pediatr  2016; 5(4): 397-403  Available  from: URL: http://www.wjgnet.com/2219-2808/full/v5/i4/397.,Non-OADS,/arxiv_data1/oa_pdf/19/b1/WJCP-5-397.PMC5099593.pdf
htm  DOI: http://dx.doi.org/10.5409/wjcp.v5.i4.397 INTRODUCTION Communication is an important way by which information  and idea is transferred between people.,Non-OADS,/arxiv_data1/oa_pdf/19/b1/WJCP-5-397.PMC5099593.pdf
"In fact, different aspects of information  processing such as sensation, perception, memory,  thought, language processing and problem-solving are  Level of evidence Study design Level Ⅰ Systematic review (with homogeneity) of RCTs RCT with statistically significant difference or narrow  confidence intervals Level Ⅱ Low quality RCT ( e.g., < 80% follow-up) Cohort study or other Prospective comparative study  Systematic review of cohort studies Level Ⅲ Case-control study or other Retrospective  comparative study  Systematic review of case-control studies Level Ⅳ Case series Poor quality case-control studies Level Ⅴ Expert opinion Narrative reviewsTable 1  Levels of evidence in medical research Adopted from URL: http://www.cebm.net.",Non-OADS,/arxiv_data1/oa_pdf/19/b1/WJCP-5-397.PMC5099593.pdf
"Available from: URL:  http://www.cebm.net/ 12 Hegde MN , Gierut J.",Non-OADS,/arxiv_data1/oa_pdf/19/b1/WJCP-5-397.PMC5099593.pdf
"Available from: URL: http://epublications.marquette.edu/ researchexchange/2011/Posters/7/ 20 Hegde MN , Noll MJ, Pecora R. A study of some factors affecting  generalization of language training.",Non-OADS,/arxiv_data1/oa_pdf/19/b1/WJCP-5-397.PMC5099593.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/19/b1/WJCP-5-397.PMC5099593.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Masashi Suzuki, MD, PhD, Assistant  Professor,  Department of Infection Control and Prevention, the  University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo  113-0033, Japan.",Non-OADS,/arxiv_data1/oa_pdf/b5/32/WJN-5-489.PMC5099594.pdf
World J Nephrol   2016; 5(6): 489-496  Available from: URL:  http://www.wjgnet.World Journal of  Nephrology WJN Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5527/wjn.v5.i6.489World J Nephrol   2016 November 6; 5(6): 489-496 ISSN 2220-6124 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/b5/32/WJN-5-489.PMC5099594.pdf
Bacteremia in hemodialysis patients com/2220-6124/full/v5/i6/489.htm  DOI: http://dx.doi.org/10.5527/ wjn.v5.i6.489 INTRODUCTION Infection is the second leading cause of death in  hemodialysis patients in many countries and is the  leading cause of death in the first year of hemodialysis  in Japan[1-3].,Non-OADS,/arxiv_data1/oa_pdf/b5/32/WJN-5-489.PMC5099594.pdf
See Data Reports on this website (available from: URL: http://www.cdc.,OADS,/arxiv_data1/oa_pdf/b5/32/WJN-5-489.PMC5099594.pdf
See observation protocols for hand hygiene and     glove use on this website (available from: URL: http://www.cdc.gov/dialysis/PDFs/collaborative/Hemodialysis-Hand-Hygiene-Observations.pdf) Catheter/vascular access care observations    Perform observations of vascular access care and catheter accessing quarterly.,Non-OADS,/arxiv_data1/oa_pdf/b5/32/WJN-5-489.PMC5099594.pdf
"See staff education on this website (available from: URL: http://www.cdc.gov/dialysis/clinician/index.html) Patient education/engagement    Provide standardized education to all patients on infection prevention topics including vascular access care, hand hygiene, risks related to catheter use,     recognizing signs of infection, and instructions for access management when away from the dialysis unit.",Non-OADS,/arxiv_data1/oa_pdf/b5/32/WJN-5-489.PMC5099594.pdf
"See patient education on this website     (available from: URL: http://www.cdc.gov/dialysis/clinician/index.html) Catheter reduction    Incorporate efforts ( e.g., through patient education, vascular access coordinator) to reduce catheters by identifying and addressing barriers to permanent     vascular access placement and catheter removal Chlorhexidine for skin antisepsis    Use an alcohol-based chlorhexidine (> 0.5%) solution as the first line skin antiseptic agent for central line insertion and during dressing     changes.",Non-OADS,/arxiv_data1/oa_pdf/b5/32/WJN-5-489.PMC5099594.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b5/32/WJN-5-489.PMC5099594.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Chun-Yuan Hsiao, FRACP, Physician  and Nephrologist,  Department of Renal Medicine, Middlemore  Hospital, Counties Manukau District Health Board, Private Bag  93311, Otahuhu, Auckland 1640,  New Zealand.",Non-OADS,/arxiv_data1/oa_pdf/cf/92/WJN-5-497.PMC5099595.pdf
METHODS A cohort of 226 patients who received their renal trans -World Journal of  Nephrology WJN Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5527/wjn.v5.i6.497World J Nephrol   2016 November 6; 5(6): 497-506 ISSN 2220-6124 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/cf/92/WJN-5-497.PMC5099595.pdf
wjgnet.com/2220 ­6124/full/v5/i6/497.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/92/WJN-5-497.PMC5099595.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/cf/92/WJN-5-497.PMC5099595.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Maria Goretti Moreira Guimarães  Penido, MD, PhD, Coordinator, Professor,  Pediatric Nephrology  Unit, Center of Nephrology, Santa Casa de Belo Horizonte  Hospital, Rua Piaui 420, Belo Horizonte, CEP 30150-320, Minas  Gerais, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/9f/dd/WJN-5-507.PMC5099596.pdf
"The following characteristics were assessed:  Socio-demographic condictions, clinical health, anthro - pometric, biochemical, lifestyle and data on food World Journal of  Nephrology WJN Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5527/wjn.v5.i6.507World J Nephrol   2016 November 6; 5(6): 507-516 ISSN 2220-6124 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/9f/dd/WJN-5-507.PMC5099596.pdf
"World J Nephrol  2016; 5(6): 507-516  Available from: URL:  http://www.wjgnet.com/2220-6124/full/ v5/i6/507.htm  DOI: http://dx.doi.org/10.5527/wjn.v5.i6.507 INTRODUCTION Child growth is not limited to increased weight and  height, but is characterized by a complex process  involving body size and number of cells influenced by  genetic, environmental and psychological factors[1,2].",Non-OADS,/arxiv_data1/oa_pdf/9f/dd/WJN-5-507.PMC5099596.pdf
"Available from: URL: http://www.who.int/childgrowth 11 Bray GA , Gray DS.",Non-OADS,/arxiv_data1/oa_pdf/9f/dd/WJN-5-507.PMC5099596.pdf
"Available from: URL:  http://www.who.int 13 Slinde F , Rossander-Hulthén L. Bioelectrical impedance: effect of 3 identical meals on diurnal impedance variation and calculation  of body composition.",OADS,/arxiv_data1/oa_pdf/9f/dd/WJN-5-507.PMC5099596.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/9f/dd/WJN-5-507.PMC5099596.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Invited manuscript Correspondence to:  Amin Roshdy Soliman, MD, PhD,  FASN, Professor  of Medicine and Nephrology, Department of  Nephrology, Kasr Al-Ainy Cairo University, 41 Manial street,  Cairo 11451, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/a9/0d/WJN-5-517.PMC5099597.pdf
After World Journal of  Nephrology WJN Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5527/wjn.v5.i6.517World J Nephrol   2016 November 6; 5(6): 517-523 ISSN 2220-6124 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/a9/0d/WJN-5-517.PMC5099597.pdf
wjgnet.com/2220-6124/full/v5/i6/517.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/0d/WJN-5-517.PMC5099597.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/a9/0d/WJN-5-517.PMC5099597.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Susumu Ookawara, MD, PhD,  Division  of Nephrology, First Department of Integrated Medicine, Saitama   Medical Center, Jichi Medical University, 1-847 Amanuma-cho,  Omiya-ku, Saitama-City, Saitama 330-8503,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/bd/89/WJN-5-524.PMC5099598.pdf
RESULTS The rSO 2 values were significantly lower in patients  undergoing HD than in healthy individuals (50.0% World Journal of  Nephrology WJN Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5527/wjn.v5.i6.524World J Nephrol   2016 November 6; 5(6): 524-530 ISSN 2220-6124 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/bd/89/WJN-5-524.PMC5099598.pdf
World J Nephrol  2016; 5(6): 524-530  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/bd/89/WJN-5-524.PMC5099598.pdf
"com/2220-6124/full/v5/i6/524.htm  DOI: http://dx.doi.org/10.5527/ wjn.v5.i6.524 INTRODUCTION According to the increase in numbers of older and  diabetic patients undergoing hemodialysis (HD), protein- energy wasting, which includes abnormal serum  biochemistry, reduced body mass, reduced muscle  mass, and decreased dietary intake, has been a concern  in the clinical setting[1].",Non-OADS,/arxiv_data1/oa_pdf/bd/89/WJN-5-524.PMC5099598.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/bd/89/WJN-5-524.PMC5099598.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Vivek B Kute, MBBS, MD, FCPS,  DM, Associate Professor,  Department of Nephrology and  Clinical Transplantation, Institute of Kidney Diseases and Research Center, Dr HL Trivedi Institute of Transplantation Sciences, B ­130,  Triveni, Ph ­1, Ahmedabad 380016,  India.",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/WJN-5-531.PMC5099599.pdf
The participants comprised ABO incompatibility  (n = 1); positive cross-match and/or presence of donor World Journal of  Nephrology WJN Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5527/wjn.v5.i6.531World J Nephrol   2016 November 6; 5(6): 531-537 ISSN 2220-6124 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/ae/3a/WJN-5-531.PMC5099599.pdf
World J Nephrol   2016; 5(6): 531­537  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/ae/3a/WJN-5-531.PMC5099599.pdf
com/2220 ­6124/full/v5/i6/531.htm  DOI: http://dx.doi.org/10.5527/ wjn.v5.i6.531 INTRODUCTION As per Indian chronic kidney disease (CKD) registry  only 2% of end stage renal disease (ESRD) patients  underwent kidney transplantation (KT).,Non-OADS,/arxiv_data1/oa_pdf/ae/3a/WJN-5-531.PMC5099599.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ae/3a/WJN-5-531.PMC5099599.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Chandra Shekhar Biyani, Consultant  Urologist,  Department of Urology, St James’s University Hospital,  Beckett Street, Leeds LS9 7TF,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/1f/d6/WJN-5-538.PMC5099600.pdf
Prevention is best achieved through dietary changes  and targeted medical therapy.World Journal of  Nephrology WJN Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5527/wjn.v5.i6.538World J Nephrol   2016 November 6; 5(6): 538-546 ISSN 2220-6124 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/1f/d6/WJN-5-538.PMC5099600.pdf
World J Nephrol  2016; 5(6): 538-546  Available from: URL:   http://www.wjgnet.com/2220-6124/full/v5/i6/538.htm  DOI:  http://dx.doi.org/10.5527/wjn.v5.i6.538 INTRODUCTION Inflammatory bowel disease (IBD) is a condition which  affects patients of all age groups and ethnicities.,Non-OADS,/arxiv_data1/oa_pdf/1f/d6/WJN-5-538.PMC5099600.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/1f/d6/WJN-5-538.PMC5099600.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Rubin Zhang, MD, FASN, Professor  of  Medicine, Department of Nephrology and Hypertension, Tulane  University School of Medicine, 1430 Tulane Ave, New Orleans,  LA 70112, United States.",Non-OADS,/arxiv_data1/oa_pdf/7d/96/WJN-5-547.PMC5099601.pdf
"Gadde B, Lee B, Kidd L, Zhang R. Antineutrophil cytoplasmic World Journal of  Nephrology WJN Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5527/wjn.v5.i6.547World J Nephrol   2016 November 6; 5(6): 547-550 ISSN 2220-6124 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/7d/96/WJN-5-547.PMC5099601.pdf
World J Nephrol  2016; 5(6): 547-550  Available from:  URL:  http://www.wjgnet.com/2220-6124/full/v5/i6/547.htm   DOI: http://dx.doi.org/10.5527/wjn.v5.i6.547 INTRODUCTION Antibodies directed against neutrophil cytoplasmic anti­ gens were first described in patients with pauci-immune  glomerulonephritis in 1982[1].,Non-OADS,/arxiv_data1/oa_pdf/7d/96/WJN-5-547.PMC5099601.pdf
"Available from:  URL: http://www.gilead.com/~/media/Files/pdfs/medicines/liver- disease/sovaldi/sovaldi_pi.pdf 4 Kellehe r TB, Afdhal NH.",Non-OADS,/arxiv_data1/oa_pdf/7d/96/WJN-5-547.PMC5099601.pdf
"Available from: URL: http://www.uptodate.com/ contents/management-of-the-side-effects-of-peginterferon- and-ribavirin-used-for-treatment-of-chronic-hepatitis-c-virus- infection?source=machineLearning&search=ribavirin anemia&sele ctedTitle=1~150§ionRank=1&anchor=H2#H2  5 Yates M , Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr  A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V , Westman  K, Vaglio A, Yalçındağ N, Jayne DR, Mukhtyar C. EULAR/ERA- EDTA recommendations for the management of ANCA-associated  vasculitis.",Non-OADS,/arxiv_data1/oa_pdf/7d/96/WJN-5-547.PMC5099601.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/7d/96/WJN-5-547.PMC5099601.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Rodolfo Iuliano, PhD,  Department of  Experimental and Clinical Medicine, University of Catanzaro,  viale Europa, località Germaneto, 88100 Catanzaro,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/bb/c2/WJN-5-551.PMC5099602.pdf
Genetic World Journal of  Nephrology WJN Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5527/wjn.v5.i6.551World J Nephrol   2016 November 6; 5(6): 551-555 ISSN 2220-6124 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/bb/c2/WJN-5-551.PMC5099602.pdf
World J Nephrol   2016; 5(6): 551­555  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/bb/c2/WJN-5-551.PMC5099602.pdf
com/2220 ­6124/full/v5/i6/551.htm  DOI: http://dx.doi.org/10.5527/ wjn.v5.i6.551 INTRODUCTION Gitelman’s syndrome (GS) is an autosomal recessive  salt-wasting disease prevalently caused by mutations  occurring in the SLC12A3  gene coding for the thiazide- sensitive NaCl cotrasporter (NCC)[1].,Non-OADS,/arxiv_data1/oa_pdf/bb/c2/WJN-5-551.PMC5099602.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/bb/c2/WJN-5-551.PMC5099602.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Yong-Yong Shi1, Yao Zhao3, 4, 7, 8 1Bio-X Institutes, Ministry of Education Key Laboratory for the Genetics  of Developmental and Neuropsychiatric Disorders, Institute of Social Cog- nitive and Behavioral Sciences, Shanghai Jiao Tong University, Shang-hai 200030, China;  2Harvard Radiation Oncology Program, Harvard  Medical School, Boston, MA02115, USA; 3Department of Neurosurgery,  Huashan Hospital, Shanghai Medical College, Fudan University, Shang-hai 200040, China;  4Shanghai Pituitary Tumor Center, Shanghai 200040,  China; 5Shanghai Key Laboratory of Psychotic Disorders, Shanghai  Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China;  6Shanghai Institute of Immunology & Depart- ment of Immunobiology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China;  7State Key Laboratory of  Medical Neurobiology, Shanghai Medical College, Fudan University, Shanghai 200040, China;  8Institute of Neurosurgery, Shanghai Medical  College, Fudan University, Shanghai 200040, China; 9Shanghai Center  for Bioinformation Technology (SCBIT), Shanghai Academy of Science and Technology, Shanghai 201203, China;  10Department of Pathology,  The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA*These six authors contributed equally to this work.Correspondence:Yong-Yong Shi a, Hai Yanb, Yao Zhaoc aTel: +86-21-62390050 E-mail: shiyongyong@gmail.com  bTel: +1-919-668-7850 E-mail: hai.yan@duke.edu cTel:+86-21-52888728 E-mail: zhaoyaohs@vip.sina.com  References 1 Melmed S. Nat Rev Endocrinol  2011; 7:257-266.",Non-OADS,/arxiv_data1/oa_pdf/62/63/cr2016114a.PMC5099864.pdf
"The sg RNA target sequences following GN 19-25NG- G(N = A, C, G or T) pattern were designed via http://tools.flycris - pr.molbio.wisc.edu/targetFinder/.",OADS,/arxiv_data1/oa_pdf/a6/5f/cr2016118a.PMC5099867.pdf
The uniqueness of each target  site was confirmed by BLAST search targeting sequence against  the C. elegans  genome (http://www.wormbase.org/tools/blast_ blat).,OADS,/arxiv_data1/oa_pdf/a6/5f/cr2016118a.PMC5099867.pdf
Please read the full license for further details at - http://creativecommons.org/ licenses/by- nc-sa/4.0/ © The Author(s) 2016,Non-OADS,/arxiv_data1/oa_pdf/a6/5f/cr2016118a.PMC5099867.pdf
Please read the full license for further details at - http://creativecommons.org/ licenses/by- nc-sa/4.0/ © The Author(s) 2016,Non-OADS,/arxiv_data1/oa_pdf/eb/07/cr2016119a.PMC5099868.pdf
Please read the full license for further details at - http://creativecommons.org/ licenses/by- nc-sa/4.0/ © The Author(s) 2016 1974.,Non-OADS,/arxiv_data1/oa_pdf/da/af/cr2016123a.PMC5099872.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/50/aapm-06-04-33526.PMC5099949.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/63/aapm-06-04-37575.PMC5099974.pdf
"Dystonia of any type occurs in 60% of patients with Parkinson’s disease (PD);2however, theFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/a2/f3/tre-06-379-7522-1.PMC5099978.pdf
Dysphagia After BoNT for PD-related CD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/a2/f3/tre-06-379-7522-1.PMC5099978.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/a2/f3/tre-06-379-7522-1.PMC5099978.pdf
Dysphagia After BoNT for PD-related CD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/a2/f3/tre-06-379-7522-1.PMC5099978.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/a2/f3/tre-06-379-7522-1.PMC5099978.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600261/DC1 Proofs of lipid exchange after NP insertionfig.,Non-OADS,/arxiv_data1/oa_pdf/48/c3/1600261.PMC5099980.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601340/DC1Permselectivity of PEDOT:PSSPrevention of passive leakageSimple model of deliveryEquivalent circuit modeling fig.,Non-OADS,/arxiv_data1/oa_pdf/91/a1/1601340.PMC5099981.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601063/DC1 Supplementary Materials and Methods table S1.,Non-OADS,/arxiv_data1/oa_pdf/87/e3/1601063.PMC5099982.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601122/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/f9/22/1601122.PMC5099983.pdf
"RCP, 1999 (http://www.rcpsych.ac.uk/college/specialinterestgroups/spirituality.aspx).",Non-OADS,/arxiv_data1/oa_pdf/48/73/bjporcpsych002816.PMC5099984.pdf
"IBGE, 2010 (http://biblioteca.ibge.gov.br/biblioteca-catalogo?view= detalhes&id=794).",Non-OADS,/arxiv_data1/oa_pdf/48/73/bjporcpsych002816.PMC5099984.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601465/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/04/f6/1601465.PMC5099985.pdf
"It was subsequently processed and analysed using FEAT (FMRI Expert Analysis Tool) version 6.0, part of FSL (fMRIB ’s Software Library http://www.fmrib.ox.ac.uk/fsl).",OADS,/arxiv_data1/oa_pdf/45/8d/bjporcpsych003376.PMC5099986.pdf
"As no oxytocin-related polymorphisms have been detected as risk variants for SCZ in large genome-wide association studies(http://www.broadinstitute.org/mpg/ricopili/), we chose a hypoth- esis-based approach for SNP selection.",Non-OADS,/arxiv_data1/oa_pdf/45/8d/bjporcpsych003376.PMC5099986.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/01/aapm-06-04-37270.PMC5099987.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1600370/DC1section SI.,Non-OADS,/arxiv_data1/oa_pdf/85/9e/1600370.PMC5099988.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601102/DC1section S1.,Non-OADS,/arxiv_data1/oa_pdf/23/81/1601102.PMC5099989.pdf
The mitochondrion in the fig ure was taken from the Servier Medical Art database (http://servier.co m/Powerpoint-image-bank).SCIENCE ADVANCES |RESEARCH ARTICLE Vidimar et al.Sci.,OADS,/arxiv_data1/oa_pdf/5f/70/1601132.PMC5099990.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601132/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/5f/70/1601132.PMC5099990.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/11/e1601266/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/11/7b/1601266.PMC5099991.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/b2/npv064.PMC5099992.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/b2/npv064.PMC5099992.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/dmw029.PMC5099994.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/46/aapm-06-04-35983.PMC5100003.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/f5/msw184.PMC5100044.pdf
"RoAM (Reconstruction ofArchaic Methylation; http://carmelab.huji.ac.il/software/ RoAM/roam.html; last accessed September 1, 2016) provides the first of such tools, allowing the reconstruction of genome-wide ancient methylation maps, but its current implementa- tion is restricted to archaic hominins (AH).",OADS,/arxiv_data1/oa_pdf/41/f5/msw184.PMC5100044.pdf
"The epiPALEOMIX package is avail able at https://bitbucket.org/ khanghoj/epipaleomix (last a ccessed September 1, 2016), to- gether with an extensive companion manual, running exam- ples, BED files, and mappability maps to ensure reproducibilityof all analyses presented in this study.",Non-OADS,/arxiv_data1/oa_pdf/41/f5/msw184.PMC5100044.pdf
"Similarly, genomic sites described as poly- morphic within dbSNP142 (http://genome.ucsc.edu/; last accessed September 1, 2016) we re disregarded as these can reflect sites where the ancient individual and the reference genome differed.",Non-OADS,/arxiv_data1/oa_pdf/41/f5/msw184.PMC5100044.pdf
"Modern Human Methylomes To compare ancient and present-day methylomes, we downloaded RRBS methylation data for 101 human tissues from UCSC ( see supplementary table S7, Supplementary Material online) (http://hgdownload.cse.ucsc.edu/goldenPath/ hg19/encodeDCC/wgEncodeHaibMethylRrbs/; last accessed September 1, 2016).",OADS,/arxiv_data1/oa_pdf/41/f5/msw184.PMC5100044.pdf
"As no hair tissue was represented in the RRBS data, we down- loaded from UCSC (http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeHaibMethyl450/; last accessed September 1, 2016) methylation data esti- mated using the Infinium HumanMethylation450BeadChip system (450K Illumina array; Sandoval et al.",OADS,/arxiv_data1/oa_pdf/41/f5/msw184.PMC5100044.pdf
The raw data was normalized over the background using LOESS (span ¼0.3) function in R (https://www.cran.r-project.,OADS,/arxiv_data1/oa_pdf/41/f5/msw184.PMC5100044.pdf
Supplementary Material Supplementary figures S1–S13 and tables S1–S7 are available atMolecular Biology and Evolution online (http://www.mbe.,OADS,/arxiv_data1/oa_pdf/41/f5/msw184.PMC5100044.pdf
"Available at: http://biorxiv.org/content/ early/2015/11/18/032060, last accessed September 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/41/f5/msw184.PMC5100044.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/ed/msw188.PMC5100047.pdf
"SF and ON acknowledge funds from eSSENCE (http://essenceofescience.se/) , Uppsala University, and the Swedish Foundation for International Cooperation in Research and Higher Education (STINT).",Non-OADS,/arxiv_data1/oa_pdf/0f/ed/msw188.PMC5100047.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/15/msw191.PMC5100049.pdf
Primers weredesigned for the conserved regions based on an alignment of genomic data from the cow ( Bos taurus ) (http://asia.ensembl.,OADS,/arxiv_data1/oa_pdf/a0/15/msw191.PMC5100049.pdf
"Sequences derived from the genomes of baiji, common minke whale, killer whale ( Orcinus orca ), sperm whale, seal (Leptonychotes weddellii ), walrus ( Odobenus rosmarus diver- gens), manatee ( Trichechus manatus latirostris ), and bowhead whale ( Balaena mysticetus ) (http://www.bowhead-whale.org/) were also used to test for positive Darwinian selection.",Non-OADS,/arxiv_data1/oa_pdf/a0/15/msw191.PMC5100049.pdf
"The protein sequences of positively selected genes were derived from the common bottlenose dolphin genome, which were ob- tained from the Ensembl genome database (http://www.ensembl.org/index.html).",OADS,/arxiv_data1/oa_pdf/a0/15/msw191.PMC5100049.pdf
"In addition, the functional informa- tion of genes identified as being under positive selection was derived from uniprot (http://www.uniprot.org/).",OADS,/arxiv_data1/oa_pdf/a0/15/msw191.PMC5100049.pdf
"Isoelectric points (pI) of mature peptides were computed by the web program Protein Calculator (http://protcalc.sourceforge.net/), and we selected the independent-samples ttest for the groups differences.",OADS,/arxiv_data1/oa_pdf/a0/15/msw191.PMC5100049.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/84/msw192.PMC5100050.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/cf/msw194.PMC5100051.pdf
"2015 ; http://www.johnpool.net/genomes.html; last accessed September 20, 2016) pr ovides the research commu- nity with genomes from multiple published sources that are generated using a common refer ence alignment pipeline.",OADS,/arxiv_data1/oa_pdf/7b/35/msw195.PMC5100052.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/35/msw195.PMC5100052.pdf
We provide sequence text files mirroring our D. melanogaster consensus sequences for D. simulans on the DGN web site (http://www.johnpool.,OADS,/arxiv_data1/oa_pdf/7b/35/msw195.PMC5100052.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/8e/msw198.PMC5100053.pdf
A phylogenetic tree was constructed by the unweighted pair group method with ar- ithmetic mean (UPGMA) method with MEGA 7 (http://www.megasoftware.net) ( Kumar et al.,OADS,/arxiv_data1/oa_pdf/6b/8e/msw198.PMC5100053.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/6e/msw206.PMC5100054.pdf
Supplementary Material Supplementary figures S1–S7 are available at Molecular Biology and Evolution online (http://www.mbe.oxfordjour nals.org/).,Non-OADS,/arxiv_data1/oa_pdf/a7/6e/msw206.PMC5100054.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/b1/msw213.PMC5100056.pdf
"Phylogenetic trees were visualized with FigTree (http://tree.bio.ed.ac.uk/software/figtree/; last accessed October 8, 2016).",OADS,/arxiv_data1/oa_pdf/26/b1/msw213.PMC5100056.pdf
"Data Availability Sequences, domain and motif predictions, and gene structure reconstructions are available at CyMoBase [http://www.cym obase.org (last accessed October 8, 2016), ( Odronitz and Kollmar 2006 )].",OADS,/arxiv_data1/oa_pdf/26/b1/msw213.PMC5100056.pdf
The global map of natural selection in our closest living relatives is available as an interactiv e browser at http://tinyurl.com/nf8qmzh.,OADS,/arxiv_data1/oa_pdf/c2/5d/msw215.PMC5100057.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/5d/msw215.PMC5100057.pdf
All the information is available as an in- teractive browser at webpage: http://tinyurl.com/nf8qmzh following the criteria and configuration of a recently pub- lished human dataset ( Pybus et al.,OADS,/arxiv_data1/oa_pdf/c2/5d/msw215.PMC5100057.pdf
"Data Access An interactive browser with the signatures of natural selec- tion for each species is available at http://tinyurl.com/ nf8qmzh (last accessed October 10, 2016).Cagan et al.",OADS,/arxiv_data1/oa_pdf/c2/5d/msw215.PMC5100057.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/76/4c/UA-8-409.PMC5100144.pdf
Available from: http://www.surveysystem.com/ sample‑size‑formula.htm.,OADS,/arxiv_data1/oa_pdf/76/4c/UA-8-409.PMC5100144.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/76/4c/UA-8-409.PMC5100144.pdf
Available from: http://www.accessdata.fda.gov/scripts/ cdrh/cfdocs/cfmaude/search.cfm.,OADS,/arxiv_data1/oa_pdf/20/e2/UA-8-418.PMC5100145.pdf
Available from: http://www.cdc.gov/nhsn/pdfs/pscmanual/7psccauticurrent.,OADS,/arxiv_data1/oa_pdf/d8/36/UA-8-423.PMC5100146.pdf
Available from: http://www.uptodate.com/contents/down‑syndrome‑clinical‑ features‑and‑diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/ac/21/UA-8-503.PMC5100165.pdf
Available from: http://www.who.int/genomics/public/geneticdiseases/en/ index1.html.,OADS,/arxiv_data1/oa_pdf/ac/21/UA-8-503.PMC5100165.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/d3/1c/JPI-7-43.PMC5100199.pdf
"J Pathol Inform 2016, 1:43  http://www.jpathinformatics.org/content/7/1/43It should be noted that image analysis done in other  pathology subspecialties or animals’ tissue might be extendable to breast pathology; however, discussion about the potentials for extending these ideas to breast pathology is out of the scope of this review.",Non-OADS,/arxiv_data1/oa_pdf/d3/1c/JPI-7-43.PMC5100199.pdf
"J Pathol Inform 2016, 1:43  http://www.jpathinformatics.org/content/7/1/43importance, only proposing a segmentation method to  handle difficulties in breast slides has been main subject of 25 reviewed studies.",Non-OADS,/arxiv_data1/oa_pdf/d3/1c/JPI-7-43.PMC5100199.pdf
"J Pathol Inform 2016, 1:43  http://www.jpathinformatics.org/content/7/1/43Diagnostically relevant areas In pathology slides, large areas are empty.",Non-OADS,/arxiv_data1/oa_pdf/d3/1c/JPI-7-43.PMC5100199.pdf
"J Pathol Inform 2016, 1:43  http://www.jpathinformatics.org/content/7/1/43The initial seeds could be used for further  fine segmentation using active contour models (ACMs), [18,19,37,39,40] Graphcuts,[5] or marker‑controlled  watershed.",OADS,/arxiv_data1/oa_pdf/d3/1c/JPI-7-43.PMC5100199.pdf
"J Pathol Inform 2016, 1:43  http://www.jpathinformatics.org/content/7/1/43into an SVM classifier which detects FP instances.",OADS,/arxiv_data1/oa_pdf/d3/1c/JPI-7-43.PMC5100199.pdf
"J Pathol Inform 2016, 1:43  http://www.jpathinformatics.org/content/7/1/43Benign versus malignant classification and distinguishing  lesion subtypes A pathologist usually inspects the breast tissue to  determine if it is a benign or malignant lesion is present  and also to identify the cancer type  (if appropriate).",Non-OADS,/arxiv_data1/oa_pdf/d3/1c/JPI-7-43.PMC5100199.pdf
"J Pathol Inform 2016, 1:43  http://www.jpathinformatics.org/content/7/1/43from cancerous tissue has been shown.",OADS,/arxiv_data1/oa_pdf/d3/1c/JPI-7-43.PMC5100199.pdf
"J Pathol Inform 2016, 1:43  http://www.jpathinformatics.org/content/7/1/43HER2.",Non-OADS,/arxiv_data1/oa_pdf/d3/1c/JPI-7-43.PMC5100199.pdf
"J Pathol Inform 2016, 1:43  http://www.jpathinformatics.org/content/7/1/43Similar to the methods for ER and PR assessment,  quantitative assessment of Ki‑67 could be done by extracting features based on either the segmented cell nuclei [50] or the percentage of stained area.",Non-OADS,/arxiv_data1/oa_pdf/d3/1c/JPI-7-43.PMC5100199.pdf
"J Pathol Inform 2016, 1:43  http://www.jpathinformatics.org/content/7/1/43breast cancer histopathology.",Non-OADS,/arxiv_data1/oa_pdf/d3/1c/JPI-7-43.PMC5100199.pdf
"J Pathol Inform 2016, 1:43  http://www.jpathinformatics.org/content/7/1/43Breast Cancer Res 2010;12:R56.",Non-OADS,/arxiv_data1/oa_pdf/d3/1c/JPI-7-43.PMC5100199.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/ff/ec/JPI-7-44.PMC5100200.pdf
"J Pathol Inform 2016, 1:44  http://www.jpathinformatics.org/content/7/1/44makes it easier for the treating physicians to grasp all  the relevant information.",Non-OADS,/arxiv_data1/oa_pdf/ff/ec/JPI-7-44.PMC5100200.pdf
RStudio version  0.99.489  (https://www.rstudio.com) is  the integrated development environment used for both running the R script and interactively analyzing the data.,OADS,/arxiv_data1/oa_pdf/ff/ec/JPI-7-44.PMC5100200.pdf
"J Pathol Inform 2016, 1:44  http://www.jpathinformatics.org/content/7/1/44RODBC, dplyr, stringr, gdata, splitstackshape, and  ggplot2.",OADS,/arxiv_data1/oa_pdf/ff/ec/JPI-7-44.PMC5100200.pdf
"J Pathol Inform 2016, 1:44  http://www.jpathinformatics.org/content/7/1/44SELECT accession_no, COALESCE  (finding, finding_ text) as report FROM path_rpt_heading as heading JOIN acc_results r  on heading.id=r.heading_id JOIN accession_2 a on r.acc_id=a.id WHERE acc_id in  (select id from accession_2 where  patient_id=(select patient_id from accession_2 where accession_no = @acc_num)) AND a.accession_no > @ acc_num AND a.created_date <=  (select dateadd  (day,  120, a2.created_date) from accession_2 a2 where  a2.accession_no  = myAccNum) AND a.acc_type_id  <>184 AND accession_no LIKE ‘S‑%’ AND  (heading.",OADS,/arxiv_data1/oa_pdf/ff/ec/JPI-7-44.PMC5100200.pdf
"J Pathol Inform 2016, 1:44  http://www.jpathinformatics.org/content/7/1/44reports.",Non-OADS,/arxiv_data1/oa_pdf/ff/ec/JPI-7-44.PMC5100200.pdf
"J Pathol Inform 2016, 1:44  http://www.jpathinformatics.org/content/7/1/44There are a total of 94 opportunities for pN update.",Non-OADS,/arxiv_data1/oa_pdf/ff/ec/JPI-7-44.PMC5100200.pdf
"J Pathol Inform 2016, 1:44  http://www.jpathinformatics.org/content/7/1/44status represents combined data from both the original  reports with synoptic reports and reports on the subsequent specimens from the same patients.",OADS,/arxiv_data1/oa_pdf/ff/ec/JPI-7-44.PMC5100200.pdf
"J Pathol Inform 2016, 1:44  http://www.jpathinformatics.org/content/7/1/44melanoma of the skin.",Non-OADS,/arxiv_data1/oa_pdf/ff/ec/JPI-7-44.PMC5100200.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.,Non-OADS,/arxiv_data1/oa_pdf/ad/c6/JPI-7-42.PMC5100202.pdf
"J Pathol Inform 2016, 1:42  http://www.jpathinformatics.org/content/7/1/42classification performance using the unique classifier  for thyroid follicular lesions.",Non-OADS,/arxiv_data1/oa_pdf/ad/c6/JPI-7-42.PMC5100202.pdf
"J Pathol Inform 2016, 1:42  http://www.jpathinformatics.org/content/7/1/42protocol by the Institutional Review Board).",Non-OADS,/arxiv_data1/oa_pdf/ad/c6/JPI-7-42.PMC5100202.pdf
"J Pathol Inform 2016, 1:42  http://www.jpathinformatics.org/content/7/1/42Nuclei Segmentation With detected nuclei seeds, it is required that the  subsequent segmentation algorithm delineate the nuclei contours efficiently and accurately with minimal manual intervention.",Non-OADS,/arxiv_data1/oa_pdf/ad/c6/JPI-7-42.PMC5100202.pdf
"J Pathol Inform 2016, 1:42  http://www.jpathinformatics.org/content/7/1/42image patch.",Non-OADS,/arxiv_data1/oa_pdf/ad/c6/JPI-7-42.PMC5100202.pdf
"J Pathol Inform 2016, 1:42  http://www.jpathinformatics.org/content/7/1/42This is so especially when a small σ is applied, where  many noisy edge pixels exist at the angle 0 and 2 π.",Non-OADS,/arxiv_data1/oa_pdf/ad/c6/JPI-7-42.PMC5100202.pdf
"J Pathol Inform 2016, 1:42  http://www.jpathinformatics.org/content/7/1/42 Figure  5:  Segmentation results from two validation datasets.",OADS,/arxiv_data1/oa_pdf/ad/c6/JPI-7-42.PMC5100202.pdf
"J Pathol Inform 2016, 1:42  http://www.jpathinformatics.org/content/7/1/42be deleted if the distance difference is over a certain  threshold, in the sense that pixels at adjacent angles on the nucleus contour should be near each other and the distance away from the nucleus center changes little.",Non-OADS,/arxiv_data1/oa_pdf/ad/c6/JPI-7-42.PMC5100202.pdf
"J Pathol Inform 2016, 1:42  http://www.jpathinformatics.org/content/7/1/42and marking function.",OADS,/arxiv_data1/oa_pdf/ad/c6/JPI-7-42.PMC5100202.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/a4/aapm-06-04-35486.PMC5100205.pdf
Available from: http://www.sca.org.,Non-OADS,/arxiv_data1/oa_pdf/49/83/ACA-19-21.PMC5100239.pdf
"3  383–399 https://doi.org/10.1083/jcb.201603080Introduction Recognition of antigen on the surface of an antigen-presenting  cell (APC) initiates signaling cascades within the T cell that  drive large-scale reorganization of its actin cytoskeleton (Bee - miller and Krummel, 2013; Yu et al., 2013; Kumari et al., 2014).",OADS,/arxiv_data1/oa_pdf/49/0a/JCB_201603080.PMC5100289.pdf
"3  369–381 https://doi.org/10.1083/jcb.201603081Introduction The transient receptor potential (TRP) superfamily is composed  of a large number of cation channels with diverse functions and  expression patterns in mammalian systems (Wu et al., 2010;  Montell, 2011).",OADS,/arxiv_data1/oa_pdf/43/7d/JCB_201603081.PMC5100290.pdf
3  415–430 https://doi.org/10.1083/jcb.201603100Introduction Cardiovascular development requires coordinated specification  and migration of endothelial cells (ECs) and depends on the  tight spatiotemporal regulation of attractive and repulsive guid- ance cues.,Non-OADS,/arxiv_data1/oa_pdf/ed/3e/JCB_201603100.PMC5100291.pdf
"3  357–368 https://doi.org/10.1083/jcb.201604118Introduction Complementary to genetic analysis, in vitro reconstitution of  intracellular processes, using defined factors, is a prerequisite to  understand the process at a molecular level.",Non-OADS,/arxiv_data1/oa_pdf/9e/67/JCB_201604118.PMC5100292.pdf
3  401–413 https://doi.org/10.1083/jcb.201604119Introduction Radiation-induced acute gastrointestinal syndrome is caused  when the body is exposed to high doses of penetrating radia - tion (usually 10 Gy or higher).,Non-OADS,/arxiv_data1/oa_pdf/2f/8f/JCB_201604119.PMC5100293.pdf
"3  345–355 https://doi.org/10.1083/jcb.201606042Introduction Cellular differentiation is a central feature of metazoan biol - ogy, driving tissue development, homeostasis, and repair.",Non-OADS,/arxiv_data1/oa_pdf/06/9b/JCB_201606042.PMC5100294.pdf
"3  335–344 https://doi.org/10.1083/jcb.201608025Introduction Morphogenesis, cell division, wound healing, and cell motility  all require the physical contraction of cell surfaces by arrays of  actin and Myosin-2 (actomyosin; Munjal and Lecuit, 2014).",Non-OADS,/arxiv_data1/oa_pdf/b2/6f/JCB_201608025.PMC5100295.pdf
"3  325–334 https://doi.org/10.1083/jcb.201608026Introduction Cellular senescence is defined as a stable cell cycle exit that can  be induced by several stimuli, including oncogenes and criti - cally shortened telomeres (Pérez-Mancera et al., 2014; Childs  et al., 2015).",Non-OADS,/arxiv_data1/oa_pdf/bc/e1/JCB_201608026.PMC5100296.pdf
3  313–323 https://doi.org/10.1083/jcb.201609081Introduction Regulation of mRNA stability and translation plays an im - portant role in controlling gene expression.,Non-OADS,/arxiv_data1/oa_pdf/37/ea/JCB_201609081.PMC5100297.pdf
"3  297–299 https://doi.org/10.1083/jcb.201610044Cellular senescence was first identified as a type of irreversible  cell cycle arrest that occurs when cells reach the end of their  replicative potential (Hayflick and Moorhead, 1961).",Non-OADS,/arxiv_data1/oa_pdf/05/3b/JCB_201610044.PMC5100298.pdf
"3  301–303 https://doi.org/10.1083/jcb.201610061Actomyosin ring closure is important for both unicellular and  multicellular events, playing roles in processes ranging from  cytokinesis to apoptotic cell extrusion and tissue movement  (Schwayer et al., 2016).",Non-OADS,/arxiv_data1/oa_pdf/4a/67/JCB_201610061.PMC5100299.pdf
"3  305–307 https://doi.org/10.1083/jcb.201610066Microtubules are cytoskeletal structures that serve as tracks for  motor-based intracellular transport and underlie the organiza - tion of biological apparatuses, including the mitotic spindle,  cilia, and the phragmoplast.",OADS,/arxiv_data1/oa_pdf/33/fd/JCB_201610066.PMC5100300.pdf
3  309–312 https://doi.org/10.1083/jcb.201610067Transient receptor potential (TRP) channels are a superfamily  of Ca2+-permeable cation nonselective channels with diverse  functions.,Non-OADS,/arxiv_data1/oa_pdf/25/38/JCB_201610067.PMC5100301.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/6f/aapm-06-04-38059.PMC5100307.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/13/aapm-06-04-37420.PMC5100341.pdf
"Published with license by Taylor & Francis Group, LLC © Deepika Ahuja, Ashish Goyal, and Partho Sarothi Ray This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
"11, 1152 –1165 http://dx.doi.org/10.1080/15476286.2016.1229734",Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
ORCID Deepika Ahuja http://orcid.org/0000-0002-3991-6089 Ashish Goyal http://orcid.org/0000-0002-9830-3987 References 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Genes Dev 1998; 12:2973-83;PMID:9765199; http://dx.doi.org/10.1101/gad.12.19.2973 2.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Oncogene 2007; 26:1306-16; PMID:17322916; http://dx.doi.org/ 10.1038/sj.onc.1210263 3.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
EMBO Rep 2006; 7:404-10; PMID:16440000; http://dx.doi.org/10.1038/sj.embor.7400623 4.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
J Mol Med (Berl) 2010; 88:645-52; PMID:20306257; http://dx.doi.org/10.1007/s00109-010-0609-2 5.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Cell Cycle 2008; 7:2189-98; PMID:18635961; http://dx.doi.org/10.4161/cc.7.14.6271 7.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
J Biol Chem 2006; 281:19387-94; PMID:16690610; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Cell Mol Life Sci 2008; 65:3168-81; PMID:18581050; http://dx.doi.org/ 10.1007/s00018-008-8252-6 11.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
FEBS Lett 2009; 583:3725-30; PMID:19818772; http://dx.doi.org/10.1016/j.febslet.2009.10.002 12.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Genes Dev 2009; 23:862-76; PMID:19293287; http://dx.doi.org/10.1101/ gad.1767609 13.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
"PLoS Genet 2011; 7(9): e1002242; PMID:21935352; http://dx.doi.org/10.1371/journal.pgen.1002242 14. van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer.",OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Nat Rev Cancer2011; 11:644-56; PMID:21822212; http://dx.doi.org/10.1038/nrc3107 15.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Cell 2006; 125:1111-24; PMID:16777601;http://dx.doi.org/10.1016/j.cell.2006.04.031 16.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Cell 2007; 131:1273-86; PMID:18155131; http://dx.doi.org/ 10.1016/j.cell.2007.11.034 17.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Cell 2005 [cited 2014 Apr 30]; 120:623-34; PMID:15766526; http://dx.doi.org/10.1016/j.cell.2004.12.038 18.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Nucleic Acids Res 2014; 42:10099-111; PMID:25123665; http://dx.doi.org/10.1093/nar/gku686 19.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Mol Cell 2011; 43:327-39; PMID:21723170; http://dx.doi.org/10.1016/j.molcel.2011.06.007 20.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Genes Dev 2010; 24:2146-56; PMID:20837656; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Clin Can- cer Res 2008; 14:2690-5; PMID:18451233; http://dx.doi.org/10.1158/ 1078-0432.CCR-07-1731 23.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Onco- gene 2007; 26:7590-5; PMID:17563749; http://dx.doi.org/10.1038/sj.onc.1210564 24.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
JAMA 2007; 297:1901-8;PMID:17473300; http://dx.doi.org/10.1001/jama.297.17.1901 25.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Genes Dev 2010; 24:478-90; PMID:20194440; http://dx.doi.org/10.1101/gad.1856210 28.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Exp Neurol 2015; 271:104-11; PMID:26024858; http://dx.doi.org/10.1016/j.expneurol.2015.04.026 30.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Brain Res 2010; 1312:120-6; PMID:19948152; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Mol Cancer Res 2009; 7:1635-44; PMID:19825990; http://dx.doi.org/10.1158/1541-7786.MCR-09-0043 32.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Biochem Biophys Res Commun 2008; 368:267-72; PMID:18230348; http://dx.doi.org/10.1016/j.bbrc.2008.01.073 33.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
"Wiley Interdiscip Rev RNA 1:214-29; PMID:21935886;http://dx.doi.org/10.1002/wrna.4 34. von Roretz C, Lian XJ, Macri AM, Punjani N, Clair E, Drouin O, Dor- moy-Raclet V, Ma JF, Gallouzi I-E. Apoptotic-induced cleavage shiftsHuR from being a promoter of survival to an activator of caspase-mediated apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Cell Death Differ 2013; 20:154-68; PMID:22955946; http://dx.doi.org/10.1038/cdd.2012.111 35.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Curr Protein Pept Sci2012; 13:372-9; PMID:22708488; http://dx.doi.org/10.2174/ 138920312801619394 36.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Mol Cell Biol 2011; 31:3790-801; PMID:21768308; http://dx.doi.org/10.1128/MCB.05639-11 37.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Mol Cell Biol 2011; 31:4219-31;PMID:21859890; http://dx.doi.org/10.1128/MCB.05955-11 38.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
J Biol Chem2011; 286:41442-54; PMID:21971048; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Mol Cancer Res 2012; 10:167-80; PMID:22049153; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Nat Commun 2013; 4:2388; PMID:24005720; http://dx.doi.org/10.1038/ncomms3388 41.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Genes Dev 2009; 23:1743-8; PMID:19574298; http://dx.doi.org/10.1101/gad.1812509 42.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Onco- gene 2016; 35:1703-15; PMID:26189797; http://dx.doi.org/10.1038/onc.2015.235 43.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Mol Cell 2011; 43:340-52;PMID:21723171; http://dx.doi.org/10.1016/j.molcel.2011.06.008 44.,OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Nucleic Acids Res 2015;43:10925-38; PMID:26400160; http://dx.doi.org/10.1093/nar/gkv959 45.,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
Annu Rev Immunol 1996; 14:649-83; PMID:8717528;http://dx.doi.org/10.1146/annurev.immunol.14.1.649RNA BIOLOGY 1165,Non-OADS,/arxiv_data1/oa_pdf/8d/b3/krnb-13-11-1229734.PMC5100343.pdf
"11, 1089 –1102 http://dx.doi.org/10.1080/15476286.2016.1211225",Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Biol Chem 1999; 274:34337-42; PMID:10567410; http://dx.doi.org/ 10.1074/jbc.274.48.34337 4.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Clin Invest 2007; 117:1314-23; PMID:17415412; http://dx.doi.org/10.1172/JCI31222 5.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Mol Cell 2011; 43:353- 68; PMID:21816343; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Mol Cell Biol 1998; 18:1489-97; PMID:9488465; http://dx.doi.org/10.1128/MCB.18.3.1489 8.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Biol Chem1998; 273:27761-4; PMID:9774382; http://dx.doi.org/10.1074/ jbc.273.43.27761 9.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Biol Chem 2001; 276:6807-16; PMID:11098054; http://dx.doi.org/10.1074/jbc.M008304200 10.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Exp Cell Res 2003; 283:184-95; PMID:12581738; http://dx.doi.org/10.1016/ S0014-4827(02)00046-0 12.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nat Struct Mol Biol 2010; 17:1358-66; PMID: 20972445; http://dx.doi.org/10.1038/nsmb.1912 13.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Cell Rep 2014; 7:1211-26; PMID:24813895;http://dx.doi.org/10.1016/j.celrep.2014.03.077 14.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Science 1994; 265:615-21; PMID:8036511; http://dx.doi.org/10.1126/science.8036511 15.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nature 1993; 363:640-4; PMID:8510758; http://dx.doi.org/10.1038/363640a0 16.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nature 1992; 359:162-5; PMID: 1522903; http://dx.doi.org/10.1038/359162a0 17.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
BMCCell Biol 2008; 9:37; PMID:18620564; http://dx.doi.org/10.1186/ 1471-2121-9-37 18.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Acta Neuro- pathol 2012; 124:383-94; PMID:22526020; http://dx.doi.org/10.1007/s00401-012-0984-6 19.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Eur J Neurosci 2012; 35:1818-36; PMID:22708593; http://dx.doi.org/10.1111/j.1460-9568.2012.08160.x 20.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Brain Res 2012;1462:40-3; PMID: 22261247; http://dx.doi.org/10.1016/j.brainres.2011.12.010 21.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Brain 2009; 132(Pt 11):2922-31; PMID:19674978; http://dx.doi.org/10.1093/brain/awp214 22.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nat RevNeurol 2012; 8:423-34; PMID: 22732773; http://dx.doi.org/10.1038/ nrneurol.2012.117 23.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Science 2009; 323:1205-8; PMID:19251627; http://dx.doi.org/10.1126/science.1166066 24.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Science 2009; 323:1208-11; PMID:19251628; http://dx.doi.org/10.1126/science.1165942 25.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nat Commun 2016; 7:10465; PMID: 26842965; http://dx.doi.org/10.1038/ncomms10465 26.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
EMBO J 2016; 35:1077- 97; PMID:26951610; http://dx.doi.org/10.15252/embj.201592559 27.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
EMBO J 2000; 19:453-62; PMID:10654943; http://dx.doi.org/10.1093/emboj/19.3.453 28.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nat Genet 2000;24:175-9; PMID:10655065; http://dx.doi.org/10.1038/72842 29.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Blood 2011;117:1156-66; PMID:21030557; http://dx.doi.org/10.1182/blood-2010-04-279349 30.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nature 2007; 447:725-9; PMID:17554309; http://dx.doi.org/10.1038/nature05862 31.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Genes Dev 2010; 24:1939-50; PMID:20810650; http://dx.doi.org/10.1101/gad.1934210 32.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Mol Cell 2010; 40:645-57; PMID:21055985; http://dx.doi.org/10.1016/j.molcel.2010.10.0221098 F. SVETONI ET AL.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Dev Cell 2013; 26:393-404;PMID:23987512; http://dx.doi.org/10.1016/j.devcel.2013.07.002 34.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Obesity (Silver Spring) 2015; 23:138-44;PMID:25407167; http://dx.doi.org/10.1002/oby.20934 35.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Exp Cell Res 2004; 296:57-63; PMID:15120994; http://dx.doi.org/10.1016/j.yexcr.2004.03.008 36.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Exp Hematol2010; 38:696-706; PMID: 20412831; http://dx.doi.org/10.1016/j.exphem.2010.04.006 37.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Acta Neuropathol Commun 2015; 3:24; PMID:25907258; http://dx.doi.org/10.1186/s40478-015-0202-6 38.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Neuroreport 2009; 20:57-61; PMID:18989236; http://dx.doi.org/10.1097/WNR.0b013e32831bedb0 39.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Sci Rep 2015; 5:9107; PMID: 25772687; http://dx.doi.org/10.1038/srep09107 40.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nucleic Acids Res.1995; 23:835-43; PMID:7708500; http://dx.doi.org/10.1093/nar/ 23.5.835 41.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Protein Cell 2011 Jun; 2(6):477-86; PMID:21748598; http://dx.doi.org/10.1007/s13238-011-1065-7 42.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
"Armstrong GA, Drapeau P. Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS.Hum Mol Genet 2013 Nov 1; 22(21):4282-92; PMID:23771027; http://dx.doi.org/10.1093/hmg/ddt278 43.",OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
PLoS One 2007; 2:e979; PMID: 17912356; http://dx.doi.org/10.1371/journal.pone.0000979 44.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Curr Neurol Neurosci Rep 2001; 1:69- 76; PMID:11898502; http://dx.doi.org/10.1007/s11910-001-0078-7 45.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nature 1993; 362:59-62; PMID:8446170; http://dx.doi.org/10.1038/362059a0 46.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
"Nat Genet 2006; 38:411-3; http://dx.doi.org/10.1038/ng1742 4 7 .D e J e s u s - H e r n a n d e zM ,M a c k e n z i eI R ,B o e v eB F ,B o x e rA L , Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al.",OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nat Genet 2008; 40:572-4; PMID: 18372902; http://dx.doi.org/10.1038/ng.1324 9 .,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
TDP-43mutations in familial and sporadic amyotrophic lateral sclerosis.Science 2008; 319:1668-72; PMID:18309045; http://dx.doi.org/ 10.1126/science.1154584 50.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Biochem Bio-phys Res Commun 2006; 351:602-11; PMID: 17084815; http://dx.doi.org/10.1016/j.bbrc.2006.10.093 51.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Science 2006; 314:130-3; PMID:17023659; http://dx.doi.org/10.1126/science.1134108 52.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nat Rev Neurol 2014; 10:337-48;PMID:24840975; http://dx.doi.org/10.1038/nrneurol.2014.78 53.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Brain 2011; 134(Pt 9):2595-609;PMID:21856723; http://dx.doi.org/10.1093/brain/awr201 54.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
EMBO J 2010; 29:2841-57; PMID:20606625;http://dx.doi.org/10.1038/emboj.2010.143 55.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Hum Mutat 2010; 31:E1377-89; PMID: 20232451; http://dx.doi.org/10.1002/humu.21241 56.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Acta Neuropa-thol 2013; 125:273-88; PMID:22961620; http://dx.doi.org/10.1007/s00401-012-1043-z 5 7 .,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
PLoS Genet 2011; 7:e1002011; PMID:21408206; http://dx.doi.org/10.1371/journal.pgen.1002011 58.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
PLoS Genet 2011; 7(8):e1002214; PMID:21829392; http://dx.doi.org/10.1371/ journal.pgen.1002214 59.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Hum Mol Genet 2012; 21:1-9;PMID:21949354; http://dx.doi.org/10.1093/hmg/ddr417 60.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Clin Invest 2011; 121:4118-26; PMID: 21881207; http://dx.doi.org/10.1172/JCI57883 61.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
A Drosophila model of FUS-related neurode-generation reveals genetic interaction between FUS and TDP-43.Hum Mol Genet 2011; 20:2510-23; PMID:21487023; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Neurosci 2013; 33(50):19590-8; PMID:24336723; http://dx.doi.org/10.1523/JNEUROSCI.3396-13.2013RNA BIOLOGY 1099,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Am J Med Genet B Neuropsychiatr Genet 2011; 156B(3):285-90; PMID:21438137; http://dx.doi.org/ 10.1002/ajmg.b.31158 64.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Neurobiol Aging 2011; 32:2323.e27-40; PMID:20674093; http://dx.doi.org/10.1016/j.neurobiolaging.2010.06.010 67.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Exp Cell Res 2009 Apr 15; 315(7):1273-86; PMID:19124016; http://dx.doi.org/ 10.1016/j.yexcr.2008.12.008 68.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Neuron 2013; 79:416-38; PMID:23931993; http://dx.doi.org/ 10.1016/j.neuron.2013.07.033 69.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Hum Mol Genet 2013; 22:1193-205; PMID:23257289; http://dx.doi.org/10.1093/hmg/dds526 70.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
BrainRes 2012; 1462:61-80; PMID:22445064; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Hum Mol Genet 2012; 21:136-49; PMID:21965298; http://dx.doi.org/10.1093/hmg/ddr448 72.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
CNS Drugs 2012;26:841-70; PMID:22950490; http://dx.doi.org/10.2165/11640070- 000000000-00000 7 4 .,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Neurol- ogy 2008; 71:1220-6; PMID:18703462; http://dx.doi.org/10.1212/ 01.wnl.0000319702.37497.72 75.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nature 1998; 393:702-5; PMID:9641683; http://dx.doi.org/10.1038/31508 76.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nature 2006; 442:916-9; PMID: 16862116; http://dx.doi.org/10.1038/nature05016 77.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Neuron 2011; 72:257-68;PMID:21944779; http://dx.doi.org/10.1016/j.neuron.2011.09.010 78.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Acta Neuropathol 2004;108:379-85; PMID:15351890; http://dx.doi.org/10.1007/s00401-004- 0900-9 79.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Acta Neuropathol 2009; 117:15-8; PMID:19015862; http://dx.doi.org/10.1007/s00401-008-0460-5 80.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Neurology 2010; 74:366-71;PMID:20124201; http://dx.doi.org/10.1212/WNL.0b013e3181ccc732 82.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Acta Neuropathol 2011; 122:99-110; PMID:21424531; http://dx.doi.org/10.1007/s00401- 011-0816-0 84.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Acta Neuropathol 2010 Jul; 120(1):33-41; PMID:20490813; http://dx.doi.org/10.1007/s00401-010-0698-6 85.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Neuro- pathol Appl Neurobiol 2013 Feb; 39(2):157-65; PMID:22497712; http://dx.doi.org/10.1111/j.1365-2990.2012.01274.x 86.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Acta Neuropathol 2012; 124(5):705-16; PMID:22842875; http://dx.doi.org/10.1007/s00401-012-1020-6 88.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
EMBO J 2012; 31(22):4258-75; PMID:22968170; http://dx.doi.org/10.1038/emboj.2012.261 89.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Cell 2012; 149(4):768-79; PMID:22579282; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Cell Sci 2015 Nov 15; 128(22):4151-9; PMID:26403203; http://dx.doi.org/10.1242/jcs.1766021100 F. SVETONI ET AL.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Gene 2012; 506(2):331-8; PMID:22771914; http://dx.doi.org/10.1016/j.gene.2012.06.088 92.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Lancet Neurol 2005; 4(2):100-10; PMID:15664542; http://dx.doi.org/10.1016/S1474-4422(05)00991-9 93.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Am J Hum Genet 2012; 91:313-9; PMID:22863194; http://dx.doi.org/10.1016/j.ajhg.2012.07.002 9 4 .,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Neurobiol Aging 2013; 34:2078.e3-4; PMID:23582660; http://dx.doi.org/10.1016/ j.neurobiolaging.2013.03.001 95.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Eur J Neurol 2014; 21:361-3; PMID:23834483;http://dx.doi.org/10.1111/ene.12231 96.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
PLoS One 2014; 9:e111989; PMID:25375143; http://dx.doi.org/10.1371/journal.pone.0111989 97.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Lancet Neurol 2009; 8:1128-39; PMID:19909911; http://dx.doi.org/10.1016/S1474-4422(09)70293-5 98.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Clin Chim Acta 2015; 449:68- 76; PMID:26048192; http://dx.doi.org/10.1016/j.cca.2015.04.042 99.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Par- kinsonism Relat Disord 2014; 20 Suppl 1:S147-9; http://dx.doi.org/10.1016/S1353-8020(13)70035-X 100.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Adv Genet 2014; 87:245-94; PMID:25311924; http://dx.doi.org/10.1016/B978-0- 12-800149-3.00005-6 101.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Sci-ence 1990; 249:505-10; PMID:2200121; http://dx.doi.org/10.1126/science.2200121 103.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
JBiol Chem 2004; 279:44834-40; PMID:15299008; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Biochim Biophys Acta 2013; 1832:375-85; PMID:23200923; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
"Morohoshi F, Arai K, Takahashi EI, Tanigami A, Ohki M. Clon- ing and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins.Genomics 1996; 38:51-7; PMID:8954779; http://dx.doi.org/10.1006/geno.1996.0591 106.",OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Genome Res 2002; 12:1231-45;PMID:12176931; http://dx.doi.org/10.1101/gr.473902 107.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nature 2002; 419:182-5; PMID:12226669; http://dx.doi.org/10.1038/nature01031108.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
EMBO J 1997; 16:4421-32; PMID:9250686; http://dx.doi.org/10.1093/emboj/16.14.4421 109.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Biol Chem 1998; 273:18086-91; PMID:9660765; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Biol Chem 2000; 275:24865-71;PMID:10827180; http://dx.doi.org/10.1074/jbc.M001661200 111.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nat Struct Mol Biol2011; 18:1428-31; http://dx.doi.org/10.1038/nsmb.2163 112.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Sci Rep2012; 2:529; PMID:22829983; http://dx.doi.org/10.1038/srep00529 113.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nat Neurosci 2012; 15:1488-97; PMID:23023293; http://dx.doi.org/10.1038/nn.3230 114.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Sci Rep 2012; 2:603; PMID:22934129; http://dx.doi.org/10.1038/srep00603 115.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
BiochimBiophys Acta 2015; 1849:1398-410; PMID:26514432; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
RNA 2013; 19:498-509; PMID:23389473; http://dx.doi.org/10.1261/rna.037804.112 117.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nature 2004; 432(7014):235-40; PMID:15531877; http://dx.doi.org/10.1038/nature03120 119.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
EMBO J 2012; 31:4502- 10; http://dx.doi.org/10.1038/emboj.2012.319 120.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nat Commun 2014; 5:4335; PMID:25004804; http://dx.doi.org/10.1038/ncomms5335 121.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Neurosci2008; 28:4322-30; PMID:18434510; http://dx.doi.org/10.1523/ JNEUROSCI.4815-07.2008 123.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Proc Natl Acad Sci U S A 2010; 107:13111-6; PMID:20616011; http://dx.doi.org/10.1073/ pnas.1006151107RNA BIOLOGY 1101,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Exp Med 2007; 204:1553-8; PMID:17606634; http://dx.doi.org/10.1084/jem.20070823 125.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Mol Brain 2013; 24; 6:26; PMID:23705811; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Neurosci 2012; 32:11213-27; PMID:22895706; http://dx.doi.org/10.1523/JNEUROSCI.0521-12.2012 127.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Neurogenet 2014; 28:30-40; PMID:24506814;http://dx.doi.org/10.3109/01677063.2013.876021 128.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Neurochem 2016; PMID:27015757; http://dx.doi.org/10.1111/jnc.13625 129.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nat Med 2004; 10:1055-63; PMID:15459709; http://dx.doi.org/10.1038/nm1113 130.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Science 1982; 216:136-44; PMID:6801762; http://dx.doi.org/10.1126/ science.6801762 131.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Virus Res 2015; 207:94-105; PMID:25656065; http://dx.doi.org/10.1016/j.virusres.2014.12.032 132.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Cell 2009; 137:146-58; PMID:19345193; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Biol Chem 2009; 284:20329-39; PMID:19465477; http://dx.doi.org/10.1074/jbc.M109.010264 136.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Proc Natl Acad Sci U S A2008; 105:6439-44; PMID:18434538; http://dx.doi.org/10.1073/ pnas.0802082105 137.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Hum Mol Genet 2010 Aug 15; 19(16):3206-18; PMID:20530643; http://dx.doi.org/10.1093/hmg/ddq230 138.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
PLoS Biol 2011; 9:e1000614; http://dx.doi.org/10.1371/journal.pbio.1000614 139.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
PLoS One2010; 5(10):e13250; PMID:20948999; http://dx.doi.org/10.1371/ journal.pone.0013250 140.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
J Biol Chem 2012; 287:23079-94; PMID:22563080; http://dx.doi.org/ 10.1074/jbc.M111.328757 141.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Ann Neurol 2011; 69:152-62; PMID:21280085; http://dx.doi.org/10.1002/ana.22246 142.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Cell 2012; 149:753-67; PMID:22579281; http://dx.doi.org/10.1016/j.cell.2012.04.017 143.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Cell 2015; 162:1066-77; PMID:26317470; http://dx.doi.org/ 10.1016/j.cell.2015.07.047 144.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Cell 1998; 94:73-82; PMID:9674429; http://dx.doi.org/10.1016/S0092-8674(00)81223-4 145.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nature 1994;372:475-8; PMID:7984243; http://dx.doi.org/10.1038/372475a0 146.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Prion 2015; 9:90-109;PMID:25738979; http://dx.doi.org/10.1080/19336896.2015.1020277 147.,Non-OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Neuron 2005; 48:885-96; PMID:16364894; http://dx.doi.org/10.1016/j.neuron.2005.12.001 148.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
Nat Neurosci 2013; 16:1530-6; PMID:23584741; http://dx.doi.org/10.1038/nn.33791102 F. SVETONI ET AL.,OADS,/arxiv_data1/oa_pdf/bb/47/krnb-13-11-1211225.PMC5100351.pdf
"11, 1075 –1077 http://dx.doi.org/10.1080/15476286.2016.1225645",Non-OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Nat Rev Genet 2003; 4:626-37; PMID:12897774; http://dx.doi.org/10.1038/nrg1125 2.,Non-OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
RNA Biol 2012; 9:563-76;PMID:22614827; http://dx.doi.org/10.4161/rna.20231 3.,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
"Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes.Genome Res 2005; 15:1034-50; PMID:16024819; http://dx.doi.org/10.1101/gr.3715005 4.",OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Nature 2005; 434:338-45; PMID:15735639; http://dx.doi.org/10.1038/nature03441 5.,Non-OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Mol Cell 2012; 46:674-90; PMID:22681889; http://dx.doi.org/10.1016/j.molcel.2012.05.021 6.,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Cell 2012; 149:1393-406; PMID:22658674; http://dx.doi.org/10.1016/j.cell.2012.04.031 7.,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Nat Rev Mol Cell Biol 2007; 8:113-26; PMID:17245413; http://dx.doi.org/10.1038/nrm2104 8.,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Nature 2012;485:264-68; PMID:22495308; http://dx.doi.org/10.1038/nature11013 9.,Non-OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Cell Rep 2012; 1:167-78; PMID:22574288; http://dx.doi.org/10.1016/j.celrep.2012.02.00110.,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Nature 1992; 355:730-32;PMID:1371331; http://dx.doi.org/10.1038/355730a0 11.,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Cell Mol Life Sci 2009; 66:1239-56; PMID:19099192; http://dx.doi.org/10.1007/s00018-008-8532-1 13.,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Annu Rev Biochem 2015; 84:325-54; PMID:25784054; http://dx.doi.org/10.1146/annurev- biochem-080111-092106 14.,Non-OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Neuropathology 2015; 35:37-43; PMID:25338872; http://dx.doi.org/10.1111/neup.12153 15.,Non-OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Gene 2016; 576:791-7; PMID:26581508; http://dx.doi.org/ 10.1016/j.gene.2015.11.009 16.,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
BMC Cancer 2010; 10:434;PMID:20716340; http://dx.doi.org/10.1186/1471-2407-10-434 17.,Non-OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Mol Cell 2007; 27:91-105; PMID:17612493;http://dx.doi.org/10.1016/j.molcel.2007.06.017 18.,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
"Gaidatzis D, van Nimwegen E, Hausser J, Zavolan M. Inference of miRNA targets using evolutionary conservation and pathway analysis.BMC Bioinformatics 2007; 8:69; PMID:17331257; http://dx.doi.org/ 10.1186/1471-2105-8-69 19.",OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Nature 2012; 485:201-06; PMID:22575960; http://dx.doi.org/10.1038/nature11112 20.,Non-OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Genes Dev 2015; 29:2037-53; PMID:26404942; http://dx.doi.org/10.1101/gad.269415.115 21.,Non-OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Cell 2015; 163:999-1010; PMID:26593424;http://dx.doi.org/10.1016/j.cell.2015.10.012 22.,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Nature 2014; 505:117-20; PMID:24284625;http://dx.doi.org/10.1038/nature12730 23.,Non-OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Cell 2015; 161:1388-99; PMID:26046440; http://dx.doi.org/10.1016/j.cell.2015.05.014 24.,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Nature 2015; 526:591-4; PMID:26458103; http://dx.doi.org/ 10.1038/nature15377 25.,Non-OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
Cell 2015; 162:1299-308; PMID:26321680; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
2012; 34:1025-34; PMID:23108796; http://dx.doi.org/10.1002/bies.201200073 27.,Non-OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
2015; 26:227-37; PMID: 26597575; http://dx.doi.org/10.1016/j.tcb.2015.10.012RNA BIOLOGY 1077,OADS,/arxiv_data1/oa_pdf/e6/cb/krnb-13-11-1225645.PMC5100352.pdf
The software and accompanying documenta- tion is available on GitHub at https://github.com/jowkar/ focalscan .,OADS,/arxiv_data1/oa_pdf/79/e8/gkw674.PMC5100559.pdf
Allthemethodspresentedinthispaperareimplemented insoftwarethatarefreelyavailableat http://kissplice.prabi.,Non-OADS,/arxiv_data1/oa_pdf/6c/27/gkw655.PMC5100560.pdf
"Data access The human data used in this study can be found through the ArrayExpress database ( http://www.ebi.ac.uk/ arrayexpress/ )undertheaccessionnumberE-GEOD-29342 and we used the individuals named NA20808, NA20809, NA20810, NA20811, NA20812, NA20813, NA20814,NA20815, NA20819, NA20826, NA06984, NA11840, NA06986, NA06989, NA06994, NA07346, NA07357, NA10851, NA11829 and NA11832.",OADS,/arxiv_data1/oa_pdf/6c/27/gkw655.PMC5100560.pdf
TheRNAseqlibrariesfrom D.mojavensis andD.arizonae are available through the NCBI Sequence Read Archive (SRA :http://www.ncbi.nlm.nih.gov/sra ) under the acces- sion no.,OADS,/arxiv_data1/oa_pdf/6c/27/gkw655.PMC5100560.pdf
TheA.tabida dataset is available through the NCBI Se- quenceReadArchive(SRA: http://www.ncbi.nlm.nih.gov/ sra) under the accession no.,OADS,/arxiv_data1/oa_pdf/6c/27/gkw655.PMC5100560.pdf
https://hal.inria.fr/inria-00514887/document .,Non-OADS,/arxiv_data1/oa_pdf/6c/27/gkw655.PMC5100560.pdf
Primer design and optimization All forward and reverse primers for quantitative PCR were designed using OligoWiz 2.0 ( http://www.cbs.dtu.dk/ services/OligoWiz/ )(14).Representativesubtelomericgenes were selected that met the following criteria: they werewithin 50 kb from the end of a chromosome; they had mi- croarray intensities of greater than 1000; and primers with quality scores >0.9 could be generated by OligoWiz.,OADS,/arxiv_data1/oa_pdf/fa/b6/gkw603.PMC5100562.pdf
Dataavailability Microarray and ChIP-seq data are available through NCBI’s GEO database ( http://www.ncbi.nlm.nih.gov/geo/ ) usingaccession number GSE83426.,OADS,/arxiv_data1/oa_pdf/fa/b6/gkw603.PMC5100562.pdf
This database con- tained30213proteinentries.Proteinswereidentifiedat99%confidencewithXCorrscorecut-offs( 27)asdeterminedby a reversed database search using the Percolator algorithm (http://per-colator.com )(28).,OADS,/arxiv_data1/oa_pdf/33/0c/gkw762.PMC5100564.pdf
The presence of Oct-1 bind- ing sites in the proximity of promoters of most of these factors(http://www.genecards.org )indicatesthattheycould be directly regulated by Oct-1.,Non-OADS,/arxiv_data1/oa_pdf/3f/75/gkw623.PMC5100579.pdf
With such a large enrichment we could map a large number of the identified regulatory regions in the 3D ge-nomicspace.Theputativeregulatoryregionsarepublically available at http://bioinf.icm.uu.se/tfnet.php .,OADS,/arxiv_data1/oa_pdf/06/a3/gkw800.PMC5100580.pdf
The tfNet tool is freely accessible through http://figshare.com/ articles/tfNet manual/1408532 and the generated putative regulatory regions for all five cell lines are made publically available on http://bioinf.icm.uu.se/tfnet.php .,OADS,/arxiv_data1/oa_pdf/06/a3/gkw800.PMC5100580.pdf
Available athttp://www.python.org ) and R (R Core Team (2014).,OADS,/arxiv_data1/oa_pdf/47/39/gkw811.PMC5100585.pdf
URL http://www.R-project.org/ .),Non-OADS,/arxiv_data1/oa_pdf/47/39/gkw811.PMC5100585.pdf
ForthetreatmentofgenomicintervalsweusedtheIRanges and Granges ( 46) libraries from Bioconductor version 3.2 (https://www.bioconductor.org/ ).,OADS,/arxiv_data1/oa_pdf/47/39/gkw811.PMC5100585.pdf
The regions selected forbinding along with the supporting experimental evidence canbeinteractivelyaccessedattheUCSCgenomebrowser: http://genome.ucsc.edu/cgi-bin/hgTracks?,OADS,/arxiv_data1/oa_pdf/47/39/gkw811.PMC5100585.pdf
"The best and final model was selected with a suite of softwares (DAMSEL, DAMSUP, DAMAVER ( 29)a n dDAMFILT) ( http://www.embl-hamburg.de/biosaxs )f o r comparison and fitting to the NMR structure.",Non-OADS,/arxiv_data1/oa_pdf/82/c2/gkw584.PMC5100586.pdf
Read mapping and gene expression analysis Thereferencegenomefortherhesusmacaquemonkey(ver- sion rheMac3) was downloaded from the UCSC GenomeBrowser ( http://genome.ucsc.edu ).,OADS,/arxiv_data1/oa_pdf/31/f2/gkw587.PMC5100587.pdf
FUNDING Fondation ARC ( http://www.arc-cancer.net ) [PJA2015120 3415 to A.A.I.,Non-OADS,/arxiv_data1/oa_pdf/af/06/gkw675.PMC5100588.pdf
]; Electricit ´ed eF r a n c e( http://www.edf.fr ) [RB 2016-17 to M.K.S.,Non-OADS,/arxiv_data1/oa_pdf/af/06/gkw675.PMC5100588.pdf
]; RFBR [15-54-16003]; Program of RAS on Molecular and Cellular Biology [6.4]; postdoctoral and doctoral fellow- ships from Fondation ARC ( http://www.arc-cancer.net ) [PDF20110603195 to I.T.,Non-OADS,/arxiv_data1/oa_pdf/af/06/gkw675.PMC5100588.pdf
"riched sequence motifs in these libraries, we used the pro- gram MERMADE (adapted from http://korflab.ucdavis.",Non-OADS,/arxiv_data1/oa_pdf/7f/c6/gkw590.PMC5100589.pdf
"Comparison of complex structures with the apo- NeC3PO structure indicated that NeC3POcanundergolargeconformationalchangeandcre- ate a wide gap between the two TraxL subunits, provid- ing a plausible pathway for substrates entering (or prod-uctsexitingfrom)theinnerstructuralcavity.Thesubstrate- bindingmodeandthecatalyticmechanismwerefurtherver- ifiedbymutagenesisand invitrocatalyticassays,whichalso revealed the structural basis for the purine base preference ofthetranslin superfamilyproteins.MATERIALS AND METHODS DNA construction The gene containing the codon-optimized cDNA (Sup- plementary Table S1) of the full-length wild-type (WT) NeC3PO was purchased from GENERAY Biotechnology Co. Ltd. in Shanghai, China ( http://www.geneary.com.cn ).",OADS,/arxiv_data1/oa_pdf/22/a0/gkw776.PMC5100593.pdf
"CRISPR /Cas9-mediated genome editingof HEK293T cells Genome editing by the CRISPR /Cas9 system was con- ducted following the previously reported protocols ( 28), where the single guide RNAs (sgRNAs) were designed by using the online sgRNA tool ( http://www.broadinstitute.",OADS,/arxiv_data1/oa_pdf/11/4d/gkw662.PMC5100597.pdf
"Therefore, we assessed whether TieA could also undergo phosphorylation; Netphosbac analy-sis (http://www.cbs.dtu.dk/services/NetPhosBac-1.0/ ) illus- trated that TieA protein sequence has the following ser- ine residues: AECK SGELK, YINN S RR, RKNL SSLLY, KNLSSLLYE which could be phosphorylated by the ser- ine kinases.",Non-OADS,/arxiv_data1/oa_pdf/ea/a5/gkw730.PMC5100599.pdf
The DUF is widely re- ported in hypothetical bacterial proteins and in particularDUF1887 was reported to be present in R-M genes along with a CRISPR associated (Cas) gene ( http://pfam.xfam.,Non-OADS,/arxiv_data1/oa_pdf/ea/a5/gkw730.PMC5100599.pdf
Resting-state fMRI data processing and statistical analysis Standard image pre-processing methods were conducted employing the SPM12 software (http://www.fil.ion.ucl.ac.uk/spm/) with the CONN toolbox (http://www.nitrc.org/projects/conn) for functional connectivity analysis.,OADS,/arxiv_data1/oa_pdf/bc/c0/bjporcpsych002683.PMC5100603.pdf
"In addition,the Artifact Detection Tools (ART: http://www.nitro.org/projects/ artifact_detect) were used to measure motion artefacts in allindividuals in both groups; we controlled for any motion artefacts by realignment parameters detected with ART.",OADS,/arxiv_data1/oa_pdf/bc/c0/bjporcpsych002683.PMC5100603.pdf
"NHS Commits to Major Transformation of Mental Health Care with Help for a Million more People , 2016; NHS England (https://www.england.nhs.uk/ mentalhealth/2016/02/15/fyfv-mh/).",Non-OADS,/arxiv_data1/oa_pdf/6e/95/bjporcpsych003814.PMC5100604.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/80/dyw197.PMC5100619.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 1517 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/c2/dyw218.PMC5100622.pdf
"Key words: Exposome, Metabolic phenotype, VOC exposure, Bioeffect monitoring, Population screening, High-resolution metabolomics, Trichlororoethylene Introduction Trichloroethylene (TCE) is a widely used industrial solvent and common organic contaminant in groundwater.1TCE is classified as carcinogenic to humans by the IARC2 [http://monographs.iarc.fr/ENG/Monographs/vol106/ index.php] and as both a carcinogenic and non- carcinogenic health hazard by the US Environmental Protection Agency (EPA).3TCE exposure has been linked to increased risk for kidney cancer,4,5non-Hodgkin’s lymphoma (NHL)6,7and liver cancer.8,9Human and ani- mal studies have identified numerous non-cancer adverse effects of TCE, including immune dysfunction10,11and ner- vous system,12renal13,14and liver15toxicity.",Non-OADS,/arxiv_data1/oa_pdf/f2/c2/dyw218.PMC5100622.pdf
"R package version 1.7 ed; 2015, https://cran.r-project.org/web /packages/nontarget/index.html (7 July 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/f2/c2/dyw218.PMC5100622.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/85/aapm-06-04-39262.PMC5100632.pdf
"The 1st Baltic Osseointegration Academy and Lithuanian University of Health Sciences Consensus Conference  9 - 10 September 2016, Kaunas, Lithuania J Oral Maxillofac Res 2016;7(3):e1 URL: http://www.ejomr.org/JOMR/archives/2016/3/e1/v7n3e1.pdf doi: 10.5037/jomr.2016.7301 http://www.ejomr.org/JOMR/archives/2016/3/e1/v7n3e1ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.",Non-OADS,/arxiv_data1/oa_pdf/b0/92/jomr-07-e1.PMC5100634.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e1/v7n3e1ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/92/jomr-07-e1.PMC5100634.pdf
"Protocol and registration The reviews were registered in PROSPERO, an  international prospective register of systematic  reviews: http://www.crd.york.ac.uk/PROSPERO/ .",Non-OADS,/arxiv_data1/oa_pdf/b0/92/jomr-07-e1.PMC5100634.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e1/v7n3e1ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/92/jomr-07-e1.PMC5100634.pdf
[URL: http://handbook.cochrane.org/ ],OADS,/arxiv_data1/oa_pdf/b0/92/jomr-07-e1.PMC5100634.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e1/v7n3e1ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b0/92/jomr-07-e1.PMC5100634.pdf
"The 1st Baltic Osseointegration Academy and Lithuanian University of Health Sciences Consensus Conference  9 - 10 September 2016, Kaunas, Lithuania J Oral Maxillofac Res 2016;7(3):e1 URL: http://www.ejomr.org/JOMR/archives/2016/3/e1/v7n3e1.pdf doi: 10.5037/jomr.2016.7301 Copyright ©  Juodzbalys G. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.",Non-OADS,/arxiv_data1/oa_pdf/b0/92/jomr-07-e1.PMC5100634.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/b0/92/jomr-07-e1.PMC5100634.pdf
"Accepted for publication: 7 September 2016 To cite this article: Padial-Molina M, López-Martínez J, O’Valle F, Galindo-Moreno P.Microbial Profiles and Detection Techniques in Peri-Implant Diseases: a Systematic ReviewJ Oral Maxillofac Res 2016;7(3):e10URL: http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10.pdfdoi: 10.5037/jomr.2016.7310 http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.",Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Aug. [Medline: 24006553 ]  [URL: http://www.ncbi.nlm.nih.gov/books/NBK154461/ ] 31.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
"To cite this article: Padial-Molina M, López-Martínez J, O’Valle F, Galindo-Moreno P. Microbial Profiles and Detection Techniques in Peri-Implant Diseases: a Systematic Review J Oral Maxillofac Res 2016;7(3):e10 URL: http://www.ejomr.org/JOMR/archives/2016/3/e10/v7n3e10.pdf doi: 10.5037/jomr.2016.7310 Copyright ©  Padial-Molina M, López-Martínez J, O’Valle F, Galindo-Moreno P. Published in the JOURNAL OF ORAL   & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.95.",Non-OADS,/arxiv_data1/oa_pdf/e0/d3/jomr-07-e10.PMC5100635.pdf
"The systematic  review and/or meta-analysis were registered in PROSPERO, an international prospective register of systematic reviews:   http://www.crd.york.ac.uk/PROSPERO/ .",OADS,/arxiv_data1/oa_pdf/e8/b1/jomr-07-e11.PMC5100636.pdf
The literature in the corresponding areas of interest was searched and reported using  the PRISMA (Preferred Reporting Item for Systematic Review and Meta-Analysis) Statement: http://www.prisma-statement.,OADS,/arxiv_data1/oa_pdf/e8/b1/jomr-07-e11.PMC5100636.pdf
Summary and Consensus Statements: Group II - Peri-Implantitis Diagnostics and Decision Tree J Oral Maxillofac Res 2016;7(3):e11 URL: http://www.ejomr.org/JOMR/archives/2016/3/e11/v7n3e11.pdf doi: 10.5037/jomr.2016.7311 http://www.ejomr.org/JOMR/archives/2016/3/e11/v7n3e11ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e8/b1/jomr-07-e11.PMC5100636.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e11/v7n3e11ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e8/b1/jomr-07-e11.PMC5100636.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e11/v7n3e11ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e8/b1/jomr-07-e11.PMC5100636.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e11/v7n3e11ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e8/b1/jomr-07-e11.PMC5100636.pdf
"Summary and Consensus Statements: Group II - Peri-Implantitis Diagnostics and Decision Tree J Oral Maxillofac Res 2016;7(3):e11 URL: http://www.ejomr.org/JOMR/archives/2016/3/e11/v7n3e11.pdf doi: 10.5037/jomr.2016.7311 Copyright ©  Tözüm TF, Dursun E, Galindo-Moreno P, Juodzbalys G, López-Martínez J, O’Valle F, Padial-Molina M,  Ramanauskaite A.",Non-OADS,/arxiv_data1/oa_pdf/e8/b1/jomr-07-e11.PMC5100636.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 9  September 2016.",Non-OADS,/arxiv_data1/oa_pdf/e8/b1/jomr-07-e11.PMC5100636.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/e8/b1/jomr-07-e11.PMC5100636.pdf
"Accepted for publication: 19 August 2016 To cite this article: Ramanauskaite A, Tervonen T. The Efficacy of Supportive Peri-Implant Therapies in Preventing Peri-Implantitis and Implant Loss: a Systematic Review of  the Literature J Oral Maxillofac Res 2016;7(3):e12 URL: http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12.pdf doi: 10.5037/jomr.2016.7312 http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.",Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
The protocol can be accessed at: http://www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID=CRD42016035621 The reporting of this systematic analysis adhered to  the Preferred Reporting Items for Systematic Review  and Meta-Analyses (PRISMA) Statement [ 13].,Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                                                                                                                                                                                                                                               Ramanauskaite and Tervonen http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
[URL: http://www.cochrane.org/cochrane-interventions-handbook ] 15.,OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
"7 | No 3 | e12 | p.10 (page number not for citation purposes)JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                       Ramanauskaite and Tervonen To cite this article: Ramanauskaite A, Tervonen T. The Efficacy of Supportive Peri-Implant Therapies in Preventing Peri-Implantitis and Implant Loss: a Systematic Review of  the Literature J Oral Maxillofac Res 2016;7(3):e12 URL: http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12.pdf doi: 10.5037/jomr.2016.7312 Copyright ©  Ramanauskaite A, Tervonen T. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH  (http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/89/1b/jomr-07-e12.PMC5100637.pdf
Non-Surgical Therapy for Peri-Implant Diseases: a Systematic Review J Oral Maxillofac Res 2016;7(3):e13 URL: http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13.pdf doi: 10.5037/jomr.2016.7313 http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
"Non-Surgical Therapy for Peri-Implant Diseases: a Systematic Review J Oral Maxillofac Res 2016;7(3):e13 URL: http://www.ejomr.org/JOMR/archives/2016/3/e13/v7n3e13.pdf doi: 10.5037/jomr.2016.7313 Copyright ©  Suárez-López del Amo F, Yu SH, Wang HL.",Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/bd/70/jomr-07-e13.PMC5100638.pdf
"Accepted for publication: 30 August 2016 To cite this article:Ramanauskaite A, Daugela P, Faria de Almeida R, Saulacic N.Surgical Non-Regenerative Treatments for Peri-Implantitis: a Systematic ReviewJ Oral Maxillofac Res 2016;7(3):e14URL: http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14.pdf doi: 10.5037/jomr.2016.7314 http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.",Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
"The  methods of the analysis and inclusion criteria were  specified in advance and documented in a protocol,  accessible through the following link: http://www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID=CRD42016043320 The reporting of this systematic analysis adhered to  the Preferred Reporting Items for Systematic Review  and Meta-Analyses (PRISMA) statement [ 26].",OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e12/v7n3e12ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
"To cite this article: Ramanauskaite A, Daugela P, Faria de Almeida R, Saulacic N. Surgical Non-Regenerative Treatments for Peri-Implantitis: a Systematic Review J Oral Maxillofac Res 2016;7(3):e14 URL: http://www.ejomr.org/JOMR/archives/2016/3/e14/v7n3e14.pdf doi: 10.5037/jomr.2016.7314 Copyright ©  Ramanauskaite A, Daugela P, Faria de Almeida R, Saulacic N. Published in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.41.",Non-OADS,/arxiv_data1/oa_pdf/bb/81/jomr-07-e14.PMC5100639.pdf
"Accepted for publication: 19 August 2016To cite this article:Daugela P, Cicciù M, Saulacic N.Surgical Regenerative Treatments for Peri-Implantitis: Meta-analysis of Recent Findings in a Systematic Literature ReviewJ Oral Maxillofac Res 2016;7(3):e15URL: http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15.pdfdoi: 10.5037/jomr.2016.7315 http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.",Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
The protocol can be accessed through the  following link: http://www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID=CRD42016033664Registration number: CRD42016033664.The reporting of this systematic analysis adhered to  the Preferred Reporting Items for Systematic Review  and Meta-Analyses (PRISMA) statement [ 19].,OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
"[Medline: 24261909 ]  [doi: 10.1902/jop.2013.130563 ] To cite this article: Daugela P, Cicciù M, Saulacic N. Surgical Regenerative Treatments for Peri-Implantitis: Meta-analysis of Recent Findings in a Systematic Literature Review J Oral Maxillofac Res 2016;7(3):e15 URL: http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15.pdf doi: 10.5037/jomr.2016.7315",Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e15/v7n3e15ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
"Copyright ©  Daugela P, Cicciù M, Saulacic N. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH  (http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/8a/5e/jomr-07-e15.PMC5100640.pdf
"The systematic  review and/or meta-analysis were registered in PROSPERO, an international prospective register of systematic reviews:   http://www.crd.york.ac.uk/PROSPERO/ .",OADS,/arxiv_data1/oa_pdf/ec/56/jomr-07-e16.PMC5100641.pdf
The literature in the corresponding areas of interest was searched and reported using  the PRISMA (Preferred Reporting Item for Systematic Review and Meta-Analysis) Statement: http://www.prisma-statement.,OADS,/arxiv_data1/oa_pdf/ec/56/jomr-07-e16.PMC5100641.pdf
Summary and Consensus Statements: Group III - Peri-Implantitis Treatment J Oral Maxillofac Res 2016;7(3):e16 URL: http://www.ejomr.org/JOMR/archives/2016/3/e16/v7n3e16.pdf doi: 10.5037/jomr.2016.7316 http://www.ejomr.org/JOMR/archives/2016/3/e16/v7n3e16ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/56/jomr-07-e16.PMC5100641.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e16/v7n3e16ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/56/jomr-07-e16.PMC5100641.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e16/v7n3e16ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/56/jomr-07-e16.PMC5100641.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e16/v7n3e16ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/56/jomr-07-e16.PMC5100641.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e16/v7n3e16ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/ec/56/jomr-07-e16.PMC5100641.pdf
"Summary and Consensus Statements: Group III - Peri-Implantitis Treatment J Oral Maxillofac Res 2016;7(3):e16 URL: http://www.ejomr.org/JOMR/archives/2016/3/e16/v7n3e16.pdf doi: 10.5037/jomr.2016.7316 Copyright ©  Suárez-López del Amo F, Faria de Almeida R, Cicciù M, Daugela P, Ramanauskaite A, Saulacic N,   Tervonen T, Wang HL, Yu SH.",Non-OADS,/arxiv_data1/oa_pdf/ec/56/jomr-07-e16.PMC5100641.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH   http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/ec/56/jomr-07-e16.PMC5100641.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/ec/56/jomr-07-e16.PMC5100641.pdf
"Accepted for publication: 7 September 2016 To cite this article:Pranskunas M, Poskevicius L, Juodzbalys G, Kubilius R, Jimbo R.Influence of Peri-Implant Soft Tissue Condition and Plaque Accumulation on Peri-Implantitis: a Systematic ReviewJ Oral Maxillofac Res 2016;7(3):e2URL: http://www.ejomr.org/JOMR/archives/2016/3/e2/v7n3e2.pdfdoi: 10.5037/jomr.2016.7302 http://www.ejomr.org/JOMR/archives/2016/3/e2/v7n3e2ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e2/v7n3e2ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
"The review was registered in PROSPERO,  an international prospective register of systematic reviews.The protocol can be accessed at: http://www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID=CRD42016033672 Registration number: CRD42016033672.",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e2/v7n3e2ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e2/v7n3e2ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e2/v7n3e2ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e2/v7n3e2ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e2/v7n3e2ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e2/v7n3e2ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
[URL: http://handbook.cochrane.org/chapter_8/8_assessing_risk_of_bias_in_included_studies.,Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e2/v7n3e2ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
"[Medline: 16966901] [doi: 10.1097/01.id.0000227078.70869.20] To cite this article:Pranskunas M, Poskevicius L, Juodzbalys G, Kubilius R, Jimbo R.Influence of Peri-Implant Soft Tissue Condition and Plaque Accumulation on Peri-Implantitis: a Systematic ReviewJ Oral Maxillofac Res 2016;7(3):e2URL: http://www.ejomr.org/JOMR/archives/2016/3/e2/v7n3e2.pdfdoi: 10.5037/jomr.2016.7302 Copyright © Pranskunas M, Poskevicius L, Juodzbalys G, Kubilius R, Jimbo R. Published in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH (http://www.ejomr.org), 9 September 2016.This is an open-access article, first published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License, which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work and is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/0d/dd/jomr-07-e2.PMC5100642.pdf
A Systematic Review and Meta-AnalysisJ Oral Maxillofac Res 2016;7(3):e3URL: http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3.pdfdoi: 10.5037/jomr.2016.7303 http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
The Review Manager software (version  5.2.6 - http://www.cochrane.org ) was used for the  assessment of heterogeneity.,OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
[URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm ] 14.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
"A Systematic Review   and Meta-Analysis J Oral Maxillofac Res 2016;7(3):e3 URL: http://www.ejomr.org/JOMR/archives/2016/3/e3/v7n3e3.pdf doi: 10.5037/jomr.2016.7303 Copyright ©  Stacchi C, Berton F, Perinetti G, Frassetto A, Lombardi T, Khoury A, Andolsek F, Di Lenarda R. Published in  the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/5e/58/jomr-07-e3.PMC5100643.pdf
"Accepted for publication: 7 September 2016 To cite this article:Maminskas J, Puisys A, Kuoppala R, Raustia A, Juodzbalys G.The Prosthetic Influence and Biomechanics on Peri-Implant Strain: a Systematic Literature Review of Finite Element StudiesJ Oral Maxillofac Res 2016;7(3):e4URL: http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4.pdfdoi: 10.5037/jomr.2016.7304 http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.",Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
This protocol could be found in PROSPERO  register: http://www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID=CRD42016037224 This review was performed following PRISMA  statements (Preferred Reporting Item for Systematic  Review and Meta-Analyses) [ 16].,OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
[URL: http://handbook.cochrane.org/ ] 18.,OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
"[Medline: 22260789 ]  [doi: 10.1016/j.ijom.2011.12.026 ] To cite this article: Maminskas J, Puisys A, Kuoppala R, Raustia A, Juodzbalys G. The Prosthetic Influence and Biomechanics on Peri-Implant Strain: a Systematic Literature Review of Finite Element Studies J Oral Maxillofac Res 2016;7(3):e4 URL: http://www.ejomr.org/JOMR/archives/2016/3/e4/v7n3e4.pdf doi: 10.5037/jomr.2016.7304 Copyright ©  Maminskas J, Puisys A, Kuoppala R, Raustia A, Juodzbalys G. Published in the JOURNAL OF ORAL &  MAXILLOFACIAL RESEARCH ( http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/7b/65/jomr-07-e4.PMC5100644.pdf
"Accepted for publication: 22 August 2016 To cite this article:Guobis Z, Pacauskiene I, Astramskaite I.General Diseases Influence on Peri-Implantitis Development: a Systematic ReviewJ Oral Maxillofac Res 2016;7(3):e5URL: http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5.pdfdoi: 10.5037/jomr.2016.7305 http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.",Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
The protocol can be accessed at: http://www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID=CRD42016033662 .,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
[URL: http://training.cochrane.org/handbook ] 14.,OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
[URL: http://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/ ] 61.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
[URL: http://www.globalresearchonline.net/pharmajournal/pharmajournal6.aspx ] 62.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
"General Diseases Influence on Peri-Implantitis Development: a Systematic Review J Oral Maxillofac Res 2016;7(3):e5 URL: http://www.ejomr.org/JOMR/archives/2016/3/e5/v7n3e5.pdf doi: 10.5037/jomr.2016.7305 Copyright ©  Guobis Z, Pacauskiene I, Astramskaite I.",Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.73.",Non-OADS,/arxiv_data1/oa_pdf/00/da/jomr-07-e5.PMC5100645.pdf
Bone Cells Dynamics during Peri-Implantitis: a Theoretical Analysis J Oral Maxillofac Res 2016;7(3):e6 URL: http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6.pdf doi: 10.5037/jomr.2016.7306 http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
"Bone Cells Dynamics during Peri-Implantitis: a Theoretical Analysis J Oral Maxillofac Res 2016;7(3):e6 URL: http://www.ejomr.org/JOMR/archives/2016/3/e6/v7n3e6.pdf doi: 10.5037/jomr.2016.7306 Copyright ©  Fernandes MH, Gomes PS.",Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH   (http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.67.",Non-OADS,/arxiv_data1/oa_pdf/35/a4/jomr-07-e6.PMC5100646.pdf
"The systematic reviews and/or meta- analyses were registered in PROSPERO, an international prospective register of systematic reviews: http://www.crd.york.",OADS,/arxiv_data1/oa_pdf/79/4c/jomr-07-e7.PMC5100647.pdf
The literature in the corresponding areas of interest was screened and reported following the PRISMA  (Preferred Reporting Item for Systematic Review and Meta-Analysis) Statement: http://www.prisma-statement.org/ .,Non-OADS,/arxiv_data1/oa_pdf/79/4c/jomr-07-e7.PMC5100647.pdf
"Summary and Consensus Statements: Group I - Peri-Implantitis Aetiology, Risk Factors and Pathogenesis J Oral Maxillofac Res 2016;7(3):e7 URL: http://www.ejomr.org/JOMR/archives/2016/3/e7/v7n3e7.pdf doi: 10.5037/jomr.2016.7307 http://www.ejomr.org/JOMR/archives/2016/3/e7/v7n3e7ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.",Non-OADS,/arxiv_data1/oa_pdf/79/4c/jomr-07-e7.PMC5100647.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e7/v7n3e7ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/79/4c/jomr-07-e7.PMC5100647.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e7/v7n3e7ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/79/4c/jomr-07-e7.PMC5100647.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e7/v7n3e7ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/79/4c/jomr-07-e7.PMC5100647.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e7/v7n3e7ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/79/4c/jomr-07-e7.PMC5100647.pdf
"Summary  and Consensus Statements: Group I - Peri-Implantitis Aetiology, Risk Factors and Pathogenesis J Oral Maxillofac Res 2016;7(3):e7 URL: http://www.ejomr.org/JOMR/archives/2016/3/e7/v7n3e7.pdf doi: 10.5037/jomr.2016.7307REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/79/4c/jomr-07-e7.PMC5100647.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e7/v7n3e7ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/79/4c/jomr-07-e7.PMC5100647.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL  RESEARCH ( http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/79/4c/jomr-07-e7.PMC5100647.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/79/4c/jomr-07-e7.PMC5100647.pdf
"Accepted for publication: 22 August 2016 To cite this article:Ramanauskaite A, Juodzbalys G.Diagnostic Principles of Peri-Implantitis: a Systematic Review and Guidelines for Peri-Implantitis Diagnosis ProposalJ Oral Maxillofac Res 2016;7(3):e8URL: http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8.pdfdoi: 10.5037/jomr.2016.7308 http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.",Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
The protocol registration number:  CRD42016033287 can be accessed at: http://www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID=CRD42016033287 The reporting of this systematic analysis adhered to  the Preferred Reporting Items for Systematic Review  and Meta-Analyses (PRISMA) Statement [ 13].,OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH Ramanauskaite and Juodzbalys http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
[URL: http://www.cochrane.org/cochrane-interventions-handbook ] 15.,OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
"7 | No 3 | e8 | p.14 (page number not for citation purposes)JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                    Ramanauskaite and Juodzbalys To cite this article: Ramanauskaite A, Juodzbalys G. Diagnostic Principles of Peri-Implantitis: a Systematic Review and Guidelines for Peri-Implantitis Diagnosis Proposal J Oral Maxillofac Res 2016;7(3):e8 URL: http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8.pdf doi: 10.5037/jomr.2016.730840.",Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e8/v7n3e8ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
"7 | No 3 | e8 | p.15 (page number not for citation purposes)JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                    Ramanauskaite and Juodzbalys Copyright ©  Ramanauskaite A, Juodzbalys G. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH  (http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/b5/f6/jomr-07-e8.PMC5100648.pdf
"Accepted for publication: 19 August 2016 To cite this article:Dursun E, Tözüm TF.Peri-Implant Crevicular Fluid Analysis, Enzymes and Biomarkers: a Systemetic ReviewJ Oral Maxillofac Res 2016;7(3):e9URL: http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9.pdfdoi: 10.5037/jomr.2016.7309 http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.",Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
7 | No 3 | e9 | p.3 (page number not for citation purposes)JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH Dursun and Tözüm http://www.crd.york.ac.uk/PROSPERO/display_ record.asp?ID=CRD42016035456.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH Dursun and Tözüm http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9ht.htm  J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
[URL: http://training.cochrane.org/handbook ] 10.,OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9ht.htm J Oral Maxillofac Res 2016 (Jul-Sep) | vol.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
"Peri-Implant Crevicular Fluid Analysis, Enzymes and Biomarkers: a Systemetic Review J Oral Maxillofac Res 2016;7(3):e9 URL: http://www.ejomr.org/JOMR/archives/2016/3/e9/v7n3e9.pdf doi: 10.5037/jomr.2016.7309 Copyright ©  Dursun E, Tözüm TF.",Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
"Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH   (http://www.ejomr.org ), 9 September 2016.",Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
"The copyright, license information and link to the original publication on ( http://www.ejomr.org ) must be  included.",Non-OADS,/arxiv_data1/oa_pdf/e5/04/jomr-07-e9.PMC5100649.pdf
"Published with license by Taylor & Francis This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/1e/kcib-09-05-1208874.PMC5100651.pdf
"5, e1208874 (3 pages)http://dx.doi.org/10.1080/19420889.2016.1208874",Non-OADS,/arxiv_data1/oa_pdf/d4/1e/kcib-09-05-1208874.PMC5100651.pdf
"Behav Ecol Sociobiol 2007; 62:15-27; http://dx.doi.org/10.1007/s00265-007-0445-8 [7] Croft DP, James R, Krause J.",Non-OADS,/arxiv_data1/oa_pdf/d4/1e/kcib-09-05-1208874.PMC5100651.pdf
"Behav Ecol Sociobiol 2009; 63:975-88; http://dx.doi.org/10.1007/s00265-009-0725-6 [9] Abell J, Kirzinger MWB, Gordon Y, Kirk J, Kok /C18es R, Lynas K, Mandinyenya B, Youldon D. A social network analysis of social cohesion in a constructed pride: impli-cations for ex situ reintroduction of the African lion (Panthera leo ).",Non-OADS,/arxiv_data1/oa_pdf/d4/1e/kcib-09-05-1208874.PMC5100651.pdf
"PloS ONE 2013; 8:1-11; http://dx.doi.org/ 10.1371/journal.pone.0082541 [10] Dunston EJ, Abell J, Doyle RE, Kirk J, Hilley VB, Forsyth A, Jenkins E, Freire R. An assessment of African lion Panthera leo sociality via social network analysis: prere- lease monitoring for an ex situ reintroduction program.Current Zool 2016; http://dx.doi.org/10.1093/cz/zow012 [11] Wey T, Blumstein DT, Shen W, Jordan F. Social network analysis of animal behaviour: a promising tool for thestudy of sociality.",Non-OADS,/arxiv_data1/oa_pdf/d4/1e/kcib-09-05-1208874.PMC5100651.pdf
"5, e1212792 (6 pages)http://dx.doi.org/10.1080/19420889.2016.1212792",Non-OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
The IUCN Red List of Threatened Species 2010; e.T61316A12462113; http://dx.doi.org/10.2305/IUCN.,Non-OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
J Trop Ecol 2012; 28:233-42; http://dx.doi.org/10.1017/S0266467412000119 [7] Anonymous.,Non-OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"Glob Change Biol 2012; 18:1725-37; http://dx.doi.org/10.1111/j.1365- 2486.2011.02636.x [10] Vil /C18a M, Espinar JL, Hejda M, Hulme PE, Jaro /C20s/C19ıkV , Maron JL, Pergl J, Schaffner U, Sun Y, Py /C20sek P. Ecologi- cal impacts of invasive alien plants: a meta-analysis oftheir effects on species, communities and ecosystems.Ecol Letters 2011; 14:702-8; http://dx.doi.org/10.1111/ j.1461-0248.2011.01628.x [11] Hulme PE, Py /C20sek P, Jaro /C20s/C19ık V, Pergl J, Schaffner U, Vil /C18a M. Bias and error in understanding plant invasion impacts.",Non-OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
Fert Res 1985; 8:107-16; http://dx.doi.org/10.1007/BF01048894 [13] Smil V. Cycles of Life.,OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
EcolLett 2008; 11:296-310; PMID:18047587; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"J Ecol 2013; 101:265-76; http://dx.doi.org/10.1111/1365- 2745.12054 [16] Haubensak KA, Parker IM.",OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"Plant Ecology 2004; 175:71-9. http://dx.doi.org/10.1023/B:VEGE.0000048088.32708.58; http://dx.doi.org/10.1023/ B:VEGE.0000048088.32708.58 [17] Niu H, Liu W, Wan F, Liu B.",OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"Plant Soil 2007; 294:73-85;http://dx.doi.org/10.1007/s11104-007-9230-8 [18] Gimeno I, Vil /C18a M, Hulme PE.",OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"J Biogeogra-phy 2006; 33:1559-65; http://dx.doi.org/10.1111/j.1365- 2699.2006.01525.x [19] Marutani M, Manalastas E. Evaluation of two methods to estimate the populations of indigenous N- ﬁxers associ- ated with tropical legumes.",OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"Plant Ecology 2015; 216:1583-95; http://dx.doi.org/10.1007/s11258-015-0542-0 [21] Cameron KC, Di HJ, Moir JL.",OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
Ann Appl Biol 2013; 162:145- 73; http://dx.doi.org/10.1111/aab.12014 [22] Scherer-Lorenzen M. The functional role of biodiversity in the context of global change.,OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"J Applied Ecol 2014;51:224-33; http://dx.doi.org/10.1111/1365-2664.12157 [24] Scherer-Lorenzen M, Palmborg C, Prinz A, Schulze E-D.",OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"J Envir Management 2016; 165:243-52; http://dx.doi.org/10.1016/j.jenvman.2015.09.039 [26] Schlesinger WH, Bernhardt ES.",OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"Geoderma 2015; 237:1-8; http://dx.doi.org/10.1016/j.geoderma.2014.08.005 [28] Quan Q, Wang CH, He NP, et al.",OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"Applied Vegetation Science 2016; 19:183-4; http://dx.doi.org/10.1111/avsc.12239 [30] Liao C, Peng R, Luo Y et al.",OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"New Phytol 2008; 177:706-14; PMID:18042198; http://dx.doi.org/10.1111/j.1469-8137.2007.02290.x [31] Bardon C, Piola F, Bellvert F, Zhou X, Wu X, Fang C, Chen J, Li B.",OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"New Phytol 2014; 204:621-31; http://dx.doi.org/10.1111/nph.12944 [32] Osborne R, Calonje M, Hill K, Stanberg L, Stevenson DW.",OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"PloS one 2015; 10:e0135152; PMID:26252495;http://dx.doi.org/10.137 1/journal.pone.0135152 [34] Fragniere Y, B /C19etrisey S, Cardinaux L, Stoffel M, Kozlowski G. Fighting their last stand?",Non-OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
J Biogeography 2015; 42:809-20; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
Commun Soil Sci Plant Anal 1984; 15:1409-16; http://dx.doi.org/10.1080/ 00103628409367568 [39] E.P.A.,OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
Proc Soil Sci Soc Am 1960; 24:277-9; http://dx.doi.org/10.2136/sssaj1960.,OADS,/arxiv_data1/oa_pdf/ad/ba/kcib-09-05-1212792.PMC5100652.pdf
"5, e1183855 (2 pages)http://dx.doi.org/10.1080/19420889.2016.1183855",Non-OADS,/arxiv_data1/oa_pdf/95/48/kcib-09-05-1183855.PMC5100653.pdf
Commun Integr Biol 2015; 8(5): e1085138; PMID:27066168; http://dx.doi.org/10.1080/19420889.2015.1085138 [2] Gustavo Caetano-Anoll /C19es.,OADS,/arxiv_data1/oa_pdf/95/48/kcib-09-05-1183855.PMC5100653.pdf
Commun Integr Biol (2016); 9(1): e1123356; http://dx.doi.org/10.1080/19420889.2015.1123356 [3] Bhakti Niskama Shanta.,OADS,/arxiv_data1/oa_pdf/95/48/kcib-09-05-1183855.PMC5100653.pdf
"Commun Integr Biol 2016; 9(2): e1160191; http://dx.doi.org/10.1080/19420889.2016.1160191 [4] Chaya MS, Nagendra HR.",OADS,/arxiv_data1/oa_pdf/95/48/kcib-09-05-1183855.PMC5100653.pdf
Int JYoga(2008); 1(1):27-32; PMID:21829281; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/48/kcib-09-05-1183855.PMC5100653.pdf
"Int J Yoga 2013; 6(1):26-30.; PMID:23440267; http://dx.doi.org/10.4103/0973-6131.105940 [7] Yash Roy RC, Gupta PK.",Non-OADS,/arxiv_data1/oa_pdf/95/48/kcib-09-05-1183855.PMC5100653.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"5, e1216740 (4 pages)http://dx.doi.org/10.1080/19420889.2016.1216740",Non-OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
Annu Rev Genet 2012; 46:311-39; PMID:23145983; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"TheEMBO Journal 2015; 34(2):169-83; PMID:25452498; http://dx.doi.org/10.15252/embj.201489455 [3] Mojica FJ, Diez-Villasenor C, Garcia-Martinez J, Soria E. Intervening sequences of regularly spaced prokaryoticrepeats derive from foreign genetic elements.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Journal of Molecular Evolution 2005; 60(2):174-82; PMID:15791728; http://dx.doi.org/10.1007/s00239-004-0046-3 [4] Bolotin A, Quinquis B, Sorokin A, Ehrlich SD.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin.Microbiology 2005; 151(Pt 8):2551-61; PMID:16079334; http://dx.doi.org/10.1099/mic.0.28048-0 [5] Pourcel C, Salvignol G, Vergnaud G. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies.",Non-OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Microbiology 2005;151(Pt 3):653-63;PMID:15758212; http://dx.doi.org/10.1099/mic.0.27437-0 [6] Barrangou R, Fremaux C, Deveau H, Richards M, Boy- aval P, Moineau S, et al.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Science 2007; 315(5819):1709-12; PMID:17379808; http://dx.doi.org/ 10.1126/science.1138140 [7] Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, Snijders AP, et al.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Science 2008; 321(5891):960-4; PMID:18703739; http://dx.doi.org/10.1126/science.1159689 [8] Rath D, Amlinger L, Rath A, Lundgren M. The CRISPR- Cas immune system: Biology, mechanisms and applica- tions.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Biochimie 2015; 117:119-28; PMID:25868999; http://dx.doi.org/10.1016/j.biochi.2015.03.025 [9] Bondy-Denomy J, Garcia B, Strum S, Du M, Rollins MF, Hidalgo-Reyes Y, et al.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
Nature2015; 526(7571):136-9; PMID:26416740; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
Nature Reviews Microbiol-ogy 2015; 13(11):722-36; PMID:26411297; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Molecular Cell 2015; 60(3):385-97; PMID:26593719;http://dx.doi.org/10.1016/j.molcel.2015.10.008 [13] Grissa I, Vergnaud G, Pourcel C. The CRISPRdb data- base and tools to display CRISPRs and to generate dictio- naries of spacers and repeats.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"BMC Bioinformatics 2007;8:172; PMID:17521438; http://dx.doi.org/10.1186/1471- 2105-8-172 [14] Koonin EV, Krupovic M. Evolution of adaptive immu- nity from transposable elements combined with innate immune systems.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Nature Reviews Genetics 2015; 16 (3):184-92; PMID:25488578; http://dx.doi.org/10.1038/nrg3859 [15] Makarova KS, Aravind L, Grishin NV, Rogozin IB, Koo- nin EV.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Nature Communications 2016; 7:10613; PMID:26837824; http://dx.doi.org/10.1038/ncomms10613 [17] Andersson AF, Ban ﬁeld JF.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Virus population dynamics and acquired virus resistance in natural microbial communities.Science 2008; 320(5879):1047-50; PMID:18497291; http://dx.doi.org/10.1126/science.1157358[18] Tyson GW, Chapman J, Hugenholtz P, Allen EE, Ram RJ, Richardson PM, et al.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Nature 2004; 428(6978):37-43; PMID:14961025; http://dx.doi.org/10.1038/nature02340 [19] Paez-Espino D, Morovic W, Sun CL, Thomas BC, Ueda K, Stahl B, et al.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Nature Communi- cations 2013; 4:1430; PMID:23385575; http://dx.doi.org/10.1038/ncomms2440 [20] Levin BR, Moineau S, Bushman M, Barrangou R. The population and evolutionary dynamics of phage and bac- teria with CRISPR-mediated immunity.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"PLoS Genetics2013; 9(3):e1003312; PMID:23516369; http://dx.doi.org/ 10.1371/journal.pgen.1003312 [21] Westra ER, van Houte S, Oyesiku-Blakemore S, Makin B, Broniewski JM, Best A, et al.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Curr Biol 2015; 25(8):1043-9; PMID: 25772450;http://dx.doi.org/10.1016/j.cub.2015.01.065 [22] van Houte S, Ekroth AK, Broniewski JM, Chabas H, Ashby B, Bondy-Denomy J, et al.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"Nature 2010; 468 (7324):647-52; PMID:21124449; http://dx.doi.org/10.1038/nature09575 [24] Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR.",OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
Nature 2013; 493(7432):429-32;PMID: 23242138; http://dx.doi.org/10.1038/nature11723e1216740-4 M. LUNDGREN,OADS,/arxiv_data1/oa_pdf/09/a9/kcib-09-05-1216740.PMC5100654.pdf
"5, e1119343 (6 pages)http://dx.doi.org/10.1080/19420889.2015.1119343",Non-OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
2015; 427(5):1038-60; PMID:25174336; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Biochim Biophys Acta 2013; 1833:332-40; http://dx.doi.org/10.1016/j.bbamcr.2012.03.019 [5] Schulz C, Schendzielorz A, Rehling P. Unlocking the pre- sequence import pathway.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Trends Cell Biol 2015; 25 (5):265-75; PMID:25542066; http://dx.doi.org/10.1016/j.tcb.2014.12.001 [6] Qiu J, Li GW, Sui YF, Song HP, Si SY, Ge W. Heat- shocked tumor cell lysate-pulsed dendritic cells induceeffective anti-tumor immune response in vivo.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Funct Integr Geno-mics 2009; 9:433-46; PMID:19633874; http://dx.doi.org/ 10.1007/s10142-009-0132-0 [8] Kawai-Yamada M, Saito Y, Jin L, Ogawa T, Kim KM, Y uL H ,T o n eY ,H i r a t aA ,U m e d aM ,U c h i m i y aH .A novel Arabidopsis gene causes Bax-like lethality in Sac- charomyces cerevisiae.",Non-OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
J Biol Chem 2005; 280:39468-73; PMID:16192270; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Plant Cell 2013; 25:1-17; http://dx.doi.org/10.1105/tpc.113.250110 [10] Reinbothe S, Gray J, Rustgi S, von Wettstein D, Rein- bothe C. Cell growth defect factor 1 is crucial for thesubstrate-dependent plastid import of NADPH:proto- chlorophyllide oxidoreductase A in Arabidopsis thali- ana.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
Biochim Biophys Acta 2010; 1803:732-9; PMID:20100523; http://dx.doi.org/10.1016/j.bbamcr.,OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
MolBiol Cell 2011; 22:4740-9; PMID:22031295; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Plos One 2013; 8(10):e78400; PMID:24194927; http://dx.doi.org/10.1371/journal.pone.0078400[15] Reinbothe S, Runge S, Reinbothe C, van Cleve B, Apel K. Substrate-dependent transport of the NADPH: proto- chlorophyllide oxidoreductase into isolated plastids.Plant Cell 1995; 7:161-72; PMID:7756827; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Plant Cell 2004;16:88-98; PMID:14688290; http://dx.doi.org/10.1105/ tpc.015008 [18] Reinbothe C, Pollmann S, Reinbothe S. Singlet oxygen links photosynthesis to translation and plant growth.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Trends Plant Sci 2010; 15:499-506; PMID:20580304; http://dx.doi.org/10.1016/j.tplants.2010.05.011 [19] Kim C, Apel K. Singlet oxygen-mediated signaling in plants: moving from ﬂu to wild type reveals an increasing complexity.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Photosynth Res 2013; 116:455-64; PMID: 23832611; http://dx.doi.org/10.1007/s11120-013-9876-4 [20] Reinbothe C, Lebedev N, Reinbothe S. A protochloro- phyllide light-harvesting complex involved in de-etiola- tion of higher plants.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Nature 1999; 397:80-4 http://dx.doi.org/10.1038/16283 [21] Reinbothe C, El Bakkouri M, Buhr F, Muraki N, Nomata J, Kurisu G, Fujita Y, Reinbothe S. Chlorophyll biosyn-thesis: spotlight on protochlorophyllide reduction.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Trends Plant Sci 2010; 15:614-24; PMID:20801074; http://dx.doi.org/10.1016/j.tplants.2010.07.002 [22] Maekawa T, Kufer TA, Schulze-Lefert P. NLR functions in plant and animal immune systems: so far and yet so close.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Nat Immunol 2011; 12:817-26; PMID:21852785; http://dx.doi.org/10.1038/ni.2083 [23] Quinlan CL, Perovoshchikova IV, Hey-Mogensen M. Sites of reactive oxygen species generation by mitochon- dria.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
Redox Biol 2013; 1:304-12; PMID:24024165; http://dx.doi.org/10.1016/j.redox.2013.04.005 [24] Mehdy MC.,OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"J Exp Bot 2009; 60:955-65; PMID:19269997; http://dx.doi.org/10.1093/ jxb/ern344 [26] Scheible WR, Fry B, Kochevenko A, Schindelasch D, Zimmerli L, Somerville S, Loria R, Somerville CR.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Plant Cell 2003; 15(8):1781-94; PMID:12897252; http://dx.doi.org/ 10.1105/tpc.013342 [27] Tsukagoshi H, Busch W, Benfey PN.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Cell 2010; 143(4):606-16; PMID: 21074051; http://dx.doi.org/10.1016/j.cell.2010.10.020 [28] Sundaravelpandian K, Chandrika NN, Schmidt W. PFT1, a transcriptional mediator complex subunit, controls rootCOMMUNICATIVE INTEGRATIVE BIOLOGY e1119343-5",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"New Phytol 2013; 197(1):151- 61; PMID:23106228; http://dx.doi.org/10.1111/nph.12000 [29] Lin CY, Huang LY, Chi WC, Huang TL, Kakimoto T, Tsai CR, Huang HJ.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"Nat Protoc 2010; 5:725-38; PMID:20360767; http://dx.doi.org/10.1038/nprot.2010.5 [31] Lo JF, Hayashi M, Woo-Kim S, Tian B, Huang JF, Fearns C, Takayama S, Zapata JM, Yang Y, Lee JD.",OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
Mol Cell Biol 2004; 24:2226-36; PMID:14993262; http://dx.doi.org/10.1128/MCB.24.6.2226-2236.2004e1119343-6 J.,Non-OADS,/arxiv_data1/oa_pdf/09/5d/kcib-09-05-1119343.PMC5100655.pdf
"5, e1208324 (7 pages)http://dx.doi.org/10.1080/19420889.2016.1208324",Non-OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"J Trop Ecol 2012; 28:233-42; http://dx.doi.org/10.1017/S0266467412000119 [7] Chapman SK, Hart SC, Cobb NS, Whitham TG, Koch GW.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"Ecology 2003;84:2867-76; http://dx.doi.org/10.1890/02-0046 [8] Fang X-M, Christenson LM, Wang F-C, Zeng J-P, Chen F-S. Pine caterpillar outbreak and stand density impactson nitrogen and phosphorus dynamics and their stoichi-ometry in Masson pine ( Pinus massoniana ) plantations in subtropical China.",Non-OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"Can J For Res 2016; 46:601-9; http://dx.doi.org/10.1139/cjfr-2015-0357 [9] Schweitzer JA, Bailey JK, Hart SC, Wimp GM, Chapman SK, Whitham TG.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
Oikos 2005; 110:133-45; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"Funct Ecol 2016; 30:819-29; http://dx.doi.org/ 10.1111/1365-2435.12589 [12] Marler TE, Dongol N. Do phytotoxic compounds in soils after scale-infested Cycas micronesica litter deposits explain reduced plant growth?",Non-OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
Commun IntegrBiol 2014; 7:e278811-3; PMID:25083170; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
Can J Forest Res 1995; 25:1858-64; http://dx.doi.org/10.1139/ x95-200 [16] Prado A.,Non-OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"[17] Schneider D, Wink M, Sporer F, Lounibos P. Cycads: their evolution, toxins, herbivores and insect pollinators.Naturwissenschaften 2002; 89:281-94; http://dx.doi.org/ 10.1007/s00114-002-0330-2 [18] Carrillo Y, Ball BA, Molina M. Stoichiometric linkages between plant litter, trophic interactions and nitrogenmineralization across the litter-soil interface.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
Soil Biol Bioch 2016; 92:102-10; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"Proc R Soc B 2013; 280:20122453PMID:23303537;http://dx.doi.org/10.1098/rspb.2012.2453 [20] Martinson HM, Schneider K, Gilbert J, Hines JE, Hamb €ack PA, Fagan WF.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"Oikos 2010; 119:741-51; http://dx.doi.org/10.1111/j.1600- 0706.2009.18545.x [22] Leitner M, Boland W, Mith €ofer A.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"New Phytol 2005; 167:597-606; PMID:15998409; http://dx.doi.org/10.1111/j.1469- 8137.2005.01426.x [23] Marler TE, Dongol N. Models to describe Cycas microne- sica leaf and strobili development.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"Agric For Entom 2001; 3:77-84; http://dx.doi.org/10.1046/j.1461-9563.2001.00100.x [26] Lovett GM, Christenson LM, Groffman PM, Jones CG, Hart JE, Mitchell MJ.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
Available at: http://dx.doi.org/ 10.2305/IUCN.UK.2010-3.RLTS.T61316A12462113.ene1208324-6 T. E. MARLER AND N. DONGOL,Non-OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"Amer J Bot 2010; 97:841-5; PMID:21622449;http://dx.doi.org/10.3732/ajb.0900251 [31] Gandhi KJK, Herms DA.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"Biol Invasions 2010;12:389-405; http://dx.doi.org/10.1007/s10530-009-9627-9 [32] Kenis M, Auger-Rozenberg MA, Roques A, Timms L, P /C19er/C19e C, Cock MJW, Settele J, Augustin S, Lopez-Vaamonde C.Ecological effects of invasive a lien insects.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
Bi ol Invasions 2009; 11:21-45; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"J. Biogeogra- phy 2002; 29:1489-503; http://dx.doi.org/10.1046/j.1365-2699.2002.00766.x [34] le Mellec A, Michalzik B.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"BioScience 2006; 56:395-405; http://dx.doi.org/10.1641/0006-3568(2006)056%5b0395:FERTEP%5d2.0.CO;2 [36] Orwig DA, Cobb RC, D ’Amato AW, Kizlinski ML, Foster DR. 2008.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"Can J For Res 2008; 38:834-43; http://dx.doi.org/ 10.1139/X07-196 [37] Marler TE, Lindstr €om AJ, Terry LI.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"Plant Signal Behav 2012; 7:760-2; PMID:22751309; http://dx.doi.org/10.4161/psb.20470 [39] Salt DE, Baxter I, Lahner B. Ionomics and the study of the plant ionome.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
Annu Rev Plant Biol 2008; 59:709-33; PMID:18251712; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
Oecologia 2012; 169:1015-24; PMID:22311255; http://dx.doi.org/10.1007/s00442-012-2267-2 [41] Marquis RJ.,Non-OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"Evolution 1990; 44:104-20; http://dx.doi.org/ 10.2307/2409527 [42] Rodriguez-Saona CR, Musser RO, Vogel H, Hum-Musser SM, Thaler JS.",OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
J Chem Ecol 2010;36:1043-57; PMID:20820890 ; http://dx.doi.org/10.1007/s10886-010-9854-7 [43] Young FJ.,OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
J Sci Food Agric 1990; 51:145-61; http://dx.doi.org/ 10.1002/jsfa.2740510202 [46] AOAC.,Non-OADS,/arxiv_data1/oa_pdf/4d/66/kcib-09-05-1208324.PMC5100656.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"5, e1216738 (5 pages)http://dx.doi.org/10.1080/19420889.2016.1216738",Non-OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"Annu Rev Microbiol 2003; 57:395-418; PMID:14527285; http://dx.doi.org/10.1146/annurev.micro.57.030502.090938 [2] Collen J, Del Rio MJ, Garc /C19ıa-Reina G, Peders /C19en M. Pho- tosynthetic production of hydrogen peroxide by Ulvari- gida C. Ag (Chlorophyta).",OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"Planta 1995; 196:225-30; http://dx.doi.org/10.1007/BF00201378 [3] Halliwell B, Gutteridge JMC.",Non-OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"Arch Biochem Biophys 1986; 246:501-14; PMID:3010861; http://dx.doi.org/10.1016/0003-9861(86) 90305-X [4] Bernroitner M, Zamocky M, Furtm €uller PG, Peschek GA, Obinger C. Occurrence, phylogeny, structure, and func- tion of catalases and peroxidases in cyanobacteria.",OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"J ExpBot 2009; 60:423-40; PMID:19129167; http://dx.doi.org/ 10.1093/jxb/ern309[5] Zamocky M, Furtm €uller PG, Obinger C. Evolution of Catalases from Bacteria to Humans.",OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"Antioxid Redox Signal 2008; 10:1527-48; PMID:18498226; http://dx.doi.org/10.1089/ars.2008.2046 [6] Bihani SC, Chakravarty D, Ballal A. Puri ﬁcation, crystal- lization and preliminary crystallographic analysis ofKatB, a manganese catalase from Anabaena PCC 7120.",OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
Acta Crystallogr Sect F Struct Biol Cryst Commun 2013; 69:1299-302; PMID:24192374; http://dx.doi.org/10.1107/S1744309113028017 [7] Fay P. Oxygen relations of nitrogen ﬁxation in cyanobac- teria.,OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"Annu Rev Microbiol 1980; 34:497-536; PMID:6108091; http://dx.doi.org/10.1146/ annurev.mi.34.100180.002433 [9] Banerjee M, Ballal A, Apte SK.",Non-OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"Biochem J 2012; 442:671-80; PMID:22150556; http://dx.doi.org/10.1042/BJ20111877 [10] Banerjee M, Ballal A, Apte SK.",OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"BMC Plant Biol 2015; 15:60; PMID:25849452; http://dx.doi.org/10.1186/s12870-015- 0444-2 [12] Tailor V, Ballal A. Over-expression of Alr4642, a novel Prx-like peroxiredoxin, defends the cyanobacterium Ana- baena PCC7120 from oxidative stress.",Non-OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"J Appl Phycol 2015; 27:2261-70; http://dx.doi.org/10.1007/s10811-014-0503-3 [13] Chakravarty D, Banerjee M, Bihani SC, Ballal A.",OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"Plant Physiol 2016; 170:761-73; PMID:26645454; http://dx.doi.org/10.1104/pp.15.01632 [14] Banerjee M, Raghavan PS, Ballal A, Rajaram H, Apte SK.",OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
Photosynth Res 2013; 118:59-70; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"J Biol Chem 2005; 280:21531-8; PMID:15805106; http://dx.doi.org/10.1074/ jbc.M412174200 [16] Los DA, Zorina A, Sinetova M, Kryazhov S, Mironov K, Zinchenko VV.",OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"Sensors (Basel) 2010; 10:2386-415; PMID:22294932; http://dx.doi.org/10.3390/s100302386 [17] Reddy BR, Apte SK, Thomas J. Enhancement of cyanobacterial salt tolerance by combined nitrogen.",OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
Plant Physiol 1989; 89:204-10; PMID:16666516; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"Plant Signal Behav 2013; 8:e23681; PMID:23425848;http://dx.doi.org/10.4161/psb.23681 [19] Moriwaki T, Yamamoto Y, Aida T, Funahashi T, Shishido T ,A s a d aM ,P r o d h a nS H ,K o m a m i n eA ,M o t o h a s h iT .Overexpression of the Escherichia coli catalase gene, katE, enhances tolerance to salinity stress in the transgenic ind- ica rice cultivar, BR5.",Non-OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"Plant Biotechnol Rep 2008; 2:41-6;http://dx.doi.org/10.1007/s11816-008-0046-7 [20] Z /C19amock /C19y M, Furtm €uller PG, Obinger C. Evolution of structure and function of Class I peroxidases.",OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"ArchBiochem Biophys 2010; 500:45-57; http://dx.doi.org/ 10.1016/j.abb.2010.03.024 [21] Bihani SC, Chakravarty D, Ballal A. KatB, a cyanobacte- rial Mn-catalase with unique active site con ﬁguration: implications for enzyme function.",OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"Free Radic Biol Med 2016; 93:118-29; PMID:26826576; http://dx.doi.org/10.1016/j.freeradbiomed.2016.01.022 [22] Kulkarni S, Ballal A, Apte SK.",OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
J Hazard Mater 2013; 262:853-861; PMID:24140537; http://dx.doi.org/10.1016/ j.jhazmat.2013.09.057COMMUNICATIVE & INTEGRATIVE BIOLOGY e1216738-5,OADS,/arxiv_data1/oa_pdf/97/6d/kcib-09-05-1216738.PMC5100657.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"5, e1197446 (19 pages)http://dx.doi.org/10.1080/19420889.2016.1197446",Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"Communicative Integrative Biol 2015; 8(5):e1085138;http://dx.doi.org/10.1080/19420889.2015.1085138 [2] Shanta BN, Muni BV.",Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
Adv Life Sci 2016; 6:13-30; http://dx.doi.org/10.5923/j.als.20160601.03 [3] Caetano-Anoll /C19es G. Creationism and intelligent design are incompatible with scienti ﬁc progress: A response to Shanta and V ^edanta.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
Communicative Integrative Biol 2016; 9(1):e1123356; http://dx.doi.org/10.1080/19420889.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"Commu- nicative Integrative Biol 2015; 8:e1059977; http://dx.doi.org/10.1080/19420889.2015.1059977 [7] Edelman DB, Baars BJ, Seth AK.",Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
ConsciousCogn 2005; 14:169-187; PMID:15766896; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
EMBO Rep 2011; 12:1221-1225; PMID:22094270; http://dx.doi.org/10.1038/embor.2011.218 [9] Buhner SH.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
J Gen Phil Sci 1994; 25:97-106; http://dx.doi.org/10.1007/BF00769279 [11] De Loof A. Organic and cultural evolution can be seam- lessly integrated using the principles of communication and problem-solving: The foundations for an extendedEvolutionary Synthesis (EES) as outlined in the Mega- Evolution concept.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
LEB 2014; 2(4):247-269; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
LEB 2015; 3(3):153- 187; http://dx.doi.org/10.9784/LEB3(3)DeLoof.01 [13] Koshland DE.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
Science 2002; 292:2215-2216; http://dx.doi.org/10.1126/science.1068489 [14] De Loof A.,OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
Int Rev Cytol 1986;104:251-352; PMID:3531065; http://dx.doi.org/10.1016/S0074-7696(08)61927-0 [15] Wikipedia: Electric ﬁsh.,OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"Bio- phys J 2004; 86:1890-1903; PMID:15041636; http://dx.doi.org/10.1016/S0006-3495(04)74255-1 [17] Jaffe LF, Nuccitelli R. An ultrasensitive probe for measur- ing steady electric extracellular electric currents.",OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"J CellBiol 1974; 63:614-628; PMID:4421919; http://dx.doi.org/10.1083/jcb.63.2.614 [18] Woodruff RI, Telfer WH.",OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
Nature 1980; 286:84-86;PMID:7393329; http://dx.doi.org/10.1038/286084a0 [19] De Loof A. Differentiation: “Keep the genome constant but change over and over again its ionic and/or macro-molecular environment ”.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
http://en.wiki pedia.org/wiki/Mitosis [21] Wikipedia: Fission (biology).,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"http://en.wikipedia.org/wiki/Fission(biology) [22] De Loof A, De Haes W, Boerjan B, Schoofs L. The fading electricity theory of ageing: the missing biophysical prin- ciple?",Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
Ageing Res Rev 2013; 12:58-63; PMID:22940501; http://dx.doi.org/10.1016/j.arr.2012.08.001 [23] WallpaperHD.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"http://www.wallpaperhd.pk/machine- learning-smart-brain-wallpaper [24] Varela F, Thompson E, Rosch E. The embodied mind: cognitive science and human experience.",Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
1977; 74:623-627; http://dx.doi.org/10.1073/ pnas.74.2.623 [27] Crick F. Central dogma of molecular biology.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"Nature 1970; 227:561-563; PMID:4913914; http://dx.doi.org/ 10.1038/227561a0 [28] Chen S, Cai D, Pearce K, Sun PY-W, Roberts AC, Glanz- man DL.",OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
Cell Mol LifeSci 2015; 72:4237-4255; PMID:26227334; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"Curr Top Med Chem 2015; 15:523-533; PMID:25714379; http://dx.doi.org/10.2174/1568026615666150225104543 [36] Lin EC, Cantiello HF.",Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"Biophys J 1993; 65:1371- 1378; PMID:8274631; http://dx.doi.org/10.1016/S0006- 3495(93)81188-3 [37] Priel A, Tuszy /C19nski JA, Woolf NJ.",OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
J Biol Phys 2010; 36:3-21; PMID:19669423; http://dx.doi.org/10.1007/ s10867-009-9153-0 [38] Wikipedia: Prokaryotic cytoskeleton.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
[accessed 2016 Apr 4].http://en.wikipedia.org/wiki/Prokaryotic cytoskeleton [39] Wikipedia: Cytoskeleton.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"http://en.wikipe dia.org/wiki/Actin [41] Frankel S, Sigel EA, Craig C, Elgin SC, Mooseker MS, Artavanis-Tsakonas S. An actin-related protein in Dro- sophila colocalizes with heterochromatin protein 1 in pericentric heterochromatin.",Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"Methods Cell Biol 2016;131:91-106; PMID:26794509; http://dx.doi.org/10.1016/bs.mcb.2015.07.003 [43] Van den Ent F, Amos LA, L €owe J. Prokaryotic origin of the actin cytoskeleton.",OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"Nature 2001; 413:39-44;PMID:11544518; http://dx.doi.org/10.1038/35092500 [44] Wang H, Xie L, Luo H, Xie J. Bacterial cytoskeleton and implications for new antibiotic targets.",OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"J Drug Target2016; 24:392-398; PMID:26548775; http://dx.doi.org/ 10.3109/1061186X.2015.1095195 [45] L €owe J, van den Ent F, Amos LA.",Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
Annu Rev Biophys Biomol Struct 2004; 33:177-198; PMID:15139810; http://dx.doi.org/10.1146/ annurev.biophys.33.110502.132647 [46] Carballido-L /C19opez R. The bacterial actin-like cytoskeleton.,OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
Microbiol Mol Biol Rev 2006; 70:888-909; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
Cold Spring Harb Perspect Biol 2010; 2(9):a000364; PMID:20630996; http://dx.doi.org/ 10.1101/cshperspect.a000364e1197446-18 A.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
J Biol Chem 2015;290:17181-17189; PMID:25957405; http://dx.doi.org/ 10.1074/jbc.R115.637876 [49] Wikipedia: Consciousness.,Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
Cell Calcium 1993; 14:736-745; PMID:8131190; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
Cell Calcium 2010; 48:102- 113; PMID:20883893; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"Annu Rev Biophys Bioeng 1977; 6:445-476; PMID:326151; http://dx.doi.org/10.1146/ annurev.bb.06.060177.002305 [60] Jaffe LF, Woodruff RI.",Non-OADS,/arxiv_data1/oa_pdf/85/cf/kcib-09-05-1197446.PMC5100658.pdf
"This is an Open Access article distributed under the terms of th e Creative Commons Attribution -Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
"5, e1238117 (6 pages)http://dx.doi.org/10.1080/19420889.2016.1238117",Non-OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
"Nature 2005; 433:421-5; PMID:15674293; http://dx.doi.org/10.1038/nature03185 [4] Satter RL, Galston AW.",OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
Annu Rev Plant Physiol 1981; 32:83-110; http://dx.doi.org/10.1146/annurev.pp.32.060181.000503 [5] Moran N. Osmoregulation of leaf motor cells.,Non-OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
"FEBS Lett 2007; 581:2337-47; PMID:17434488; http://dx.doi.org/ 10.1016/j.febslet.2007.04.002 [6] James AB, Monreal JA, Nimmo GA, Kelly CL, Herzyk P, Jenkin GI, Nimmo HG.",OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
Science 2008; 322:1832-5; PMID:19095940; http://dx.doi.org/10.1126/science.1161403 [7] Stolarz M. Circumnutation as a visible plant action and reaction.,OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
Plant Signal Behav 2009; 4:380-7; PMID:19816110; http://dx.doi.org/10.4161/psb.4.5.8293 [8] Kuramoto Y.,OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
"Nature 2001; 410:277-84; PMID:11258383; http://dx.doi.org/10.1038/35065745 [11] Anderson PA, Pettijohn DE.",OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
"Science 1960; 131:1098; PMID:13793437; http://dx.doi.org/10.1126/science.131.3407.1098 [12] Blasius B, Huppert A, Stone L. Complex dynamics and phase synchronization in spatially extended ecological systems.",OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
"Nature 1999; 399:354-9; PMID:10360572;http://dx.doi.org/10.1038/20676 [13] Ciszak M, Comparini D, Mazzolai B, Balu /C20ska F, Arecchi FT, Vicsek T, Mancuso S. Swarming behavior in plant roots.",OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
"PLoS ONE 2012; 7:e29759; PMID:22272246;http://dx.doi.org/10.1371/journal.pone.0029759 [14] Krause J, Ruxton GD, Krause S. Swarm intelligence in ani- mals and humans.",OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
"Trends Ecol Evol 2010; 25:28-34; PMID:19735961; http://dx.doi.org/10.1016/j.tree.2009.06.016 [15] Parrish JK, Edelstein-Keshet L. Complexity, pattern and evolutionary trade-offs in animal aggregation.",OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
Science1999; 284:99-101; PMID:10102827; http://dx.doi.org/ 10.1126/science.284.5411.99 [16] Spurny M. Synchronization of oscillatory rhythms of stems and leaves.,OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
"Biol Plant 1976; 18:277-82; http://dx.doi.org/10.1007/BF02922373 [17] Cerd /C19a-Olmedo E, Corrochano LM.",OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
Phys Rev Lett 1980; 45:712; http://dx.doi.org/10.1103/PhysRevLett.45.712 [19] Huygens Ch.,Non-OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
"Ionic current changes associated with the gravity-induced bending response in roots of Zea mays L. Plant Physiol 1992; 100:1417-26; PMID:16653140; http://dx.doi.org/10.1104/pp.100.3.1417 [22] Balu /C20ska F, Mancuso S. Ion channels in plants: from bio- electricity, via signaling, to behavioral actions.",OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
"Plant Sig- nal Behav 2013; 8:23009; PMID:23221742; http://dx.doi.org/10.4161/psb.23009 [23] Balu /C20ska F, Mancuso S. Root apex transition zone as oscillatory zone.",OADS,/arxiv_data1/oa_pdf/6b/c4/kcib-09-05-1238117.PMC5100659.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/59/aapm-06-04-39314.PMC5100663.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/7d/aapm-06-04-37822.PMC5100664.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/59/aapm-06-05-33979.PMC5100679.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/50/rjw175.PMC5100687.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/73/rjw181.PMC5100688.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/14/rjw176.PMC5100689.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/32/kww085.PMC5100830.pdf
The SAS code and a simulated data set are provided in Web Appendix 2 and on our web-site ( http://resp.med.ubc.ca ).,OADS,/arxiv_data1/oa_pdf/3f/32/kww085.PMC5100830.pdf
"Ottawa, ON, Canada: Canadian Thoracic Society; 2010. http://www.respiratoryguidelines.ca/sites/all/ ﬁles/CTS_ COPD_report.pdf .",Non-OADS,/arxiv_data1/oa_pdf/3f/32/kww085.PMC5100830.pdf
"2014 [Accessed from April 5, 2015] http://search.unaids.org/search.asp?",Non-OADS,/arxiv_data1/oa_pdf/18/0d/nihms807701.PMC5101021.pdf
"Accepted for publication Oct 10, 2016. doi: 10.21147/j.issn.1000-9604.2016.05.01 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.05.01   Introduction As  we  know,  the  current  standard  management  of nasopharyngeal carcinoma (NPC) is multimodality therapybased on intensity-modulated radiation therapy (IMRT), and the treatment strategy for each patient is determined mainly according to the Union for International Cancer Control/American Joint Cancer Committee (UICC/AJCC)  Original Article  © Chinese Journal of Cancer Research.",Non-OADS,/arxiv_data1/oa_pdf/1c/d8/cjcr-28-5-467.PMC5101220.pdf
Available at: http://www.nccn.org/professionals/physician_gls/ pdf/head-and-neck.pdf2.,Non-OADS,/arxiv_data1/oa_pdf/1c/d8/cjcr-28-5-467.PMC5101220.pdf
"Accepted for publication Aug 29, 2016. doi: 10.21147/j.issn.1000-9604.2016.05.02 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.05.02    Original Article  © Chinese Journal of Cancer Research.",Non-OADS,/arxiv_data1/oa_pdf/33/e2/cjcr-28-5-478.PMC5101221.pdf
"Accepted for publication Sep 13, 2016. doi: 10.21147/j.issn.1000-9604.2016.05.03 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.05.03   Introduction Combined small cell lung carcinoma (C-SCLC) is defined as  small  cell  lung  cancer  (SCLC)  combined  with  anadditional  component  that  consists  of  any  of  the histological types of non-small cell lung cancer (NSCLC), usually adenocarcinoma (AC), squamous cell carcinoma (SCC) or large cell carcinoma (LCC) (1-3).",Non-OADS,/arxiv_data1/oa_pdf/c3/ce/cjcr-28-5-486.PMC5101222.pdf
"Accepted for publication Jan 06, 2016. doi: 10.21147/j.issn.1000-9604.2016.05.04 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.05.04 characteristics of ALK (+) lung adenocarcinoma by  application of 2011 IASLC/ATS/ERS new classification of lung adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/b9/18/cjcr-28-5-495.PMC5101223.pdf
Available online: http://globocan.iarc.fr 2.,Non-OADS,/arxiv_data1/oa_pdf/b9/18/cjcr-28-5-495.PMC5101223.pdf
"Accepted for publication Jul 06, 2016. doi: 10.21147/j.issn.1000-9604.2016.05.05 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.05.05   Introduction As the second common cancer and the third leading cause of cancer-related death in Korea, gastric cancer remains a major public health issue (1).",Non-OADS,/arxiv_data1/oa_pdf/02/6d/cjcr-28-5-503.PMC5101224.pdf
"Accepted for publication Oct 09, 2016. doi: 10.21147/j.issn.1000-9604.2016.05.06 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.05.06   Introduction Gastric cancer is one of the most common neoplasms and causes  millions  of  deaths  worldwide  each  year.",Non-OADS,/arxiv_data1/oa_pdf/6e/e7/cjcr-28-5-511.PMC5101225.pdf
"Accepted for publication Mar 16, 2016. doi: 10.21147/j.issn.1000-9604.2016.05.07View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.05.07 course.",Non-OADS,/arxiv_data1/oa_pdf/84/db/cjcr-28-5-519.PMC5101226.pdf
"Accepted for publication Jan 08, 2016. doi: 10.21147/j.issn.1000-9604.2016.05.08 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.05.08 course of the disease (2).",Non-OADS,/arxiv_data1/oa_pdf/5b/a5/cjcr-28-5-528.PMC5101227.pdf
"Accepted for publication Jan 07, 2016. doi: 10.21147/j.issn.1000-9604.2016.05.09View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.05.09 Introduction  Hepatocellular carcinoma (HCC) is the sixth most common  cancer worldwide (748,300 new cases per year) and the third  most common cause of cancer-related deaths causes (695,900 deaths per year) (1).",Non-OADS,/arxiv_data1/oa_pdf/c8/fd/cjcr-28-5-536.PMC5101228.pdf
"Accepted for publication Mar 27, 2016. doi: 10.21147/j.issn.1000-9604.2016.05.10View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2016.05.10",Non-OADS,/arxiv_data1/oa_pdf/20/b9/cjcr-28-5-543.PMC5101229.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncom-mercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, pro- vide a link to the Creative Commons license, and indicate if changes weremade.",Non-OADS,/arxiv_data1/oa_pdf/16/d3/330_2016_Article_4279.PMC5101279.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/10/aapm-06-05-36607.PMC5101410.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/ff/aapm-06-05-37577.PMC5101418.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/07/aapm-06-05-39476.PMC5101420.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/b8/aapm-06-05-39256.PMC5101422.pdf
Available at: http://www.unesco.org/culture/ich/en/RL/washoku-traditional-dietary-cul-tures-of-the-japanese-notably-for-the-celebration-of-new-year-00869 (last accessed 12May 2015).,Non-OADS,/arxiv_data1/oa_pdf/fd/5b/hr201676a.PMC5101423.pdf
Available at: http://www.mhlw.go.jp/ ﬁle/04-Houdouhappyou-10904750-Kenkoukyoku-Gantaisa- kukenkouzoushinka/0000106403.pdf (last accessed 12 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/fd/5b/hr201676a.PMC5101423.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/4.0/ rThe Author(s) 2016DASH-JUMP in Japanese people with hypertension A Kawamura et al 785 Hypertension Research",Non-OADS,/arxiv_data1/oa_pdf/fd/5b/hr201676a.PMC5101423.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/de/aapm-06-05-39226.PMC5101425.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/df/aapm-06-05-38943.PMC5101427.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/40/aapm-06-05-38550.PMC5101436.pdf
Supplementary information of this article can be found on the Cellular & Molecular Immunology ’s website (http://www.nature.com/cmi).,Non-OADS,/arxiv_data1/oa_pdf/ad/ad/cmi201580a.PMC5101449.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Antigen load modulates CD8 1T-cell immunity A Ochel et al Cellular & Molecular Immunology815",Non-OADS,/arxiv_data1/oa_pdf/ad/ad/cmi201580a.PMC5101449.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/90/aapm-06-05-38337.PMC5101537.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/78/aapm-06-05-38293.PMC5101544.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Long-lasting increases in CP-AMPARs induced by junk-foods MF Oginsky et al 2986 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/10/a9/npp2016111a.PMC5101548.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Progressive neuroadaptations induced by nicotine L Adermark et al 3059 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/2b/bc/npp2016118a.PMC5101553.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/82/aapm-06-05-37778.PMC5101596.pdf
"[http://dx.doi.org/10.1136/ard.61.10.895 ] [PMID: 12228160 ] [2] Naredo E, Gamero F, Bonilla G, Uson J, Carmona L, Laffon A. Ultrasonographic assessment of inflammatory activity in rheumatoid arthritis: comparison of extended versus  reduced joint evaluation.",Non-OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"[http://dx.doi.org/10.1002/1529-0131(200012)43:12<2762::AID-ANR16>3.0.CO;2-# ] [PMID: 11145034 ] [4] Hartung W, Kellner H, Strunk J, et al.",OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"Treatment Response in Knee Joint Arthritis by Ultrasound The Open Rheumatology Journal, 2016, Volume 10    87 [http://dx.doi.org/10.1002/acr.21574 ] [PMID: 22183834 ] [5] Schäfer  VS,  Fleck  M,  Kellner  H,  et  al.",Non-OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"[http://dx.doi.org/10.1186/1471-2474-14-358 ] [PMID: 24351026 ] [6] Szkudlarek  M,  Klarlund  M,  Narvestad  E,  et  al.",OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"[http://dx.doi.org/10.1186/ar1904 ] [PMID: 16519793 ] [7] Drossaers-Bakker KW, Kroon HM, Zwinderman AH, Breedveld FC, Hazes JM.",OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"[http://dx.doi.org/10.1093/rheumatology/39.9.998 ] [PMID: 10986305 ] [8] Amor B, Santos RS, Nahal R, Listrat V, Dougados M. Predictive factors for the longterm outcome of spondyloarthropathies.",Non-OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"[http://dx.doi.org/10.1002/acr.22458 ] [PMID: 25186552 ] [10] Hauer  RW,  Schmidt  WA,  Bohl-Bühler  M,  et  al.",OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"[http://dx.doi.org/10.1007/s003930170062 ] [PMID: 11475601 ] [11] Backhaus M, Burmester GR, Gerber T, et al.",OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"[http://dx.doi.org/10.1136/ard.60.7.641 ] [PMID: 11406516 ] [12] Backhaus M, Ohrndorf S, Kellner H, et al.",OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"[http://dx.doi.org/10.1002/art.24646 ] [PMID: 19714611 ] [13] Aletaha D, Neogi T, Silman AJ, et al.",OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"[http://dx.doi.org/10.1002/art.27584 ] [PMID: 20872595 ] [14] Hetland ML, Østergaard M, Ejbjerg B, et al.",OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"[http://dx.doi.org/10.1136/annrheumdis-2011-200632 ] [PMID: 22302316 ] [15] Landewé RB, Boers M, Verhoeven AC, et al.",OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"[http://dx.doi.org/10.1002/art.10083 ] [PMID: 11840436 ] [16] Naredo  E,  Collado  P,  Cruz  A,  et  al.",OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
[http://dx.doi.org/10.1002/art.22461 ] [PMID: 17266071 ] © Schäfer et al.,OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/d2/TORJ-10-81.PMC5101627.pdf
"© Mathiak and Klasen; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/2e/TONIJ-10-125.PMC5101628.pdf
"[http://dx.doi.org/10.1002/art.38239] [PMID: 24504808] [2] Somers EC, Marder W, Cagnoli P, et al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1002/art.38238] [PMID: 24504809] [3] Alarcón GS, McGwin G Jr, Roseman JM, et al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1002/art.20548] [PMID: 15334435] [4] Urowitz  MB,  Gladman  DD,  Ibañez  D,  et  al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1002/acr.20648] [PMID: 21954226] [5] Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both?",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1016/j.jaut.2014.01.019] [PMID: 24518855] [7] Tan EM, Cohen AS, Fries JF, et al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
[http://dx.doi.org/10.1002/art.1780251101] [PMID: 7138600] [8] Hochberg MC.,Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1002/art.1780400928] [PMID: 9324032] [9] Petri M, Orbai AM, Alarcón GS, et al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1002/art.34473] [PMID: 22553077] [10] Bertsias GK, Pamfil C, Fanouriakis A, Boumpas DT.",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
[http://dx.doi.org/10.1038/nrrheum.2013.103] [PMID: 23838616],OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1002/art.20561] [PMID: 15529364] [12] Liu  CC,  Manzi  S,  Danchenko  N,  Ahearn  JM.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1007/s11926-004-0012-5] [PMID: 15355750] [13] Amezcua-Guerra LM, Higuera-Ortiz V, Arteaga-García U, Gallegos-Nava S, Hübbe-Tena C. Performance of the 2012 Systemic Lupus International Collaborating Clinics and the 1997 American College of Rheumatology classification criteria for systemic lupus erythematosus in a real-life scenario.",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1002/acr.22422] [PMID: 25073545] [14] Pons-Estel GJ, Wojdyla D, McGwin G Jr, et al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1177/0961203313512883] [PMID: 24285098] [15] Bodolay E, Csiki Z, Szekanecz Z, et al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1007/s00296-011-2234-y] [PMID: 22116525] [17] Doria A, Gatto M, Zen M, Iaccarino L, Punzi L. Optimizing outcome in SLE: treating-to-target and definition of treatment goals.",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1016/j.autrev.2014.01.055] [PMID: 24480071] [18] Urowitz M, Gladman DD, Ibañez D, et al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1002/acr.22299] [PMID: 24497416] [19] Oglesby A, Korves C, Laliberté F, et al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1007/s40258-014-0085-x] [PMID: 24573911] [20] Meacock  R,  Dale  N,  Harrison  MJ.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1007/s40273-012-0007-4] [PMID: 23329592] [21] Narayanan S, Wilson K, Ogelsby A, Juneau P, Durden E. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States.",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1097/JOM.0000000000000008] [PMID: 24202242] [22] Satoh M, Chan EK, Ho LA, et al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1002/art.34380] [PMID: 22237992] [23] Meroni PL, Schur PH.",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
[http://dx.doi.org/10.1136/ard.2009.127100] [PMID: 20511607] [24] Suresh E. Systemic lupus erythematosus: diagnosis for the non-specialist.,Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.12968/hmed.2007.68.10.27324] [PMID: 17974296] [25] Hanly JG, Thompson K, McCurdy G, Fougere L, Theriault C, Wilton K. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1016/j.jim.2009.10.003] [PMID: 19836394] [26] Liu CC, Manzi S, Kao AH, Navratil JS, Ahearn JM.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1016/j.rdc.2009.12.003] [PMID: 20202597] [27] Kao AH, Navratil JS, Ruffing MJ, et al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1002/art.27267] [PMID: 20187154] [28] Kalunian  KC,  Chatham  WW,  Massarotti  EM,  et  al.",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1002/art.34669] [PMID: 22932861] [29] Yang DH, Chang DM, Lai JH, Lin FH, Chen CH.",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1093/rheumatology/kep161] [PMID: 19553377] [30] Putterman C, Furie R, Ramsey-Goldman R, et al.",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1136/lupus-2014-000056] [PMID: 25396070] [31] Askanase A, Hui-Yuen J, Conklin J, et al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1136/lupus-2015-000127] [PMID: 26870391] [33] Petri MA, van Vollenhoven RF, Buyon J, et al.",OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"[http://dx.doi.org/10.1002/art.37995] [PMID: 23754628] [34] Floris A, Piga M, Cauli A, Mathieu A. Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment.",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
[http://dx.doi.org/10.1016/j.autrev.2016.02.019] [PMID: 26921641] © Mossell et al.,OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/e0/TORJ-10-71.PMC5101629.pdf
[http://dx.doi.org/10.1146/annurev.neuro.24.1.897 ] [PMID: 11520922 ] [2] Domjan M. Pavlovian conditioning: a functional perspective.,Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
[http://dx.doi.org/10.1146/annurev.psych.55.090902.141409 ] [PMID: 15709933 ] [3] American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-5.,Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1056/NEJMoa040603 ] [PMID: 15229303 ] [5] Hoge CW, Terhakopian A, Castro CA, Messer SC, Engel CC.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1176/ajp.2007.164.1.150 ] [PMID: 17202557 ] [6] Milliken CS, Auchterlonie JL, Hoge CW.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1001/jama.298.18.2141 ] [PMID: 18000197 ] [7] Gates MA, Holowka DW, Vasterling JJ, Keane TM, Marx BP, Rosen RC.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1037/a0027649 ] [PMID: 23148803 ] [8] Hartley CA, Phelps EA.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1038/npp.2009.121 ] [PMID: 19710632 ] [9] Greco JA, Liberzon I. Neuroimaging of Fear-Associated Learning.",Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
[http://dx.doi.org/10.1038/npp.2015.255 ] [PMID: 26294108 ] [10] LeDoux J.,OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.cub.2007.08.005 ] [PMID: 17956742 ] [11] Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2008.11.015 ] [PMID: 19100329 ] [13] Lissek S, Bradford DE, Alvarez RP, et al.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1093/scan/nst096 ] [PMID: 23748500 ] [14] Gottfried JA, Dolan RJ.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
[http://dx.doi.org/10.1038/nn1314 ] [PMID: 15361879 ] [15] Phelps  EA.,Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.conb.2004.03.015 ] [PMID: 15082325 ] [16] Dunsmoor  JE,  Bandettini  PA,  Knight  DC.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2007.11.042 ] [PMID: 18203622 ] [17] Knight  DC,  Waters  NS,  King  MK,  Bandettini  PA.  Learning-related  diminution  of  unconditioned  SCR  and  fMRI  signal  responses.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2009.07.012 ] [PMID: 19616105 ] [18] Wood KH, Ver Hoef LW, Knight DC.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2011.12.048 ] [PMID: 22227141 ] [19] Hartley CA, Phelps EA.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
[http://dx.doi.org/10.1037/h0022977 ] [PMID: 5908829 ] [21] Kimmel E. Judgments of UCS intensity and diminution of the UCR in classical GSR conditioning.,Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1037/h0024333 ] [PMID: 6040088 ] [22] Marcos JL, Redondo J.",Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/S0301-0511(99)00007-1 ] [PMID: 10403199 ] [23] Wood KH, Kuykendall D, Ver Hoef LW, Knight DC.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.2174/1874440001307010041 ] [PMID: 24478811 ] [24] Wood KH, Wheelock MD, Shumen JR, Bowen KH, Ver Hoef LW, Knight DC.",Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2015.06.086 ] [PMID: 26149610 ] [25] Garfinkel SN, Abelson JL, King AP, et al.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.4287-13.2014 ] [PMID: 25274821 ] [26] Milad MR, Pitman RK, Ellis CB, et al.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1038/nrn3492 ] [PMID: 23635870 ] [28] Steiger F, Nees F, Wicking M, Lang S, Flor H. Behavioral and central correlates of contextual fear learning and contextual modulation of cued fear in posttraumatic stress disorder.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.ijpsycho.2015.06.009 ] [PMID: 26149734 ] [29] Gold AL, Morey RA, McCarthy G. Amygdala-prefrontal cortex functional connectivity during threat-induced anxiety and goal distraction.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.jad.2012.08.006 ] [PMID: 22910447 ] [31] van Wingen GA, Geuze E, Caan MW, et al.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1186/2045-5380-1-8 ] [PMID: 22738227 ] [33] Acheson DT, Geyer MA, Baker DG, Nievergelt CM, Yurgil K, Risbrough VB.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.psyneuen.2014.09.030 ] [PMID: 25444643 ] [34] Wheelock MD, Sreenivasan KR, Wood KH, Ver Hoef LW, Deshpande G, Knight DC.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2014.08.005 ] [PMID: 25111474 ] [35] Kim EJ, Pellman B, Kim JJ.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1101/lm.037291.114 ] [PMID: 26286651 ] [36] Dretsch MN, Thiel KJ, Athy JR, Born S, Prue-Owens K. Posttraumatic stress disorder in the U.S. Warfighter: Sensitivity to punishment and antidepressant use contribute to decision-making performance.",Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
[http://dx.doi.org/10.1177/1534765612455228 ] [37] Grillon C. Models and mechanisms of anxiety: evidence from startle studies.,Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1007/s00213-007-1019-1 ] [PMID: 18058089 ] [38] Alho K, Rinne T, Herron TJ, Woods DL.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.heares.2013.08.001 ] [PMID: 23938208 ] [39] Nazimek  JM,  Hunter  MD,  Hoskin  R,  Wilkinson  I,  Woodruff  PW.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.neuropsychologia.2013.07.019 ] [PMID: 23933483 ] [40] Morawetz C, Bode S, Baudewig J, Jacobs AM, Heekeren HR.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1002/hbm.23053 ] [PMID: 26537018 ] [41] Cornwell BR, Baas JM, Johnson L, et al.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2007.04.055 ] [PMID: 17566766 ] [42] Weathers FW, Blake DD, Schnurr PP, Kaloupek DG, Marx BP, Keane TM.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
Available from: http://www.ptsd.va.gov .,Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
Available from: http://www.ptsd.va.gov .,Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.7205/MILMED-D-12-00223 ] [PMID: 23707820 ] [45] King DW, King LA, Vogt DS.",Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
[http://dx.doi.org/10.1016/S0033-3182(71)71529-1 ] [PMID: 5172937 ] [47] Zung WW.,OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
[http://dx.doi.org/10.1016/S0033-3182(71)71479-0 ] [PMID: 5172928 ],OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
[http://dx.doi.org/10.1111/j.1360-0443.1993.tb02093.x ] [PMID: 8329970 ] [49] Johns MW.,OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
[http://dx.doi.org/10.3791/3083 ] [52] Cox RW.,Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1006/cbmr.1996.0014 ] [PMID: 8812068 ] [53] Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain.",Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.1315-04.2004 ] [PMID: 15306654 ] [55] Wiech K, Kalisch R, Weiskopf N, Pleger B, Stephan KE, Dolan RJ.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.2568-06.2006 ] [PMID: 17079679 ] [56] Kerr DL, McLaren DG, Mathy RM, Nitschke JB.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.3389/fpsyg.2012.00557 ] [PMID: 23550176 ] [57] Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1056/NEJMoa072972 ] [PMID: 18234750 ] [58] Hoge CW, Goldberg HM, Castro CA.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1056/NEJMp0810606 ] [PMID: 19369664 ] [59] Orsini CA, Kim JH, Knapska E, Maren S. Hippocampal and prefrontal projections to the basal amygdala mediate contextual regulation of fear after extinction.",Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.4095-11.2011 ] [PMID: 22114293 ] [60] Jin J, Maren S. Fear renewal preferentially activates ventral hippocampal neurons projecting to both amygdala and prefrontal cortex in rats.",Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1038/srep08388 ] [PMID: 25669753 ] [61] Giustino TF, Maren S. The Role of the Medial Prefrontal Cortex in the Conditioning and Extinction of Fear.",Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.3389/fnbeh.2015.00298 ] [PMID: 26617500 ] [62] Vasterling JJ, Proctor SP, Amoroso P, Kane R, Heeren T, White RF.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1001/jama.296.5.519 ] [PMID: 16882958 ] [63] Goodman AM, Katz JS, Dretsch MN.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1016/j.jbtep.2015.07.006 ] [PMID: 26255051 ] [64] Dretsch MN, Williams K, Emmerich T, et al.",OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1017/S0033291716000532 ] [PMID: 27348599 ] [66] Pile V, Barnhofer T, Wild J. Updating versus  exposure to prevent consolidation of conditioned fear.",Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
[http://dx.doi.org/10.1371/journal.pone.0122971 ] [PMID: 25902141 ] © Dretsch et al.,Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/17/TONIJ-10-111.PMC5101630.pdf
"[http://dx.doi.org/10.1086/591708] [PMID: 18710327] [2] Diavatopoulos DA, Short KR, Price JT, et al.",OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.1096/fj.09-146779] [PMID: 20097876] [3] Dhanoa A, Fang NC, Hassan SS, Kaniappan P, Rajasekaram G. Epidemiology and clinical characteristics of hospitalized patients with pandemic influenza A (H1N1) 2009 infections: the effects of bacterial coinfection.",Non-OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.1186/1743-422X-8-501] [PMID: 22050645] [4] Nelson GE, Gershman KA, Swerdlow DL, Beall BW, Moore MR. Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USA.",Non-OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.3201/eid1802.110714] [PMID: 22306234] [5] Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.",Non-OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
[http://dx.doi.org/10.4049/jimmunol.1201916] [PMID: 23028058] [7] Prevention of perinatal group B streptococcal disease: a public health perspective.,Non-OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.7326/0003-4819-123-6-199509150-00003] [PMID: 7639440] [9] Johri AK, Paoletti LC, Glaser P, et al.",OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.1038/nrmicro1552] [PMID: 17088932] [10] Suvorov A, Ustinovitch I, Meringova L, et al.",OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.1128/JB.184.22.6384-6386.2002] [PMID: 12399509] [13] Ustinovitch I, Vlasov G, Totolyan A, Suvorov A. Cloning and expression of gene fragment IgA-binding protein of group B streptococci.",OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.1007/BF02825670] [PMID: 11097034] [14] Kling DE, Gravekamp C, Madoff LC, Michel JL.",OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.1007/BF02931468] [PMID: 16110924] [17] Berry AM, Paton JC.",Non-OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.2217/17460913.4.2.201] [PMID: 19257847] [20] Desheva YA, Rudenko LG, Rekstin AR, Swayne DE, Cox NJ, Klimov AI.",OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.1371/journal.pone.0087962] [PMID: 24533064] [24] McHugh KJ, Mandalapu S, Kolls JK, Ross TM, Alcorn JF.",OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.1371/journal.pone.0082865] [PMID: 24324838] [25] Mina  MJ,  McCullers  JA,  Klugman  KP.",OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.1128/mBio.01040-13] [PMID: 24549845] [26] Kasper DL, Paoletti LC, Wessels MR, et al.",OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
[http://dx.doi.org/10.1172/JCI119042] [PMID: 8941648] © Desheva et al.,OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/2b/TOMICROJ-10-168.PMC5101632.pdf
"[http://dx.doi.org/10.1002/jor.21359 ] [PMID: 21520254 ] [2] Conrozier T, Mathieu P, Vignon E, Piperno M, Rinaudo M. Differences in the osteoarthritic synovial fluid composition and rheology between patients with or without flare: a pilot study.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1136/ard.2009.113100 ] [PMID: 19762361 ] [4] Schurz J, Ribitsch V. Rheology of synovial fluid.",OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.3810/pgm.2013.01.2618 ] [PMID: 23391675 ] [8] Zhang W, Moskowitz RW, Nuki G, et al.",OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1016/j.joca.2007.12.013 ] [PMID: 18279766 ] [9] Zhang W, Nuki G, Moskowitz RW, et al.",OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1016/j.joca.2010.01.013 ] [PMID: 20170770 ] [10] Langworthy MJ, Saad A, Langworthy NM.",OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.3810/psm.2010.06.1792 ] [PMID: 20631473 ] [11] Mathieu P, Conrozier T, Vignon E, Rozand Y, Rinaudo M. Rheologic behavior of osteoarthritic synovial fluid after addition of hyaluronic acid: a pilot study.",OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
[http://dx.doi.org/10.1007/s11999-009-0867-x ] [PMID: 19418104 ] [12] Moreland LW.,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1186/ar623 ] [PMID: 12718745 ] [13] Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent?",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1053/sarh.2002.33720 ] [PMID: 12219318 ] [14] Masuko K, Murata M, Yudoh K, Kato T, Nakamura H. Anti-inflammatory effects of hyaluronan in arthritis therapy: Not just for viscosity.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.2147/IJGM.S5495 ] [PMID: 20360891 ] [15] Bagga H, Burkhardt D, Sambrook P, March L. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
[PMID: 16652425 ] [16] Synvisc® (hylan G-F 20) Prescribing Information Genzyme Biosurgery Available at: http://www.synviscone.com/ .,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"Clinical Efficacy of Hylan The Open Rheumatology Journal, 2016, Volume 10    99 [http://dx.doi.org/10.1016/S0149-2918(98)80052-0 ] [PMID: 9663358 ] [18] Raynauld JP, Torrance GW, Band PA, et al.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1053/joca.2002.0798 ] [PMID: 12127830 ] [19] Wang CT, Lin J, Chang CJ, Lin YT, Hou SM.",OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1016/j.knee.2008.02.012 ] [PMID: 18430574 ] [21] Chevalier X, Jerosch J, Goupille P, et al.",OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1136/ard.2008.094623 ] [PMID: 19304567 ] [22] Scale D, Wobig M, Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1016/S0011-393X(05)80166-3 ] [23] Dickson DJ, Hosie G, English JR. A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1007/s10067-004-1043-z ] [PMID: 15599642 ] [25] Kotevoglu N, Iyibozkurt PC, Hiz O, Toktas H, Kuran B.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1007/s00296-005-0611-0 ] [PMID: 15959784 ] [26] Diracoglu D, Vural M, Baskent A, Dikici F, Aksoy C. The effect of viscosupplementation on neuromuscular control of the knee in patients with osteoarthritis.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.3233/BMR-2009-0207 ] [PMID: 20023357 ] [27] Chou CW, Lue KH, Lee HS, Lin RC, Lu KH.",OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1016/S0929-6646(09)60387-9 ] [PMID: 19666354 ] [28] Waddell DD, Cefalu CA, Bricker DC.",OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1185/030079903125002090 ] [PMID: 14594522 ] [29] Waddell DD, Bricker DC.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1185/030079905X56501 ] [PMID: 16083536 ] [31] Raynauld JP, Goldsmith CH, Bellamy N, et al.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1016/j.joca.2004.10.018 ] [PMID: 15694572 ] [32] Petrella RJ, Wakeford C. Pain relief and improved physical function in knee osteoarthritis patients receiving ongoing hylan G-F 20, a high- molecular-weight hyaluronan, versus other treatment options: data from a large real-world longitudinal cohort in Canada.",OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.2147/DDDT.S88473 ] [PMID: 26508838 ] [33] Pal S, Thuppal S, Reddy KJ, et al.",OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.2174/1874312901408010054 ] [PMID: 25328555 ] [34] Waddell DD, Bricker DC.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
[http://dx.doi.org/10.1016/S1063-4584(05)80013-5 ] [PMID: 8689457 ],OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
[http://dx.doi.org/10.18553/jmcp.2007.13.2.113 ] [PMID: 17330972 ] © Heger et al.,OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/TORJ-10-88.PMC5101633.pdf
"[http://dx.doi.org/10.1016/S1364-6613(98)01231-5 ] [PMID: 21227253 ] [2] Middleton FA, Strick PL.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.3880-04.2005 ] [PMID: 15930384 ] [4] Ullsperger M, von Cramon DY.",Non-OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1111/j.1460-9568.2005.04152.x ] [PMID: 15978024 ] [6] Bischoff-Grethe A, Hazeltine E, Bergren L, Ivry RB, Grafton ST.",Non-OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2008.08.038 ] [PMID: 18834944 ] [7] Marco-Pallarés J, Müller SV, Münte TF.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1097/WNR.0b013e3282e9a58c ] [PMID: 17712267 ] [8] Keitz M, Koerts J, Kortekaas R, Renken R, de Jong BM, Leenders KL.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1016/j.brainres.2008.07.110 ] [PMID: 18718454 ] [9] Seger CA, Cincotta CM.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1093/cercor/bhj092 ] [PMID: 16373455 ] [10] Haruno M, Kawato M. Different neural correlates of reward expectation and reward expectation error in the putamen and caudate nucleus during stimulus-action-reward association learning.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1152/jn.00382.2005 ] [PMID: 16192338 ] [11] Jocham G, Klein TA, Neumann J, von Cramon DY, Reuter M, Ullsperger M. Dopamine DRD2 polymorphism alters reversal learning and associated neural activity.",Non-OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.5195-08.2009 ] [PMID: 19321766 ] [12] Bechtereva NP, Gretchin VB.",Non-OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1016/S0074-7742(08)60392-X ] [PMID: 4887001 ] [13] Bechtereva NP, Shemyakina NV, Starchenko MG, Danko SG, Medvedev SV.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1016/j.ijpsycho.2005.06.005 ] [PMID: 16169106 ] [14] Ullsperger M, Danielmeier C, Jocham G. Neurophysiology of performance monitoring and adaptive behavior.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
[http://dx.doi.org/10.1152/physrev.00041.2012 ] [PMID: 24382883 ] [15] Haber SN.,OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
[http://dx.doi.org/10.1016/j.jchemneu.2003.10.003 ] [PMID: 14729134 ],OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.3286-05.2005 ] [PMID: 16354931 ] [17] Jocham G, Neumann J, Klein TA, Danielmeier C, Ullsperger M. Adaptive coding of action values in the human rostral cingulate zone.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.0349-09.2009 ] [PMID: 19515916 ] [18] Mueller VA, Brass M, Waszak F, Prinz W. The role of the preSMA and the rostral cingulate zone in internally selected actions.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2007.06.018 ] [PMID: 17681798 ] [19] Garrison J, Erdeniz B, Done J.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1016/j.neubiorev.2013.03.023 ] [PMID: 23567522 ] [20] Cincotta CM, Seger CA.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1162/jocn.2007.19.2.249 ] [PMID: 17280514 ] [21] Daniel R, Pollmann S. Comparing the neural basis of monetary reward and cognitive feedback during information-integration category learning.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.2205-09.2010 ] [PMID: 20053886 ] [22] Daniel R, Pollmann S. Striatal activations signal prediction errors on confidence in the absence of external feedback.",Non-OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2011.11.058 ] [PMID: 22146752 ] [23] Guggenmos M, Wilbertz G, Hebart MN, Sterzer P. Mesolimbic confidence signals guide perceptual learning in the absence of external feedback.",Non-OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.7554/eLife.13388 ] [PMID: 27021283 ] [24] Hollerman JR, Schultz W. Dopamine neurons report an error in the temporal prediction of reward during learning.",Non-OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
[http://dx.doi.org/10.1038/1124 ] [PMID: 10195164 ] [25] Schultz W. Behavioral theories and the neurophysiology of reward.,Non-OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1146/annurev.psych.56.091103.070229 ] [PMID: 16318590 ] [26] Daniel R, Pollmann S. A universal role of the ventral striatum in reward-based learning: evidence from human studies.",Non-OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1016/j.nlm.2014.05.002 ] [PMID: 24825620 ] [27] Lleras A, Von Mühlenen A. Spatial context and top-down strategies in visual search.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1163/1568568041920113 ] [PMID: 15559114 ] [28] Chun MM, Jiang Y. Contextual cueing: implicit learning and memory of visual context guides spatial attention.",Non-OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1006/cogp.1998.0681 ] [PMID: 9679076 ] [29] Jiang Y, Chun MM.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
[http://dx.doi.org/10.1080/713756001 ] [PMID: 11765735 ] [30] Brainard DH.,Non-OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1163/156856897X00357 ] [PMID: 9176952 ] [31] Haxby JV, Guntupalli JS, Connolly AC, et al.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
"[http://dx.doi.org/10.1016/j.neuron.2011.08.026 ] [PMID: 22017997 ] [32] Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM.",OADS,/arxiv_data1/oa_pdf/a3/99/TONIJ-10-126.PMC5101634.pdf
